updated December 15, 1997

Transcription

List of publications Jürgen Rehm, Ph.D.
-1–
updated February 2016
List of publications
1
2
3
4
5
6
articles and other contributions to peer-reviewed journals
monographs, edited books or journals
book chapters
book reviews, abstracts, short contributions, articles without peer review
final reports of research projects
presentations at meetings and conferences, webinars
Overall impact indicators:
•
more than 700 contributions to peer-reviewed journals, including high impact journals such as Lancet, BMJ, PLOS Medicine, JAMA
Psychiatry (formerly Archives of General Psychiatry), BMC Medicine, Journal of Hepatology, Canadian Medical Association Journal,
American Journal of Epidemiology, or International Journal of Epidemiology
•
overall h-index: 91 (since 2011: 70)
•
more than 48,000 citations (more than 5,000 per year after 2010, more than 9,000 in 2014 and more than 10,000 in 2015)
•
more than 500 presentations, most of them invited
1 Articles and other contributions to peer-reviewed journals
In press or accepted for publication:
775. Rehm, J., Larsen, E., Lewis-Laietmark, C., Gheorghe, P., Poznyak, V., Rekve, D., & Fleischmann, A. (2016). Estimation of unrecorded alcohol
consumption in low-, middle-, and high income economies for 2010. Alcoholism: Clinical and Experimental Research
774. Rehm, J., Anderson, P. Fischer, B., Gual, A., & Room, R. (2016). Substance use and marked reversals of population life expectancy.
Implications for policy. BMC Medicine.
773. Shuper, P.A., Joharchi, N., Irving, H., Fletcher, D., Kovacs, C., Loutfy, M.R., Walmsley, S.L., Wong, D., & Rehm, J. (in press). Differential
predictors of ART adherence among HIV monoinfected vs. HIV/HCV coinfected individuals. AIDS Care. doi: 10.1080/09540121.2016.1158396
772. Rehm, J., Roerecke, M., & Room, R. (2016). All-cause mortality risks for “moderate drinkers”: what are the implications for burden of disease
studies and low-risk drinking guidelines? Journal of Studies on Alcohol and Drugs
771. Rehm, J., Gmel, G., Sierra, C., & Gual, A. (2016). Reduction of mortality associated by a better detection of hypertension and alcohol problems
in primary health care in Spain. Adicciones
770. Shield, K.D., Kurdyak, P., Shuper, P., & Rehm, J. (in press). Disability and functioning of patients who use psychiatric hospital emergency
services. Journal of Clinical Psychiatry.
769. Aalto, M., Jula, A., Keinänen-Kiukaanniemi, S., Liira, H., Räsänen, K., Rehm, J., Syvänne, M., & Huttunen, J.K. (accepted). Alkoholin haitallinen
käyttö kohonneen verenpaineen aiheuttajana. Suomen Lääkärilehti.
published:
768. Trigo, J.M., Lagzdins, D., Rehm, J., Selby, P., Gamaleddin, I., Fischer, B., Barnes, A.J., Huestis, M.A., & Le Foll, B. (2016). Effects of fixed or selftitrated dosages of Sativex on cannabis withdrawal and cravings. Drug and Alcohol Dependence, doi: 10.1016/j.drugalcdep.2016.02.020.
[Epub ahead of print Feb 23] [PMID: 26925704]
767. Manthey, J., Gual, A., Jakubczyk, A., Pieper, L., Probst, C., Struzzo, P., Trapencieris, M., Wojnar, M. & Rehm, J. (2016). Alcohol use disorders
in Europe: a comparison of general population and primary health care prevalence rates. Journal of Substance Use
doi:10.3109/14659891.2015.1063719 [epub ahead of print: Jan 21]
766. Anderson, P., & Rehm, J. (2016). Evaluating alcohol industry action to reduce the harmful use of alcohol. Alcohol & Alcoholism. pii: agv139.
[Epub ahead of print Jan 11] [PMID: 26755639]
765. Popova, S., Lange, S., Shield, K.D., Mihic, A., Chudley, A.E., Mukherjee, R.A.S., Bekmuradov, D., & Rehm, J. (2016). Co-morbidity of Fetal
Alcohol Spectrum Disorder: A systematic literature review and metaanalysis. Lancet. doi: 10.1016/S0140-6736(15)01345-8. [epub ahead of
print: Jan 5] [PMID: 26777270]
http://dx.doi.org/10.1016/S0140-6736(15)01345-8
764. Barrio, P., Miquel, L., Moreno-España, J., Martínez, A., Ortega, L., Teixidor, L., Manthey, J., Rehm, J., & Gual, A. (2016). Alcohol in Primary
Care. Differential characteristics between alcohol-dependent patients who are receiving or not receiving treatment. El alcohol en atención
primaria. Características diferenciales entre los pacientes dependientes del alcohol que han solicitado o no tratamiento. Adicciones, [epub
ahead of print: March] doi: 10.20882/adicciones.779
763. Fischer, B., Kurdyak, P., Goldner, E., Tyndall, M., & Rehm, J. (2016). Treatment of prescription opioid disorders in Canada: looking at the ‘other
epidemic’? Substance Abuse Treatment, Prevention, and Policy, 11(1), 12. doi: 10.1186/s13011-016-0055-4. [PMID: 26952717]
762. Odlaug, B.L., Gual, A., DeCourcy, J., Perry, R., Pike, J., Heron, L., & Rehm, J. (2016). Alcohol dependence, co-occurring conditions and
attributable burden. Alcohol and Alcoholism, 51(2), 201-209. doi: 10.1093/alcalc/agv088. [PMID: 26246514]
761. Praud, D., Rota, M., Rehm, J., Shield, K.D., Zatoński, W., Hashibe, M., La Vecchia, C., & Boffetta, P. (2016). Cancer incidence and mortality
attributable to alcohol consumption. International Journal of Cancer 138(6), 1380-1387. doi: 10.1002/ijc.29890. [PMID: 26455822]
-2–
760. Fischer, B., Imtiaz, S., Rudzinski, K., & Rehm, J. (2016). Crude estimates of cannabis-attributable mortality and morbidity in Canada–
implications for public health focused intervention priorities. Journal of Public Health, 38(1). 183-188. doi:10.1093/pubmed/fdv005 [PMID:
25630540]
759. Marmet, S., Rehm, J., & Gmel, G. (2016). The importance of age groups in estimates of alcohol-attributable mortality: impact on trends in
Switzerland between 1997 and 2011. Addiction, 111(2), 255–262. doi: 10.1111/add.13164. [PMID: 26360121]
758. Gual, A., Zarco, J., Colom, J.F., & Rehm, J., for the Grupo para el Estudio de la Hipertensión y Trastorno por Consumo de Alcohol (2016).
Cribado precoz e intervención breve en el consumo perjudicial de alcohol para mejorar el tratamiento de la hipertensión arterial en atención
primaria. Medicina Clinica, 146(2), 81–85. doi: 10.1016/j.medcli.2015.07.014. [PMID: 26520609]
[Early screening and brief intervention in alcohol misuse to improve the treatment of hypertension in primary care]
757. Shuper, P.A., Joharchi, N., & Rehm, J. (2016). Protocol for a controlled experiment to identify the causal role of acute alcohol consumption in
condomless sex among HIV-positive MSM: study procedures, ethical considerations, and implications for HIV prevention. AIDS and Behavior,
20(Suppl 1), 173-84. doi: 10.1007/s10461-015-1128-5 [PMID: 26163147]
756. Ferreira-Borges, C., Rehm, J., Dias, S., Babor, T., & Parry, C.D. (2016). The impact of alcohol consumption on African people in 2012: an
analysis of burden of disease. Tropical Medicine & International Health, 21(1), 52-60. doi: 10.1111/tmi.12618. [PMID: 26448195]
755. De Oliveira, C., Cheng, J., Vigod, S., Rehm, J., & Kurdyak, P. (2016). Patients with high mental health costs incur over 30 percent more costs
than other high-cost patients. Health Affairs, 35(1), 36-43. doi:10.1377/hlthaff.2015.0278 [PMID: 26733699]
754. Rehm, J., & Room, R. (2015). Cultural specificity in alcohol use disorders. Lancet. [Epub ahead of print Sep 3] doi: 10.1016/S01406736(15)00123-3 [PMID: 26343842]
753. Shield, K.D., Monteiro, M., Roerecke, M., Smith, B., & Rehm, J. (2015). Alcohol consumption and burden of disease in the Americas in 2012:
implications for alcohol policy. Pan American Journal of Public Health/Rev Panam Salud Publica, 38(6), 442-449.
http://iris.paho.org/xmlui/bitstream/handle/123456789/18558/v38n6a2_442-449.pdf?sequence=1&isAllowed=y
752. Collart, F., de Timary, P., Dom, G., Dor, B.D., Duprez, D., Lengelé, J.-P., Matthys, F., Peuskens, H., Rehm, J., & Stärkel, P. (2015). Alcoholinduced hypertension: an important healthcare target in Belgium. Acta Clinica Belgica: International Journal of Clinical and Laboratory
Medicine, 70(6), 389-395 doi: 10.1179/2295333715Y.0000000039. [PMID: 26135944]
751. Feingold, D., Weiser, M., Rehm, J., & Lev-Ran, S. (2015). The association between cannabis use and anxiety disorders: results from a
population-based representative sample. European Neuropsychopharmacology [Epub ahead of print Dec 29] doi:
10.1016/j.euroneuro.2015.12.037 [PMID: 26775742]
750. Luquiens, A., Whalley, D., Laramée, P., Falissard, B., Kostogianni, N., Rehm, J., Manthey, J., Paille, F., & Aubin, H.J. (2015). Validation of a new
patient-reported outcome instrument of health-related quality of life specific to patients with alcohol use disorder: the Alcohol Quality of Life
Scale (AQoLS). Quality of Life Research, doi: 10.1007/s11136-015-1190-5 [Epub ahead of print Nov 20] [PMID: 26589528]
749. Sornpaisarn, B., Shield, K.D., Cohen J.E., Schwartz, R., & Rehm, J. (2015). The association between taxation increases and changes in alcohol
consumption and traffic fatalities in Thailand. Journal of Public Health, doi: 10.1093/pubmed/fdv163. [Epub ahead of print Nov 20] [PMID:
26590388].
748. Samokhvalov, A.V., Rehm, J., & Roerecke, M. (2015). Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic
review and a series of meta-analyses. EBioMedicine, 2(12), 1996–2002. doi:10.1016/j.ebiom.2015.11.023. [PMID: 26844279]
747. Imtiaz, S., Shield, K.D., Roerecke, M., Cheng, J., Popova, S., Kurdyak, P., Fischer, B., & Rehm, J. (2015). The burden of disease attributable to
cannabis use in Canada in 2012. Addiction, doi: 10.1111/add.13237. [Epub ahead of print Nov 24] [PMID: 26598973]
746. Rehm, J., Anderson, P., Manthey, J., Shield, K.D., Struzzo, P., Wojnar, M., & Gual, A. (2015). Alcohol use disorders in primary health care –
what do we know and where do we go? Alcohol and Alcoholism doi: 10.1093/alcalc/agv127 [epub ahead of print Nov 15] [PMID: 26574600]
745. Ogeil, R.P., Gao, C.X., Rehm, J., Gmel, G., & Lloyd, B. (2015). Temporal changes in alcohol-related mortality and morbidity in Australia.
Addiction, doi: 10.1111/add.13213. [Epub ahead of print Oct 24] [PMID: 26498429]
744. Rahhali, N., Millier, A., Briquet, B., Laramée, P., Aballéa, S., Toumi, M., François, C., Rehm, J., & Daeppen, J.-B. (2015). Modelling the
consequences of a reduction in alcohol consumption among patients with alcohol dependence based on real-life observational data. BMC
Public Health, 15(1), 271. doi: 10.1186/s12889-015-2606-4 [PMID: 26690081]
743. Feingold, D., Fox, J., Rehm, J., & Lev-Ran, S. (2015). Natural outcome of cannabis use disorder: a three-year longitudinal follow-up. Addiction,
110(12), 1963-1974. .. doi: 10.1111/add.13071. [PMID: 26212076]
742. Kontis, V., Mathers, C.D., Bonita, R., Stevens, G.A., Rehm, J., Shield, K.D., Riley, L.M., Poznyak, V., Jabbour, S., Madanlal Garg, R., Hennis, A.,
Fouad, H.M., Beaglehole, R. & Ezzati, M. (2015). Regional contributions of six preventable risk factors to achieving the 25×25 noncommunicable disease mortality reduction target: a modelling study. Lancet Global Health, 3(12), e746-e757. doi: 10.1016/S2214109X(15)00179-5. [PMID: 26497599]
741. Jakubczyk, A., Rehm, J., Manthey, J., Gual, A., & Marcin, W. (2015). Czy lekarze Podstawowej Opieki Zdrowotnej rozpoznają u swoich
pacjentów uzależnienie od alkoholu? Polskie wyniki europejskiego projektu badawczego APC. Alkoholizm i Narkomania (Alcoholism and Drug
Addiction), 28(3), 163–171. doi:10.1016/j.alkona.2015.06.005
[Do general practitioners recognize alcohol dependence? Polish results of the European APC study]
740. Samokhvalov, A.V., & Rehm, J. (2015). Opioid-induced constipation reversal in response to placebo in a patient with a history of IBS receiving
methadone maintenance therapy. BMJ Case Reports. Published online: Nov 13, 15. doi: 10.1136/bcr-2015-211954 [PMID: 26567239]
739. Kimber, M., Rehm, J., & Ferro, M.A. (2015). Measurement invariance of the WHODAS 2.0 in a population-based sample of youth. PLoS ONE
10(11), e0142385. doi:10.1371/journal.pone.0142385 [PMID: 26565410]
738. Rehm, J. (2015). Commentary on Cherpitel et al. (2015): improving global estimates of alcohol-attributable injury. Addiction, 110(11), 1733–
1734. doi: 10.1111/add.13138
737. Rehm, J., Manthey, J., Struzzo, P., Gual, A., & Wojnar, M. (2015). Who receives treatment for alcohol use disorders in the European Union? A
cross-sectional representative study in primary and specialized health care. European Psychiatry, 30(8), 885-893. doi:
10.1016/j.eurpsy.2015.07.012 [PMID: 26647862]
-3–
http://dx.doi.org/10.1016/j.eurpsy.2015.07.012
736. Roerecke, M., Sørensen, P., Laramée, P., & Rehm, J. (2015). Clinical relevance of nalmefene versus placebo in alcohol treatment: reduction in
mortality risk. Journal of Psychopharmacology, 29(11), 1152-1158. doi: 10.1177/0269881115602487 [PMID: 26349557]
735. Sornpaisarn, B., Kaewmungkun, C., & Rehm, J. (2015). Assessing patterns of alcohol taxes produced by various types of excise tax methods - a
simulation study. Alcohol and Alcoholism, 50(6), 639-646. doi: 10.1093/alcalc/agv065 [PMID: 26094246]
734. Popova, S., Lange, S., Burd, L., & Rehm, J. (2015). The economic burden of Fetal Alcohol Spectrum Disorder in Canada in 2013. Alcohol and
Alcoholism, [Epub ahead of print Oct 21] [PMID: 26493100]
http://dx.doi.org/10.1093/alcalc/agv117
733. Miquel, L., Barrio, P., Moreno-España, J., Ortega, L., Manthey, J., Rehm, J., & Gual, A. (2015). Detección y prevalencia del trastorno por uso de
alcohol en los centros de atención primaria de Cataluña. Atención Primaria. doi: 10.1016/j.aprim.2015.04.006. [Epub ahead of print Oct 5]
[PMID: 26455328]
[Detection and prevalence of alcohol use disorders in primary health care in Catalonia]
732. Sornpaisarn, B., Shield, K.D., Cohen, J.E., Schwartz, R. & Rehm, J. (2015). Can pricing deter adolescents and young adults from starting to drink:
an analysis of the effect of alcohol taxation on drinking initiation among Thai adolescents and young adults. Journal of Epidemiology and
Global Health, 5(4 Suppl 1), S45-S57. doi: 10.1016/j.jegh.2015.05.004. PMID: 26079927
731. GBD 2013 Risk Factors Collaborators (Forouzanfar, M.H., Alexander, L., Anderson, H.R., Bachman, V.F., Biryukov, S., Brauer, M., Burnett, R.,
Casey, D., Coates, M.M., Cohen, A., Delwiche, K., Estep, K., Frostad, J.J., Kc, A., Kyu, H.H., Moradi-Lakeh, M., Ng, M., Slepak, E.L., Thomas, B.A.,
Wagner, J., Aasvang, G.M., Abbafati, C., Ozgoren, A.A., Abd-Allah, F., Abera, S.F., Aboyans, V., Abraham, B., Abraham, J.P., Abubakar, I., AbuRmeileh, N.M.E., Aburto, T.C., Achoki, T., Adelekan, A., Adofo, K., Adou, A.K., Adsuar, J.C., Afshin, A., Agardh, E.E., Al Khabouri, M.J., Al Lami,
F.H., Alam, S.S., Alasfoor, D., Albittar, M.I., Alegretti, M.A., Aleman, A.V., Alemu, Z.A., Alfonso-Cristancho, R., Alhabib, S., Ali, R., Ali, M.K., Alla,
F., Allebeck, P., Allen, P.J., Alsharif, U., Alvarez, E., Alvis-Guzman, N., Amankwaa, A.A., Amare, A.T., Ameh, E.A., Ameli, O., Amini, H., Ammar,
W., Anderson, B.O., Antonio, C.a.T., Anwari, P., Cunningham, S.A., Arnlöv, J., Arsenijevic, V.S.A., Artaman, A., Asghar, R.J., Assadi, R., Atkins,
L.S., Atkinson, C., Avila, M.A., Awuah, B., Badawi, A., Bahit, M.C., Bakfalouni, T., Balakrishnan, K., Balalla, S., Balu, R.K., Banerjee, A., Barber,
R.M., Barker-Collo, S.L., Barquera, S., Barregard, L., Barrero, L.H., Barrientos-Gutierrez, T., Basto-Abreu, A.C., Basu, A., Basu, S., Basulaiman,
M.O., Ruvalcaba, C.B., Beardsley, J., Bedi, N., Bekele, T., Bell, M.L., Benjet, C., Bennett, D.A., Benzian, H., Bernabé, E., Beyene, T.J., Bhala, N.,
Bhalla, A., Bhutta, Z.A., Bikbov, B., Abdulhak, A.a.B., Blore, J.D., Blyth, F.M., Bohensky, M.A., Başara, B.B., Borges, G., Bornstein, N.M., Bose, D.,
Boufous, S., Bourne, R.R., Brainin, M., Brazinova, A., Breitborde, N.J., Brenner, H., Briggs, A.D.M., Broday, D.M., Brooks, P.M., Bruce, N.G.,
Brugha, T.S., Brunekreef, B., Buchbinder, R., Bui, L.N., Bukhman, G., Bulloch, A.G., Burch, M., Burney, P.G.J., Campos-Nonato, I.R., Campuzano,
J.C., Cantoral, A.J., Caravanos, J., Cárdenas, R., Cardis, E., Carpenter, D.O., Caso, V., Castañeda-Orjuela, C.A., Castro, R.E., Catalá-López, F.,
Cavalleri, F., Çavlin, A., Chadha, V.K., Chang, J.-C., Charlson, F.J., Chen, H., Chen, W., Chen, Z., Chiang, P.P., Chimed-Ochir, O., Chowdhury, R.,
Christophi, C.A., Chuang, T.-W., Chugh, S.S., Cirillo, M., Claßen, T.K.D., Colistro, V., Colomar, M., Colquhoun, S.M., Contreras, A.G., Cooper, C.,
Cooperrider, K., Cooper, L.T., Coresh, J., Courville, K.J., Criqui, M.H., Cuevas-Nasu, L., Damsere-Derry, J., Danawi, H., Dandona, L., Dandona, R.,
Dargan, P.I., Davis, A., Davitoiu, D.V., Dayama, A., De Castro, E.F., De La Cruz-Góngora, V., De Leo, D., De Lima, G., Degenhardt, L., Del PozoCruz, B., Dellavalle, R.P., Deribe, K., Derrett, S., Jarlais, D.C.D., Dessalegn, M., Deveber, G.A., Devries, K.M., Dharmaratne, S.D., Dherani, M.K.,
Dicker, D., Ding, E.L., Dokova, K., Dorsey, E.R., Driscoll, T.R., Duan, L., Durrani, A.M., Ebel, B.E., Ellenbogen, R.G., Elshrek, Y.M., Endres, M.,
Ermakov, S.P., Erskine, H.E., Eshrati, B., Esteghamati, A., Fahimi, S., Faraon, E.J.A., Farzadfar, F., Fay, D.F.J., Feigin, V.L., Feigl, A.B.,
Fereshtehnejad, S.-M., Ferrari, A.J., Ferri, C.P., Flaxman, A.D., Fleming, T.D., Foigt, N., Foreman, K.J., Paleo, U.F., Franklin, R.C., Gabbe, B.,
Gaffikin, L., Gakidou, E., Gamkrelidze, A., Gankpé, F.G., Gansevoort, R.T., García-Guerra, F.A., Gasana, E., Geleijnse, J.M., Gessner, B.D.,
Gething, P., Gibney, K.B., Gillum, R.F., Ginawi, I.a.M., Giroud, M., Giussani, G., Goenka, S., Goginashvili, K., Dantes, H.G., Gona, P., De Cosio,
T.G., González-Castell, D., Gotay, C.C., Goto, A., Gouda, H.N., Guerrant, R.L., Gugnani, H.C., Guillemin, F., Gunnell, D., Gupta, R., Gupta, R.,
Gutiérrez, R.A., Hafezi-Nejad, N., Hagan, H., Hagstromer, M., Halasa, Y.A., Hamadeh, R.R., Hammami, M., Hankey, G.J., Hao, Y., Harb, H.L.,
Haregu, T.N., Haro, J.M., Havmoeller, R., Hay, S.I., Hedayati, M.T., Heredia-Pi, I.B., Hernandez, L., Heuton, K.R., Heydarpour, P., Hijar, M., Hoek,
H.W., Hoffman, H.J., Hornberger, J.C., Hosgood, H.D., Hoy, D.G., Hsairi, M., Hu, G., Hu, H., Huang, C., Huang, J.J., Hubbell, B.J., Huiart, L.,
Husseini, A., Iannarone, M.L., Iburg, K.M., Idrisov, B.T., Ikeda, N., Innos, K., Inoue, M., Islami, F., Ismayilova, S., Jacobsen, K.H., Jansen, H.A.,
Jarvis, D.L., Jassal, S.K., Jauregui, A., Jayaraman, S., Jeemon, P., Jensen, P.N., Jha, V., Jiang, F., Jiang, G., Jiang, Y., Jonas, J.B., Juel, K., Kan, H.,
Roseline, S.S.K., Karam, N.E., Karch, A., Karema, C.K., Karthikeyan, G., Kaul, A., Kawakami, N., Kazi, D.S., Kemp, A.H., Kengne, A.P., Keren, A.,
Khader, Y.S., Khalifa, S.E.a.H., Khan, E.A., Khang, Y.-H., Khatibzadeh, S., Khonelidze, I., Kieling, C., Kim, D., Kim, S., Kim, Y., Kimokoti, R.W.,
Kinfu, Y., Kinge, J.M., Kissela, B.M., Kivipelto, M., Knibbs, L.D., Knudsen, A.K., Kokubo, Y., Kose, M.R., Kosen, S., Kraemer, A., Kravchenko, M.,
Krishnaswami, S., Kromhout, H., Ku, T., Defo, B.K., Bicer, B.K., Kuipers, E.J., Kulkarni, C., Kulkarni, V.S., Kumar, G.A., Kwan, G.F., Lai, T., Balaji,
A.L., Lalloo, R., Lallukka, T., Lam, H., Lan, Q., Lansingh, V.C., Larson, H.J., Larsson, A., Laryea, D.O., Lavados, P.M., Lawrynowicz, A.E., Leasher,
J.L., Lee, J.-T., Leigh, J., Leung, R., Levi, M., Li, Y., Li, Y., Liang, J., Liang, X., Lim, S.S., Lindsay, M.P., Lipshultz, S.E., Liu, S., Liu, Y., Lloyd, B.K.,
Logroscino, G., London, S.J., Lopez, N., Lortet-Tieulent, J., Lotufo, P.A., Lozano, R., Lunevicius, R., Ma, J., Ma, S., Machado, V.M.P., Macintyre,
M.F., Magis-Rodriguez, C., Mahdi, A.A., Majdan, M., Malekzadeh, R., Mangalam, S., Mapoma, C.C., Marape, M., Marcenes, W., Margolis, D.J.,
Margono, C., Marks, G.B., Martin, R.V., Marzan, M.B., Mashal, M.T., Masiye, F., Mason-Jones, A.J., Matsushita, K., Matzopoulos, R., Mayosi,
B.M., Mazorodze, T.T., Mckay, A.C., Mckee, M., Mclain, A., Meaney, P.A., Medina, C., Mehndiratta, M.M., Mejia-Rodriguez, F., Mekonnen, W.,
Melaku, Y.A., Meltzer, M., Memish, Z.A., Mendoza, W., Mensah, G.A., Meretoja, A., Mhimbira, F.A., Micha, R., Miller, T.R., Mills, E.J.,
Misganaw, A., Mishra, S., Ibrahim, N.M., Mohammad, K.A., Mokdad, A.H., Mola, G.L., Monasta, L., Hernandez, J.C.M., Montico, M., Moore,
A.R., Morawska, L., Mori, R., Moschandreas, J., Moturi, W.N., Mozaffarian, D., Mueller, U.O., Mukaigawara, M., Mullany, E.C., Murthy, K.S.,
Naghavi, M., Nahas, Z., Naheed, A., Naidoo, K.S., Naldi, L., Nand, D., Nangia, V., Narayan, K.M.V., Nash, D., Neal, B., Nejjari, C., Neupane, S.P.,
Newton, C.R., Ngalesoni, F.N., De Dieu Ngirabega, J., Nguyen, G., Nguyen, N.T., Nieuwenhuijsen, M.J., Nisar, M.I., Nogueira, J.R., Nolla, J.M.,
Nolte, S., Norheim, O.F., Norman, R.E., Norrving, B., Nyakarahuka, L., Oh, I.-H., Ohkubo, T., Olusanya, B.O., Omer, S.B., Opio, J.N., Orozco, R.,
Pagcatipunan, R.S., Jr., Pain, A.W., Pandian, J.D., Panelo, C.I.A., Papachristou, C., Park, E.-K., Parry, C.D., Caicedo, A.J.P., Patten, S.B., Paul, V.K.,
Pavlin, B.I., Pearce, N., Pedraza, L.S., Pedroza, A., Stokic, L.P., Pekericli, A., Pereira, D.M., Perez-Padilla, R., Perez-Ruiz, F., Perico, N., Perry,
S.a.L., Pervaiz, A., Pesudovs, K., Peterson, C.B., Petzold, M., Phillips, M.R., Phua, H.P., Plass, D., Poenaru, D., Polanczyk, G.V., Polinder, S., Pond,
C.D., Pope, C.A., Pope, D., Popova, S., Pourmalek, F., Powles, J., Prabhakaran, D., Prasad, N.M., Qato, D.M., Quezada, A.D., Quistberg, D.a.A.,
Racapé, L., Rafay, A., Rahimi, K., Rahimi-Movaghar, V., Rahman, S.U., Raju, M., Rakovac, I., Rana, S.M., Rao, M., Razavi, H., Reddy, K.S., Refaat,
A.H., Rehm, J., Remuzzi, G., Ribeiro, A.L., Riccio, P.M., Richardson, L., Riederer, A., Robinson, M., Roca, A., Rodriguez, A., Rojas-Rueda, D.,
Romieu, I., Ronfani, L., Room, R., Roy, N., Ruhago, G.M., Rushton, L., Sabin, N., Sacco, R.L., Saha, S., Sahathevan, R., Sahraian, M.A., Salomon,
730.
729.
728.
727.
726.
725.
724.
723.
722
721.
720.
719.
-4–
J.A., Salvo, D., Sampson, U.K., Sanabria, J.R., Sanchez, L.M., Sánchez-Pimienta, T.G., Sanchez-Riera, L., Sandar, L., Santos, I.S., Sapkota, A.,
Satpathy, M., Saunders, J.E., Sawhney, M., Saylan, M.I., Scarborough, P., Schmidt, J.C., Schneider, I.J.C., Schöttker, B., Schwebel, D.C., Scott,
J.G., Seedat, S., Sepanlou, S.G., Serdar, B., Servan-Mori, E.E., Shaddick, G., Shahraz, S., Levy, T.S., Shangguan, S., She, J., Sheikhbahaei, S.,
Shibuya, K., Shin, H.H., Shinohara, Y., Shiri, R., Shishani, K., Shiue, I., Sigfusdottir, I.D., Silberberg, D.H., Simard, E.P., Sindi, S., Singh, A., Singh,
G.M., Singh, J.A., Skirbekk, V., Sliwa, K., Soljak, M., Soneji, S., Søreide, K., Soshnikov, S., Sposato, L.A., Sreeramareddy, C.T., Stapelberg, N.J.C.,
Stathopoulou, V., Steckling, N., Stein, D.J., Stein, M.B., Stephens, N., Stöckl, H., Straif, K., Stroumpoulis, K., Sturua, L., Sunguya, B.F.,
Swaminathan, S., Swaroop, M., Sykes, B.L., Tabb, K.M., Takahashi, K., Talongwa, R.T., Tandon, N., Tanne, D., Tanner, M., Tavakkoli, M., Te Ao,
B.J., Teixeira, C.M., Téllez Rojo, M.M., Terkawi, A.S., Texcalac-Sangrador, J.L., Thackway, S.V., Thomson, B., Thorne-Lyman, A.L., Thrift, A.G.,
Thurston, G.D., Tillmann, T., Tobollik, M., Tonelli, M., Topouzis, F., Towbin, J.A., Toyoshima, H., Traebert, J., Tran, B.X., Trasande, L., Trillini, M.,
Trujillo, U., Dimbuene, Z.T., Tsilimbaris, M., Tuzcu, E.M., Uchendu, U.S., Ukwaja, K.N., Uzun, S.B., Van De Vijver, S., Van Dingenen, R., Van
Gool, C.H., Van Os, J., Varakin, Y.Y., Vasankari, T.J., Vasconcelos, A.M.N., Vavilala, M.S., Veerman, L.J., Velasquez-Melendez, G.,
Venketasubramanian, N., Vijayakumar, L., Villalpando, S., Violante, F.S., Vlassov, V.V., Vollset, S.E., Wagner, G.R., Waller, S.G., Wallin, M.T.,
Wan, X., Wang, H., Wang, J., Wang, L., Wang, W., Wang, Y., Warouw, T.S., Watts, C.H., Weichenthal, S., Weiderpass, E., Weintraub, R.G.,
Werdecker, A., Wessells, K.R., Westerman, R., Whiteford, H.A., Wilkinson, J.D., Williams, H.C., Williams, T.N., Woldeyohannes, S.M., Wolfe,
C.D.A., Wong, J.Q., Woolf, A.D., Wright, J.L., Wurtz, B., Xu, G., Yan, L.L., Yang, G., Yano, Y., Ye, P., Yenesew, M., Yentür, G.K., Yip, P., Yonemoto,
N., Yoon, S.-J., Younis, M.Z., Younoussi, Z., Yu, C., Zaki, M.E., Zhao, Y., Zheng, Y., Zhou, M., Zhu, J., Zhu, S., Zou, X., Zunt, J.R., Lopez, A.D., Vos,
T.& Murray, C.J.) (2015). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and
metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet,
386(10010), 2227-2364. e46-e55 doi: 10.1016/S0140-6736(15)00128-2. [PMID: 26364544]
.Aspis, I., Feingold, D., Weiser, M., Rehm, J., Shoval, G., & Lev-Ran, S. (2015). Cannabis use and mental health-related quality of life among
individuals with depressive disorders. Psychiatry Research, 230(2), 341-349. doi:10.1016/j.psychres.2015.09.014 [PMID: 26388103]
Laramée, P., Leonard, S., Buchanan-Hughes, A., Warnakula, S., Daeppen, J.-B., Rehm (2015). Risk of all-cause mortality in alcohol-dependent
individuals: a systematic literature review and meta-analysis. EBioMedicine, 2(10), 1394–1404. doi: 10.1016/j.ebiom.2015.08.040 [PMID:
26629534]
http://dx.doi.org/10.1016/j.ebiom.2015.08.040
Laramée, P., Leonard, S., Buchanan-Hughes, A., Warnakula, S., Daeppen, J.-B., Rehm (2015). Alcohol dependence and mortality: implications
for treatment – Authors' reply. EBioMedicine, 2(10), 1283. doi:10.1016/j.ebiom.2015.09.032 [PMID: 26629509]
Lange, S., Probst, C., Quere, M., Rehm, J., & Popova, S. (2015). Alcohol use, smoking and their co-occurrence during pregnancy among
Canadian women, 2003 to 2011/12. Addictive Behaviors, 50, 102–109.-doi:10.1016/j.addbeh.2015.06.018 [PMID: 26117214]
Lange, S., Quere, M., Shield, K.D., Rehm, J., & Popova, S. (2015). Alcohol use and self-perceived mental health status among pregnant and
breastfeeding women in Canada: a secondary data analysis. BJOG: An International Journal of Obstetrics & Gynaecology. doi: 10.1111/14710528.13525. [Epub ahead of print Sep 6] [PMID: 26344418]
Manthey, J., Probst, C., Hanschmidt, F., & Rehm, J. (2015). Identification of smokers, drinkers and risky drinkers by general practitioners.
Drug and Alcohol Dependence, 154, 93-99. doi: 10.1016/j.drugalcdep.2015.06.017. [PMID: 26130336]
Ilie, G., Mann, R.E., Hamilton, H., Adlaf, E.M., Boak, A., Asbridge, M., Rehm, J., & Cusimano, M.D. (2015). Substance use and related harms
among adolescents with and without traumatic brain injury. Journal of Head Trauma Rehabilitation, 30(5), 293-301. doi:
10.1097/HTR.0000000000000101 [PMID: 25427256]
Ilie, G., Boak, A., Mann, R.E., Adlaf, E.M., Hamilton, H., Asbridge, M., Rehm, J., & Cusimano, M.D. (2015). Energy drinks, alcohol, sports and
traumatic brain injuries among adolescents. PLoS One, 10(9), e0135860. doi: 10.1371/journal.pone.0135860. [PMID: 26375286]
Ilie, G., Vingilis, E.R., Mann, R.E., Hamilton, H., Toplak, M., Adlaf, E.M., Kolla, N., Ialomiteanu, A., van der Mass, M., Asbridge, M., VingilisJaremko, L., Rehm, J., & Cusimano, M.D. (2015). The association between traumatic brain injury and ADHD in a Canadian adult sample.
Journal of Psychiatric Research, 69, 174-179. doi: 10.1016/j.jpsychires.2015.08.004. [PMID: 26343610].
Rehm, J., & Poznyak, V. (2015). On monitoring unrecorded alcohol consumption. Alkoholizm i Narkomania (Alcoholism and Drug Addiction),
28(2), 79–89. doi:10.1016/j.alkona.2015.06.003.
Popova, S., Lange, S., Burd, L., & Rehm, J. (2015). Cost attributable to FASD in the Canadian correctional system. International Journal of Law
and Psychiatry, 41(July-August), 76-81.. doi:10.1016/j.ijlp.2015.03.010. [PMID: 25846557]
http://www.sciencedirect.com/science/article/pii/S0160252715000497
Global Burden of Disease Study 2013 Collaborators (Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F.,
Davis, A., Degenhardt, L., Dicker, D., Duan, L., Erskine, H., Feigin, V. L., Ferrari, A. J., Fitzmaurice, C., Fleming, T., Graetz, N., Guinovart, C.,
Haagsma, J., Hansen, G. M., Hanson, S. W., Heuton, K. R., Higashi, H., Kassebaum, N., Kyu, H., Laurie, E., Liang, X., Lofgren, K., Lozano, R.,
Macintyre, M. F., Moradi-Lakeh, M., Naghavi, M., Nguyen, G., Odell, S., Ortblad, K., Roberts, D. A., Roth, G. A., Sandar, L., Serina, P. T.,
Stanaway, J. D., Steiner, C., Thomas, B., Vollset, S. E., Whiteford, H., Wolock, T. M., Ye, P., Zhou, M., Ãvila, M. A., Aasvang, G. M., Abbafati, C.,
Ozgoren, A. A., Abd-Allah, F., Aziz, M. I. A., Abera, S. F., Aboyans, V., Abraham, J. P., Abraham, B., Abubakar, I., Abu-Raddad, L. J., Abu-Rmeileh,
N. M. E., Aburto, T. C., Achoki, T., Ackerman, I. N., Adelekan, A., Ademi, Z., Adou, A. K., Adsuar, J. C., Arnlov, J., Agardh, E. E., Al Khabouri, M. J.,
Alam, S. S., Alasfoor, D., Albittar, M. I., Alegretti, M. A., Aleman, A. V., Alemu, Z. A., Alfonso-Cristancho, R., Alhabib, S., Ali, R., Alla, F., Allebeck,
P., Allen, P. J., Almazroa, M. A., Alsharif, U., Alvarez, E., Alvis-Guzman, N., Ameli, O., Amini, H., Ammar, W., Anderson, B. O., Anderson, H. R.,
Antonio, C. a. T., Anwari, P., Apfel, H., Arsenijevic, V. S. A., Artaman, A., Asghar, R. J., Assadi, R., Atkins, L. S., Atkinson, C., Badawi, A., Bahit, M.
C., Bakfalouni, T., Balakrishnan, K., Balalla, S., Banerjee, A., Barker-Collo, S. L., Barquera, S., Barregard, L., Barrero, L. H., Basu, S., Basu, A.,
Baxter, A., Beardsley, J., Bedi, N., Beghi, E., Bekele, T., Bell, M. L., Benjet, C., Bennett, D. A., Bensenor, I. M., Benzian, H., Bernabe, E., Beyene,
T. J., Bhala, N., Bhalla, A., Bhutta, Z., Bienhoff, K., Bikbov, B., Abdulhak, A. B., Blore, J. D., Blyth, F. M., Bohensky, M. A., Basara, B. B., Borges,
G., Bornstein, N. M., Bose, D., Boufous, S., Bourne, R. R., Boyers, L. N., Brainin, M., Brauer, M., Brayne, C. E. G., Brazinova, A., Breitborde, N. J.
K., Brenner, H., Briggs, A. D. M., Brooks, P. M., Brown, J., Brugha, T. S., Buchbinder, R., Buckle, G. C., Bukhman, G., Bulloch, A. G., Burch, M.,
Burnett, R., Cardenas, R., Cabral, N. L., Nonato, I. R. C., Campuzano, J. C., Carapetis, J. R., Carpenter, D. O., Caso, V., Castaneda-Orjuela, C. A.,
Catala-Lopez, F., Chadha, V. K., Chang, J.-C., Chen, H., Chen, W., Chiang, P. P., Chimed-Ochir, O., Chowdhury, R., Christensen, H., Christophi, C.
A., Chugh, S. S., Cirillo, M., Coggeshall, M., Cohen, A., Colistro, V., Colquhoun, S. M., Contreras, A. G., Cooper, L. T., Cooper, C., Cooperrider, K.,
Coresh, J., Cortinovis, M., Criqui, M. H., Crump, J. A., Cuevas-Nasu, L., Dandona, R., Dandona, L., Dansereau, E., Dantes, H. G., Dargan, P. I.,
718.
717.
716.
715.
714.
713.
712.
-5–
Davey, G., Davitoiu, D. V., Dayama, A., De La Cruz-Gongora, V., De La Vega, S. F., De Leo, D., Del Pozo-Cruz, B., Dellavalle, R. P., Deribe, K.,
Derrett, S., Des Jarlais, D. C., Dessalegn, M., Deveber, G. A., Dharmaratne, S. D., Diaz-Torne, C., Ding, E. L., Dokova, K., Dorsey, E. R., Driscoll, T.
R., Duber, H., Durrani, A. M., Edmond, K. M., Ellenbogen, R. G., Endres, M., Ermakov, S. P., Eshrati, B., Esteghamati, A., Estep, K., Fahimi, S.,
Farzadfar, F., Fay, D. F. J., Felson, D. T., Fereshtehnejad, S.-M., Fernandes, J. G., Ferri, C. P., Flaxman, A., Foigt, N., Foreman, K. J., Fowkes, F. G.
R., Franklin, R. C., Furst, T., Futran, N. D., Gabbe, B. J., Gankpe, F. G., Garcia-Guerra, F. A., Geleijnse, J. M., Gessner, B. D., Gibney, K. B., Gillum,
R. F., Ginawi, I. A., Giroud, M., Giussani, G., Goenka, S., Goginashvili, K., Gona, P., De Cosio, T. G., Gosselin, R. A., Gotay, C. C., Goto, A., Gouda,
H. N., Guerrant, R. L., Gugnani, H. C., Gunnell, D., Gupta, R., Gupta, R., Gutierrez, R. A., Hafezi-Nejad, N., Hagan, H., Halasa, Y., Hamadeh, R. R.,
Hamavid, H., Hammami, M., Hankey, G. J., Hao, Y., Harb, H. L., Haro, J. M., Havmoeller, R., Hay, R. J., Hay, S., Hedayati, M. T., Pi, I. B. H.,
Heydarpour, P., Hijar, M., Hoek, H. W., Hoffman, H. J., Hornberger, J. C., Hosgood, H. D., Hossain, M., Hotez, P. J., Hoy, D. G., Hsairi, M., Hu, H.,
Hu, G., Huang, J. J., Huang, C., Huiart, L., Husseini, A., Iannarone, M., Iburg, K. M., Innos, K., Inoue, M., Jacobsen, K. H., Jassal, S. K., Jeemon, P.,
Jensen, P. N., Jha, V., Jiang, G., Jiang, Y., Jonas, J. B., Joseph, J., Juel, K., Kan, H., Karch, A., Karimkhani, C., Karthikeyan, G., Katz, R., Kaul, A.,
Kawakami, N., Kazi, D. S., Kemp, A. H., Kengne, A. P., Khader, Y. S., Khalifa, S. E. a. H., Khan, E. A., Khan, G., Khang, Y.-H., Khonelidze, I., Kieling,
C., Kim, D., Kim, S., Kimokoti, R. W., Kinfu, Y., Kinge, J. M., Kissela, B. M., Kivipelto, M., Knibbs, L., Knudsen, A. K., Kokubo, Y., Kosen, S., Kramer,
A., Kravchenko, M., Krishnamurthi, R. V., Krishnaswami, S., Defo, B. K., Bicer, B. K., Kuipers, E. J., Kulkarni, V. S., Kumar, K., Kumar, G. A., Kwan,
G. F., Lai, T., Lalloo, R., Lam, H., Lan, Q., Lansingh, V. C., Larson, H., Larsson, A., Lawrynowicz, A. E. B., Leasher, J. L., Lee, J.-T., Leigh, J., Leung,
R., Levi, M., Li, B., Li, Y., Li, Y., Liang, J., Lim, S., Lin, H.-H., Lind, M., Lindsay, M. P., Lipshultz, S. E., Liu, S., Lloyd, B. K., Ohno, S. L., Logroscino, G.,
Looker, K. J., Lopez, A. D., Lopez-Olmedo, N., Lortet-Tieulent, J., Lotufo, P. A., Low, N., Lucas, R. M., Lunevicius, R., Lyons, R. A., Ma, J., Ma, S.,
Mackay, M. T., Majdan, M., Malekzadeh, R., Mapoma, C. C., Marcenes, W., March, L. M., Margono, C., Marks, G. B., Marzan, M. B., Masci, J.
R., Mason-Jones, A. J., Matzopoulos, R. G., Mayosi, B. M., Mazorodze, T. T., Mcgill, N. W., Mcgrath, J. J., Mckee, M., Mclain, A., Mcmahon, B.
J., Meaney, P. A., Mehndiratta, M. M., Mejia-Rodriguez, F., Mekonnen, W., Melaku, Y. A., Meltzer, M., Memish, Z. A., Mensah, G., Meretoja,
A., Mhimbira, F. A., Micha, R., Miller, T. R., Mills, E. J., Mitchell, P. B., Mock, C. N., Moffitt, T. E., Ibrahim, N. M., Mohammad, K. A., Mokdad, A.
H., Mola, G. L., Monasta, L., Montico, M., Montine, T. J., Moore, A. R., Moran, A. E., Morawska, L., Mori, R., Moschandreas, J., Moturi, W. N.,
Moyer, M., Mozaffarian, D., Mueller, U. O., Mukaigawara, M., Murdoch, M. E., Murray, J., Murthy, K. S., Naghavi, P., Nahas, Z., Naheed, A.,
Naidoo, K. S., Naldi, L., Nand, D., Nangia, V., Narayan, K. M. V., Nash, D., Nejjari, C., Neupane, S. P., Newman, L. M., Newton, C. R., Ng, M.,
Ngalesoni, F. N., Nhung, N. T., Nisar, M. I., Nolte, S., Norheim, O. F., Norman, R. E., Norrving, B., Nyakarahuka, L., Oh, I. H., Ohkubo, T., Omer,
S. B., Opio, J. N., Ortiz, A., Pandian, J. D., Panelo, C. I. A., Papachristou, C., Park, E.-K., Parry, C. D., Caicedo, A. J. P., Patten, S. B., Paul, V. K.,
Pavlin, B. I., Pearce, N., Pedraza, L. S., Pellegrini, C. A., Pereira, D. M., Perez-Ruiz, F. P., Perico, N., Pervaiz, A., Pesudovs, K., Peterson, C. B.,
Petzold, M., Phillips, M. R., Phillips, D., Phillips, B., Piel, F. B., Plass, D., Poenaru, D., Polanczyk, G. V., Polinder, S., Pope, C. A., Popova, S.,
Poulton, R. G., Pourmalek, F., Prabhakaran, D., Prasad, N. M., Qato, D., Quistberg, D. A., Rafay, A., Rahimi, K., Rahimi-Movaghar, V., Rahman,
S. U., Raju, M., Rakovac, I., Rana, S. M., Razavi, H., Refaat, A., Rehm, J., Remuzzi, G., Resnikoff, S., Ribeiro, A. L., Riccio, P. M., Richardson, L.,
Richardus, J. H., Riederer, A. M., Robinson, M., Roca, A., Rodriguez, A., Rojas-Rueda, D., Ronfani, L., Rothenbacher, D., Roy, N., Ruhago, G. M.,
Sabin, N., Sacco, R. L., Ksoreide, K., Saha, S., Sahathevan, R., Sahraian, M. A., Sampson, U., Sanabria, J. R., Sanchez-Riera, L., Santos, I. S.,
Satpathy, M., Saunders, J. E., Sawhney, M., Saylan, M. I., Scarborough, P., Schoettker, B., Schneider, I. J. C., Schwebel, D. C., Scott, J. G.,
Seedat, S., Sepanlou, S. G., Serdar, B., Servan-Mori, E. E., Shackelford, K., Shaheen, A., Shahraz, S., Levy, T. S., Shangguan, S., She, J.,
Sheikhbahaei, S., Shepard, D. S., Shi, P., Shibuya, K., Shinohara, Y., Shiri, R., Shishani, K., Shiue, I., Shrime, M. G., Sigfusdottir, I. D., Silberberg,
D. H., Simard, E. P., Sindi, S., Singh, J. A., Singh, L., Skirbekk, V., Sliwa, K., Soljak, M., Soneji, S., Soshnikov, S. S., Speyer, P., Sposato, L. A.,
Sreeramareddy, C. T., Stoeckl, H., Stathopoulou, V. K., Steckling, N., Stein, M. B., Stein, D. J., Steiner, T. J., Stewart, A., Stork, E., Stovner, L. J.,
Stroumpoulis, K., Sturua, L., Sunguya, B. F., Swaroop, M., Sykes, B. L., Tabb, K. M., Takahashi, K., Tan, F., Tandon, N., Tanne, D., Tanner, M.,
Tavakkoli, M., Taylor, H. R., Te Ao, B. J., Temesgen, A. M., Have, M. T., Tenkorang, E. Y., Terkawi, A. S., Theadom, A. M., Thomas, E., ThorneLyman, A. L., Thrift, A. G., Tleyjeh, I. M., Tonelli, M., Topouzis, F., Towbin, J. A., Toyoshima, H., Traebert, J., Tran, B. X., Trasande, L., Trillini, M.,
Truelsen, T., Trujillo, U., Tsilimbaris, M., Tuzcu, E. M., Ukwaja, K. N., Undurraga, E. A., Uzun, S. B., Van Brakel, W. H., Van De Vijver, S.,
Dingenen, R. V., Van Gool, C. H., Varakin, Y. Y., Vasankari, T. J., Vavilala, M. S., Veerman, L. J., Velasquez-Melendez, G., Venketasubramanian,
N., Vijayakumar, L., Villalpando, S., Violante, F. S., Vlassov, V. V., Waller, S., Wallin, M. T., Wan, X., Wang, L., Wang, J., Wang, Y., Warouw, T. S.,
Weichenthal, S., Weiderpass, E., Weintraub, R. G., Werdecker, A., Wessells, K. R. R., Westerman, R., Wilkinson, J. D., Williams, H. C., Williams,
T. N., Woldeyohannes, S. M., Wolfe, C. D. A., Wong, J. Q., Wong, H., Woolf, A. D., Wright, J. L., Wurtz, B., Xu, G., Yang, G., Yano, Y., Yenesew,
M. A., Yentur, G. K., Yip, P., Yonemoto, N., Yoon, S.-J., Younis, M., Yu, C., Kim, K. Y., Zaki, M. E. S., Zhang, Y., Zhao, Z., Zhao, Y., Zhu, J., Zonies,
D., Zunt, J. R., Salomon, J. A. & Murray, C. J. L.) (2015). Global, regional, and national incidence, prevalence, and years lived with disability for
301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Lancet, 386(9995), 743–800. doi: 10.1016/S0140-6736(15)60692-4. [PMID: 26063472]
Rehm, J. (2015). Light or moderate drinking is linked to alcohol related cancers, including breast cancer. British Medical Journal, 351, h4400
doi: 10.1136/bmj.h4400 [PMID: 26286217}
Probst, C., Manthey, J., Martinez, A., & Rehm, J. (2015). Alcohol use disorder severity and reported reasons not to seek treatment: a crosssectional in European primary care practices. Substance Abuse Treatment, Prevention, and Policy, 10(1), 32. doi: 10.1186/s13011-015-0028z. [PMID: 26264215]
Rehm, J., Allamani, A., Elekes, Z., Jakubczyk, A., Manthey, J., Probst, P., Struzzo, P., Della Vedova, R., Gual, A., & Wojnar, M. (2015). Alcohol
dependence and treatment utilization in Europe - a representative cross-sectional study in primary care. BMC Family Practice, 16, 90. doi:
10.1186/s12875-015-0308-8 [PMID: 26219430]
http://www.biomedcentral.com/1471-2296/16/90
Fischer, B., Jones, W., Murphy, Y., Ialomiteanu, A., & Rehm, J. (2015). Recent developments in prescription opioid related dispensing and
harm indicators in Ontario, Canada. Pain Pysician, 18(4), E659-E662. [PMID: 26218958}
Lachenmeier, D.W., Gill, J.S., Chick, J. & Rehm, J. (2015). The total margin of exposure of ethanol and acetaldehyde for heavy drinkers
consuming cider or vodka. Food and Chemical Toxicology, 83, 210-214. doi: 10.1016/j.fct.2015.05.006. [PMID: 26116882]
Probst, C., Moyo, D., Purshouse, R., & Rehm J. (2015). Transition probabilities for four states of alcohol use in adolescence and young
adulthood: what factors matter when? Addiction, 110(8), 1272–1280. doi: 10.1111/add.12985. [PMID: 25959142]
Ilie, G., Mann, R.E., Ialomiteanu, A., Adlaf, E.M., Hamilton, H., Wickens, C.M., Asbridge, M., Rehm, J., & Cusimano, M.D. (2015). Traumatic
brain injury, driver aggression and motor vehicle collisions in Canadian adults. Accident Analysis and Prevention, 81, 1-7. doi:
10.1016/j.aap.2015.04.021 [PMID: 25935425]
-6–
711. Ilie, G., Adlaf, E.M., Mann, R.E., Ialomiteanu, A., Hamilton, H., Rehm, J., Asbridge, M. & Cusimano, M.D. (2015). Associations between a
history of traumatic brain injuries and current cigarette smoking, cannabis use, nonmedical opioid use, and elevated psychological distress in
a population sample of Canadian adults. Journal of Neurotrauma, 32(14), 1130-1134. doi:10.1089/neu.2014.3619 [PMID: 25496189].
710. Shield, K.D. & Rehm, J. (2015). Global risk factor rankings: the importance of age-based health loss inequities caused by alcohol and other risk
factors. BMC Research Notes, 8, 231. doi: 10.1186/s13104-015-1207-8 [PMID: 26054859]
709. Rehm, J., & Fischer, B. (2015). Cannabis legalization with strict regulation, the overall superior policy option for public health. Clinical
Pharmacology and Therapeutics, 97(6), 541-544. doi: 10.1002/cpt.93. [PMID: 25677377]
708. Shield, K.D. & Rehm, J. (2015). Russia-specific relative risks and their effects on the estimated alcohol-attributable burden of disease. BMC
Public Health, 15, 482. doi: 10.1186/s12889-015-1818-y [PMID: 25958382]
707. Kraus. L., Pabst, A., Piontek, D., Gmel, G., Shield, K.D., Frick, H., & Rehm, J. (2015). Temporal changes in alcohol-related morbidity and
mortality in Germany. European Addiction Research, 21(5), 262-272. doi: 10.1159/000381672.1159/000381672 [PMID: 25967383]
http://www.karger.com/DOI/10.1159/000381672
706. Rehm, J., Allamani, A., Aubin, H.J., Della Vedova, R., Elekes, Z., Frick, U., Jakubczyk, A., Kostogianni, N., Landsmane, I., Manthey, J., Miquel, L.,
Paille, F., Pieper, L., Probst, C., Scafuri, F., Shield, K.D., Snikere, S., Struzzo, P., Trapencieris, M., Voller, F., Wittchen, H.U., Gual, A. & Wojnar,
M. (2015). People with alcohol use disorders in specialized care in eight different European countries. Alcohol and Alcoholism, 50(3), 310318. doi: 10.1093/alcalc/agv009 [PMID: 25716113]
705. Roerecke, M., Shield, K.D., Higuchi, S., Yoshimura, A., Larsen, E., Rehm, M.X., & Rehm.J. (2015). Estimates of alcohol-related oesophageal
cancer burden in Japan: systematic review and meta-analyses. Bulletin of the World Health Organization, 93(5), 329–338C. doi:
http://dx.doi.org/10.2471/BLT.14.142141 ; [PMID: 26229204]
http://www.who.int/bulletin/volumes/93/5/14-142141.pdf?ua=1
704. Probst, C., Roerecke, M., Behrendt, S., & Rehm, J. (2015). Gender differences in socioeconomic inequality of alcohol-attributable mortality – a
systematic review and meta-analysis. Drug and Alcohol Review, 34(3), 267-77. doi: 10.1111/dar.12184. [PMID: 25109218]
703. Rehm, J., & Roerecke, M. (2015). Patterns of drinking and liver cirrhosis – what do we know and where do we go? Journal of Hepatology, 62,
1000-1001. doi: 10.1016/j.jhep.2015.01.027 [PMID: 25646887]
702. Roerecke, M., & Rehm, J. (2015). Alcohol and ischaemic heart disease risk-finally moving beyond interpretation of observational
epidemiology. Addiction, 110(5), 723-725. doi: 10.1111/add.12787 [PMID: 25613090]
701. Nutt, D.J., Rehm, J., van den Brink, W., Gorwood, P., & Buchsbaum, M.S. (2015). Progress in mind: Focus on alcohol use disorders, an Elsevier
Resource Centre. Psychiatry Research, 226(2-3), 513-514. doi: 10.1016/j.psychres.2015.01.013. [PMID: 25724487]
700. Larsen, E., Gheorghe, P., Rehm, M.X., & Rehm, J. (2015.) Treatment for alcohol use disorders in Canada. Journal of Addiction Medicine and
Therapy, 3(1), 1013.
http://www.jscimedcentral.com/Addiction/earlyonline.php
699. Fischer, B., Blanken, P., Da Silveira, D., Gallassi, A., Goldner, E.M., Rehm, J., Tyndall, M., & Wood (2015). Effectiveness of secondary
prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies.
International Journal of Drug Policy, 26(4), 352-363. doi: 10.1016/j.drugpo.2015.01.002 [PMID: 25662894]
698. Connor, J., Kydd, R., Shield, K., & Rehm, J. (2015). The burden of disease and injury attributable to alcohol in New Zealanders under 80 years
of age: marked disparities by ethnicity and sex. New Zealand Medical Journal, 128(1409), 15-28. [PMID: 25721958]
697. Kraus, L., Piontek, D., Pfeiffer-Gerschel, T., & Rehm, J. (2015). Inanspruchnahme gesundheitlicher Versorgung durch Alkoholabhängige.
Suchttherapie, 16(1), 18-26. doi: 10.1055/s-0034-1376999
http://dx.doi.org/10.1055/s-0034-1376999
[Health care utilization of people with alcohol dependence]
696. Lachenmeier, D.W., & Rehm, J. (2015). Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of
exposure approach. Scientific Reports, 5, 8126. doi: 10.1038/srep08126. [PMID: 25634572]
695. Fischer, B., Murphy, Y., Kurdyak, P., Goldner, E., & Rehm, J. (2015). Medical Marijuana Programs - why might they matter for public health
and why should we better understand their impacts? Preventive Medicine Reports, 2, 53–56. doi: 10.1016/j.pmedr.2014.12.006
[PMID: 26844050]
694. Fischer, B., Burnett, C., & Rehm, J. (2015). Considerations towards a population health approach to reduce prescription opioid-related harms
(with a primary focus on Canada). Drugs: Education, Prevention & Policy, 22(1), 60-65. doi:10.3109/09687637.2014.936827
693. Cunningham, J.A., Hendershot, C.S., & Rehm, J. (2015). Randomized controlled trial of a minimal versus extended Internet-based intervention
for problem drinkers: study protocol. BMC Public Health, 15(1), 21. doi:10.1186/s12889-015-1347-8 [PMID: 25604206]
692. Rehm, J., Allamani, A., Elekes, Z., Jakubczyk, A., Landsmane, I., Manthey, J., Moreno-España, J., Pieper, L., Probst, C., Snikere, S., Struzzo, P.,
Della Vedova, R., Voller, F., Wittchen, H.-U., Gual, A., & Wojnar, M. (2015). General practitioners recognizing alcohol dependence: a large
cross-sectional study in six European countries. Annals of Family Medicine, 13(1), 28-32. doi: 10.1370/afm.1742. [PMID: 25583889].
691. Easton, B., Sarnocinska-Hart, A., Burd, L., Rehm, J. & Popova, S. (2015). The cost of lost productivity due to Fetal Alcohol Spectrum Disorderrelated premature mortality. Journal of Population Therapeutics and Clinical Pharmacology, Incorporating Fetal Alcohol Research, 22(1), e3e8. [PMID: 25594934]
Available from http://www.jptcp.com/pubmed.php?articleId=502
690. Feingold, D., Weiser, M., Rehm, J., & Lev-Ran, S. (2015). The association between cannabis use and mood disorders: A longitudinal study.
Journal of Affective Disorders, 172, 211-218. doi: 10.1016/j.jad.2014.10.006. [PMID: 25109218] http://dx.doi.org/10.1016/j.jad.2014.10.006
689. Chaiton, M.O., Cohen, J.E., Rehm, J., Abdulle, M. & O'Loughlin, J. (2015). Confounders or intermediate variables? Testing mechanisms for the
relationship between depression and smoking in a longitudinal cohort study. Addictive Behaviors, 42, 154-161. doi:
10.1016/j.addbeh.2014.11.026 [PMID: 25462665]
688. Rehm, J., Anderson, P., Barry, J., Dimitrov, P., Elekes, Z., Feijão, F., Frick, U., Gual, A., Gmel G. jun., Kraus, L., Marmet, S., Raninen, J., Rehm,
687.
686.
685.
684.
683.
682.
681.
680.
679.
678.
677.
676.
675.
674.
673.
672.
671.
670.
669.
668.
667.
666.
665.
-7–
M.X., Scafato, E., Shield, K.D., Trapencieris, M., & Gmel, G. (2015). Prevalence of and potential influencing factors for alcohol dependence in
Europe. European Addiction Research, 21(1), 6-18. doi: 10.1159/000365284 [PMID: 25342593]
http://www.karger.com/DOI/10.1159/000365284
Samokhvalov, A.V., Selby, P., Bondy, S.J., Chaiton, M., Ialomiteanu, A., Mann, R., & Rehm, J. (2014). Smokers who seek help in specialized
cessation clinics: How special are they compared to smokers in general population? Journal of Smoking Cessation, 9(2), 76-84.
doi:10.1017/jsc.2013.23.
Urbanoski, K., Rehm, J., Lange, S., & Popova, S. (2014). Comorbid mental disorders among clients in addiction treatment: The costs of care.
International Journal of Alcohol and Drug Research, 3(4), 297 – 304. doi:10.7895/ijadr.v3i4.183
http://ijadr.org/index.php/ijadr/article/view/183.
Chaiton, M., Mecredy, G., Rehm, J. & Samokhvalov, A.V. (2014). Tobacco retail availability and smoking behaviours among patients seeking
treatment at a nicotine dependence treatment clinic. Tobacco Induced Diseases, 12, 19. doi:10.1186/1617-9625-12-19
Rehm, J., Gmel, G., Kiefer, F., Kreutz, R., Kugler, J., Müller-Walther, M., Sandow, P., & Weisser, B. (2014). Verbessertes HypertonieManagement durch Alkohol-Screening und Folgeinterventionen in der Hausarztpraxis. Deutsche Medizinische Wochenschrift, 139(48), 2457–
2462. doi: 10.1055/s-0034-1387417 [PMID: 25409405].
[Improvement of management of hypertension by implementation of alcohol screening and subsequent interventions in primary practice]
Popova, S., Lange, S., Burd, L., Shield, K., & Rehm, J. (2014). Cost of speech-language interventions for children and youth with foetal alcohol
spectrum disorder in Canada. International Journal of Speech-Language Pathology, 16(6), 571-581. doi: 10.3109/17549507.2013.862858.
[PMID: 24345001]
Rudzinski, K., Dawe, M., McGuire, F., Shuper, P.A., Rehm, J., & Fischer, B. (2014). Reflections regarding future cannabis use among highfrequency users in a Canadian university student population. Journal of Research on Adolescence, 24(4), 598–607. doi: 10.1111/jora.12087.
Imtiaz, S., Shield, K.D., Fischer, B., & Rehm, J. (2014). Harms of prescription opioid use in the United States. Substance Abuse Treatment,
Prevention, and Policy, 9(1), 43. doi:10.1186/1747-597X-9-43, [PMID: 2535216]
Lopez, A.D., Williams, T.N., Levin, A., Tonelli, M., Singh, J.A., Burney, P.G.J., Rehm, J., Volkow, N.D., Koob, G., & Ferri, C.P. (2014).
Remembering the forgotten non-communicable diseases. BMC Medicine, 12, 200. doi:10.1186/s12916-014-0200-8
http://www.biomedcentral.com/1741-7015/12/200 [PMID: 25604462]
Rehm, J., Lachenmeier, D.W., & Room, R. (2014). Why does society accept a higher risk for alcohol than for other voluntary or involuntary
risks? BMC Medicine, 12, 189. doi: 10.1186/s12916-014-0189-z http://www.biomedcentral.com/1741-7015/12/189 [PMID: 25424648]
Roerecke, M., & Rehm, J. (2014). Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses
and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Medicine, 12, 182.
doi: 10.1186/s12916-014-0182-6 [PMID: 25567363] http://www.biomedcentral.com/1741-7015/12/182
Easton, B., Burd, L., Sarnocinska-Hart, A., Rehm, J., & Popova, S. (2014). Productivity losses due to morbidity attributable to Fetal Alcohol
Spectrum Disorder in Canada: A demographic approach. Journal of Studies on Alcohol and Drugs, 75(6), 1011-1017. [PMID: 25343659].
Ilie, G., Adlaf, E.M., Mann, R.E., Boak, A., Hamilton, H., Asbridge, M., Colantonio, A., Turner, N.E., Rehm, J., & Cusimano, M.D. (2014). The
moderating effects of sex and age on the association between traumatic brain injury and harmful psychological correlates among adolescents.
PLoS One, 9(9), e108167. doi: 10.1371/journal.pone.0108167. eCollection 2014. [PMID: 25268238]
Lachenmeier, D.W., Kanteres, F., & Rehm, J. (2014). Alcoholic beverage strength discrimination by taste may have an upper threshold.
Alcoholism: Clinical and Experimental Research, 38(9), 2460-2467. doi: 10.1111/acer.12511. [PMID: 25257295]
Marmet, S., Rehm, J., & Gmel, G. (2014). Reply to the letter to the editor of J. G. Heckmann. Swiss Medical Weekly, 144, w14029. doi:
10.4414/smw.2014.14029. [PMID: 25255387]
Parry, C.D.H, Morojele, N.K., Myers, B.J., Kekwaletswe, C.T., Manda, S.O.M., Sorsdahl, K., Ramjee, G., Hahn, J.A., Rehm, J., & Shuper, P.A.
(2014). Efficacy of an alcohol-focused intervention for improving adherence to antiretroviral therapy (ART) and HIV treatment outcomes - a
randomised controlled trial protocol. BMC Infectious Diseases, 14(1), 500. doi: 10.1186/1471-2334-14-500 [PMID: 25212696]
Laramée, P., Brodtkorb, T.H., Rahhali, N., Knight, C., Barbosa, C., François, C., Toumi, M., Daeppen, J.B., & Rehm, J. (2014). The costeffectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol
dependent patients with high/very high drinking risk levels: a Markov model. BMJ Open, 4(9), e005376. doi: 10.1136/bmjopen-2014-005376
[PMID: 25227627]
François, C., Laramée, P., Rahhali, N., Chalem, Y., Aballéa, S., Millier, A., Bineau, S., Toumi, M., & Rehm, J. (2014). The clinical relevance of
reducing alcohol consumption in alcohol dependence: a predictive microsimulation model. European Addiction Research, 20(6), 269-284.
doi:10.1159/000362408 [PMID: 25228120]
Roerecke, M., & Rehm, J. (2014). Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis. Open Heart, 1,
e000135. doi:10.1136/openhrt-2014-000135 [PMID: 25332827]
Rehm, J., & Roerecke, M. (2014). Time to rethink the ischaemic heart disease effects of low to moderate alcohol consumption? BMJ (rapid
response to BMJ, 2014, 349, g4164s; July 15,2014) http://www.bmj.com/content/349/bmj.g4164/rapid-responses
Rehm, J. (2014). Re-examining the theory about the collectivity of changes in alcohol consumption. Addiction, 109(9), 1397–1398.
doi:10.1111/add.12644 [PMID: 25039973]
Kontis, V., Mathers, C.D., Rehm, J., Stevens, G.A., Shield, K.D., Bonita, R., Riley, L.M., Poznyak, V., Beaglehole, R. & Ezzati, M. (2014).
Contribution of six risk factors to achieving the “25×25” NCD mortality reduction target. Lancet, 384(9941), 427 – 437. pii: S01406736(14)60616-4. doi: 10.1016/S0140-6736(14)60616-4. [PMID: 24797573]
Probst, C., Roerecke, M., Behrendt, S., & Rehm, J. (2014). Socioeconomic differences in alcohol-attributable mortality compared to all-cause
mortality: a systematic review and meta-analysis. International Journal of Epidemiology, 43(4), 1314-1327. doi: 10.1093/ije/dyu043 [PMID:
24618188]
Yaltonskaya, A., Yaltonsky, V., Kolpakov, Y., Abrosimov, I., Tanner, V., Pervakov, K., Rehm, J., & Popova, S. (2014). Potreblenie alkogolia vo
vremia beremennosti i fetal’niy alkogol’niy spektr narusheniy v Rossii: sistematicheskiy obzor literaturi. [Alcohol consumption during
664.
663.
662.
661.
660.
659.
658.
657.
656.
655.
654.
653.
652.
651.
650.
649.
648.
647.
646.
645.
-8–
pregnancy and Fetal Alcohol Spectrum Disorders in Russian Federation. A systematic literature review]. Narkologiya. Rossiyskaya Akademiya
Meditsinskih Nauk [Narcology. Russian Academy of Medical Sciences], 6(150), 80-90. ISSN 1682-8313.
Lev-Ran, S., Florentin, I., Feingold, D., & Rehm, J. (2014). Individuals receiving specialized treatment for drug and alcohol dependence and
gambling disorder in Israel - characteristics and implications for prevalence estimates. Substance Abuse, 35(3), 268-275. doi:
10.1080/08897077.2014.907860 [PMID: 24779614]
Asbridge, M., Mann, R., Cusimano, M.D., Tallon, J.M., Pauley, C., & Rehm, J. (2014). Cycling-related crash risk and the role of cannabis and
alcohol: a case-crossover study. Preventive Medicine, 66, 80-86. doi: 10.1016/j.ypmed.2014.06.006 [PMID: 24945694]
Lachenmeier, D.W., Monakhova, Y.B., & Rehm, J. (2014). Influence of unrecorded alcohol consumption on liver cirrhosis mortality. World
Journal of Gastroenterology, 20(23), 7217-7222. doi: 10.3748/wjg.v20.i23.1 [PMID: 24966592]
Wells, S., Tremblay, P.F., Flynn, A., Russell, E., Kennedy, J., Rehm, J., Van Uum, S., Koren, G., & Graham, K. (2014). Associations of hair cortisol
concentration with self-reported measures of stress and mental health-related factors in a pooled database of diverse community samples.
Stress, 17(4), 334-342. doi:10.3109/10253890.2014.930432 [PMID: 24903269]
Fischer, B., Gooch, J., Goldman, B., Kurdyak, P., & Rehm, J. (2014). Non-medical prescription opioid use, prescription opioid-related harms and
public health in Canada: An update 5 years later. Canadian Journal of Public Health, 105(2), e146-e149. [PMID: 24886852]
Marmet, S., Rehm, J., Gmel, G. jun., Frick, H., & Gmel, G. (2014). Alcohol-attributable mortality in Switzerland in 2011 - age-specific causes of
death and impact of heavy versus non-heavy drinking. Swiss Medical Weekly, 144, w13947. doi: 10.4414/smw.2014.13947. [PMID:
24845076]
Roerecke, M., & Rehm, J. (2014). Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and metaanalysis. International Journal of Epidemiology, 43(3), 906–919. doi:10.1093/ije/dyu018 [PMID 24513684].
Rehm, J., Kailasapillai, S., Larsen, E., Rehm, M.X., Samokhvalov, A.V., Shield, K.D., Roerecke, M., & Lachenmeier, D.W. (2014). A systematic
review of the epidemiology of unrecorded alcohol consumption and the chemical composition of unrecorded alcohol. Addiction, 109(6), 880893. doi: 10.1111/add.12498. [PMID: 24467748]
Patra, J., Jha, P., Rehm, J., & Suraweera, W. (2014). Tobacco smoking, alcohol drinking, diabetes, low body mass index and the risk of selfreported symptoms of active tuberculosis: Individual Participant Data (IPD) meta-analyses of 72,684 individuals in 14 high tuberculosis burden
countries. PLOS One, 9(5), e96433. doi: 10.1371/journal.pone.0096433. eCollection 2014. [PMID: 24789311]
Rehm, J. (2014). What can we learn from Russia about alcohol epidemiology and alcohol policy? Comment on: Zaridze et al. (2014). Alcohol
and mortality in Russia: prospective observational study of 151,000 adults. Lancet, 383(9927), 1440-1442. doi:10.1016/S0140-6736(14)600386
Ilie, G., Mann, R.E., Boak, A., Adlaf, E.M., Hamilton, H., Asbridge, M., Rehm, J., & Cusimano, M.D. (2014). Suicidality, bullying and other
conduct and mental health correlates of traumatic brain injury in adolescents. PLOS One, 9(4), e94936. doi: 10.1371/journal.pone.0094936
[PMID: 24736613]
Rehm, J., Rehm, M.X., Shield, K.D., Gmel, G., Frick, U., & Mann, K. (2014). Reduzierung alkoholbedingter Mortalität durch Behandlung der
Alkoholabhängigkeit. Sucht, 60(2), 93-105. doi: 10.1024/0939-5911.a000299
[Decrease in alcohol-attributable mortality by treatment of alcohol dependence]
Rehm, J., Rehm, M.X., Gmel, G., Frick, U. (2014). Wie vermindern wir alkoholbedingte Krankheitslast? Sucht, 60(2), 115-116. doi:
10.1024/0939-5911.a000303
[How to reduce alcohol-attributable burden of disease?]
Rehm, J., Rehm, M.X., Gmel, G., Frick, U. (2014). Replik. Forschung und klinische Praxis - Grenzen und Möglichkeiten einer Praxisverbesserung
durch Forschungsergebnisse. Sucht, 60(2), 127-129. doi: 10.1024/0939-5911.a000300
[Research and clinical practice –limitations and possibilities of improving practice by research]
Nosyk, B., Fischer, B., Sun, H., Marsh, D.C., Kerr, T., Rehm, J. & Anis, A.H. (2014). High levels of opioid analgesic co-prescription among
methadone maintenance treatment clients in British Columbia, Canada: Results from a population-level retrospective cohort study. American
Journal on Addictions, 23(3), 257-64. doi: 10.1111/j.1521-0391.2014.12091.x. [PMID: 24724883]
Shuper, P.A., Joharchi, N., & Rehm, J. (2014). Personality as a predictor of unprotected sexual behavior among people living with HIV/AIDS: a
systematic review. AIDS and Behavior, 18(2), 398-410. doi: 10.1007/s10461-013-0554-5. [PMID: 23835736]
Asbridge, M., Mann, R., Cusimano, M.D., Trayling, C., Roerecke, M., Tallon, J.M., Whipp, A., & Rehm, J. (2014). Cannabis and traffic collision
risk: findings from a case-crossover study of injured drivers presenting to emergency departments. International Journal of Public Health,
59(2), 395-404. doi: 10.1007/s00038-013-0512-z. [PMID: 24061594]
Rehm, J., Dawson, D., Frick, J., Gmel, G., Roerecke, M., Shield, K.D., & Grant, B. (2014). Burden of disease associated with alcohol use
disorders in the United States. Alcoholism: Clinical and Experimental Research, 38(4), 1068–1077. doi: 10.1111/acer.12331 [PMID:
24428196]
Lange, S., Shield, K.D., Koren, G., Rehm, J., & Popova, S. (2014). Prenatal alcohol exposure: a comparison of the prevalence obtained via selfreports versus meconium testing. A comprehensive literature review and meta-analysis. BMC Pregnancy and Childbirth, 14, 127. doi:
10.1186/1471-2393-14-127.
Fischer, B., Jones, W., & Rehm. J. (2014). Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update
with a focus on recent interventions. BMC Health Services Research, 14(1), 90. doi:10.1186/1472-6963-14-90 [PMID: 24572005]
http://www.biomedcentral.com/1472-6963/14/90
644. Kerridge, B.T., Khan, M.R., Rehm, J., & Sapkota, A. (2014). Terrorism, civil war and related violence and substance use disorder morbidity and
mortality: a global analysis. Journal of Epidemiology and Global Health, 4(1), 61-72. doi: 10.1016/j.jegh.2013.10.003. [PMID: 24534337]
643. Samokhvalov, A.V., & Rehm, J. (2014). Premature mortality in patients with epilepsy. Lancet, 383(9916), 511. doi: 10.1016/S01406736(14)60179-3. [PMID: 24506902]
642. Shield, K.D., Rehm, J., Rehm, M.X., Gmel, G., & Drummond, C. (2014). The potential impact of increased treatment rates for alcohol
dependence in the United Kingdom in 2004. BMC Health Services Research, 14(1), 53. [PMID: 24499391]
-9–
641. Lev-Ran, S., Roerecke, M., Le Foll, B., George, T.P., McKenzie, K., & Rehm, J. (2014). The association between cannabis use and depression: a
systematic review and meta-analysis of longitudinal studies. Psychological Medicine, 44(4), 797-810. doi:10.1017/S0033291713001438.
[PMID: 23795762]
640. Popova, S., Lange, S., Burd, L., & Rehm, J. (2014). Canadian children and youth in care: the cost of Fetal Alcohol Spectrum Disorder. Child and
Youth Care Forum, 43, 83–96. doi 10.1007/s10566-013-9226-x. [PMID: 24489454]
Available from http://link.springer.com/article/10.1007%2Fs10566-013-9226-x
639. Goldner, E.M., Lusted, A., Roerecke, M., Rehm, J., & Fischer, B. (2014). Prevalence of axis-1 psychiatric (with focus on depression and anxiety)
disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and metaanalysis. Addictive Behaviors, 39(3), 520-31. http://dx.doi.org/10.1016/j.addbeh.2013.11.022. [PMID: 24333033]
638. Fischer, B., Keates, A., Bühringer, G., Reimer, J., & Rehm, J. (2014). Non-medical use of prescription opioids and prescription opioid-related
harms: why so markedly higher in North America compared to the rest of the world? Addiction, 109(2), 177-181. doi: 10.1111/add.12224.
[PMID: 23692335]
637. Fischer, B., Keates, A., Bühringer, G., Reimer, J., & Rehm, J. (2014). Considering prescription opioid-related harms in the population: Response
to commentaries. Addiction, 109(2), 186-188. doi: 10.1111/add.12423 [PMID: 24422613]
636. Nutt, D.J. & Rehm, J. (2014). Doing it by numbers: a simple approach to reducing the harms of alcohol. Journal of Psychopharmacology,
28(1), 3-7. doi:10.1177/0269881113512038. [PMID: 24399337]
635. Popova, S., Yaltonskaya, A., Yaltonsky, V., Kolpakov, Y., Abrosimov, I., Pervakov, K., Tanner, V., & Rehm, J. (2014). What is happening in the
Russian research community regarding research on prenatal alcohol exposure and Fetal Alcohol Spectrum Disorders? Alcohol and Alcoholism,
49(1), 84-95. doi: 10.1093/alcalc/agt156 [PMID: 24158024]
http://alcalc.oxfordjournals.org/content/early/2013/10/23/alcalc.agt156.abstract?keytype=ref&ijkey=fmTH3gl6niCgvdO
634. Rehm, J., Anderson, P., Gual, A., Kraus, L., Marmet, S., Nutt, D.J., Room, R., Samokhvalov, A.V., Shield, K.D., Scafato, E., Trapencieris, M.,
Wiers, R.W., & Gmel, G. (2014). The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al.
(2013). Alcohol and Alcoholism, 49(1), 118-122. doi: 10.1093/alcalc/agt171. [PMID: 24226811]
633. Fischer, B., Jones, W., Urbanoski, K., Skinner, R., & Rehm, J. (2014). Correlations between prescription opioid analgesic dispensing levels and
related mortality and morbidity in Ontario, Canada, 2005–2011. Drug and Alcohol Review, 33(1), 19-26. doi: 10.1111/dar.12089. [PMID:
24261474]
632. Lachenmeier, D.W., Godelmann, R., Witt, B., Riedel, K., & Rehm, J. (2014). Can resveratrol in wine protect against the carcinogenicity of
ethanol? A probabilistic dose-response assessment. International Journal of Cancer, 134(1), 144-153. doi: 10.1002/ijc.28336. [PMID:
23784940]
631. Rehm, J., & Hingson, R. (2013). Measuring the Burden. Alcohol’s evolving impact on individuals, families, and society. Alcohol Research:
Current Reviews, 35(2), 117-118. [PMID: 24881319]
630. Hingson, R., & Rehm, J. (2013). Measuring the Burden. Alcohol’s evolving impact. Alcohol Research: Current Reviews, 35 (2), 122-127. [PMID:
24881320]
629. Shield, K.D., Parry, C., & Rehm, J. (2013). Chronic diseases and conditions related to alcohol use. Alcohol Research: Current Reviews, 35(2),
155-173. [PMID: 24881324]
628. Rehm, J., & Shield, K.D. (2013). Alcohol and mortality. Global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010.
Alcohol Resarch: Current Reviews 35(2), 174-183. [PMID: 24881325]
627. Poznyak, V., Fleischmann, A., Rekve, D., Rylett, M., Rehm, J., & Gmel, G. (2013). The World Health Organization’s Global Monitoring System
on Alcohol and Health. Alcohol Research: Current Reviews, 35 (2), 244-249. [PMID: 24881333]
626. Bergmann, M.M., Rehm, J., Klipstein-Grobusch, K., Boeing, H., Schütze, M., Drogan, D., Overvad, K., Tjonneland, A., Halkjaer, J., Fagherazzi, G.,
Boutron-Ruault, M.C., Clavel-Chapelon, F., Teucher, B., Kaaks, R., Trichopoulou, A., Benetou, V., Trichopoulos, D., Palli, D., Pala, V., Tumino, R.,
Vineis, P., Beulens, J.W. J., Redondo, M.L., Duell, E.J., Molina-Montes, E., Navarro, C., Barricarte, A., Arriola, L., Allen, N.E., Crowe, F.L., Khaw,
K.T., Wareham, N., Romaguera, D., Wark, P.A., Romieu, I., Nunes, L., Riboli, E. & Ferrari, P. (2013). The association of pattern of lifetime
alcohol use and cause of death in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. International Journal of
Epidemiology, 42(12), 1772-1790. doi:10.1093/ije/dyt154 [PMID: 24415611]
625. Roerecke, M., Gual, T., & Rehm, J. (2013). Reduction of alcohol consumption and subsequent mortality in alcohol use disorders: systematic
review and meta-analyses. Journal of Clinical Psychiatry, 74(12), e1181–e1189. doi: 10.4088/JCP.13r08379 [PMID: 24434106]
624. Rehm, J. & Lachenmeier, D. (2013). Unrecorded alcohol and lead poisoning. American Journal of Medicine, 126(12), e39. doi:
10.1016/j.amjmed.2013.05.019. [PMID: 24262744]
623. Rehm, J. (2013). The role of the comparison group in epidemiology and general limitations. Commentary on Fekjaer: Alcohol - a universal
preventive agent? A critical analysis. Addiction, 108(12), 2058-2059. doi: 10.1111/add.12189. [PMID: 24237894]
622. Lusted, A., Roerecke, M., Goldner, E., Rehm, J., & Fischer, B. (2013). Prevalence of pain among non-medical prescription opioid users in
substance use treatment populations: systematic review and meta-analysis. Pain Physician, 16(6), e671-e684. [PMID: 24284850]
http://www.painphysicianjournal.com/2013/november/2013;16;E671-E684.pdf
621. Kerridge, B.T., Khan, M.R., Rehm, J., & Sapkota, A. (2013). Conflict and diarrheal and related diseases: a global analysis. Journal of
Epidemiology and Global Health, 3(4), 269-277. doi: 10.1016/j.jegh.2013.05.002. [PMID: 24206798]
620. Whiteford, H.A., Degenhardt, L., Rehm, J., Baxter, A.J., Ferrari, A.J., Erskine, H.E., Charlson, F.J., Norman, R.E., Flaxman, A.D., Johns, N.,
Burstein, R., Murray, C.J.L., & Vos, T. (2013). Global burden of disease attributable to mental and substance use disorders: findings from the
Global Burden of Disease Study 2010. Lancet, 382(9904), 1575-1586. doi:10.1016/S0140-6736(13)61611-6 [PMID:23993280]
619. Lev-Ran, S., Le Foll, B., McKenzie, K., George, T.P., & Rehm, J. (2013). Bipolar disorder and co-occurring cannabis use disorders:
Characteristics, co-morbidities and clinical correlates. Psychiatry Research, 209(3), 459-465. doi: 10.1016/j.psychres.2012.12.014
[PMID:23312479]
618. Rehm, J., Marmet, S., Anderson, P., Gual, A., Kraus, L., Nutt, D.J., Room, R., Samokhvalov, A.V., Scafato, E., Trapencieris, M., Wiers, R.W., &
- 10 –
Gmel, G. (2013). Defining substance use disorders: do we really need more than heavy use? Alcohol and Alcoholism, 48(6), 633-640. doi:
10.1093/alcalc/agt127 [PMID: 23926213]
617. Kerr, W.C., Greenfield, T.K., Ye, Y., Bond, J., & Rehm, J. (2013). On French and American paradoxes. Addiction, 108(11), 2029-30. doi:
10.1111/add.12272. [PMID: 23848347]
616. Ratnasingham, S., Cairney, J., Manson, H., Rehm, J., Lin, E., & Kurdyak, P. (2013). The burden of mental illness and addiction in Ontario.
Canadian Journal of Psychiatry, 58(9), 529-537. [PMID: 24099501]
615. Rehm, J., Shield, K.D., Vos, T., Murray, C.J., & Lim, S. (2013). Alcohol-related road traffic injury and Global Burden of Disease 2010 - Authors'
reply. Lancet, 382(9898), 1093. doi: 10.1016/S0140-6736(13)62015-2. [PMID: 24075042]
614. Lange, S., Shield, K.D., Rehm, J., & Popova, S. (2013). Prevalence of Fetal Alcohol Spectrum Disorders in child care settings: A meta-analysis.
Pediatrics, 132(4), e980-95. doi:10.1542/peds.2013-0066 [PMID: 24019412]
613. Flynn, A., Tremblay, P.F., Rehm, J., & Wells, S. (2013). A modified random walk door-to-door recruitment strategy for collecting social and
biological data relating to mental health, substance use, addiction, and violence problems in a Canadian community. International Journal of
Alcohol and Drug Research, 2(2), 7-16. doi: 10.7895/ijadr.v2i2.143 (http://dx.doi.org/10.7895/ijadr.v2i2.143 )
612. Giesbrecht, N., Sapag, J.C., Pemjean, A., Marquez, J., Khenti, A., Rehm, J., & Minoletti, A. (2013). A National Alcohol Strategy For Chile:
rationale, development, content and status of implementation. International Journal of Alcohol and Drug Research, 2(2), 17-29. doi:
10.7895/ijadr.v2i2.128 (http://dx.doi.org/10.7895/ijadr.v2i2.128 )
611. Lachenmeier, D.W., Monakhova, Y.B., Rehm, J., Kuballa, T, & Straub, I (2013). Occurrence of carcinogenic aldehydes in alcoholic beverages
from Asia. International Journal of Alcohol and Drug Research, 2 (2), 31-36. doi: 10.7895/ijadr.v2i2.88
(http://dx.doi.org/10.7895/ijadr.v2i2.88 )
610. Rehm, J., Rehm, M.X., Alho, H., Allamani, A., Aubin, H-J., Bühringer, G., Daeppen, J-B., Frick, U., Gual, A., & Heather, N. (2013). Alcohol
dependence treatment in the EU: a literature search and expert consultation about the availability and use of guidelines in all EU countries
plus Iceland, Norway, and Switzerland. International Journal of Alcohol and Drug Research, 2(2), 53-67. doi: 10.7895/ijadr.v2i2.89.
(http://dx.doi.org/10.7895/ijadr.v2i2.89)
609. Popova, S., Lange, S., & Rehm, J. (2013). Twenty percent of breastfeeding women in Canada consume alcohol. Journal of Obstetrics and
Gynaecology Canada, 35(8), 695-696. [PMID: 24007703]
608. Rehm, J., & Shield, K.D. (2013). The impact of counfounding and alcohol consumption patterns on the calculated risks of alcohol-relateddiseases. Commentary on Naimi et al: “Confounding and Studies of ‘Moderate’ Alcohol Consumption: The Case of Drinking Frequency and
Implications for Low-Risk Drinking Guidelines.” Addiction, 108(9), 1544–1553. doi: 10.1111/add.12074. [PMID: 23947725]
607. Roerecke, M., & Rehm, J. (2013). Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction, 108(9), 1562–1578.
doi:10.1111/add.12231 [PMID: 23627868]
606. Samokhvalov, A.V., Gamaleddin, I., Sproule, B., & Rehm, J. (2013). Naltrexone may block euphoria-like placebo effect. BMJ Case Reports,
Published online: Aug 07, 2013. doi:10.1136/bcr-2013-010098 [PMID: 23925680]
605. Lev-Ran, S., Le Foll, B., McKenzie, K., George, T.P. & Rehm, J. (2013). Cannabis use and cannabis use disorders among individuals with mental
illness. Comprehensive Psychiatry, 54(6), 589-598. doi:pii: S0010-440X(13)00018-7. 10.1016/j.comppsych.2012.12.021. [PMID: 23375264]
604. Rehm, J., & Frick, U. (2013). Establishing disability weights from pairwise comparisons for a US burden of disease study. International Journal
of Methods in Psychiatric Research, 22(2), 144–154. doi: 10.1002/mpr.1383. [PMID: 23716479]
603. Rehm, J., & Roerecke, M. (2013). Reduction of drinking in problem drinkers and all-cause mortality. Alcohol and Alcoholism, 48(4), 509-513.
doi: 10.1093/alcalc/agt021 [PMID: 23531718].
602. Shield, K.D., Rehm, J., Gmel, G., Rehm, M.X., & Allamani, A. (2013). Alcohol consumption, alcohol dependence, and related mortality in Italy
in 2004: effects of treatment-based interventions on alcohol dependence. Substance Abuse Treatment, Prevention, and Policy, 8, 21.
doi:10.1186/1747-597X-8-21. [PMID: 23758914]
601. Popova, S., Lange, S., Burd, L., Urbanoski, K., & Rehm, J. (2013). Cost of specialized addiction treatment of clients with Fetal Alcohol Spectrum
Disorder in Canada. BMC Public Health, 13(1), 570. http://www.biomedcentral.com/1471-2458/13/570 [PMID: 23758674]
600. Shield, K.D., Rehm, J., Rehm, M.X., Gmel, G., & Aubin, H.J. (2013). Alcohol consumption, alcohol dependence and related harms in France:
increasing public health by increasing the availability of treatment for alcohol dependence. Journal of Addiction Research & Therapy. S7, 005.
http://dx.doi.org/10.4172/2155-6105.S7-005
599. Lima, M.C.P., Kerr-Correa, F., & Rehm, J. (2013). Consumo de álcool e risco para doença coronariana na região metropolitana de São Paulo:
uma análise do Projeto GENACIS. Revista Brasileira de Epidemiologia, 16(1), 49-57. http://dx.doi.org/10.1590/S1415-790X2013000100005
[PMID: 23681322]
[Alcohol consumption pattern and Coronary Heart Disease risk in Metropolitan São Paulo: analyses of GENACIS Project].
598. Rehm, J., Samokhvalov, A., & Shield, K.D. (2013). Global burden of alcoholic liver diseases. Journal of Hepatology, 59(1), 160-168. doi:pii:
S0168-8278(13)00184-0. 10.1016/j.jhep.2013.03.007. [PMID: 23511777]
597. Lachenmeier, D.W., & Rehm, J. (2013). What is the main source of human exposure to higher alcohols and is there a link to immunotoxicity?
Immunopharmacology and Immunotoxicology, 35(3), 451–453. doi: 10.3109/08923973.2013.794147. [PMID: 23672528]
596. Kerr, W.C., Greenfield, T.K., Ye, Y., Bond, J., & Rehm, J. (2013). Are the 1976-1985 birth cohorts heavier drinkers? Age-period-cohort analyses
of the National Alcohol Surveys 1979-2010. Addiction, 108(6), 1038-1048. doi: 10.1111/j.1360-0443.2012.04055.x. [PMID: 22897662]
595. Fischer, B., Ialomiteanu, A., Boak, A., Adlaf, E., Rehm, J., Mann, R.E. (2013). Prevalence and key covariates of non-medical prescription opioid
use among the general secondary student and adult populations in Ontario, Canada. Drug and Alcohol Review, 32(3), 276-287. doi:
10.1111/dar.12025 [PMID: 23305232]
594. Fischer, B., Jones, W., & Rehm, J. (2013). High correlations between levels of consumption and mortality related to strong prescription opioid
analgesics in British Columbia and Ontario, 2005 – 2009. Pharmacoepidemiology and Drug Safety, 22(4), 438-442. doi: 10.1002/pds.3404
[PMID: 23319301]
- 11 –
593. Flam-Zalcman, R., Mann, R.E., Stoduto, G., Nochajski, T.H., Rush, B.R., Koski-Jännes, A., Wickens, C.M., Thomas, R.K., & Rehm, J. (2013).
Evidence from regression-discontinuity analyses for beneficial effects of a criterion-based increase in alcohol treatment. International Journal
of Methods in Psychiatric Research, 22(1), 59–70. doi: 10.1002/mpr.1374. [PMID: 23165605]
592. Grigoriadis, G., VonderPorten, E.H., Mamisashvili, L., Roerecke, M., Rehm, J., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A.,
& Ross, L.E. (2013). Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review
and meta-analysis of the best evidence. Journal of Clinical Psychiatry, 74(4), e293-308. Doi: 10.4088/JCP.12r07966 [PMID: 23656855]
591. Shield, K.D., Jones, W., Rehm, J., & Fischer, B. (2013). Use and nonmedical use of prescription opioid analgesiscs in the general population of
Canada and correlations with dispensing levels in 2009. Pain Research & Management, 18(2), 69-74. [PMID: 23662288]
590. Bagnardi, V., Botteri, E., Rota, M., Pelucchi, C., Corrao, G., Rehm, J., Boffetta, P., & La Vecchia, C. (2013). Response to “Light drinking has
positive public health consequences”. Annals of Oncology, 24(5), 1421-1422. doi: 10.1093/annonc/mdt103 [PMID: 23493139]
589. Shield, K.D., Rylett, M., Gmel, G.sen., Gmel, G.jun., Kehoe-Chan, T., & Rehm, J. (2013). Global alcohol exposure estimates by country, territory
and region for 2005 – a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addiction, 108(5),
912-922. doi: 10.1111/add.12112. [PMID: 23347092].
588. Popova, S., Lange, S., Burd, L., Chudley, A.E., Clarren, S.K., & Rehm, J. (2013). Cost of Fetal Alcohol Spectrum Disorder diagnosis in Canada.
PLOS One, 8(4), e60434. doi:10.1371/journal.pone.0060434 [PMID: 23593216]
587. Ross, L.E., Grigoriadis, S., Mamisashvili, L., VonderPorten, E.H., Roerecke, M., Rehm, J., Dennis, C.L., Koren, G., Steiner, M., Mousmanis, P., &
Cheung, A. (2013). Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and metaanalysis. JAMA Psychiatry, 70(4), 436-43. doi: 10.1001/jamapsychiatry.2013.684. [PMID: 23446732]
586. Nelson, D.E., Jarman, D.W., Rehm, J., Greenfield, T.K., Rey, G., Kerr, W.C., Miller, P., Shield, K.D., Ye, Y. & Naimi, T.S. (2013). Alcoholattributable cancer deaths and years of potential life lost in the United States. American Journal of Public Health, 103(4), 641-648. doi:
10.2105/AJPH.2012.301199 [PMID: 23409916]
585. Kerridge, B.T., Saha, T.D., Gmel, G., & Rehm, J. (2012). Taxometric analysis of DSM-IV and DSM-5 Alcohol Use disorders. Drug and Alcohol
Dependence, 129(1-2), 60-69. pii: S0376-8716(12)00374-2. doi: 10.1016/j.drugalcdep.2012.09.010. [PMID: 23122488]
584. Gmel, G., Shield, K.D., Kehoe-Chan, T.A.K., & Rehm. J. (2013). The effects of capping the alcohol consumption distribution and relative risk
functions on the estimated number of deaths attributable to alcohol consumption in the European Union in 2004. BMC Medical Research
Methodology, 13(1), 24. http://www.biomedcentral.com/1471-2288/13/24 [PMID: 23419127]
583. Rehm, J., Rehm, M.X., Shield, K.D., Gmel, G., & Gual, A. (2013). Alcohol consumption, alcohol dependence and related harms in Spain, and the
effect of treatment-based interventions on alcohol dependence. Adicciones, 25(1), 11-18. http://www.adicciones.es/files/011018%20SHIELD_con%20apendice.pdf [PMID: 23487275]
582. Lev-Ran, S., Imtiaz, S., Rehm, J., & Le Foll, B. (2013). Exploring the association between lifetime prevalence of mental illness and transition
from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC).
American Journal on Addictions, 2(2), 93-98. doi: 10.1111/j.1521-0391.2013.00304.x. [PMID: 23414492]
581. Neufeld, M., & Rehm, J. (2013). Alcohol consumption and mortality in Russia since 2000 – are there any changes following the alcohol policy
changes starting in 2006? Alcohol and Alcoholism, 48(2), 222-230. doi: 10.1093/alcalc/ags134 [PMID: 23299570]
580. Fischer, B., Ialomiteanu, A., Kurdyak, P., Mann, R.E., & Rehm, J. (2013). Reductions in non-medical prescription opioid use among adults in
Ontario, Canada: are recent policy interventions working? Substance Abuse Treatment, Prevention, and Policy, 8(1), 7. doi:10.1186/1747597X-8-7 [PMID: 23406368]
579. Lev-Ran, S., Le Strat, Y., Imtiaz, S., Rehm, J., & Le Foll, B. (2013). Gender differences in prevalence of substance use disorders among
individuals with lifetime exposure to substances: results from a large representative sample. American Journal on Addictions, 22(1), 7-13. doi:
10.1111/j.1521-0391.2013.00321.x. [PMID: 23398220]
578. Samokhvalov, A.V., Paton-Gay, C.L., Balchand, K., & Rehm, J. (2013). Phenibut dependence. BMJ Case Reports, Published online: Feb 07o,
2013. doi:10.1136/bcr-2012-008381 [PMID: 23391959]
577. Rehm, J., Borges, G., Gmel, G., Graham, K., Grant, B., Parry, C., Poznyak, V. & Room R. (2013). The comparative risk assessment for alcohol as
part of the Global Burden of Disease 2010 study: What changed from the last study? International Journal of Alcohol and Drug Research, 2(1),
1-5. doi: 10.7895/ijadr.v2i1.132 http://www.ijadr.org/index.php/ijadr/article/view/132/93
576. Shield, K.D., Samokhvalov, A.V., & Rehm, J. (2013). Global burden of tuberculosis and lower respiratory infections attributable to alcohol
consumption in 2004. International Journal of Alcohol and Drug Research, 2(1), 11-18. doi: 10.7895/ijadr.v2i1.49
http://www.ijadr.org/index.php/ijadr/article/view/49/96
575. Shield, K.D., Shuper, P.A., Gmel, G. jun., & Rehm, J. (2013). Global Burden of HIV/AIDS in 2004 resulting from alcohol attributable nonadherence to medication regimes. International Journal of Alcohol and Drug Research, 2(1), 19-44. doi: 10.7895/ijadr.v2i1.52
http://www.ijadr.org/index.php/ijadr/article/view/52/97.
574. Sornpaisarn, B., Shield, K., Cohen, J., Schwartz, R., & Rehm, J. (2013). Elasticity of alcohol consumption, alcohol- related harms, and drinking
initiation in low- and middle-income countries: a systematic review and meta-analysis. International Journal of Alcohol and Drug Research,
2(1). 45-58. doi: 107895/ijadr.v2i1.50 http://www.ijadr.org/index.php/ijadr/article/view/50/98
573. Room, R., Bloomfield, K., Grittner, U., Gustafsson, N.-K, Mäkelä, P., Österberg, E., Ramstedt, M., Rehm, J., Wicki, M., & Gmel (2013). What
happened to alcohol consumption and problems in the Nordic countries when alcohol taxes were decreased and borders opened?
International Journal of Alcohol and Drug Research, 2(1), 77-87. doi: 10.7895/ijadr.v2i1.58
572. Rehm, J., Shield, K.D., Rehm, M.X., Gmel, G., & Frick. U. (2013). Modelling the impact of alcohol dependence on mortality burden and the
effect of available treatment interventions in the European Union. European Neuropsychopharmacology, 23(2), 89-97.
doi:10.1016/j.euroneuro.2012.08.001 [PMID: 22920734]
571. Bagnardi, V., Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V., Scotti, S., Jenab, M., Turati, F., Pasquali, E., Pelucchi, C., Bellocco, R.,
Negri, E., Corrao, G., Rehm, J., Boffetta, P., & La Vecchia, C. (2013). Light alcohol drinking and cancer: a meta-analysis. Annals of Oncology,
- 12 –
24(2), 301-308. doi:10.1093/annonc/mds337 [PMID 22910838]
570. Ye, Y., Bond, J., Cherpitel, C.J., Stockwell, T., Macdonald, S., & Rehm, J. (2013). Risk of injury due to alcohol: evaluating potential bias using the
case-crossover usual frequency method. Epidemiology, 24(2), 240-243. doi: 10.1097/EDE.0b013e3182801cb4 [PMID: 23348068]
569. Wickens, C.M., Mann, R.E., Stoduto, G., Ialomiteanu, A., Smart, R.G., & Rehm, J. (2013). The impact of probable anxiety and mood disorder on
self-reported collisions: a population study. Journal of Affective Disorders, 145(1), 253–255. http://dx.doi.org/10.1016/j.jad.2012.04.046
[PMID: 23031745]
568. Roerecke, M., & Rehm, J. (2013). What is best evidence in epidemiology? A reply to Stockwell (2012). Addiction, 108(2), 427-428. doi:
10.1111/j.1360-0443.2012.04051.x. [PMID: 23331884]
567. Roerecke, M., & Rehm, J. (2013). On the evidence of a cardioprotective effect of alcohol consumption. Addiction. 108(2), 429-431. doi:
10.1111/add.12076. [PMID: 23331886]
566. Parry, C., Ferreira-Borges, C. Poznyak, V., Lönnroth, K., & Rehm, J. (2013). The International Study on Alcohol and Infectious Diseases: three
priorities for research. Addiction, 108(1), 1-2. doi: 10.1111/j.1360-0443.2012.04000.x. [PMID: 23075088].
565. Shield, K.D., Gmel, G., Kehoe-Chan, T., Dawson, D.A., Grant, B.F., & Rehm, J. (2013). Mortality and potential years of life lost attributable to
alcohol consumption by race and sex in the United States in 2005. PLOS One, 8(1), e51923. doi:10.1371/journal.pone.0051923. [PMID:
23300957]
564. Shield, K.D., Ialomiteanu, A., Fischer, B., & Rehm, J. (2013). Assessing the prevalence of non-medical prescription opioid use in the Canadian
general adult population: evidence of large variation depending on survey questions used. BMC Psychiatry, 13(1), 6. doi:10.1186/1471-244X13-6 [PMID: 23286378].
563. Lachenmeier, D.W., & Rehm, J. (2013). Is there a relationship between alcohol quality and health? Alcohol & Alcoholism, 48(1), 127-129. doi:
10.1093/alcalc/ags101 [PMID: 22986011]
562. Fischer, B., Dawe, M., McGuire, F., Shuper, P.A., Capler, R., Bilsker, D., Jones, W., Taylor, B., Rudzinski, K., & Rehm, J. (2013). Feasibility and
impact of brief interventions for frequent cannabis users in Canada. Journal of Substance Abuse Treatment. 44(1), 132-138. doi:
10.1016/j.jsat.2012.03.006. [PMID: 22520278]
561. Lachenmeier, D.W., Monakhova, Y.B., Markova, M., Kuballa, T. & Rehm, J. (2013). What happens if people start drinking mouthwash as
surrogate alcohol? A quantitative risk assessment. Food and Chemical Toxicology, 51(1), 173–178. doi: 10.1016/j.fct.2012.09.031. [PMID:
23041419]
560. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S.Y., Alvarado, M., Anderson,
H.R., Anderson, L.M., Andrews, K.G. , Atkinson, C., Baddour, L.M., Barker-Collo, S., Bartels, D.H., Bell, M.L., Benjamin, E.J., Bennett, D., Bhalla,
K., Bikbov, B., Abdulhak, A.B., Birbeck, G., Blyth, F., Bolliger, I., Boufous, S., Bucello, C., Burch, M., Burney, P., Carapetis, J., Chen, H., Chou, D.,
Chugh, S.S., Luc E Coffeng, C. , Colan, S.D., Colquhoun, S., Colson, K.E. , Condon, J., Connor, M.D., Cooper, P.T., Corriere, M., Cortinovis, M.,
Courville de Vaccaro, K., Couser, W., Cowie, B.C., Criqui, M.H., Cross, M., Dabhadkar, K.C., Dahodwala, N., Diego De Leo, D., Degenhardt, L.,
Delossantos, A., Denenberg, J., Des Jarlais, D.C., Dharmaratne, S.D., Dorsey, E.R., Driscoll, T., Duber, H., Ebel, B., Erwin, P.J. , Espindola, P.,
Ezzati, M. , Feigin, V. , Flaxman, A.D. , Forouzanfar, M.H., Fowkes, F.G.R., Franklin, R., Fransen, M., Freeman, M.K. , Gabriel, S.E., Gakidou, E. ,
Gaspari, F., Gillum, R.F., Gonzalez-Medina, D., Halasa, Y.A. , Haring, D. , Harrison, J.E., Havmoeller, R., Hay, R.J., Hoen, B. , Hotez, P.J., Hoy, D. ,
Jacobsen, K.H., James, S.L., Jasrasaria, R., Jayaraman, S., Johns, N. , Karthikeyan, G., Kassebaum, N., Keren, A., Khoo, J-P., Knowlton, L.M. ,
Kobusingye, O., Koranteng, A. , Krishnamurthi, R., Lipnick, M., Lipshultz, S.E. , Lockett Ohno, S., Mabweijano, J., MacIntyre, M.F., Mallinger, L.,
March, L., Marks, G.B. , Marks, R. , Matsumori, A., Matzopoulos, R., Mayosi, B.M., McAnulty, J.H., McDermott, M.M. , McGrath, J., Mensah,
G.A. , Merriman, T.R. , Michaud, C., Miller, M., Miller, T.R., Mock, C., Mocumbi, A.O., Mokdad, A.A., Moran, A., Mulholland, K., Nair, M.N.,
Naldi, L., Narayan, K.M.V., Nasseri, K., Norman, P., O'Donnell, M., Omer, S.B. , Ortblad, K., Osborne, R., Ozgediz, D., Pahari, B. , Pandian, J.D.,
Panozo Rivero, A. , Perez Padilla, R., Perez-Ruiz, F. , Perico, N., Phillips, D., Pierce, K., Pope, C.A. , Porrini, E., Pourmalek, F. , Raju, M. ,
Ranganathan, D., Rehm, J.T., Rein, D.B., Remuzzi, G. , Rivara, F., Roberts, T., Rodriguez De León, F., Rosenfeld, L.C., Rushton, L., Sacco, R.L.,
Salomon, J.A., Sampson, U., Sanman, E., Schwebel, D.C., Segui-Gomez, M., Shepard, D.S., Singh, D., Singleton, J., Sliwa, K. , Smith, E., Steer, A.,
Taylor, J.A. , Thomas, B., Tleyjeh, I.M. , Towbin, J.A., Truelsen, T. , Undurraga, E.A., Venketasubramanian, N., Vijayakumar, L., Vos, T., Wagner,
G.R., Wang, M., Wang, W. , Watt, K., Weinstock, M.A., Weintraub, R., Wilkinson, J.D., Woolf, A.D., Wulf, S., Yeh, P-H., Yip, P. , Zabetian, A.,
Zheng, Z-J., Lopez, A.D., & Murray, C.J.L. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a
systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(9859), 2095-2128. doi:10.1016/S0140-6736(12)61728-0 [PMID:
23245604]
559. Salomon, J.A., Vos, T., Hogan, D.R., Gagnon, M., Naghavi, M., Mokdad, A. , Begum, N., Shah, R., Karyana, M., Kosen, S., Farje, M.R., Moncada,
G., Dutta, A., Sazawal, S., Dyer, A., Seiler, J. , Aboyans, V., Baker, L., Baxter, A., Benjamin, E.J., Bhalla, K., Abdulhak, A.B., Blyth, F., Bourne, R.,
Braithwaite, T., Brooks, P., Brugha, T.S., Bryan-Hancock, C., Buchbinder, R., Burney, P., Calabria, B., Chen, H., Chugh, S.S., Cooley, R., Criqui,
M.H., Cross, M., Dabhadkar, K.C., Dahodwala, N., Davis, A., Degenhardt, L., Díaz-Torné, C., Dorsey, E.R., Driscoll, T., Edmond, K., Elbaz, A.,
Ezzati, M., Feigin, V., Ferri, C.P., Flaxman, A.D., Flood, L., Fransen, M., Fuse, K., Gabbe, B.J., Gillum, R.F., Haagsma, J., Harrison, J.E.,
Havmoeller, R., Hay, R.J., Hel-Baqui, A., Hoek, H.W., Hoffman, H. , Hoegland, E., Hoy, D., Jarvis, D., Karthikeyan, G., Knowlton, L.M., Lathlean,
T., Leasher, J.L., Lim, S.S., Lipshultz, S.E., Lopez, A.D., Lozano, R., Lyons, R., Malekzadeh, R., Marcenes, W., March, L., Margolis, D.J., McGill, N.,
McGrath, J., Mensah, G.A., Meyer, A-C., Michaud, C., Moran, A., Mori, R., Murdoch, M.E., Naldi, L., Newton, C.R., Norman, R., Omer, S.B.,
Osborne, R., Pearce, N., Perez-Ruiz, F., Perico, N., Pesudovs, K., Phillips, D., Pourmalek, F., Prince, M., Rehm, J.T., Remuzzi, G., Richardson, K.,
Room, R., Saha, S., Sampson, U., Sanchez-Riera, L., Segui-Gomez, M., Shahraz, S., Shibuya, K., Singh, D., Sliwa, K., Smith, E., Soerjomataram, I.,
Steiner, T., Stolk, W.A., Stovner, L.J., Sudfeld, C., Taylor, H.R., Tleyjeh, I.M., Van der Werf, M.J., Watson, W.L., Weatherall, D.J., Weintraub, R.,
Weisskopf, M.G., Whiteford, H., Wilkinson, J.D., Woolf, A.D., Zheng, Z.J., & Murray, C.J.L. (2012). Common values in assessing health
outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet, 380(9859),
2129-2143. doi: 10.1016/S0140-6736(12)61680-8. [PMID: 23245605]
558. Vos, T., Flaxman, A.D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J.A., Abdalla, S., Aboyans, V., Abraham, J.,
Ackerman, I., Aggarwal, R., Ahn, S.Y., Ali, M.K., Alvarado, M., Anderson, H.R., Anderson, L.M., Andrews, K.G., Atkinson, C., Baddour, L.M.,
Bahalim, A.N., Barker-Collo, S., Barrero, L.H., Bartels, D.H., Basáñez, M.G., Baxter, A., Bell, M.L., Benjamin, E.J., Bennett, D., Bernabé, E., Bhalla,
K., Bhandari, B., Bikbov, B., Abdulhak, A.B., Birbeck, G., Black, J.A., Blencowe, H., Blore, J.D., Blyth, F., Bolliger, I., Bonaventure, A., Boufous, S.,
Bourne, R., Boussinesq, M., Braithwaite, T., Brayne, C., Bridgett, L., Brooker, S., Brooks, P., Brugha, T.S., Bryan-Hancock, C., Bucello, C.,,
- 13 –
Buchbinder, R., Buckle, G., Budke, C.M., Burch, M., Burney, P., Burstein, R., Calabria, B., Campbell, B., Canter, C.E., Carabin, H., Carapetis, J.,
Carmona, L., Cella, C., Charlson, F., Chen, H., Cheng, A.T., Chou, D., Chugh, S.S., Coffeng, L.E., Colan, S.D., Colquhoun, S., Colson, K.E., Condon,
J., Connor, M.D., Cooper, L.T., Corriere, M., Cortinovis, M., de Vaccaro, K.C., Couser, W., Cowie, B.C., Criqui, M.H., Cross, M., Dabhadkar, K.C.,
Dahiya, M., Dahodwala, N., Damsere-Derry, J., Danaei, G., Davis, A., De Leo, D., Degenhardt, L., Dellavalle, R., Delossantos, A., Denenberg, J.,
Derrett, S., Des Jarlais, D.C., Dharmaratne, S.D., Dherani, M., Diaz-Torne, C., Dolk, H., Dorsey, E.R., Driscoll, T., Duber, H., Ebel, B., Edmond, K.,
Elbaz, A., Ali, S.E., Erskine, H., Erwin, P.J., Espindola, P., Ewoigbokhan, S.E., Farzadfar, F., Feigin, V., Felson, D.T., Ferrari, A., Ferri, C.P., Fèvre,
E.M., Finucane, M.M., Flaxman, S., Flood, L., Foreman, K., Forouzanfar, M.H., Fowkes, F.G., Franklin, R., Fransen, M., Freeman, M.K., Gabbe,
B.J., Gabriel, S.E., Gakidou, E., Ganatra, H.A., Garcia, B., Gaspari, F., Gillum, R.F., Gmel, G., Gosselin, R., Grainger, R., Groeger, J., Guillemin, F.,
Gunnell, D., Gupta, R., Haagsma, J., Hagan, H., Halasa, Y.A., Hall, W., Haring, D., Haro, J.M., Harrison, J.E., Havmoeller, R., Hay, R.J., Higashi, H.,
Hill, C., Hoen, B., Hoffman, H., Hotez, P.J., Hoy, D., Huang, J.J., Ibeanusi, S.E., Jacobsen, K.H., James, S.L., Jarvis, D., Jasrasaria, R., Jayaraman, S.,
Johns, N., Jonas, J.B., Karthikeyan, G., Kassebaum, N., Kawakami, N., Keren, A., Khoo, J.P., King, C.H., Knowlton, L.M., Kobusingye, O.,
Koranteng, A., Krishnamurthi, R., Lalloo, R., Laslett, L.L., Lathlean, T., Leasher, J.L., Lee, Y.Y., Leigh, J., Lim, S.S., Limb, E., Lin, J.K., Lipnick, M.,
Lipshultz, S.E., Liu, W., Loane, M., Ohno, S.L., Lyons, R., Ma, J., Mabweijano, J., Macintyre, M.F., Malekzadeh, R., Mallinger, L., Manivannan, S.,
Marcenes, W., March, L., Margolis, D.J., Marks, G.B., Marks, R., Matsumori, A., Matzopoulos, R., Mayosi, B.M., McAnulty, J.H., McDermott,
M.M., McGill, N., McGrath, J., Medina-Mora, M.E., Meltzer, M., Mensah, G.A., Merriman, T.R., Meyer, A.C., Miglioli, V., Miller, M., Miller, T.R.,
Mitchell, P.B., Mocumbi, A.O., Moffitt, T.E., Mokdad, A.A., Monasta, L., Montico, M., Moradi-Lakeh, M., Moran, A., Morawska, L., Mori, R.,
Murdoch, M.E., Mwaniki, M.K., Naidoo, K., Nair, M.N., Naldi, L., Narayan, K.V., Nelson, P.K., Nelson, R.G., Nevitt, M.C., Newton, C.R., Nolte, S.,
Norman, P., Norman, R., O'Donnell, M., O'Hanlon, S., Olives, C., Omer, S.B., Ortblad, K., Osborne, R., Ozgediz, D., Page, A., Pahari, B., Pandian
JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV,
Polinder, S., Pope 3rd, C.A. , Popova, S., Porrini, E., Pourmalek, F., Prince, M., Pullan, R.L., Ramaiah, K.D., Ranganathan, D., Razavi, H., Regan,
M., Rehm, J.T., Rein, D.B., Remuzzi, G., Richardson, K., Rivara, F.P., Roberts, T., Robinson, C., De Leòn, F.R., Ronfani, L., Room, R., Rosenfeld,
L.C., Rushton, L., Sacco, R.L., Saha, S., Sampson, U., Sanchez-Riera, L., Sanman, E., Schwebel, D.C., Scott, J.G., Segui-Gomez, M., Shahraz, S.,
Shepard, D.S., Shin, H., Shivakoti, R., Singh, D., Singh, G.M., Singh, J.A., Singleton, J., Sleet, D.A., Sliwa, K., Smith, E., Smith, J.L., Stapelberg, N.J.,
Steer, A., Steiner, T., Stolk, W.A., Stovner, L.J., Sudfeld, C., Syed, S., Tamburlini, G., Tavakkoli, M., Taylor, H.R., Taylor, J.A., Taylor, W.J.,
Thomas, B., Thomson, W.M., Thurston, G.D., Tleyjeh, I.M., Tonelli, M., Towbin, J.A., Truelsen, T, Tsilimbaris, M.K., Ubeda, C., Undurraga, E.A.,
van der Werf, M.J., van Os, J., Vavilala, M.S., Venketasubramanian, N., Wang, M., Wang, W., Watt, K., Weatherall, D.J., Weinstock, M.A.,
Weintraub, R., Weisskopf, M.G., Weissman, M.M., White, R.A., Whiteford, H., Wiersma, S.T., Wilkinson, J.D., Williams, H.C., Williams, S.R.,
Witt, E., Wolfe, F., Woolf, A.D., Wulf, S., Yeh, P.H., Zaidi, A.K., Zheng, Z.J., Zonies, D., Lopez, A.D., Murray, C.J. (2012). Years lived with
disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lancet, 380(9859), 2163-2196. doi: 10.1016/S0140-6736(12)61729-2. [PMID: 23245607]
557. Murray, C.J.L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A.D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J.A., Abdalla, S., Aboyans, V.,
Abraham, J., Ackerman, I., Aggarwal, R., Ahn, S.Y., Ali, M.K., Alvarado, M., Anderson, H.R., Anderson, L.M., Andrews, K.G., Atkinson, C.,
Baddour, L.M., Bahalim, A.N., Barker-Collo, S., Barrero, L.H., Bartels, D.H., Basáñez, G., Baxter, A., Bell, M.L., Benjamin, E.J., Bennett, D.,
Bernabé, E., Bhalla, K., Bhandari, B., Bikbov, B., Abdulhak, A.B., Birbeck, G., Black, J.A., Blencowe, H., Blore, J.D., Blyth, F., Bolliger, I.,
Bonaventure, A., Boufous, S., Bourne, R., Boussinesq, M., Braithwaite, T., Brayne, C., Bridgett, L., Brooker, S., Brooks, P., Brugha, T.S., BryanHancock, C., Bucello, C., Buchbinder, R., Buckle, G., Budke, C.M., Burch, M., Burney, P., Burstein, R., Calabria, B., Campbell, B., Canter, C.E.,
Carabin, H., Carapetis, J., Carmona, L., Cella, C., Charlson, F., Chen, H., Cheng, A.T-A., Chou, D., Chugh, S.S., Coffeng, C.E., Colan, S.D.,
Colquhoun, S., Colson, K.E., Condon, J., Connor, M.D., Cooper, L.T., Corriere, M., Cortinovis, M., Courville de Vaccaro, K., Couser, W., Cowie,
B.C., Criqui, M.H., Cross, M., Dabhadkar, K.C., Dahiya, M., Dahodwala, N., Damsere-Derry, J., Danaei, G., Davis, A., De Leo, D., Degenhardt, L.,
Dellavalle, R., Delossantos, A., Denenberg, J., Derrett, S., Des Jarlais, D.C., Dharmaratne, S.D., Dherani, M., Diaz-Torne, C., Dolk, H., Dorsey,
E.R., Driscoll, T., Duber, H., Ebel, B., Edmond, K., Elbaz, A., Eltahir Ali, S., Erskine, H., Erwin, P.J., Espindola, P., Ewoigbokhan, S.E., Farzadfar, F.,
Feigin, V., Felson, D.T., Ferrari, A., Ferri, C.P., Fèvre, E.M., Finucane, M.M., Flaxman, S., Flood, L., Foreman, K., Forouzanfar, M.H., Fowkes, F.G.,
Fransen, M., Freeman, M.K., Gabbe, B.J., Gabriel, S.E., Gakidou, E., Ganatra, H.A., Garcia, B., Gaspari, F., Gillum, R.F., Gmel, G., GonzalezMedina, D., Gosselin, R., Grainger, R., Grant, B., Groeger, J., Guillemin, F., Gunnell, D., Gupta, R., Haagsma, J., Hagan, H., Halasa, Y.A., Hall, W.,
Haring, D., Haro, J.M., Harrison, J.E., Havmoeller, R., Hay, R.J., Higashi, H., Hill, C., Hoen, B., Hoffman, H., Hotez, P.J., Hoy, D., Huang, J.J.,
Ibeanusi, S.E., Jacobsen, K.H., James, S.L., Jarvis, D., Jasrasaria, R., Jayaraman, S., Johns, N., Jonas, J.B., Karthikeyan, G., Kassebaum, N.,
Kawakami, N., Keren, A., Khoo, J-P., King, C.H., Knowlton, L.M., Kobusingye, O., Koranteng, A., Krishnamurthi, R., Laden, F., Lalloo, R., Laslett,
L.L., Lathlean, T., Leasher, J.L., Lee, Y.Y., Leigh, J., Levinson, D., Lim, S.S., Limb, E., Lin, J.K., Lipnick, M., Lipshultz, S.E., Liu, W., Loane, M.,
Lockett Ohno, S., Lyons, R., Mabweijano, J., MacIntyre, M.F., Malekzadeh, R., Mallinger, L., Manivannan, S., Marcenes, W., March, L.,
Margolis, D.J., Marks, G.B., Marks, R., Matsumori, A., Matzopoulos, R., Mayosi, B.M., McAnulty, J.H., McGrath, J., Medina Mora, M.E., Meltzer,
M., Mensah, G.A., Merriman, T.R., Meyer, A-C., Miglioli, V., Miller, M., Miller, T.R., Mitchell, P.B., Mock, C., Mocumbi, A.O., Moffitt, T.E.,
Mokdad, A.A., Monasta, L., Montico, M., Moradi-Lakeh, M., Moran, A., Morawska, L., Mori, R., Murdoch, M.E., Mwaniki, M.K., Naidoo, K.,
Nair, M.N., Naldi, L., Narayan, K.M.V., Nevitt, M.C., Newton, C.R., Nolte, S., Norman, P., Norman, R., O'Donnell, M., O'Hanlon, S., Olives, C.,
Omer, S.B., Ortblad, K., Osborne, R., Ozgediz, D., Page, A., Pahari, B., Pandian, J.D., Panozo Rivero, A., Patten, S.B., Pearce, N., Perez Padilla, R.,
Perico, N., Pesudovs, K., Phillips, D., Phillips, M.R., Pierce, K., Pion, S., Polanczyk, G.V., Polinder, S., Pope III, C.A., Popova, S., Porrini, E.,
Pourmalek, F., Prince, M., Pullan, R.L., Ramaiah, K.D., Ranganathan, D., Razavi, H., Regan, M., Rehm, J.T., Rein, D.B., Remuzzi, G., Richardson,
K., Rivara, F.P., Roberts, T., Robinson, C., Rodriguez De León, F., Ronfani, L., Room, R., Rosenfeld, L.C., Rushton, L., Sacco, R.L., Saha, S.,
Sampson, U., Sanchez-Riera, L., Sanman, E., Schwebel, D.C., Scott, J.G., Segui-Gomez, M., Shahraz, S., Shepard, D.S., Shin, H., Shivakoti, R.,
Singh, D., Singh, G.M., Singh, J.A., Singleton, J., Sleet, D.A., Sliwa, K., Smith, E., Smith, J.L., Stapelberg, N.J.C, Steer, A., Steiner, T., Stolk, W.A.,
Stovner, L.J., Sudfeld, C., Syed, S., Tamburlini, G., Tavakkoli, M., Taylor, H.R., Taylor, J.A., Taylor, W.J., Thomas, B., Thomson, W.M., Thurston,
G.D., Tleyjeh, I.M., Tonelli, M., Towbin, J.A., Truelsen, T., Tsilimbaris, M.K., Ubeda, C., Undurraga, E.A., Van der Werf, M.J., Van Os, J., Vavilala,
M.S., Venketasubramanian, N., Wang, M., Wang, W., Watt, K., Weatherall, D.J., Weinstock, M.A., Weintraub, R., Weisskopf, M.G., Weissman,
M.M., White, R.A., Whiteford, H., Wiebe, N., Wiersma, S.T., Wilkinson, J.D., Williams, H.C., Williams, S.R.M., Witt, E., Wolfe, F., Woolf, A.D.,
Wulf, S., Yeh, P-H., Zaidi, A.K.M., Zheng, Z.J., Zonies, D., & Lopez, A.D. (2012). Disability-adjusted life years (DALYs) for 291 diseases and
injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(9859), 2197-2223. doi:
10.1016/S0140-6736(12)61689-4. [PMID: 23245608]
556. Lim, S.S., Vos, T., Flaxman, A.D., Danaei, G., Shibuya, K., Adair-Rohani, H., Amann, M., Anderson, H.R., Andrews, K.G., Aryee, M., Atkinson, C.,
Bacchus, L.J., Bahalim, A.N., Balakrishnan, K., Balmes, J. , Barker-Collo, S. , Baxter, A., Bell, M.L., Blore, J.D., Blyth, F., Bonner, C., Borges, G.,
Bourne, R., Boussinesq, M., Brauer, M., Brooks, P. , Bruce, N.G., Brunekreef, B., Bryan-Hancock, C., Bucello, C., Buchbinder, R., Bull, F., Burnett,
555.
554.
553.
552.
551.
550.
549.
548.
547.
546.
545.
544.
543.
542.
541.
540.
539.
538.
537.
536.
- 14 –
R.T., Byers, T.E., Calabria, B., Carapetis, J., Carnahan, E., Chafe, Z., Charlson, F., Chen, H., Chen, J.S., Cheng, T-A., Child, J.C., Cohen, A., Colson,
K.E., Cowie, B.C., Darby, S. , Darling, S., Davis, A., Degenhardt, L., Dentener, F., Des Jarlais, D.C., Devries, K., Dherani, M., Ding, E.L., Dorsey,
E.R., Driscoll, T., Edmond, K., Ali, S.E., Engell, R.E., Erwin, P.J., Fahimi, S., Falder, G., Farzadfar, F., Ferrari, A., Finucane, M.M., Flaxman, S.,
Fowkes, F.G., Freedman, G., Freeman, M.K., Gakidou, E., Ghosh, S., Giovannucci, E., Gmel, G., Graham, K., Grainger, R., Grant, B., Gunnell, D.,
Gutierrez, H.R., Hall, W., Hoek, H.W., Hogan, A., Hosgood III, H.D., Hoy, D., Hu, H., Hubbell, B.J., Hutchings, S.J., Ibeanusi, S.E., Jacklyn, G.L.,
Jasrasaria, R., Jonas, J.B., Kan, H., Kanis, J.A., Kassenbaum, N., Kawakami, N., Khang, Y-H., Khatibzadeh, S., Khoo, J-P., Kok, C., Laden, F., Lalloo,
R., Lan, Q., Lathlean, T., Leasher, J.L., Leigh, J. , Li, Y., Lin, J.K., Lipshultz, S.E., London, S., Lozano, R., Lu, Y., Mak, J., Malekzadeh, R., Mallinger,
L., Marcenes, W., March, L., Marks, R.E., Martin, R.E., McGale, P., McGrath, J., Mehta, S., Mensah, G.A., Merriman, T.R., Micha, R., Michaud,
C., Mishra, V., Hanafiah, K.M., Mokdad, A.A., Morawska, L., Mozaffarian, D., Murphy, T., Naghavi, M., Neal, B., Nelson, P.K., Nolla, J.M.,
Norman, R., Olives, C., Omer, S.B., Orchard, J., Osborne, R.h., Ostro, B., Page, A., Pandey, K.D., Parry, C.D., Passmore, E., Patra, J., Pearce, N.,
Pelizarri, P.M., Petzold, M., Phillips, M.R., Pope, D., Pope III, C.A., Powles, J., Rao, M., Razavi, H., Rehfuess, E.A., Rehm, J.T., Ritz, B., Rivara, F.P.,
Roberts, T., Robinson, C., Rodriguez-Portales, J.A., Romieu, I., Room, R., Rosenfeld, L.C., Roy, A., Rushton, L., Salomon, J.A., Sampson, U.,
Sanchez-Riera, L., Sanman, E., Sapkota, A., Seedat, S., Shi, P., Shield, K.D., Shivakoti, R., Singh, G.M., Sleet, D.A., Smith, E., Smith, K.R.,
Stapelberg, N.J., Steenland, K., Stöckl, H., Stovner, P., Straif, K., Straney, L., Thurston, G.D., Tran, J.H., Dingenen, R.V., Van Donkelaar, A.,
Lennert Veerman, J., Vijayakumar, L., Weintraub, R., Weissman, M.M., White, R.A., Whiteford, H., Wiersma, S.T., Wilkinson, J.D., Williams,
H.C., Williams, W., WIlson, N., Woolf, A.D., Yip, P., Zielinski, J.M., Lopez, A.D., Murray, C.L., & Ezzati, M. (2012). A comparative risk assessment
of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the
Global Burden of Disease Study 2010. Lancet, 380(9859), 2224-2260. doi:10.1016/S0140-6736(12)61766-8 [PMID: 23245609]
Katt, M., Chase, C., Samokhvalov, A.V., Argento, E., Rehm, J., & Fischer, B. (2012). Feasibility and outcomes of a community-based taper-tolow-dose-maintenance suboxone treatment program for prescription opioid dependence in a remote First Nations community in Northern
Ontario. Journal of Aboriginal Health, 9(1), 52-59.
Lev-Ran, S., Le Foll, B., McKenzie, K., & Rehm, J. (2012). Cannabis use and mental health-related quality of life among individuals with anxiety
disorders. Journal of Anxiety Disorders, 26(8), 799-810. doi: 10.1016/j.janxdis.2012.07.002. [PMID: 23023160].
Fischer, B., Lusted, A., Roerecke, M., Taylor, B., & Rehm, J. (2012). The prevalence of mental health and pain symptoms in general population
samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis. Journal of Pain, 13(11), 1029-1044. doi:
10.1016/j.jpain.2012.07.013. [PMID: 23040158]
Roerecke, M., & Rehm, J. (2012). Alcohol intake revisited: risks and benefits. Current Atherosclerosis Reports, 14(6), 556-562. doi:
10.1007/s11883-012-0277-5. [PMID: 22864603]
Soyka, M., Träder, A., Klotsche, J., Haberthür, A., Bühringer, G., Rehm, J., & Wittchen, H.U. (2012). Criminal behavior in opioid-dependent
patients before and during maintenance therapy: 6-year follow-up of a nationally representative cohort sample. J Forensic Sci., 57(6),15241530. doi: 10.1111/j.1556-4029.2012.02234.x. [PMID: 22845057]
Klotsche, J., Ferger, D., Leistner, D., Pieper, L., Zeiher, A.M., Wittchen H.-U., & Rehm, J. (2012). Binary regression: total gain in positive and
negative predictive. Biometrical Journal, 54(6), 808-823. doi: 10.1002/bimj.201100104. [PMID: 23044820]
Babor, T., Rehm, J., Jernigan, D., Vaeth, P., Monteiro, M., & Lehman, H. (2012). Alcohol, diabetes and public health interventions in the
Americas. Revista Panamericana de Salud Pública/Pan American Journal of Public Health, 32(2), 151–155. [PMID: 23099877]
Mann, R.E., Ialomiteanu, A.R., Chan, V., Cheung, J.T.W., Stoduto, G., Ala-Leppilampi, K., Wickens, C.M., & Rehm, J. (2012). Relationships of
alcohol use and alcohol problems to probable anxiety and mood disorder. Contempory Drug Problems, 39(2), 247-263.
Taylor, B., & Rehm, J. (2012). The relationship between alcohol consumption and fatal motor vehicle injury: high risk at low alcohol levels.
Alcoholism: Clinical and Experimental Research, 36(10),1827-1834. doi: 10.1111/j.1530-0277.2012.01785.x. [PMID: 22563862]
Rehm, J. (2012). Cost of illness studies for alcohol consumption – Why are they still in demand? Nordic Studies on Alcohol and Drugs, 29(4),
345-347.
Popova, S., Lange, S., Burd, L., & Rehm, J. (2012). Health care burden and cost associated with Fetal Alcohol Syndrome in Canada: Based on
official Canadian data. PLOS One, 7(8), e43024. [PMID: 22900084]
Fischer, B., Nakamura, N., Urbanoski, K., Rush, B., & Rehm, J. (2012). Correlations between population levels of prescription opioid use and
prescription-opioid-related substance use treatment admissions in the USA and Canada since 2001. Public Health, 126(9), 749-751. [PMID:
22770736]
Sornpaisarn, B., Shield, K.D., & Rehm, J. (2012). Alcohol taxation policy in Thailand: implications for other low- to middle-income countries.
Addiction, 107(8), 1372-1384. [PMID: 22324742]
Sornpaisarn, B., Shield, K., & Rehm (2012). Two-chosen-one taxation: examining its potential effectiveness to reduce drinking initiation and
heavy alcohol consumption in low- to middle-income countries. Addiction, 107(8), 1389-1390. [PMID: 22779414]
Reissner, V., Kokkevi, A., Schifano, F., Room, R., Storbjörk, J., Stohler, R., Difuria, L., Rehm, J., Geyer, M., Hölscher, F., & Scherbaum, N. (2012).
Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project).
European Psychiatry, 27(6), 455-462. [PMID: 21277750]
Martin, G., & Rehm, J. (2012). The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: a review of the
evidence. Canadian Journal of Psychiatry, 57(6), 350–358. [PMID: 22682572]
Patra, J., Giesbrecht, N., Rehm, J., Bekmuradov, D., & Popova, S. (2012). Are alcohol prices and taxes an evidence-based approach to reducing
alcohol-related harm and promoting public health and safety? A systematic literature review. Contemporary Drug Problems, 39(1), 7-48.
Rudzinski, K., McGuire, F., Dawe, M., Shuper, P., Bilsker, D., Capler, R., Rehm, J. & Fischer, B. (2012). Brief Intervention (BI) experiences and
perceptions among high-frequency cannabis users in a Canadian university student population. Contemporary Drug Problems, 39(1), 49-72.
Rehm, J. & Pollock, B. (2012). Why do we need yet another journal? International Journal of Alcohol and Drug Research, 1(1).
Roerecke, M., & Rehm, J. (2012). The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic
review and meta-analysis. Addiction, 107(7), 1246-60. doi: 10.1111/j.1360-0443.2012.03780.x [PMID: 22229788]
- 15 –
535. Popova, S. & Rehm, J. (2012). Commentary on Jarl & Gerdtham (2012): Further evidence of the reversal of alcohol-related risk of oesophageal
cancer after alcohol cessation. Addiction, 107(7), 1244–1245. [PMID: 22672374]
534. Lev-Ran, S., Imtiaz, S., Taylor, B.J., Shield, K.D., Rehm, J., Le Foll, B. (2012). Gender differences in health-related quality of life among cannabis
users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence. 123(1-3), 190-200.
[PMID: 22143039]
533. Schwappach, D., Popova, S., Mohapatra, S., Patra, J., Godinho, A., & Rehm, J. (2012). Strategies for evaluating the economic value of drugs in
alcohol dependence treatment. Drug and Alcohol Dependence, 122(3), 165-173. [PMID: 21924845]
532. Shield, K., Gmel, G., Patra, J., & Rehm, J. (2012). Global burden of injuries attributable to alcohol consumption in 2004: a novel way of
calculating the burden of injuries attributable to alcohol consumption. Population Health Metrics, 10(1), 9. [PMID 22607112]
531. Lachenmeier, D.W., Przybylski, M.C., & Rehm, J. (2012). Comparative risk assessment of carcinogens in alcoholic beverages using the margin
of exposure approach. International Journal of Cancer, 131(6), E995–E1003. doi: 10.1002/ijc.27553. [PMID: 22447328]
530. Fischer, B., Jones, W., Shuper, P., & Rehm, J. (2012). 12-month follow-up of an exploratory 'brief intervention' for high-frequency cannabis
users among Canadian university students. Substance Abuse Treatment, Prevention, and Policy, 7, 15. doi: 10.1186/1747-597X-7-15. [PMID:
22538183]
529. Kehoe, T., Gmel, G. jun., Shield, K., Gmel, G. sen., & Rehm, J. (2012). Determining the best population-level alcohol consumption model and
its impact on estimates of alcohol-attributable harms. Population Health Metrics, 10(1), 6. doi: 10.1186/1478-7954-10-6 [PMID: 22490226]
528 Shield, K.D., Kehoe, T., Taylor, B., Patra, J., & Rehm, J. (2012). Alcohol-attributable burden of disease and injury in Canada, 2004.
International Journal of Public Health, 57(2), 391-401. [PMID: 21465246]
527. Lachenmeier, D.W., & Rehm, J. (2012). Illegally produced alcohol. Perhaps not such a great threat to public health in the UK. British Medical
Journal, 344, e2251.
526. Kurdyak, P., Gomes, T., Yao, Z., Mamdani, M.M., Hellings, C., Fischer, B., Rehm, J., Bayoumi, A.M., & Juurlink, D.N. (2012). Use of other opioids
during methadone therapy: a population-based study. Addiction, 107(4), 776-780. [PMID: 22050078]
525. Lachenmeier, D.W., & Rehm, J. (2012). Moderate red wine drinking does not help cut women’s breast cancer risk. Journal of Women`s
Health, 21(4), 469-470. [PMID: 22385052]
524. Shield, K.D., & Rehm, J. (2012). Difficulties with telephone-based surveys on alcohol in high-income countries: the Canadian example.
International Journal of Methods in Psychiatric Research, 21(1), 17-28. [PMID: 22337654]
523. Room, R., & Rehm, J. (2012). Clear criteria based on absolute risk: reforming the basis of guidelines on low-risk drinking. Drug and Alcohol
Review, 31(2), 135-140. [PMID: 22168584]
522. Rehm, J. & Patra, J. (2012). Different guidelines for different countries? On the scientific basis of low-risk drinking guidelines and their
implications. Drug and Alcohol Review, 31(2), 156-161. [PMID: 22150871]
521. Popova, S., Stade, B., Lange, S., & Rehm, J. (2012). A model for estimating the economic impact of Fetal Alcohol Spectrum Disorder. Journal
of Population Therapeutics and Clinical Pharmacology, 19(1), e51-e65.
520. Frick, U., Irving, H., Rehm, J. (2012). Social relationships as a major determinant in the valuation of health states. Quality of Life Research.
21(2), 209-213. [PMID: 21633877]
519. Fischer, B., Dawe, M., McGuire, F., Irving, H., Shuper, P., Jones, W., Rudzinski, K. & Rehm, J. (2012). Characteristics of and predictors of health
problems from use among high-frequency cannabis users in a Canadian university student population. Drugs: Education, Prevention, and
Policy, 19(1), 49-58. (doi: 10.3109/09687637.2011.614970)
518. Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H.U., Jönsson, B., Jordanova, A., Musayev, A., Gabilondo, A., Maercker, A., Melin, B.,
Walder, B., Gannon, B., Schlehofer, B., Faravelli, C., Allgulander, C., Ljungcrantz, C., Jacobi, C., Muresanu, D.F., Hilton Jones, D., Ehler, E., Beghi,
E., Norwood, F., Aguilera, F., Jacobi, F., Kobelt, G., Meinlschmidt, G., Steinhausen, H.C., Verschuuren, J., Vallat, J.M., Glaus, J., Reese, J.P., van
Os, J., Bentzen, J., Alonso, J., Garcia-Ibanez, J., Dams, J., Rehm, J., Lauer, K., von Wild, K., Karampampa, K., Stovner, L.J., Vécsei, L., Fratiglioni,
L., van den Berg, L.H., Jönsson, L., Salvador-Carulla, L., Perrin, M., Milenkova, M., Knapp, M., Preisig, M., Moscarelli, M., Ekman, M., Linde, M.,
Pugliatti, M., Rogers, M.M., Tenovuo, O., Van den Bergh, P., Azouvi, P., Vos, P., Jennum, P., Martinez-Leal, R., Dodel, R., Simon, R., Lieb, R.,
Drabsch, S., Otero, S., Kurth, T., Xu, W., Winter, Y., CDBE2010 study group, & European Brain Council (2012). The economic cost of brain
disorders in Europe. European Journal of Neurology, 19(1), 155-62. [PMID: 22175760]
517. Shield, K.D., Taylor, B., Kehoe, T., Patra, J., & Rehm, J. (2012). Mortality and potential years of life lost attributable to alcohol consumption in
Canada in 2005. BMC Public Health, 12(1), 91. [PMID: 22293064]
516. Lachenmeier, D.W., Monakhova, Y.B., Samokhvalov, A.V., & Rehm, J. (2012). Causality between polyhexamethyleneguanidine occurrence in
unrecorded alcohol and cholestatic hepatitis outbreak in Russia. Clinical Toxicology, 50(2), 154-155.[PMID: 22216917]
515. Rehm, J., Shield, K.D., Joharchi, N., & Shuper, P.A. (2012). Alcohol consumption and the intention to engage in unprotected sex: systematic
review and meta-analysis of experimental studies. Addiction, 107(1), 51–59. [PMID: 22151318]
514. Popova, S., Patra, J., Sarnocinska-Hart, A., Gnam, W.H., Giesbrecht, N., & Rehm, J. (2012). Costs of privatization vs. government alcohol
retailing systems: Canadian example. Drug and Alcohol Review, 31(1), 4-12. [PMID: 21355934]
513. Popova, S., Patra, J., Gnam, W., Sarnocinska Hart, A., Mann, R., & Rehm, J. (2011). Alcohol-related laws and avoidable burden and its costs
due to motor vehicle collisions in Canada. Contemporary Drug Problems, 38(3), 467-485.
512. Solodun, Y.V., Monakhova, Y.B., Kuballa, T., Samokhvalov, A.V., Rehm, J., & Lachenmeier, D.W. (2011). Unrecorded alcohol consumption in
Russia: toxic denaturants and disinfectants pose additional risks. Interdisciplinary Toxicology, 4(4), 198-205. [PMID: 22319254]
511. Nakamura, N., Dawe, M., McGuire, F., Rudzinski, K., Jones, W., Rehm, J., & Fischer, B. (2011). Gender differences in cannabis use related
characteristics in high frequency using Canadian university students: An exploratory study. Women's Health and Urban Life, 10(2), 81-93.
510. Rehm, J. (2011). The risks associated with alcohol use and alcoholism. Alcohol Research and Health, 34(2), 135-143. [PMID: 22330211]
509. Roerecke, M., Greenfield, T., Kerr, W., Bondy, S., Cohen, J., & Rehm, J. (2011). Heavy drinking occasions in relation to ischaemic heart disease
mortality – An 11-22 year follow-up of the 1984 and 1995 US National Alcohol Surveys. International Journal of Epidemiology, 40(5), 1401-
- 16 –
1410. [PMID: 22039198]
508. Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., Gannon, B.,
Jones, D.H., Jennum, P., Jordanova, A., Jönsson, L., Karampampa, K., Knapp, M., Kobelt, G., Kurth, T., Lieb, R., Linde, M., Ljungcrantz, C.,
Maercker, A., Melin, B., Moscarelli, M., Musayev, A., Norwood, F., Preisig, M., Pugliatti, M., Rehm, J., Salvador-Carulla, L., Schlehofer, B.,
Simon, R., Steinhausen, H.C., Stovner, L.J., Vallat, J.M., den Bergh, P.V., van Os, J., Vos, P., Xu, W., Wittchen, H.U., Jönsson, B., Olesen, J.; on
behalf of the CDBE2010 study group (2011). Cost of disorders of the brain in Europe 2010. European Neuropsychopharmacology, 21(10), 718779. [PMID: 21924589]
507. Zatonski, W., Manczuk, M., Sulkowska, U., Didkowska, J., Wojciechowska, U., Tarkowski, W., Przewozniak, K., Gumkowski, J., Janik-Koncewicz,
K., Boffetta, P., Campos, H., LaVecchia, C., Powles, J., Rehm, J., Willet, W., Negri, E., Aaro, L., Boyle, P., Gilmore, A., Jougla, E., Moreno, J.M.,
Lowenfels, A., Paccaud, F., Peto, R., Petric, V.K., Puska, P., Klumbiene, J., Pudule, I., Kiivet, R., Aaviksoo, A., Albreht, T., Kaposvari, C., Dimitrov,
P., Holcatova, I., Pilipcinova, A., Poledne, R., Marcinkova, D., Furtunescu, F., Bagnardi, V., Baliunas, D., Brozova, J., Vrbanova, H., Bene, M.,
West, R., Jarvis, M., Bohm, G., Kunze, M., Gisle, L., Joossens, L., Storm, H., Laatikainen, T., Wilquin, J.J., Ratte, S., Thyrian, R., Gallus, S.,
Zeegers, T., Prins, T., Munoz, E.F., Karlsson, A.S., Halicka, E., Lund, J., Moskalewicz, J., Patra, J., Pavillon, G., Popova, S., Scotti, L., & Taylor, B.
(2011). Epidemiological analysis of health situation development in Europe and its causes until 1990. Annals of Agricultural and
Environmental Medicine, 18(2), 194-202.
506. Fischer, B., Jones, W., Krahn, M., & Rehm, J. (2011). Differences and changes in levels and trends of prescription opioid analgesic (POA) use
dispensed from retail pharmacies in Canada, 2005 – 2010. Pharmacoepidemiology and Drug Safety, 20(12), 1269-77. [PMID: 21755568]
505. Kerr, W., Greenfield, T., Bond, J., Ye, Y., & Rehm, J. (2011). Race and ethnicity group differences in all-cause mortality risk from alcohol
consumption patterns in the US National Alcohol Surveys. American Journal of Epidemiology, 174(7), 769-778. [PMID: 21856649]
504. Lachenmeier, D.W., Taylor, B., & Rehm, J. (2011). Lack of evidence for a causal association between the type of alcoholic beverage and the
incidence of acute pancreatitis. Pancreas, 40(7), 1143-1144. [PMID: 21926552]
503. Fischer, B., Jeffries, V., Hall, W., Room, R., Goldner, E., & Rehm, J. (2011). Lower risk cannabis use guidelines for Canada (LRCUG): a narrative
review of evidence and recommendations. Canadian Journal of Public Health, 102(5):324-327. [PMID: 22032094]
502. Shield, K.D., Ialomiteanu, A., Fischer, B., Mann, R.E., & Rehm, J. (2011). Non-medical use of prescription opioids among Ontario adults: data
from the 2008/2009 CAMH Monitor. Canadian Journal of Public Health, 102(5), 330-335. [PMID: 22032096]
501. Popova, S., Lange, S., Bekmuradov, D., Mihic, A., & Rehm, J. (2011). Fetal Alcohol Spectrum Disorder prevalence estimates in correctional
systems: a systematic literature review. Canadian Journal of Public Health, 102(5), 336-340. [PMID: 22032097]
500. McGuire, F., Dawe, M., Shield, K.D., Rehm, J., & Fischer, B. (2011). Driving under the influence of cannabis or alcohol in a cohort of high
frequency cannabis users: prevalence and reflections on current interventions. Canadian Journal of Criminology and Criminal Justice, 53(2),
247-262.
499. Wittchen, H.U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., Fratiglioni, L.,
Jennum, P., Lieb, R., Maercker, A., van Os, J., Preisig, M., Salvador-Carulla, L., Simon, R., & Steinhausen, H.C. (2011). The size and burden of
mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology, 21(9), 655–679. [PMID: 21896369]
498. Soyka, M., Träder, A., Klotsche, J., Backmund, M., Bühringer, G., Rehm, J., & Wittchen, H.U. (2011). Six-year mortality rates of patients in
methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study. Journal of Clinical
Psychopharmacology, 31(5), 678-680. [PMID: 21881461]
497. Parry, C., Patra, J., & Rehm, J. (2011). Alcohol consumption and non-communicable diseases: epidemiology and policy implications.
Addiction, 106(10), 1718–1724. [PMID: 21819471]
496. Wittchen, H.-U., Bühringer, G., & Rehm, J. (2011). Editorial zu Ergebnissen und Schlussfolgerungen der PREMOS-Studie. Suchtmedizin in
Forschung und Praxis, 13(5), 200-201.
[Predictors, moderators and outcome of substitution treatment in the German PREMOS study.]
495. Langer, K., Wittchen, H.-U., Bühringer, G., & Rehm, J. (2011). Die Substitutionsbehandlung Opioidabhängiger: Grundlagen,
Versorgungssituation und Problembereiche. Suchtmedizin in Forschung und Praxis, 13(5), 202-212.
[Opioid maintenance treatment of opioid dependent patients: background, care structure and challenges.]
494. Wittchen, H.-U., Rehm, J., Soyka, M., Langer, K., Träder, A., Trautmann, S., & Bühringer, G. (2011). Ziele und Methodik der PREMOS-Studie
(PREdictors, Moderators and Outcome of Substitution treatments). Suchtmedizin in Forschung und Praxis, 13(5), 213-226.
[Aims and Methods of the PREMOS Study (PREdictors, Moderators and Outcome of Substitution treatments)]
493. Wittchen, H.-U., Bühringer, G., Rehm, J., Soyka, M., Träder, A., & Trautmann, S. (2011). Die soziale, klinische und therapeutische Situation von
Substitutionspatienten: Der Status der PREMOS-Patienten bei Studienbeginn (Baseline t1). Suchtmedizin in Forschung und Praxis, 13(5), 227231.
[The social, clinical and treatment situation of opioid maintenance treatment in a prevalence sample of patients at baseline.]
492. Wittchen, H.-U., Bühringer, G., Rehm, J., Soyka, M., Träder, A., Mark, K., & Trautmann, S. (2011). Der Verlauf und Ausgang von
Substitutionspatienten unter den aktuellen Bedingungen der deutschen Substitutionsversorgung nach 6 Jahren. Suchtmedizin in Forschung
und Praxis, 13(5), 232-246.
[The 6-years course and outcome of opioid maintenance treatment of 1.624 patients in the German substitution system.]
491. Soyka, M., Träder, A., Klotsche, J., Backmund, M., Bühringer, G., Rehm, J., & Wittchen, H.U. (2011). Mortalität in der langfristigen
Substitution: Häufigkeit, Ursachen und Prädiktoren. Suchtmedizin in Forschung und Praxis, 13(5), 247-252.
[Mortality in long-term opioid maintenance treatment in Germany: frequency, causes and predictors.]
490. Wittchen, H.-U., Trautmann, S., Träder, A., Klotsche, J., Backmund, M., Bühringer, G., & Rehm, J. (2011). Abstinenz als ein Behandlungsziel der
opiatgestützten Substitutionstherapie: Häufigkeit und Risiken. Suchtmedizin in Forschung und Praxis, 13(5), 253-257.
[Abstinence as a treatment goal in opiate maintenance treatments: frequency and risks.]
489. Wittchen, H,-U., Träder, A., Klotsche, J., Backmund, M., Bühringer, G., & Rehm, J. (2011). Die Rolle der Psychosozialen Begleitung in der
langfristigen Substitutionsbehandlung. Suchtmedizin in Forschung und Praxis, 13(5), 258-262.
[The role of psychosocial Interventions in long-term opioid-maintenance treatment of opioid-dependent patients in Germany]
- 17 –
488. Wittchen, H,-U., Träder, A., Klotsche, J., Backmund, M., Bühringer, G., Rehm, J., & Soyka, M. (2011). Die Rolle des Substitutionsmittels und
seiner Dosierung in der langfristigen Substitutionsbehandlung. Suchtmedizin in Forschung und Praxis, 13(5), 263-268.
[The role of different substitution drugs and dosage in long-term opioid maintenance treatment]
487. Wittchen, H,-U., Bühringer, G., Rehm, J., & Klotsche, J. (2011). Die Stabilität der 6-Jahres-Langzeitbefunde in PREMOS: Ein Vergleich mit den
7-Jahres-Daten ein Jahr später. Suchtmedizin in Forschung und Praxis, 13(5), 269-271.
[The stability of 6-year course and outcome data about opioid maintenance treatment: a comparison of 6 to 7-year data]
486. Wittchen, H,-U., Bühringer, G., Rehm, J., & Trautmann, S. (2011). Einrichtungscharakteristika und Behandlungsformate von
Substitutionseinrichtungen. Suchtmedizin in Forschung und Praxis, 13(5), 272-277.
[Characteristics of substitution settings and treatment format in Germany]
485. Wittchen, H,-U., Bühringer, G., & Rehm, J. (2011). Zusammenfassung der Ergebnisse der PREMOS (PREdictors, Moderators and Outcome of
Substitution treatments) -Studie. Suchtmedizin in Forschung und Praxis, 13(5), 280-286.
[Summary of the results of the PREMOS (PREdictors, Moderators and Outcome of Substitution treatments) study]
484. Wittchen, H,-U., Rehm, J., Gölz, J., Kraus, M., Schäfer, M., Soyka, M., Scherbaum, N., Backmund, M., & Bühringer, G. (2011).
Schlussfolgerungen und Empfehlungen für eine bedarfs- und zielgruppengerechtere Gestaltung der langfristigen Substitution
Opioidabhängiger. Suchtmedizin in Forschung und Praxis, 13(5), 287-293.
[Conclusions and recommendations for a more relevant treatment layout in long-term opioid substitution therapy]
483. Wittchen, H.-U., Bühringer, G., & Rehm, J. (2011). Kurzbericht der an das Bundesministerium für Gesundheit. Suchtmedizin in Forschung und
Praxis, 13(5), 294-295.
[Short report of the PREdictors, Moderators and Outcome of Substitution treatments (PREMOS) study to the German Ministry of Health]
482. Lange, S., Rehm, J., & Popova, S. (2011). The effectiveness of criminal justice diversion initiatives in North America: a systematic literature
review. International Journal of Forensic Mental Health. 10, 200-214. doi: 10.1080/14999013.2011.598218
481. Le Strat, Y., Rehm, J., & Le Foll, B. (2011). How generalizable to community samples are clinical trial results for treatment of nicotine
dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey. Tobacco
Control, 20(5), 338-43. [PMID: 21212379]
480. Amari, E., Rehm, J., Goldner, E., & Fischer, B. (2011). Non-medical prescription opioid use and mental health and pain comorbidities: A
narrative review. Canadian Journal of Psychiatry, 56(8), 495–502. [PMID: 21878161] (plus two e-Tables downloadable from the journal
website)
479. Popova, S., Mohapatra, S., Patra, J., Duhig, A., & Rehm, J. (2011). A literature review of cost-benefit analyses for the treatment of alcohol
dependence. International Journal of Environmental Research and Public Health, 8(8), 3351-3364. [PMID: 21909311]
478. Room, R., Rehm, J., & Parry, C. (2011). Alcohol and non-communicable diseases (NCDs): time for a serious international public health effort.
Addiction, 106(9), 1547-1548. [PMID: 21815918]
477. Mann, R.E., Paglia-Boak, A., Adlaf, E.M., Beitchman, J., Wolfe, D., Wekerle, C., Hamilton, H., & Rehm. J. (2011). Estimating the prevalence of
anxiety and mood disorders in an adolescent general population: an evaluation of the GHQ12. International Journal of Mental Health and
Addiction, 9(4), 410–420. DOI 10.1007/s11469-011-9334-5
476. Patra, J., Bakker, R., Irving, H., Jaddoe, V.W.V., Malini, S., & Rehm, J. (2011). Dose-response relationship between alcohol consumption before
and during pregnancy and risk of low birth weight, preterm birth and small for gestational age (SGA) – A systematic review and metaanalyses. BJOG: An International Journal of Obstetrics & Gynaecology, 118(12):1411-21. [PMID: 21729235]
475. Rehm, J., & Roerecke, M. (2011). Alcohol, the heart and the cardiovascular system – what do we know and where should we go? Drug and
Alcohol Review, 30(4), 335–337. [PMID: 21726306]
474. Lachenmeier, D.W., Leitz, J., Schoeberl, K., Kuballa, T., Straub, I., & Rehm, J. (2011). Quality of illegally and informally produced alcohol in
Europe: results from the AMPHORA project. Adicciones, 23(2), 133-140. [PMID: 21647540]
473. Gmel, G., Kuntsche, E., & Rehm, J. (2011). Risky single occasion drinking: bingeing is not bingeing. Addiction, 106(6), 1037-1045. [PMID:
21564366]
472. Gmel, G., Kuntsche, E., & Rehm, J. (2011). Risky single occasion drinking research: the four stages of enlightenment. Addiction, 106(6), 10501051. [PMID: 21564371]
471. Taylor, B., Shield, K., & Rehm, J. (2011). Combining best evidence: A novel method to calculate the alcohol-attributable fraction and its
variance for injury mortality. BMC Public Health, 11, 265. [PMID: 21524291]
470. Rehm, J. (2011). Die Globale Strategie zur Reduktion schädlichen Alkoholkonsums: ein erster Schritt zu einer „Rahmenkonvention Alkohol“
der WHO Mitgliedstaaten? Sucht, 57(2), 81-83.
[Global strategy to reduce the harmful use of alcohol: first step towards an alcohol framework convention?]
469. Shield, K., Rehm, M., Patra, J., Sornpaisarn, B., & Rehm, J. (2011). Global and country specific adult per capita consumption of alcohol, 2008.
Sucht,.57(2), 99-117.
468. Popova, S., Stade, B., Bekmuradov, D., Lange, S., & Rehm, J. (2011). What do we know about the economic impact of Fetal Alcohol Spectrum
Disorder? A systematic literature review. Alcohol and Alcoholism, 46(4), 490-497. [PMID: 21515625]
467. Gmel, G. Jun., Shield, K.D., Frick, H., Kehoe, T., Gmel, G., & Rehm, J. (2011). Estimating uncertainty of alcohol-attributable fractions for
infectious and chronic diseases. BMC Medical Research Methodology, 11, 48. [PMID: 21496313]
466. Schütze, M., Boeing, H., Pischon, T., Rehm, J, Kehoe, T., Gmel, G., Olsen, A., Tjønneland, A., Dahm, C.C., Overvad, K., Clavel-Chapelon, F.,
Boutron-Ruault, M.-C., Trichopoulou, A., Benetou, V., Zylis, D., Kaaks, R., Rohrmann, S., Palli, D., Berrino, F., Tumino, R., Vineis, P., Rodríguez,
L., Agudo, A., Sánchez, M.-J., Dorronsoro, M., Chirlaque, M.D., Barricarte, A., Peeters, P.H., van Gils, C.H., Khaw, K.-T., Wareham, N., Allen,
N.E., Key, T., Boffetta, P., Slimani, N., Jenab, M., Romaguera, D., Wark, P.A., Riboli, E., & Bergmann, M.M. (2011). Alcohol-attributable burden
of cancer incidence in 8 European countries based on results from a prospective cohort study. British Medical Journal, 342, d1584. doi:
10.1136/bmj.d1584. [PMID: 21474525]
465. Mann, R.E., Cheung, J.T.W., Ialomiteanu, A., Stoduto, G., Chan, V., Wickens, C.M., Ala-Leppilampi, K., Goldbloom, D., & Rehm, J. (2011).
464.
463.
462.
461.
460.
459.
458.
457.
456.
455.
454.
453.
452.
451.
450.
449.
448.
447.
446.
445.
444
443.
442.
441.
440.
439.
- 18 –
Estimating prevalence of anxiety and mood disorder in survey data using the GHQ12: exploration of threshold values. European Journal of
Psychiatry, 25(2), 81-91. http://dx.doi.org/10.4321/S0213-61632011000200003
Rehm, J., Frick, U., & Fischer, B. (2011). Substanzgebrauchsstörungen“ – ein neuer Ansatz im DSM 5? Sucht, 57(1), 54-55. DOI: 10.1024/09395911.a000073
[English Translation: Substance-Use Disorders – A new Approach in DSM 5?]
Nakamura, N., Ialomiteanu, A., Rehm, J., & Fischer, B. (2011). Prevalence and characteristics of substance use among Chinese and South
Asians in Canada. Journal of Ethnicity in Substance Abuse, 10(1), 39-47. [PMID: 21409703]
Klotsche, J., Reese, J.P., Winter, Y., Oertel, W.H., Irving, H., Wittchen, H.-U., Rehm, J., & Dodel, R. (2011). Trajectory classes of decline in
health-related quality of fife in Parkinson's Disease: a pilot study. Value in Health, 14(2), 329-338. [PMID: 21402301]]
Rehm, J., Giesbrecht, N., Gliksman, L., Graham, K., Le, A.D., Mann, R.E., Room, R., Rush, B., Tyndale, R.F., & Wells, S. (2011). Substance abuse
research in a modern health care centre: the case of the Centre for Addiction and Mental Health. Addiction, 106(4), 689-697. [PMID:
20491727]
Patra, J., Rehm, J., Popova, S. (2011). Avoidable alcohol-attributable criminality and its costs due to selected interventions in Canada.
International Journal of Drug Policy, 22(2), 109-119. [PMID: 21242081]
Lachenmeier, D.W., Taylor, B.J., & Rehm, J. (2011). Alcohol under the radar: do we have policy options regarding unrecorded alcohol?
International Journal of Drug Policy, 22(2), 153-160. [PMID: 21242085]
Rehm, J. & Scafato, E. (2011). Indicators of alcohol consumption and attributable harm for monitoring and surveillance in European Union
countries. Addiction, 106(Suppl.1), 4-10. [PMID: 21324016]
Rehm, J., Zatonski, W., Taylor, B. & Anderson, P. (2011). Epidemiology and alcohol policy in Europe. Addiction, 106(Suppl.1), 11-19. [PMID:
21324017]
Lachenmeier, D.W., Schoeberl, K., Kanteres, F., Kuballa, T., Sohnius, E.-M., & Rehm, J. (2011). Is contaminated unrecorded alcohol a health
problem in the European Union? A review of existing and methodological outline for future studies. Addiction, 106(Suppl.1), 20-30. [PMID:
21324018]
Lachenmeier, D.W., Kanteres, F., & Rehm, J. (2011). Epidemiology-based risk assessment using the benchmark dose/margin of exposure
approach: the example of ethanol and liver cirrhosis. International Journal of Epidemiology, 40(1), 210-218. [PMID: 20819784]
Roerecke, M., & Rehm, J. (2011). Ischemic heart disease mortality and morbidity in former drinkers: a meta-analysis. American Journal of
Epidemiology, 73(3), 245-258. [PMID: 21156750]
Gmel, G., Shield, K.D., & Rehm, J. (2011). Developing a method to derive alcohol-attributable fractions for HIV/AIDS mortality based on
alcohol’s impact on adherence to antiretroviral medication. Population Health Metrics, 9(1), 5. [PMID: 21320310]
Wells, S., Flynn, A., Graham, K., Rehm, J., Cairney, J., Kates, N., Kennedy, J.L., Lobo, D.S.S., Chaiton, M., Menzies, M., Tyndale, R.F., & Verjee, Z.
(2011). Using a mobile laboratory to study mental health, addictions and violence: a research plan. Challenges, 2(1), 1-18.
DOI:10.3390/challe2010001
Room, R. & Rehm, J. (2011). Alcohol and non-communicable diseases-cancer, heart disease and more. Addiction, 106(1), 1-2. [PMID:
21143685]
Rehm, J., Patra, J., Gnam, W., Sarnocinska-Hart, A., & Popova, S. (2011). Avoidable cost of alcohol abuse in Canada. European Addiction
Research, 17(2), 72-79. [PMID: 21150206]
Popova, S., Stade, B., Johnston, M., MacKay, H., Lange, S., Bekmuradov, D., & Rehm, J. (2011). Evaluating the cost of Fetal Alcohol Spectrum
Disorder. Journal of Studies on Alcohol and Drugs, 72(1), 163-164. [PMID: 21144395]
Lachenmeier, D.W., Kanteres, F., & Rehm, J. (2011). Is it possible to distinguish vodka by taste? Comment on Structurability: A Collective
Measure of the Structural Differences in Vodkas. Journal of Agricultural and Food Chemistry, 59(1), 464-465.. [PMID: 21133407]
Parry, C.D.H., Rehm, J., & Morojele, N.K. (2010). Is there a causal relationship between alcohol and HIV? African Journal of Drug and Alcohol
Studies, 9(2), 81-92.
http://www.crisanet.org/docs/AJDAS_vol_9_No_2.pdf
Chaiton, M., Cohen, J., O'Loughlin, J., & Rehm, J. (2010). Use of cigarettes to improve affect and depressive symptoms in a longitudinal study
of adolescents. Addictive Behaviors, 35(12), 1054-1060. [PMID: 20691543]
Rehm, J. (2010). Supervised injectable heroin better at reducing street heroin use than supervised injectable methadone or optimised oral
methadone. Evidence Based Mental Health, 13(4), 126. [PMID: 21036988].
Samokhvalov, A.V., Irving, H.M., Rehm, J. (2010). Alcohol as a risk factor for atrial fibrillation: a systematic review and meta-analysis.
European Journal of Cardiovascular Prevention and Rehabilitation, 17(6), 706-712. [PMID: 21461366]
Samokhvalov, A.V., Irving, H.M., & Rehm, J. (2010). Alcohol consumption as a risk factor for pneumonia: systematic review and meta-analysis.
Epidemiology and Infection, 138(12), 1789-95. [PMID: 20380771]
Samokhvalov, A.V., Popova, S., Room, R., Ramonas, M., & Rehm, J. (2010). Disability associated with alcohol abuse and dependence.
Alcoholism: Clinical and Experimental Research, 34(11), 1871-1878. [PMID: 20662803]
Lachenmeier, D.W, & Rehm, J. (2010). Does Oxygenated Alcohol Reduce Hangover? Letter to the editor in regard to Baek, Lee, and Kwon
(2010): ‘‘Influence of Dissolved Oxygen Concentration on the Pharmacokinetics of Alcohol in Humans’’. Alcoholism: Clinical and Experimental
Research, 34(10), 1671-1672. [PMID: 20608907]
Fischer, B., Nakamura, N., Ialomiteanu, A., Paglia-Boak, A., & Rehm, J. (2010). Assessing the prevalence of non-medical prescription opioid
use in the general Canadian population: methodological issues and questions. Canadian Journal of Psychiatry, 55(9), 606-609. [PMID:
20840808].
Lachenmeier, D.W., Samokhvalov, A.V., Leitz, J., Schoeberl, K., Kuballa, T., Linskiy, I.V., Minko, O.I., & Rehm, J. (2010). The composition of
unrecorded alcohol from Ukraine: is there a toxicological concern beyond ethanol alone? Food and Chemical Toxicology, 48(10), 2842–2847.
[PMID: 20638436]
- 19 –
438. Üstün, T.B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., Saxena, S., von Korff, M., Pull, C. in collaboration with
WHO/NIH Joint Project Collaborators (2010). Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the
World Health Organization, 88(11), 815-823.
http://www.who.int/bulletin/volumes/88/11/09-067231.pdf
437. Mohapatra, S., Irving, H., Paglia-Boak, A., Wekerle, C., Adlaf, E., & Rehm, J. (2010). History of family involvement with child protective
services as a risk factor for bullying in Ontario Schools. Child and Adolescent Mental Health, 15(3), 130–176. DOI: 10.1111/j.14753588.2009.00552.x
436. Roerecke, M., & Rehm, J. (2010). Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis.
American Journal of Epidemiology, 171(6), 633-644. [PMID: 20142394]
435. Patra, J., Gliksman, L., Fischer, B., Newton-Taylor, B., Belenko, S., Ferrari, M., Kersta, S., & Rehm, J. (2010). Factors associated with treatment
compliance and its effects on retention among participants in a court mandated treatment program. Contemporary Drug Problems, 37(2),
289-313.
434. Lachenmeier, D.W, & Rehm, J. (2010). Von Schwarzbrennern und Vieltrinkern. Die Auswirkungen des deutschen Branntweinmonopols auf
den gesundheitlichen Verbraucherschutz.
[Bootleggers and heavy drinkers. The impact of the German alcohol monopoly on public health and consumer safety.]
Sucht, 56(2), 91-93.
433. Zatonski, W., Sulkowska, U., Manczuk, M., Rehm, J., Lowenfels, A.B., & La Vecchia, C. (2010). Liver cirrhosis mortality in Europe, with special
attention to central and eastern Europe. European Addiction Research. 16, 193-201. [PMID: 20606444]
432. Gerlich, M.G., & Rehm, J. (2010). Recall bias in case-crossover designs studying the potential influence of alcohol consumption. Journal of
Studies on Alcohol and Drugs, 71(4), 619. [PMID: 20557830]
431. Lachenmeier, D.W., Lima, M.P.C, Nóbrega, I.C.C., Pereira, J.A.P., Kerr-Corrêa, F., Kanteres, F., & Rehm, J. (2010). Cancer risk assessment of
ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquira. BMC Cancer, 10(1), 266.
[PMID: 20529350]
430. Barbosa, C., Taylor, B., Godfrey, C., Rehm, J., Parrott, S., & Drummond, C. (2010). Modelling lifetime QALYs and health care costs from
different drinking patterns over time: a Markov model. International Journal of Methods in Psychiatric Research, 19(2), 97-109. [PMID:
20506446]
429. Fischer, B., Rehm, J., Irving, H., Ialomiteanu, A., Fallu, J.-S., & Patra, J. (2010). Typologies of cannabis users and associated characteristics
relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey. International Journal of
Methods in Psychiatric Research, 19(2), 110-124. [PMID: 20506447]
428. Patra, J., Taylor, B., Irving, H., Roerecke, M., Baliunas, D., Mohapatra, S., & Rehm, J. (2010). Alcohol consumption and the risk of morbidity
and mortality from different stroke types - A systematic review and meta-analysis. BMC Public Health, 10(1), 258. [PMID: 20482788]
427. Samokhvalov, A.V., Irving, H., Mohapatra, S., & Rehm, J. (2010). Alcohol consumption, unprovoked seizures and epilepsy: a systematic review
and meta-analysis. Epilepsia, 51(7), 1177-1184. [PMID: 20074233]
426. Drugs and Public Policy Group (2010). Drug Policy and the Public Good: a summary of the book. Addiction, 105(7), 1137–1145. [PMID:
20642498]
(The Drugs and Public Policy Group consisted of: Babor, T.F., Caulkins, J.C., Edwards, G., Fischer, B., Foxcroft, D.R., Humphreys, K., Obot, I.S.,
Rehm, J., Reuter, P., Room, R., Rossow, I., & Strang, J)
425. Reissner, V., Baune, B., Kokkevi, A., Schifano, F., Room, R., Palm, J., Stohler, R., DiFuria, L., Rehm, J., Hölscher, F., Schwarzer, C., & Scherbaum,
N. (2010). Burnout, coping and job satisfaction in service staff treating opioid addicts-from Athens to Zurich. Stress and Health, 26(2), 149159.
424. Linden, R., Mann, RE., Smart, RG., Vingilis, E., Solomon, R., Chamberlain, E., Asbridge, M., Rehm, J., Fischer, B., Stoduto, G., Wilk, P., Roerecke,
M., Trayling, C., Wiesenthal, DL. (2010). Research, policy development, and progress: antisocial behaviour and the automobile. Canadian
Public Policy, 26, S81-S93.
423. Baliunas, D., Rehm, J., Irving, H., & Shuper, P. (2010). Alcohol consumption and risk of incident human immunodeficiency virus infection: a
meta-analysis. International Journal of Public Health, 55(3), 159-166. [PMID: 19949966]
422. Mohapatra, S., Patra, J., Popova, S., Duhig, A., & Rehm, J. (2010). Social cost of heavy drinking and alcohol dependence in high-income
countries. International Journal of Public Health, 55(3), 149-157. [PMID: 20024666]
421. Rehm, J. (2010). Commentary on Rey et al. (2010): How to improve estimates on alcohol-attributable burden? Addiction, 105(6), 1030-1031.
[PMID: 20659062]
420. Bond, J., Ye Y., Cherpitel, C.J., Room, R., Rehm, J., Borges, G., Cremonte, M., Gmel, G., Hao, W., Sovinova, H., & Stockwell, T. (2010). The
relationship between self-reported drinking and BAC level in emergency room injury cases: is it a straight line? Alcoholism: Clinical and
Experimental Research, 34(6), 1118-25. [PMID: 20374201]
419 Frick, U., Rehm, J., Zullino, D., Fernando, M., Wiesbeck, G., Ammann, J., & Uchtenhagen, A. (2010). Long-term follow-up of orally
administered diacetylmorphine substitution treatment. European Addiction Research, 16(3), 131-138. [PMID: 2042445]
418. Alcohol and Public Policy Group (2010). Alcohol: no ordinary commodity - a summary of the second edition. Addiction, 105(5), 769–779.
[PMID: 20331569]
(The Alcohol and Public Policy Group consisted of: Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J., Hill,
L., Holder, H., Homel, R., Livingstone, M., Österberg, E., Rehm, J., Room, R., & Rossow, I.)
417. Rehm, J., Baliunas, D., Borges, G.L.G., Graham, K., Irving, H.M., Kehoe, T., Parry, C.D., Patra, J., Popova, S., Poznyak,V., Roerecke, M., Room, R.,
Samokhvalov, A.V., & Taylor, B. (2010). The relation between different dimensions of alcohol consumption and burden of disease - an
overview. Addiction, 105(5). 817-843. [PMID: 20331573]
416. Rehm, J., Taylor, B., Mohapatra, S., Irving, H., Baliunas, D., Patra, J., & Roerecke, M. (2010). Alcohol as a risk factor for liver cirrhosis – a
systematic review and meta-analysis. Drug and Alcohol Review, 29(4), 437-445. [PMID: 20636661]
- 20 –
415. Rehm, J., Kanteres, F., & Lachenmeier, D.W. (2010). Unrecorded consumption, quality of alcohol and health consequences. Drug and Alcohol
Review, 29(4), 426-436. [PMID: 20636660]
414. Cheung, J.T.W., Mann, R.E., Ialomiteanu, A., Stoduto, G., Chan, V., Ala-Leppilampi, K., & Rehm, J. (2010). Anxiety and mood disorders and
cannabis use. American Journal of Drug and Alcohol Abuse, 36(2), 118-122. [PMID: 20337509]
413. Taylor, B., Irving, H.M., Kanteres, F., Room, R., Borges, G., Cherpitel, C., Greenfield, T., & Rehm, J. (2010). The more you drink, the harder you
fall: a systematic review and meta-analysis of how acute alcohol consumption and injury or collision risk increase together. Drug and Alcohol
Dependence, 110(1-2):108-16. [PMID: 20236774]
412. Rehm, J., Kehoe, T., Gmel, G. jun., Stinson, F., Grant, B. & Gmel, G. sen. (2010). Statistical modeling of volume of alcohol exposure for
epidemiological studies of population health: the US example. Population Health Metrics, 8, 3. [PMID: 20202213]
411. Ialomiteanu, A. R., Giesbrecht, N., Adlaf, E. M., Irving, H., Paglia-Boak, A., & Rehm, J. (2010). An exploratory approach to analyzing alcohol
control policy opinions held by Ontario adults. International Journal of Environmental Research and Public Health, 7(3), 827-841. [PMID:
20617006]
410. Fischer, B., Nakamura, N., Rush, B., Rehm, J., & Urbanoski, K. (2010). Changes in and characteristics of admissions to substance use
treatment related to problematic prescription opioid use in Ontario, 2004-2009. Drug and Alcohol Dependence, 109(3), 257-260. [PMID:
20197216]
409. Rehm, J. & Frick, U. (2010). Valuation of health states in the U.S. study to establish disability weights: lessons from the literature.
International Journal of Methods in Psychiatric Research, 19(1), 18-33. [PMID: 20191661]
408. Frick, U., Wiedermann, W., Schaub, M., Uchtenhagen, A., & Rehm, J. (2010). Heroingestützte Behandlung in der Schweiz im Langzeitverlauf
1994-2007: Einflussfaktoren auf den Behandlungserfolg. Psychiatrische Praxis, 37(4), 175-82. [PMID: 20148381]
[Prognostic Factors from a Long-Term Follow-up of Heroin-Assisted Treatment in Switzerland 1994-2007.]
407. Shuper, P.A., Neuman, M., Kanteres, F., Baliunas, D., Joharchi, N., & Rehm, J. (2010). Causal considerations on alcohol and HIV/AIDS - a
systematic review. Alcohol and Alcoholism, 45(2), 159-166. [PMID: 20061510]
406. Rehm, J., & Parry, C.D. (2009). Alcohol consumption and infectious diseases in South Africa. Lancet, 374(9707), 2053. [PMID: 20109832]
405. Greenfield, T.K., Ye, Y., Kerr, W., Bond, J., Rehm, J., & Giesbrecht, N. (2009). Externalities from alcohol consumption in the 2005 US National
Alcohol Survey: implications for policy. International Journal of Environmental Research and Public Health, 6, 3205-3224. [PMID: 20049257]
404. Fischer, B. & Rehm, J. (2009). Deaths related to prescription opioids. Canadian Medical Association Journal, 181(12), 881-882. [PMID:
19969577]
403. Rehm, J., Samokhvalov, A.V., Neuman, M.G., Room, R., Parry, C.D., Lönnroth, K., Patra, J., Poznyak, V., & Popova, S. (2009). The association
between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health, 9(1), 450. [PMID: 19961618]
402. Giesbrecht, N., & Rehm, J. (2009). Assessing quitter effects: disaggregating current nondrinkers. Journal of the American Geriatric Society, 57
(11), 2174-2175. [PMID: 20121978]
401. Leitz, J., Kuballa, T., Rehm, J., Lachenmeier, D.W. (2009). Chemical analysis and risk assessment of diethyl phthalate in alcoholic beverages
with special regard to unrecorded alcohol. PLOS One, 4(12), e8127. [PMID: 19956573]
400. Room, R., Rehm, J., Ramstedt, M., & Österberg, E. (2009). Policy changes and effects on individual consumption: Complexities of
measurement and of influences. Addiction Research and Theory, 17(6), 588 - 590.
399. Room, R., Österberg, E., Ramstedt, M., & Rehm, J. (2009). Explaining change and stasis in alcohol consumption. Addiction Research and
Theory, 17(6), 562 - 576.
398. Rehm, J. & Room, R. (2009). Monitoring of alcohol use and attributable harm from an international perspective. Contemporary Drug
Problems, 36(3-4), 575-588.
397. Stockwell, T., Buxton, J., Duff, C., Marsh, D., Macdonal, S., Michelow, W., Saewyc, E., Richard, K., Hanson, R., Cohen, I., Corrado, R., Chow, C.,
Ivsins, A., Nicholson, D., Pakula, B., Puri, A., Rehm, J., Sturge, J., Tu, A., & Zhao, J. (2009). The British Columbia Alcohol and Other Drug
Monitoring System: Overview and Early Progress Contemporary Drug Problems, 36(3-4), 459-485.
396. Kanteres, F., Rehm, J., & Lachenmeier, D. (2009). Artisanal alcohol production in Mayan Guatemala: chemical safety evaluation with special
regard to acetaldehyde contamination. Science of the Total Environment, 407(22), 5861-5868. [PMID: 19729189]
395. Shuper, P.A., Joharchi, N., Irving, H. & Rehm,J. (2009). Alcohol as a correlate of unprotected sexual behavior among people living with
HIV/AIDS: review and meta-analysis. AIDS and Behavior, 13(6), 1021-1036. [PMID: 19618261]
394. Baliunas, D., Taylor, B., Irving, H., Roerecke, M., Patra, J., Mohapatra, S., & Rehm, J. (2009). Alcohol as a risk factor for type 2 diabetes – a
systematic review and meta-analysis. Diabetes Care, 32(11), 2123-2132. [PMID: 19875607]
393. Taylor, B., Irving, H.M., Baliunas, D., Roerecke, M., Patra, J., Mohapatra, S., & Rehm, J. (2009). Alcohol and hypertension: gender differences
in dose-response relationships determined through systematic review and meta-analysis. Addiction, 104(12), 1981-1990. doi:
10.1111/j.1360-0443.2009.02694.x [PMID: 19804464]
392. Room, R. & Rehm, J. (2009). Commentary on Hickman et al. (2009): The place of risk in drug policies. Addiction, 104(11), 1862-1863. [PMID:
19832787}
391. Rehm, J. & Room, R. (2009). Why do we need international regulations for alcohol control? Nordic Studies on Alcohol and Drugs, 24(4), 447450.
390. Rehm, J. & Mathers, C. (2009). Global comparative risk assessment – what level of detail can be achieved? Lancet, 374, 477.
389. Lachenmeier, D.W., Ganss, S., Rychlak, B., Rehm, J., Sulkowska, U., Skiba, M., & Zatonski, W. (2009). Association between quality of cheap
and unrecorded alcohol products and public health consequences in Poland. Alcoholism: Clinical and Experimental Research, 33(10), 17571769. [PMID: 19572980]
388. Chaiton, M.O., Cohen, J.E., O'Loughlin, J. & Rehm, J. (2009). A systematic review of longitudinal studies on the association between
depression and smoking in adolescents. BMC Public Health, 9(1), 356. [PMID: 19772635]
- 21 –
387. Klotsche, J., Ferger, D., Pieper, L., Rehm, J., & Wittchen, HU. (2009). A novel nonparametric approach for estimating cut-offs in continuous
risk indicators with application to diabetes epidemiology. BMC Medical Research Methodology, 9(1), 63. [PMID: 19744332]
396. Patra, J., Taylor, B., & Rehm, J. (2009). Deaths associated with high-volume drinking of alcohol among adults in Canada in 2002: a need for
primary care intervention? Contemporary Drug Problems, 36(2), 283-301.
385. Thombs, D.L., Olds, R.S., Bondy, S.J., Winchell, J., Baliunas, D., & Rehm, J. (2009). Undergraduate drinking and academic performance: a
prospective investigation with objective measures. Journal of Studies on Alcohol and Drugs, 70(5), 776-785. [PMID: 19737503].
384. Rehm, J. (2009). Commentary on Cobiac et al. (2009): How to use science to improve alcohol policy? Addiction, 104(10), 1656-1657. [PMID:
21265907]
383. Lachenmeier, D.W., Kuballa, T., Lima, M.C.P., Nóbrega, I.C.C., Kerr-Corrêa, F., Kanteres, F., & Rehm. J. (2009). Ethyl carbamate analysis in
German fruit spirits and Brazilian sugarcane spirits (cachaça): improved sample cleanup with automated parallel evaporation. Deutsche
Lebensmittel-Rundschau, 105(8), 507-512.
382. Popova, S., Patra, J. & Rehm, J. (2009). Avoidable portion of tobacco-attributable acute care hospital days and its cost due to implementation
of different intervention strategies in Canada. International Journal of Environmental Research and Public Health, 6(8), 2179-2192. [PMID:
19742208] doi:10.3390/ijerph6082179
381. Lachenmeier, D.W., Pham, A.T.H., Popova, S., & Rehm, J. (2009). The quality of alcohol products in Vietnam and its implications for public
health. International Journal of Environmental Research and Public Health, 6(8), 2090-2101. [PMID: 19742208] doi:10.3390/ijerph6082090
380. Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009). Global burden of disease and injury and
economic cost attributable to alcohol use and alcohol use disorders. Lancet, 373(9682), 2223-2233. [PMID: 19560604]
379. Rehm, J., & Room, R. (2009). A case study in how harmful alcohol consumption can be. Lancet, 373(9682), 2176-2177. [PMID: 19560585]
378. Irving, H.M., Samokhvalov, A., & Rehm, J. (2009). Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP Journal
of the Pancreas, 10(4), 387-392. [PMID: 19581740]
377. Lachenmeier, D.W., & Rehm, J. (2009). Unrecorded alcohol: a threat to public health? Addiction, 104(6), 875-877. [PMID: 19466914].
376. Danaei, G., Ding, E., Mozaffarian, D., Taylor, B., Rehm, J., Murray, D.J.L., & Ezzati, M. (2009). The preventable causes of death in the United
States: comparative risk assessment of lifestyle, dietary, and metabolic risk factors. PLOS Medicine, 6(4), e1000058. [PMID: 19399161].
375. Gerlich, M.R., Krämer, A., Gmel, G., Maggiorini, M., Lüscher, T.F., Rickli, H., Kleger, G.R., & Rehm, J. (2009). Patterns of alcohol consumption
and acute myocardial infarction – A case-crossover analysis. European Addiction Research, 15(3), 143-149. [PMID: 19390198]
374. Kanteres, F., Lachenmeier, D.W., & Rehm, J. (2009). The contribution of acetaldehyde from alcohol to cancer: a review and exposure estimate
for Germany. Sucht, 55(2), 111–117.
373. Wittchen, H.-U., Behrendt, S., Höfler, M., Perkonigg, A., Rehm, J., Lieb, R., & Beesdo, K. (2009). A typology of cannabis-related problems
among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs.
Drug and Alcohol Dependence, 102(1-3), 151-157. [PMID: 19362792]
372. Kanteres, F., Lachenmeier, D.W., & Rehm, J. (2009). Alcohol in Mayan Guatemala: consumption, distribution, production, and composition of
Cuxa. Addiction, 104(5), 752-759. [PMID: 19215596]
371. Lachenmeier, D., Kanteres, F., & Rehm, J. (2009). The effect of phytophenols in alcoholic beverages on alcohol dehydrogenase 1: Is there
really evidence for an inhibition of metabolic toxicity of alcohol? Metabolism, 58(6), 889-890. [PMID: 19375127]
370. Lachenmeier, D., Kanteres, F., & Rehm, J. (2009). Unrecorded alcohol in Russia: is there more to it than just ethanol? Alcoholism: Clinical and
Experimental Research, 33(5), 759-760. [PMID: 19320624]
369. Lachenmeier, D.W., Kanteres, F., & Rehm, J. (2009). Carcinogenicity of acetaldehyde in alcoholic beverages: risk assessment outside of
ethanol metabolism. Addiction, 104(4), 533-550. [PMID: 19335652]
368 Fischer, B., Rehm, J., & Hall, W. (2009). Cannabis Use in Canada – the need for a ‘public health’ approach. Canadian Journal of Public Health,
100(2), 101-103. [PMID: 19839283]
367. Popova, S., Patra, J., Mohapatra, S., Fischer, B., & Rehm, J. (2009). How many people in Canada use prescription opioids non-medically in
general and street drug-using populations? Canadian Journal of Public Health, 100(2), 104-108. [PMID: 19839284]
366. Patra, J., Fischer, B., Maksimowska, S., & Rehm, J. (2009). Profiling poly-substance use typologies in a multi-site cohort of illicit opioid and
other drug users in Canada - a latent class analysis (LCA). Addiction Research & Theory, 17(2),168 - 185.
365. Rehm, J. & Frick, U. (2009). Alcohol use as a risk factor for burden of disease: methodological considerations. Addiction Research and Theory,
17(1), 99-103.
Editorial:
364. Parry, C., Rehm, J., Poznyak, V., & Room, R. (2009). Alcohol and infectious diseases: an overlooked causal linkage? Addiction, 104(3), 331332. [PMID: 19207335]
363. Fischer, B., De Leo, J.A., Allard, C., Firestone-Cruz, M., Patra, J. & Rehm, J. (2009). Exploring street market dynamics for prescription opioid
misuse in Canada: data from Toronto and Victoria. Canadian Journal of Criminology and Criminal Justice, 51(1), 55-72.
362. Gmel, G., Kuendig, H., Rehm, J., Schreyer, N., & Daeppen, J.-B. (2009). Alcohol and cannabis use as risk factors for injury – a case-crossover
analysis in a Swiss hospital emergency department. BMC Public Health, 9, 40. [PMID: 19178706].
361. Fischer, B., Gittens, J., Kendall, P., & Rehm, J. (2009). Thinking the unthinkable: Could the increasing misuse of prescription opioids among
street drug users offer benefits for public health? Public Health, 123(2), 145-146. [PMID: 19157469]
360. Lachenmeier, D.W., Kanteres, F., Kuballa, T., López, M.G., & Rehm, J. (2009). Ethyl carbamate in alcoholic beverages from Mexico (Tequila,
Mezcal, Bacanora, Sotol) and Guatemala (Cuxa): Market Survey and Risk Assessment. International Journal of Environmental Research and
Public Health, 6(1), 349-360. [PMID: 19440288]
359. Kerr, W.C., Greenfield, T.K., Bond, J., Ye, Y., & Rehm, J. (2009). Age-period-cohort modelling of alcohol volume and heavy drinking days in the
US National Alcohol Surveys: Divergence in younger and older adult trends. Addiction, 104(1), 27–37. [PMID: 19133886]
- 22 –
358. Samokhvalov, A.V., Pidkorytov, V.S., Linskiy, I.V., Minko, O.I., Minko, O.O., Rehm, J., & Popova, S. (2009). Thematic papers – services in the
former Soviet Union: Alcohol use and addiction services in Ukraine. International Psychiatry, 6(1), 5-7.
357. Lachenmeier, D.W., Sarsh, B., & Rehm, J. (2009). The composition of alcohol products from markets in Lithuania and Hungary, and potential
health consequences: a pilot study. Alcohol & Alcoholism, 44(1), 93-102. [PMID: 19033379]
356. Rehm, J. (2009). Commentary: Alcohol poisoning in Russia: implications for monitoring and comparative risk factor assessment. International
Journal of Epidemiology, 38(1), 154-155. [PMID: 18824468]
Editorial:
355. Room, R., Schmidt, L., Rehm, J., Mäkelä, P. (2008). International regulation of alcohol. A framework convention is needed, as for tobacco
.
control British Medical Journal, 337, a2364. [PMID: 18988646]
354. Fischer, B., Gittins, J., & Rehm, J. (2008). Characterizing the “awakening elephant” of prescription opioid misuse in North America:
epidemiology, harms, interventions. Contemporary Drug Problems, 35(2/3), 397-426.
353. Rehm, J., & Kanteres, F. (2008). Alcohol industry sponsorship in sport: research and policy considerations. Addiction, 103(12), 1967–1968.
[PMID: 19469739]
352. Fischer, B., Patra, J., Firestone Cruz, M., Gittins, J., & Rehm, J. (2008). Comparing heroin users and prescription opioid users in a Canadian
multi-site population of illicit opioid users. Drug and Alcohol Review, 27(6), 625- 632. [PMID: 18608456]
351. Behrendt, S., Wittchen, H.-U., Höfler, M., Lieb, R., Low, N.C.P., Rehm, J., & Beesdo, K. (2008). Risk and speed of transitions to first alcohol
dependence symptoms in adolescents: a 10-year longitudinal community study in Germany. Addiction, 103(10), 1638–1647. [PMID:
18821874]
350. Rehm, J., Room, R., & Taylor, B. (2008). Method for moderation: measuring lifetime risk of alcohol-attributable mortality as a basis for
drinking guidelines. International Journal of Methods in Psychiatric Research, 17(3), 141-151. [PMID: 18763694]
349. Taylor, B., Rehm, J., Room, R., Patra, J., & Bondy, S. (2008). Determination of lifetime injury mortality risk in Canada in 2002 by drinking
amount per occasion and number of occasions. American Journal of Epidemiology, 168(10), 1119-1125. [PMID: 18718895]
348. Taylor, B., Rehm, J., Room, R., Patra, J., & Bondy, S. (2008). Taylor et al. respond to "Alcohol and Trauma and Chronic Disease Mortality".
American Journal of Epidemiology, 168(10), 1130-1131. [PMID: 18711005]
347. Rehm, J., Irving, H., Ye, Y., Kerr, W.C., Bond, J., & Greenfield, T.K. (2008). Are lifetime abstainers the best control group in alcohol
epidemiology? On the stability and validity of reported lifetime abstention. American Journal of Epidemiology, 168(8), 866-871. [PMID:
18701442]
346. Rehm, J., Irving, H., Ye, Y., Kerr, W.C., Bond, J., & Greenfield, T.K. (2008). Rehm et al. respond to "Never, or Hardly Ever?" American Journal of
Epidemiology, 168(8), 876-877. [PMID: 18701441]
345. Annaheim, B., Rehm, J., & Gmel, G. (2008). How to screen for problematic cannabis use in population surveys. An evaluation of the Cannabis
Use Disorders Identification Test (CUDIT) in a Swiss sample of adolescents and young adults. European Addiction Research, 14(4), 190-197.
[PMID: 18583916]
344. Rehm, J. (2008). Key future research questions on mediators and moderators of behaviour change processes for substance abuse.
International Journal of Methods in Psychiatric Research, 17(S1), S83-S87. [PMID: 18543369]
343. Fischer, B., & Rehm, J. (2008). Nonmedical use of prescription opioids: furthering a meaningful research agenda. Journal of Pain, 9(6), 490493. [PMID: 18514135]
342. Roerecke, M., Obot, I.S., Patra, J., & Rehm, J. (2008). Volume of alcohol consumption, patterns of drinking and burden of disease in subSaharan Africa, 2002. African Journal of Drug and Alcohol Studies, 7(1), 1-16.
341. Fischer, B., Firestone Cruz, M., Patra, J., & Rehm, J. (2008). Predictors of methadone maintenance treatment utilization in a multiside cohort
of illicit opioid users (OPICAN). Journal of Substance Abuse Treatment, 34(3), 340-346. [PMID: 17614236]
340. Wittchen, H.-U., Apelt, S.M., Soyka, M., Gastpar, M., Backmund, M., Gölz, J., Kraus, M.R., Tretter, F., Schäfer, M., Siegert, J., Scherbaum, N.,
Rehm, J., & Bühringer, G. (2008). Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution
centers and primary care facilities in Germany: A naturalistic study in 2694 patients. Drug and Alcohol Dependence. 95(3), 245-57. [PMID:
18337025]
339. Fischer, B., Rehm, J., Goldman, B., & Popova, S. (2008). Non-medical use of prescription opioids and public health in Canada. An urgent call
for research and interventions development. Canadian Journal of Public Health, 99(3), 182-184. [PMID: 18615937]
338. Rehm, J. & Greenfield, T. (2008). Public alcohol policy: current directions and new opportunities. Clinical Pharmacology & Therapeutics,
83(4), 640-643. [PMID: 18305457]
337. Poikolainen, K., Rehm, J. & Zatonski, W. (2008). Alkoholin osuus kuolleisuuteen Suomessa, Tanskassa ja Ruotsissa vuonna 2002. Suomen
lääkärilehti (Finnish Medical Journal), 63, 613-618. [The influence of alcohol on mortality in Finland, Denmark and Sweden in 2002].
336. Heeb, J.-L., Gmel, G., Rehm, J. & Mohler-Kuo, M. (2008). Exploring daily variations of drinking in the Swiss general population. A growth curve
analysis. International Journal of Methods in Psychiatric Research, 17(1), 1-11. [PMID: 18286462]
335. Rehm, J., & Fischer, B (2008). “Head to Head debate: Should heroin be prescribed to heroin misusers? YES” British Medical Journal, 336, 70.
[PMID: 18187720]
334. Gmel, G., Wicki, M., Rehm, J., & Heeb, J.-L. (2008). Estimating regression to the mean and true effects of an Intervention in a four-wave panel
study. Addiction, 103(1), 32-41. [PMID: 17995991]
333. Fischer, B., Powis, J., Firestone Cruz, M., Rudzinski, K. & Rehm, J. (2008). Hepatitis C virus transmission among oral crack users: viral detection
on crack paraphernalia. European Journal of Gastroenterology and Hepatology, 20(1), 29-32. [PMID: 18090987]
332. Ejim, O.S., Brands, B., Rehm, J., & Lachenmeier, D.W. (2007). Composition of surrogate alcohol from South-Eastern Nigeria. African Journal of
Drug and Alcohol Studies, 6(2), 65-74.
331. Fischer, B. & Rehm, J. (2007). Understanding the parameters of non-medical use of prescription drugs: moving beyond mere numbers.
Addiction, 102 (12), 1931–1932.
- 23 –
330. Rehm, J., Taylor, B., Roerecke, M., & Patra, J. (2007). Alcohol consumption and alcohol-attributable burden of disease in Switzerland, 2002.
International Journal of Public Health, 52(6), 383-392.
329. Rehm, J., Gnam, W., Popova, S., Baliunas, D., Brochu, S., Fischer, B., Patra, J., Sarnocinska-Hart, A., & Taylor, B. (2007). The costs of alcohol,
illegal drugs and tobacco in Canada 2002. Journal of Studies on Alcohol and Drugs, 68(6), 886-95.
Editorial:
328. Rehm, J. & van den Brink, W. (2007). 15 Jahre Forschung zu ärztlich verschriebenem Heroin: Wie passen die Ergebnisse des deutschen
Heroinversuchs in das Puzzle der schweizerischen und niederländischen Ergebnisse? Sucht, 53(5), 262-264.
327. Baliunas, D., Patra, J., Rehm, J., Popova, S., & Taylor, B. (2007). Smoking-attributable morbidity: acute care hospital diagnoses and days of
treatment in Canada. BMC Public Health, 7(1), 247. [PMID: 17877815]
326. Reimer, J., Lorenzen, J., Baetz, B., Fischer, B., Rehm, J., Backmund, M., & Haasen C.(2007). Injection drug use, multiple hepatitis virus
infections, and migration: a German study. Substance Use & Misuse. 42(9), 1353-65.
325. Lachenmeier, D., Rehm, J., & Gmel, G. (2007). Surrogate alcohol: what do we know and where do we go? Alcoholism: Clinical and
Experimental Research, 31(10), 1613–1624.
324. Annaheim, B., Rehm, J., Neuenschwander, M., & Gmel, G. (2007). „Mit Kiffen aufhören.“ Die Bereitschaft zur Verhaltensänderung bei
Cannabisgebrauchenden in der Schweiz. International Journal of Public Health, 52(4), 233-241.
[Quitting hash. The readiness for behaviour change among cannabis users in Switzerland]
323. Manzoni, P., Fischer, B., & Rehm, J. (2007). Local drug-crime-dynamics among a Canadian multi-site sample of untreated opioid users.
Canadian Journal of Criminology and Criminal Justice, 49(3), 341-374.
322. Patra, J., Taylor, B., & Rehm, J. (2007). The disease burden of alcohol consumption. Canadian Medical Association Journal, 177(1), 65.
321. Baliunas, D., Patra, J., Rehm, J., Popova, S., Kaiserman, M., & Taylor, B. (2007). Smoking-attributable mortality and potential years of life lost
in Canada 2002: conclusions for prevention and policy. Chronic Diseases in Canada, 27(4), 154-162.
320. Rehm, J., & Gmel, G. (2007). Alcohol consumption and public health in Russia. Lancet, 369(9578), 1975-1976.
319. Rehm, J., Patra, J., & Popova, S. (2007). Alcohol drinking cessation and its effect on oesophageal and head and neck cancers: a pooled
analysis. International Journal of Cancer, 121(5), 1131-1137.
318. Roerecke, M., Rehm, J., & Patra, J. (2007). Alcohol and burden of disease in Switzerland: implications for policy. Sucht, 53(3), 138-142.
317. Patra, J., Taylor, B., Rehm, J., Baliunas, J., & Popova, S. (2007). Substance-attributable morbidity and mortality changes to Canada's
epidemiological profile: measurable differences over a ten-year period. Canadian Journal of Public Health, 98(3), 228-234.
316. Fischer, B., Oviedo-Joekes, E., Blanken, P., Haasen, C., Rehm, J., Schechter, M., Strang, J., & van den Brink, W. (2007). Heroin-Assisted
Treatment (HAT) a decade later: A brief update on science and politics. Journal of Urban Health, 84(4), 552-62.
315. Rehm, J., Sulkowska, U., Manczuk, M., Boffetta, P., Powles, J., Popova, S., & Zatonski, W. (2007). Alcohol accounts for a high proportion of
premature mortality in central and eastern Europe. International Journal of Epidemiology, 36, 458-467.
http://ije.oxfordjournals.org/cgi/content/full/dyl294v2
314. Rehm, J., Klotsche, J., & Patra, J. (2007). Comparative quantification of alcohol exposure as risk factor for global burden of disease.
International Journal of Methods in Psychiatric Research, 16(2), 66-76.
313. Rehm, J., Patra, J., & Taylor, B. (2007). Harms, benefits and net effects on mortality of moderate drinking of alcohol among adults in Canada
in 2002. Annals of Epidemiology. 17, S81-S86.
312. Toumbourou, J.W., Stockwell, T., Neighbors, C., Marlatt, G.A., Sturge, J., & Rehm, J. (2007). Interventions to reduce harm associated with
adolescent substance use: a literature review. Lancet. 369(9570), 1391-1401.
311. Rehm, J. (2007). Global denken, lokal handeln: Verhältnisprävention im lokalen und regionalen System. Abhängigkeiten, 13(1), 20-26.
[Global thinking, local actions: Prevention in local and regional systems]
310. Stockwell, T., Chikritzhs, T., Bostrom, A., Fillmore, K., Kerr, W., Rehm, J., & Taylor, B. (2007). Alcohol-caused mortality in Australia and Canada:
scenario analyses using different assumptions about cardiac benefit. Journal of Studies on Alcohol and Drugs, 68(3), 345-352.
309. Popova, S., Rehm, J., Patra, J., Baliunas, D., & Taylor, B. (2007). Illegal drug-attributable morbidity in Canada 2002. Drug and Alcohol Review,
26(3), 251-263.
308. Wittchen, H.U., Fröhlich, C., Behrendt, S., Günther, A., Rehm, J., Zimmermann, P., Lieb, R., & Perkonigg A. (2007). Cannabis use and cannabis
use disorders and their relationship to mental disorders: A 10-year prospective-longitudinal community study in adolescents. Drug and
Alcohol Dependence, 88 (Suppl 1), S60-70.
307. Firestone Cruz, M., Fischer, B., Patra, J., Kalousek, K., Newton-Taylor, B., Rehm, J., & Tyndall, M. (2007). Prevalence and associated factors of
hepatitis C infection (HCV) in a multi-site Canadian population of illicit opioid and other drug users (OPICAN). Canadian Journal of Public
Health, 98(2), 130-133.
306. Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F., Bouvard, V., Altieri, A., Cogliano, V., on behalf of the WHO International Agency for
Research on Cancer Monograph Working Group (2007). Carcinogenicity of alcoholic beverages. Lancet Oncology, 8(4), 292-293.
(J. Rehm was part of the WHO International Agency for Research on Cancer Monograph Working Group.)
Editorial:
st
305. Fischer, B., & Rehm, J. (2007). Illicit Opioid Use in the 21 century: Witnessing a paradigm shift? Addiction, 102(4), 499-501.
304. Monga, N., Rehm, J., Fischer, B., Brissette, S., Bruneau, J., El-Guebaly, N., Noel, L., Tyndall, M., Wild, C., Leri, F., Fallu, J.S., & Bahl, S. (2007).
Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug and Alcohol Dependence, 88(1), 18.
303. Firestone Cruz, M., Patra, J., Fischer, B., Rehm, J., & Kalousek, K. (2007). Public opinion towards supervised injection facilities and prescribed
heroin treatment in Ontario, Canada. International Journal of Drug Policy, 18(1), 54-61. [PMID: 17689344]
302. Rehm, J. (2007). On the limitations of observational studies. Addiction Research and Theory, 15(1), 20-22.
- 24 –
301. Popova, S., Rehm, J., Patra, J., & Zatonski, W. (2007). Comparing alcohol consumption in Central and Eastern Europe to other European
countries. Alcohol and Alcoholism, 42(5), 465-73. http://alcalc.oxfordjournals.org/cgi/content/full/agl124v3
300. Graham, K., Massak, A., Demers, A., & Rehm, J. (2007). Does the association between alcohol consumption and depression depend on how
they are measured? Alcoholism: Clinical and Experimental Research, 31(1), 78-88.
299. Taylor, B., Rehm, J., Patra, J., Popova, S., & Baliunas, D. (2007). Alcohol-attributable morbidity and resulting health care costs in Canada in
2002: recommendations for policy and prevention. Journal of Studies on Alcohol and Drugs, 68(1):36-47.
298. Kerr, W.C., Greenfield, T.K, Bond, J., Ye, Y., & Rehm, J. (2007). Age-period-cohort influences on trends in past year marijuana use in the US
from the 1984, 1990, 1995 and 2000 National Alcohol Surveys. Drug and Alcohol Dependence, 86(1), 132-138.
297. Reimer, J., Lorenzen, J., Baetz, B., Fischer, B., Rehm, J., Haasen, C., & Backmund, M. (2007). Multiple viral hepatitis in injection drug users and
associated risk factors. Journal of Gastroenterology and Hepatology, 22(1), 80-85.
296. Rehm, J., Taylor, B., Patra, J. & Gmel, G. (2006). Avoidable burden of disease: conceptual and methodological issues in substance abuse
epidemiology. International Journal of Methods in Psychiatric Research, 15(4), 181-191.
Editorial:
295. Rehm, J. & Taylor, B. (2006). Alcohol consumption, stroke and public health – an overlooked relation? Addiction, 101(12), 1679-1681.
294. Fischer, B., Rehm, J., Patra, J., Kalousek, K., Haydon, E., Tyndall, M., & El-Guebaly, N. (2006). Crack across Canada: Comparing crack users and
crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction, 101(12), 1760-1770.
293. Gmel, G. & Rehm, J. (2006). Zusammenfassende Gesundheitsmasse von Sterblichkeit und Krankheit: Der steinige Weg zwischen PYLL, YLD,
DALY und HALE. Suchttherapie, 7, 143-153.
292. Popova, S., Rehm, J, & Patra, J. (2006). Illegal drug-attributable mortality and potential years of life lost in Canada 2002: implications for
prevention and policy. Contemporary Drug Problems, 33(3), 343-366.
291. Rehm, J., Greenfield, T., & Kerr, W. (2006). Patterns of drinking and mortality from different diseases – an overview. Contemporary Drug
Problems, 33(2), 205-235.
290. Fallu, J.-S., Rehm, J., Kuntsche, E.N., Grichting, E., Monga, N., Adlaf, E.M., Bondy, S.J. & Gmel., G. (2006). Volume et profil de consommation
d’alcool des élèves de des camarades scolaire comme prédicteurs de l’aggression et de la victimisation : une analyse multiniveaux auprès
d’adolescents suisses. Sozial- und Präventivmedizin (International Journal of Public Health), 51 (6), 363-372. [Volume and profile of alcohol
consumption among students and classmates as predictors of aggression and victimization: a multilevel analysis among Swiss adolescents]
289. Fischer, B., Kalousek, K., Rehm, J., Powis, J., Krajden, M., & Reimer, J. (2006). Hepatitis C, illicit drug use and public health: Does Canada really
have a viable plan? Canadian Journal of Public Health, 97(6), 485-488.
288. Fischer, B., Rehm, J., Patra, J., & Firestone-Cruz, M. (2006). Changes in illicit opioid use profiles across Canada. Canadian Medical Association
Journal, 175(11), 1385-1387.
287. Cherpitel, C.J., Ye, Y., Bond, J., Rehm, J., Cremonte, M., Neves, O., Moskalewicz, J., Swiatkiewicz, G., & Giesbrecht, N. (2006). The effect of
alcohol consumption on emergency department services use among injured patients: a cross-national emergency room study. Journal of
Studies on Alcohol, 67(6), 890-897.
286. Kuntsche, E., Gmel, G., & Rehm, J. (2006). The Swiss Teaching Style Questionnaire (STSQ) and adolescent problem behaviors. Swiss Journal of
Psychology, 65(3), 147-155.
285. Fischer, B., Popova, S., Rehm, J., & Ivsins, A. (2006). Drug-related overdose deaths in British Columbia and Ontario 1992-2002. Canadian
Journal of Public Health, 97(5), 384-387.
284. Frick, U., Rehm, J., Kovacic S., Ammann J., Uchtenhagen A. (2006). A prospective cohort study on orally administered heroin substitution for
severely addicted opioid users. Addiction, 101(11), 1631-1639.
283. Rehm, J., Taylor, B., & Room, R. (2006). Global burden of disease from alcohol, illicit drugs and tobacco. Drug and Alcohol Review, 25(6), 503513.
282. Chisholm, D., Doran, C., Shibuya, K., & Rehm, J. (2006). Comparative cost-effectiveness of policy instruments for reducing the global burden
of alcohol, tobacco and illicit drug use. Drug and Alcohol Review, 25(6), 553-565.
281. Kuntsche, E., Gmel, G., Wicki, M., Rehm, J., & Grichting, E. (2006). Disentangling gender and age effects of risky single occasion drinking
during adolescence. European Journal of Public Health, 16(6), 670-675.
280. Neuman, M.G., Monteiro, M., & Rehm, J. (2006). Drug interactions between psychoactive substances and antiretroviral therapy in individuals
infected with human immunodeficiency and hepatitis viruses. Substance Use & Misuse, 41(10), 1395-1463.
279. Rehm, J. Giesbrecht, N., Patra, J., & Roerecke, M. (2006). Estimating chronic-disease deaths and hospitalizations due to alcohol use in Canada
in 2002 implications for policy and prevention strategies. Preventing Chronic Disease, 3(4). Available from:
http://www.cdc.gov/pcd/issues/2006/oct/05_0009.htm.
Editorial:
278. Fischer, B., & Rehm, J. (2006). Illicit opioid use and treatment for opioid dependence: challenges for Canada and beyond.. Canadian Journal
of Psychiatry, 51(10), 621-623.
277. Fischer, B., Firestone-Cruz, M., & Rehm, J. (2006). Illicit opioid use and its key characteristics: A select overview and evidence from a Canadian
multi-site cohort of illicit opioid users (OPICAN). Canadian Journal of Psychiatry, 51(10), 624-634.
276. Frick, U., Ammann J., Kovacic S., Bürki C., Mohler M., Käser, R., Gerlich M., Güttinger,F., Gschwend P., & Rehm, J. (2006). Qualitätssicherung
in der Heroin gestützten Behandlung (HegeBe) der Schweiz seit 2001: Methodische Anmerkungen zu Zielkriterien, Adjustierung des PatientenMix und Zentrumsvergleichen. Gesundheitsökonomie & Qualitätsmanagement, 11(3), 155-161.
275. Fischer, B., Manzoni, P., & Rehm, J. (2006). Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN
cohort). European Journal of Addiction Research, 12(4), 230-239.
274. Fischer, B., Reimer, J., Firestone, M., Kalousek, K., Rehm, J. & Heathcote, J. (2006). Treatment for hepatitis C virus (HCV) and cannabis use in
illicit drug user patients: questions and implications. European Journal of Gastroenterology & Hepatology, 18(10), 1039-42.
- 25 –
273. Taylor, B., & Rehm, J. (2006). When risk factors combine: The interaction between alcohol and smoking for aerodigestive cancer, coronary
heart disease, and traffic and fire injury. Addictive Behaviors, 31(9), 1522-1535.
272. Boffetta, P., Hashibe, M., La Vecchia, C., Zatonski, W., & Rehm, J. (2006). The burden of cancer attributable to alcohol drinking. International
Journal of Cancer, 119(4), 884-887.
271. Gerlich, M., Gschwend, P., Uchtenhagen, A., Kramer, A., & Rehm, J. (2006). Prevalence of hepatitis and HIV infections and vaccination rates in
patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. Eur J Epidemiol., 21(7), 545-549.
270. Rehm, J., Taylor, B., & Patra, J. (2006). Volume of alcohol consumption, patterns of drinking and burden of disease in the European region
2002. Addiction, 101(8), 1086-1095.
269. Rehm, J. (2006). Lifetime illicit drug use and drug dependence are common by the age of 25 in New Zealand. Evid Based Ment Health, 9(3),
86.
268. Borges, G., Cherpitel, C., Orozco, R., Bond, J., Ye, Y., Macdonald, S., Rehm, J., & Poznyak, V. (2006). Multicenter study of acute alcohol use and
non-fatal injuries: data from the WHO Collaborative Study on Alcohol and Injuries. Bulletin of the World Health Organization, 84(6), 453-460.
Editorial:
267. Rehm, J. & Frick, U. (2006). Wie nützlich ist eine gesundheitsökonomische Suchtforschung für die Planung und Implementation von
Interventionen? Sucht, 52(2), 102-103.
266. Zhang, B., Cohen, J., Ferrence, R., & Rehm, J. (2006). The impact of tobacco tax cuts on smoking initiation among Canadian young adults.
American Journal of Preventive Medicine, 30(6), 474-479.
265. Noël, L., Fischer, B., Tyndall, M.W., Bradet, R., Rehm, J., Brissette, S., Brochu, S., Bruneau, J., el-Guebaly, N., & Wild, CT. (2006). Health and
social services accessed by a cohort of Canadian illicit opioid users outside of treatment. Canadian Journal of Public Health, 97(3), 166-170.
264. Fischer, B., Rodopoulos, J., Rehm, J., & Ivsins, A. (2006). Toking and driving: Characteristics of Canadian university students who drive after
cannabis use - an exploratory pilot study. Drugs: Education, Prevention, Policy, 13(2), 179-187.
263. Manzoni, P., Brochu, S., Fischer, B., & Rehm, J. (2006). Determinants of property crime among illicit opiate users outside of treatment across
Canada. Deviant Behavior, 27(3), 351-376..
262. Popova, S., Rehm, J., Fischer, B. (2006). An overview of illegal opioid use and health services utilization in Canada. Public Health, 120(4), 320328.
261. Wicki, M., Gmel, G., Kuntsche, E., Rehm, J., & Grichting, E. (2006). Is alcopop consumption in Switzerland associated with riskier drinking
patterns and more alcohol-related problems? Addiction, 101(4), 522-533.
260. Rehm, J., Patra, J., & Popova, S. (2006). Alcohol-attributable mortality and potential years of life lost in Canada 2001: implications for
prevention and policy. Addiction, 101(3), 373-384.
259. Rehm, J., Babor, T., & Room, R. (2006). Education, persuasion and the reduction of alcohol-related harm: a reply to Craplet. Addiction,
101(3), 452-453.
258. Dürsteler-MacFarland, K., Stohler, R., Modovanyi, A., Rey, S., Basdekis, R., Gschwend, P., Eschmann, S., & Rehm, J. (2006). Complaints of
heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine. Drug and Alcohol Dependence, 81(3), 231-239.
257. Leri, F, Stewart, J., Fischer, B., Rehm, J.,Brissette, S., Brochu, S., Bruneau, J., El-Guebaly, N., Noel, L., Tyndall, M., & Wild, C. (2005). Patterns of
opioid and cocaine co-use: a descriptive study in a Canadian sample of untreated opioid-dependent individuals. Experimental and Clinical
Psychopharmacology, 13(4), 303-10.
256. Connor, J., Broad, J., Rehm, J., Vander Hoorn, S., & Jackson, R. (2005). Patterns of drinking and estimates of alcohol-related mortality in New
Zealand. Contemporary Drug Problems, 32(4), 527-546.
255. Taylor, B., Rehm, J. & Gmel, G. (2005). Moderate alcohol consumption and the gastrointestinal tract. Digestive Diseases, 23(3-4), 170-176.
254. Taylor, B., & Rehm, J. (2005). Moderate alcohol consumption and diseases of the gastrointestinal system: a review of pathophysiological
processes. Digestive Diseases, 23(3-4), 177-180.
253. Rehm, J. & Monteiro, M. (2005). Alcohol consumption and burden of disease in the Americas – implications for alcohol policy. Revista
Panamericana de Salud Pública/Pan American Journal of Public Health, 18(4/5), 241-248.
252. Rehm, J., Zhang, B., Bondy, S., Ashley, M.J., Cohen, J., Ferrence, R., Jain, M., Miller, A., & Rohan, T. (2005). The effect of smoking on the
relationship between alcohol consumption and all-cause mortality in Canadian women. Contemporary Drug Problems, 32, 373-386.
251. Haydon, E., Rehm, J., Fischer, B., Monga, N., & Edlaf, E. (2005). Prescription drug abuse in Canada and the diversion of prescription drugs into
the illicit drug market. Canadian Journal of Public Health, 96(6), 459-461.
250. Cherpitel, C., Yu, Y., Bond, J., Rehm, J., Poznyak, V., Macdonald, S., Stafström, M., & Hao, W. (2005). Multi-level analysis of alcohol-related
injury among emergency room patients: a cross-national study. A research report from the Emergency Room Collaborative Alcohol Analysis
Project (ERCAAP) and the WHO Collaborative Study on Alcohol and Injuries. Addiction, 100, 1840-1850.
249. Farley, J., Vasdev, S., Fischer, B., Haydon, E., Rehm, J., & Farley, T.A. (2005). Feasibility and outcome of HCV treatment in a Canadian federal
prison population. American Journal of Public Health, 95(10), 1737-1739.
248. Fischer, B., Vasdev, S., Haydon, E., Baliunas, D. & Rehm, J. (2005). Acceptabilité d’un traitement du virus de l’hépatite C chez les utilisateurs
de drogues injectables au Canada. Presse Médicale, 34, 1209-1212.
247. Neuenschwander, M., Frick, U., Gmel, G., & Rehm, J. (2005). Cannabiskonsum in der Schweiz: Prävalenz und Determinanten für
Risikokonsum. Suchttherapie, 6, 126-132.
246. Cherpitel, C., Bond, J., Ye, Y., Room, R., Poznyak, V., Rehm, J., & Peden, M. (2005). Clinical assessment compared to breathalyzer readings in
the emergency room: concordance of ICD-10 Y90 and Y91 codes. Emergency Medicine Journal, 22, 689-695.
245. Rehm, J., Monga, N., Adlaf, E., Taylor, B., Bondy, S.J., & Fallu, J.-S. (2005). School matters: Drinking dimensions and their effects on alcohol
related problems among Ontario Secondary School Students. Alcohol and Alcoholism. 40(6), 569-574.
244. Zobel, F. and Cannabis Monitoring Group Switzerland (2005). The revision of the Swiss law on narcotics – A case study in applied drug policy.
- 26 –
Addiction, 100, 1198.
243. Güttinger, F., & Rehm, J. (2005). Konsummuster bei verschiedenen Gruppen von Kokaingebrauchern in Zürich: Implikationen für das
Drogenhilfesystem. Sucht, 51(4), 225-232.
242. Wild, C., El-Guebaly, N., Fischer, B., Brissette, S., Brochu, S., Bruneau, J., Noël, L., Rehm, J., Tyndall, M., & Mun, P. (2005). Comorbid
depression among untreated illicit opiate users: results from a multi-site Canadian study. Canadian Journal of Psychiatry, 50, 512-518.
241. Güttinger, F., & Rehm, J. (2005). Die Situation von sogenannten „Problemopioidabhängigen“ in der Stadt Zürich. Abhängigkeiten, 11(2), 4961.
240. Farley, J., Vasdev, S., Fischer, B., Rehm, J., & Haydon, E. (2005). Hepatitis C treatment in a Canadian federal correctional population:
Preliminary feasibility and outcomes. International Journal of Prisoner Health, 1(1), 13-18.
239. Rehm, J., Room, R., van den Brink, W., & Jacobi, F. (2005). Alcohol use disorders in EU countries and Norway: an overview of the
epidemiology. European Neuropsychopharmacology, 15, 377-388.
238. Rehm, J., Room, R., van den Brink, W., & Kraus,L. (2005). Problematic drug use and drug use disorders in EU countries and Norway: an
overview of the epidemiology. European Neuropsychopharmacology, 15, 389-397.
237. Rehm, J., Frick, U., Hartwig, C., Gutzwiller, F., Gschwend, P., & Uchtenhagen, A. (2005). Mortality in heroin-assisted treatment in Switzerland
1994–2000. Drug and Alcohol Dependence, 79(2), 137-143.
236. Hüsler, G., Werlen, E., & Rehm, J. (2005). The action plan – A new instrument to collect data on interventions in secondary prevention in
adolescents. Substance Use & Misuse, 40, 761-777.
235. Jain, M.G., Miller, A.B., Rohan, T.E., Rehm, J., Bondy, S.J., Ashley, M.J., Cohen, J.E., & Ferrence, R.G. (2005). Body mass index and mortality in
women: follow-up of the Canadian National Breast Screening Study cohort. International Journal of Obesity and Related Metabolic Disorders,
29(7), 792-797.
234. Andlin-Sobocki, P. & Rehm, J. (2005). Cost of addiction in Europe. European Journal of Neurology, 12(s1), 28-33.
233. Fischer, B., Rehm, J., Brissette, S., Brochu, S., Bruneau, J., El-Guebaly, N., Noël, L., Tyndall, M.W., Wild, C.T., Mun, P., & Baliunas, D. (2005).
Illicit Opioid Use in Canada - Comparing Social, Health and Drug Use Characteristics of Untreated Users in Five Cities (OPICAN Study). Journal
of Urban Health: Bulletin of the New York Academy of Medicine, 82(2), 250-266.
232. Taylor, B., & Rehm, J. (2005). J-shape or linear relationship between alcohol consumption and depression: Does it matter? Addiction, 100,
871-872..
231. Gmel, G., Heeb, J.-L., Rezny, L., Rehm, J., & Mohler-Kuo, M. (2005). Drinking patterns and traffic casualties in Switzerland: matching survey
data and police records to design preventive action. Public Health, 119(5), 426-436.
230. Murray, R., Connett, J.E., Mäkelä, P., & Rehm, J. (2005). Difficulty in demonstrating a risk from drinking pattern in fourteen years of coronary
heart disease morbidity and mortality: the Lung Health Study. Addictive Behaviors, 30, 875-887.
229. Connor, J., Broad, J., Rehm, J., Vander Hoorn, S., & Jackson, R. (2005). The burden of death, disease and disability due to alcohol in New
Zealand. New Zealand Medical Journal, 118 (1213), April 15, U1412.
228. Frick, U., Kharraz, A., Hauser, S., Wiegand, R., Rehm, J., von Kovatsits, U., & Eichhammer, P. (2005). Comparison perception of singular
transcranial magnetic stimuli by subjectively electrosensitive subjects in comparison to general population controls. Bioelectromagnetics, 26,
287-298.
227. Zhang, B., Ferrence, R., Cohen, J., Bondy, S., Ashley, M.J., Rehm, J., Jain, M., Rohan, T., & Miller, A. (2005). Smoking cessation and lung cancer
mortality in a cohort of middle-aged Canadian women. Annals of Epidemiology, 15(4), 302-309.
226. Room, R., Babor, T., & Rehm, J. (2005). Alcohol and public health: a review. Lancet, 365, 519-530.
Editorial:
225. Rehm, J. (2005). Die Rolle von Bevölkerungsumfragen in modernen Monitoringsystemen für legale und illegale Drogen. Sucht, 51 (Sonderheft
1), S4-S5.
224. Fischer, B. & Rehm, J. (2005). Response to commentatries by A. Uchtenhagen and R. Newman. European Addiction Research, 11, 13-14.
223. Fischer, B., Rehm, J., Kim, G. & Kirst, M. (2005). Eyes wide shut? A conceptual and empirical critique of methadone maintenance treatment
(MMT). European Addiction Research, 11, 1-9.
222. Rehm, J. (2005). Selection and self-selection: how to determine the real impact of alcohol on health-care utilization and costs? Addiction,
100 (1), 28-29.
221. Gmel, G., & Rehm, J. (2004). Measuring alcohol consumption. Contemporary Drug Problems, 31, 467-540.
220. Chisholm, D., Rehm, J., van Ommeren, M., & Monteiro, M. (2004). Reducing the global burden of hazardous alcohol use: a comparative costeffectiveness analysis. Journal of Studies on Alcohol, 65, 782-793.
219. Güttinger, F., & Rehm, J. (2004). Die Nutzung von Hilfe und Unterstützungsangeboten von verschiedenen Gruppen von Kokaingebrauchern in
Zürich. Suchttherapie, 5, 174-179.
218. Kerr, W.C., Greenfield, T.K., Bond, J., Ye, Y., & Rehm, J. (2004). Age, period and cohort influences on beer, wine and spirits consumption
trends in the US National Alcohol Surveys. Addiction, 99(9), 1111-1120.
217. Haasen, C., Prinzleve, M., Zurhold, H., Rehm, J., Guettinger, F., Fischer, G., Jagsch, R., Olsson, B., Ekendahl, M., Verster, A., Camposeragna, A.,
Pezous, A.-M., Gossop, M., Manning, V., Cox, G., Ryder, N., Gerevich, J., Bacskai, E., Casas, M., Matali, J. L. & Krausz, M. (2004). Cocaine use in
Europe - a multi-centre study: Methodology and prevalence estimates. European Addiction Research, 10(4), 139-146.
216. Prinzleve, M., Haasen, C., Zurhold, H., Matali, J. L., Bruguera, E., Gerevich, J., Bacskai, E., Ryder, N., Butler, S., Manning, V., Gossop, M., Pezous,
A.-M., Verster, A., Camposeragna, A., Andersson, P., Olsson, B., Primorac, A., Fischer, G., Guettinger, F., Rehm, J. & Krausz, M. (2004). Cocaine
use in Europe - a multi-centre study: Patterns of use in different groups. European Addiction Research, 10(4), 147-155.
215. Frick, U., Lerch, S., Rehm, J., & Crotti, C. (2004). Pilotstudie zur Rezeptierung von Benzodiazepinen in der Schweiz: Beeinflusst die kognitive
Verfügbarkeit von Gesetzesvorschriften das ärztliche Verschreibungsverhalten? Das Gesundheitswesen, 66, 499-504.
- 27 –
214. Graham, K., Demers, A., Rehm, J., & Gmel, G. (2004). Problems with the graduated frequency approach to measuring alcohol consumption:
results from a pilot study in Toronto, Canada. Alcohol and Alcoholism, 39(5), 455-62.
213. Fischer, B., Brissette, S., Brochu, S., Bruneau, J., el-Guebaly, N., Noël, L., Rehm, J., Tyndall, M., Wild, C., Mun, P., Haydon, E., & Baliunas, D.
(2004). Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. Canadian Medical Association Journal, 171(3), 235239.
212. Fischer, B., Haydon, E., Rehm, J., Krajden, M., & Reimer, J. (2004). Injection drug use and the hepatitis C virus: considerations for a targeted
treatment approach – The case study of Canada. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 81, 428-447.
Editorial:
211. Rehm, J., Fischer, B., Graham, K., Haydon, E., Mann, R., & Room, R. (2004). The importance of environmental modifiers of the relationship
between substance use and harm. Addiction, 99, 663-666.
210. Mohler-Kuo, M., Rehm, J., Heeb, J.-L., & Gmel, G. (2004). Decreased taxation, spirits consumption and alcohol-related problems in
Switzerland. Journal of Studies on Alcohol, 65, 266-273.
209. Rehm, J., Fischer, F., & Frick, U. (2004). Public Health, Forschung und Suchtmittelindustrie. Sucht, 50(2), 143-145.
208. Rehm, J. & Frick, U. (2004). Epidemiologische und ökonomische Aspekte von Substanzmittelgebrauch. Sucht aktuell, 11(1), 6-10.
207. Uchtenhagen, A. & Rehm, J. (2004). Langzeitbehandlung in heroingestützer Behandlung in der Schweiz. Abhängigkeiten, 10, 12-15.
206. Kuntsche, E., Rehm, J., & Gmel, G. (2004). Characteristics of binge drinkers in Europe. Social Science and Medicine, 59(1), 113-127.
205. Gschwend, P., Rehm, J., Blättler, R., Steffen, T., Seidenberg, A., Christen, S., Bürki, C., & Gutzwiller, F. (2004). Dosages in the prescription of
heroin and other narcotics to chronic opioid addicts in Switzerland – Swiss national cohort study. European Addiction Research, 10(1), 41-48.
Editorial:
204. Gmel, G., Rehm, J., & Room, R. (2004). Contrasting individual level and aggregate level studies in alcohol research? Combining them is the
answer. Addiction Research and Theory, 12(1), 1-10.
203. Rehm, J., Gmel, G., Sempos, C.T., & Trevisan, M. (2003). Alcohol-related mortality and morbidity. Alcohol Research & Health, 27(1), 39-51.
202. Gmel, G. & Rehm, J. (2003). Harmful alcohol use. Alcohol Research & Health, 27(1), 52-62.
201. Heeb, J.-L., Gmel, G., Zurbrügg, C., Kuo, M., & Rehm, J. (2003). Changes in alcohol consumption following a reduction in the price of spirits: a
natural experiment in Switzerland. Addiction, 98(10), 1433-1446.
200. Fichter, M.M., Quadflieg, N., Rehm, J. (2003). Predicting the outcome of eating disorders using structural equation modeling. International
Journal of Eating Disorders. 34(3), 292-313.
199. Alcohol & Public Policy Group (2003). Alcohol: no ordinary commodity. A summary of the book. Addiction, 98(10), 1343-1350.
(The Alcohol and Public Policy Group consisted of: Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J.,
Gruenewald, P., Hill, L., Holder, H., Homel, R., Österberg, E., Rehm, J., Room, R., & Rossow, I.)
198. Babor, T., Room, R., Rehm, J., Giesbrecht, N., Rossow, I., Österberg, E., Grube, J., Graham, K., & Hill, L. (2003). No ordinary commentary: a
response to our gentle critics. Addiction, 98(10), 1367-1370.
197. Rehm, J., Rehn, N., Room, R., Monteiro, M., Gmel, G., Jernigan, D. & Frick, U. (2003). The global distribution of average volume of alcohol
consumption and patterns of drinking. European Addiction Research, 9(4), 147-156.
196. Rehm, J., Room, R., Monteiro, M., Gmel, G., Graham, K., Rehn, N., Sempos, C.T., & Jernigan, D. (2003). Alcohol as a risk factor for global
burden of disease. European Addiction Research, 9(4), 157-164.
195. Room, R., Graham, K., Rehm, J., Jernigan, D., & Monteiro, M. (2003). Drinking and its burden in a global perspective: policy considerations
and options. European Addiction Research, 9(4), 165-175.
194. Rehm, J., Room, R., Graham, K., Monteiro, M., Gmel, G., & Sempos,C.T. (2003). The relationship of average volume of alcohol consumption
and patterns of drinking to burden of disease - An overview. Addiction, 98(10), 1209-1228.
193. Fischer, B., Haydon, E., Kim, G., Rehm, J., & El-Guebaly, N. (2003). Screening for antisocial personality disorders in drug users – a qualitative
feasibility study. International Journal of Methods in Psychiatric Research, 12(3), 151-156.
192. Ezzati, M., Vander Hoorn, S., Rodgers, A., Lopez, A.D., Mathers, C.D., Murray, C.J.L. & the Comparative Risk Assessment Collaborating Group
(2003). Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet, 362, 271-280.
191. Gmel, G., Gutjahr, E., & Rehm, J. (2003). How stable is the risk curve between alcohol and all-cause mortality and what factors influence the
shape? A precision-weighted hierarchical meta-analysis. European Journal of Epidemiology, 18 (7), 631-642.
190. Bammer, G., van den Brink, W., Gschwend, P., Hendriks, V., & Rehm, J. (2003). What can the Swiss and Dutch trials tell us about the potential
risks associated with heroin prescribing? Drug & Alcohol Review, 22, 361-369.
189. Rehm, J., Fischer, B., Haydon, E., & Room, R. (2003). Abstinence ideology and somatic treatment for addicts – ethical considerations.
Addiction Research and Theory, 11 (5), 287-293.
188. Rehm, J. & Gmel, G. (2003). Alcohol consumption and total mortality/morbidity: definitions and methodological implications. Best Practice &
Research Clinical Gastroenterology, 17 (4), 497-505.
187. De Guia, N.A., Cohen, J.E., Ashley, M.J., Ferrence, R., Rehm, J., Studlar, D., & Northrup, D. (2003). Dimensions underlying legislator support for
tobacco control policies. Tobacco Control, 12, 133-139.
186. Kuo, M., Heeb, J.-L., Gmel, G., & Rehm, J. (2003). Does price matter? The effect of decreased price on spirits consumption in Switzerland.
Alcoholism: Clinical and Experimental Research, 27 (4), 720-725.
185. Rehm, J. (2003). Suchtmittel und Public Health. Suchttherapie, 4, 72-75.
184. Rehm, J. (2003). Zur vergleichenden Bewertung von Interventionen im Bereich Alkohol: Welche Massnahme ist am kosteneffektivsten?
Abhängigkeiten, 9, 16-19.
183. Gschwend, P., Eschmann, S., Güttinger, F., Hosek, M., Rehm, J., & Uchtenhagen, A. (2003). Acht Jahre Erfahrung mit der heroingestützten
Behandlung in der Schweiz – aktuelle Ergebnisse und künftige Weiterentwicklung. Therapeutische Umschau. 60, 355-360.
- 28 –
Editorial:
182. Rehm, J. (2003). Ein Paradigmenwechsel in der Alkoholforschung. Sucht, 49(2), 84-85.
181. Rehm, J., Room, R., Graham, K., & Frick, U. (2003). Trinkmenge, Trinkmuster und ihre Beziehung zu Morbidität und Mortalität – Ein Überblick.
Sucht, 49(2), 87-94.
180. Gmel, G., Rehm, J., & Frick, U. (2003). Trinkmuster, Pro-Kopf-Konsum von Alkohol und koronare Mortalität. Sucht, 49(2), 95-104.
179. Gmel, G., Rehm, J. & Kuntsche, E. (2003). Binge drinking in Europe: definitions, epidemiology, and consequences. Sucht, 49(2), 105-116.
178. Güttinger, F., Gschwend, P., Schulte, B., Rehm, J. & Uchtenhagen, A. (2003). Evaluating long-term effects of heroin-assisted treatment - The
results of a 6-year follow-up. European Addiciton Research, 9 (2), 73-79.
177. Gmel, G., & Rehm, J. (2003). Marginality revised – on the empirical basis and practical implications of Skog’s revised theory of collective
displacement: a reply to Skogs’ commentary. Drug & Alcohol Review, 22, 93-94.
176. Rey-Riek, S., Gschwend, P., & Rehm, J. (2003). Validität von Selbstangaben zum Drogenkonsum in der heroingestützten Behandlung in der
Schweiz. Sucht, 49, 28-33.
Editorial:
175. Rehm, J., Fischer, B. & Frick, U. (2003). „Public Health“ und ökonomische Studien im Bereich Sucht. Suchttherapie, 4, 1.
174. Rehm, J. (2003). Ist Suchtprävention generell wirtschaftlich? Suchttherapie, 4, 8-11.
173. Rey-Riek, S., Güttinger, F., & Rehm, J. (2003). Lohnt sich betriebliche Suchtprävention? Zu Effektivität und Effizienz betrieblicher
Alkoholprävention. Suchttherapie, 4, 12-17.
172. Gschwend, P., Rehm, J., Eschmann, S., & Uchtenhagen, U. (2003). Heroingestützte Behandlung für Opioidabhängige in der Schweiz von 1994
bis 2001 – Inanspruchnahme und Charakteristik der Ein- und Austretenden. Das Gesundheitswesen, 65 (2), 75-80.
171. Rehm, J., Sempos, C.T. & Trevisan, M. (2003). Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease
– a review. Journal of Cardiovascular Risk, 10 (1), 15-20.
170. Sempos, C.T., Rehm, J., Wu, T., Crespo, C., & Trevisan, M. (2003). Average volume of alcohol consumption and all-cause mortality in African
Americans: The NHEFS cohort. Alcoholism: Clinical and Experimental Research, 27 (1), 88-92.
169. Sempos, C.T., Rehm, J., Crespo, C., & Trevisan, M. (2002). No protective effect of alcohol consumption on coronary heart disease (CHD) in
African Americans. Average volume of drinking over the life course and CHD morbidity and mortality in a U.S. national cohort. Contemporary
Drug Problems, 29, 805-820.
168. Güttinger, F., Gschwend, P., Schulte, B., Rehm, J., & Uchtenhagen, A. (2002). Die Lebenssituation von Drogenabhängigen in der Heroin
gestützten Behandlung in der Schweiz - Eine 6-Jahres-Katamnese. Sucht, 48, 370-378.
167. Ezzati, M., Lopez, A.D., Rodgers, A., Vander Hoorn, S., Murray, C.J.L. and the Comparative Risk Assessment Collaborating Group (2002).
Selected major risk factors and global and regional burden of disease. Lancet, 360, 1347-1360. (contribution of J. Rehm as head of working
group on alcohol in Comparative Risk Assessment Collaborating Group).
166. Fischer, B., Rehm, J., Kim, G., & Robins, A. (2002). Safer injection facilities (SIFs) for injection drug users (IDUs) in Canada: A review and call for
an evidence-focused pilot trial. Canadian Journal of Public Health, 93, 336-338.
165. Rehm, J. & Fischer, B. (2002). Von kontrollierten klinischen Studien zu einer Gestaltung des Behandlungssystems für Suchtkranke. Sucht, 48,
310-311.
164. Fischer, B., Rehm, J., Kirst, M., Casas, M., Hall, W., Krausz, M., Metrebian, N., Reggers, J., Uchtenhagen, A., van den Brink, W., & van Ree, J.M.
(2002). Heroin-assisted treatment as a response to the public health problem of opiate dependence. European Journal of Public Health, 12,
228-234.
163. Frick, U., Rehm, J., & Eichhammer, P. (2002). Risk perception, somatization, and self report of complaints related to electromagnetic fields – A
randomized survey study. International Journal of Hygiene and Environmental Health, 205, 353-360.
162. Frei, A. & Rehm, J. (2002). Die Prävalenz psychischer Komorbidität unter Opiatabhängigen: eine Metaanalyse bisheriger Studien.
Psychiatrische Praxis, 29, 258-262.
161. Arbeitsgruppe HeGeBe Doppeldiagnosen (2002). Komorbidität: psychische Störungen bei Opiatabhängigen zu Beginn einer Heroin gestützten
Behandlung. Psychiatrische Praxis, 29, 251-257.
160. Rehm, J. & Eschmann, S. (2002). Global monitoring of average volume of alcohol consumption. Zeitschrift für Sozial- und Präventivmedizin
47(1), 48-58.
159. Gschwend, P., Rehm, J., Lezzi, S., Blättler, R., Steffen, T., Gutzwiller, F., & Uchtenhagen, A. (2002). Development of a monitoring system for
heroin-assisted substitution treatment in Switzerland. Zeitschrift für Sozial- und Präventivmedizin, 47(1), 33-38.
158. Rehm, J. (2002). Noch ein weiter Weg zu evidenzbasierter Gesundheitspolitik im Bereich Substanzmissbrauch... Sucht, 48, 133-134.
157. Rehm, J. (2002). The role of consumers. Reflections on the possibilities and limits of user interviews in opiate addiction treatment.
Substance Use & Misuse, 37(4), 533-536.
Editorial:
156. Fischer, B., Rehm, J., Uchtenhagen, A., & Kirst, M. (2002). Compulsory treatment – What do we know and where should we go? European
Addiction Research, 8(2), 52-53.
155. Grichting, E., Uchtenhagen, A., & Rehm, J. (2002). Modes and impact of coercive inpatient treatment for drug-related conditions in
Switzerland. European Addiction Research, 8(2), 78-83.
154. Rehm, J., Fischer, B., Krausz, M., Gschwend, P. & Uchtenhagen, A (2002). Heroin presciption for opioid addicts. Lancet, 359, 890.
153. Gschwend, P., Eschmann, S., Güttinger, F., Rey-Riek, S., Rehm, J., & Uchtenhagen, A. (2002). Konsum von Kokain vor, in und nach der Heroin
gestützten Behandlung in der Schweiz. Suchttherapie, 3, 8-12.
152. Greenfield, T., Rehm, J., & Rogers, J.D. (2002). Effects of depression and social integration on the relationship between alcohol consumption
and all-cause mortality. Addiction, 97, 29-38.
- 29 –
151. Rehm, J. & Gmel, G. (2002). Average volume of alcohol consumption, patterns of drinking patterns and mortality among young Europeans in
1999. Addiction, 97, 95-109.
150. Robert T. Trotter, R.T., Üstün, B., Chatterji, S., Rehm, J.., Room, R., & Bickenbach, J. (2001). Cross-cultural applicability research on
disablement: models and methods for the revision of an international classification. Human Organization, 60(1), 13-27.
doi:10.17730/humo.60.1.ba5dnhqr7ek65jbx
149. Rehm, J., Gschwend, P., Steffen, T., Gutzwiller, F., Dobler-Mikola, A. & Uchtenhagen, A. (2001). Feasibility, safety, and efficacy of injectable
heroin prescription for refractory opioid addicts: a follow-up study. Lancet, 358, 1417-1420. [PMID: 11705488]
148. Rehm, J., Gutjahr, E., & Gmel, G. (2001). Alcohol and all-cause mortality: a pooled analysis. Contemporary Drug Problems, 28, 337-361.
147. Gmel, G., Heeb, J.-L., & Rehm, J. (2001). Is frequency of drinking an indicator of problem drinking? A psychometric analysis of a modified
version of the alcohol use disorders identification test in Switzerland. Alcohol and Drug Dependence, 64, 151-163.
146. Scherbaum, N., Beckmann, J.P., Klein, S. & Rehm, J. (2001). Medizinethische Aspekte der ärztlichen Heroinverschreibung. Der Nervenarzt, 72
(9), 717-722.
Editorial:
145. Rehm, J. & Gmel, G. (2001). Applying principles of comparative risk analysis to substance-abuse related burden. European Addiction
Research, 7 (3), 95-97.
144. Gutjahr, E., Gmel, G., & Rehm, J. (2001). Relation between average alcohol consumption and disease: an overview. European Addiction
Research, 7 (3), 117-127.
143. Gmel, G., Rehm, J., & Frick, U. (2001). Methodological approaches to conducting pooled cross-sectional time series analysis: the example of
the association between all-cause mortality and per capita alcohol consumption for men in 15 European states. European Addiction
Research, 7 (3), 128-137.
142. Rehm, J., Monteiro, M., Room, R., Gmel, G., Jernigan, D., Frick, U., & Graham, K. (2001). Steps towards constructing a global comparative risk
analysis for alcohol consumption: determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum,
and dealing with different consequences. European Addiction Research, 7 (3), 138-147.
141. Rehm, J., Gmel, G., Room, R. & Frick, U. (2001). Average volume of alcohol consumption, drinking patterns and related burden of mortality in
young people in established market economies of Europe. European Addiction Research, 7 (3), 148-151.
140. Rehm, J. & Gmel, G. (2001). Aggregate time-series regression in the field of alcohol. Addiction, 96(7), 945-954.
139. Frick, U., Rehm, J., Krischker, S., & Cording, C. (2001). Herr Tur-Tur und die Krankenhausvergleiche: Ein Besuch in der Psychiatrie-Oase.
Gesundheitswesen, 63 (7), 435-439.
Editorial:
138. Frick, U., Rehm, J., & Cording, C. (2001). Brauchen wir eine psychiatrische Gesundheitsökonomie? – Wozu wir eine psychiatrische
Gesundheitsökonomie brauchen. Psychiatrische Praxis, 28 (Special Issue 1), S1-S6.
137. Rehm, J. (2001). Von der „burden of disease“ Forschung zur Konzeption eines integrierten Versorgungssystems für Substanzabusus am
Beispiel Ontario. Psychiatrische Praxis, 28 (Special Issue 1), S68-S72.
th
136. Warner, J., Her, M., Gmel, G., & Rehm, J. (2001). Can legislation prevent debauchery? Mother Gin and public health in 18 -century England.
American Journal of Public Health, 91(3), 375-384.
135. Dombrowski, D., Uchtenhagen, A., & Rehm, J. (2001). Casino Gambling in Switzerland – The legal situation, politics and prospects for
prevention and harm reduction. eGambling The Electronic Journal of Gambling Issues (www.camh.net/egambling/issue4/policy/index.html).
134. Fischer, B., Medved, W., Kirst, M., Rehm, J., & Gliksman, L. (2001). Illicit opiates and crime: Results of an untreated user cohort in Toronto.
Canadian Journal of Criminology, 43(2), 197-217 (ISSN 0704-9722).
133. Fischer, B. & Rehm, J. (2001). Some reflections on the relationship of risk, harm and responsibility in recent tobacco lawsuits, and implications
for public health. Canadian Journal of Public Health, 92 (1), 7-8.
132. Rehm, J., Greenfield, T.K., & Rogers, J.D. (2001). Average volume of alcohol consumption, patterns of drinking and all-cause mortality.
Results from the U.S. National Alcohol Survey. American Journal of Epidemiology, 153(1), 64-71.
131. Ashley, M.J., Rehm, J., Bondy, S., Single, E., & Rankin, J. (2000). Beyond ischemic heart disease: are there other health benefits from drinking
alcohol? Contemporary Drug Problems, 27, 735-777.
130. Gmel, G., Rehm, J., Room, R., & Greenfield, T.K. (2000). Dimensions of alcohol-related social harm in survey research Journal of Substance
Abuse, 12, 113-138.
129. Rehm, J. & Gmel, G. (2000). Aggregating dimensions of alcohol consumption to predict medical and social consequences. Journal of
Substance Abuse, 12, 155-168.
128. Wall, R., Rehm, J., Fischer, B., Brands, B., Gliksman, L., Stewart, J., Medved, W., & Blake, J. (2000). Social costs of untreated opioid
dependence. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 77(4), 688-722.
127. Rohan, T.E., Jain, M., Rehm, J.T., Ashley, M.J., Bondy, S.J., Ferrence, R.G., Cohen, J.E., & Miller, A.B. (2000). Cigarette smoking and risk of
death from colorectal cancer. Colorectal Disease, 2, 298-303.
126. Gmel, G. & Rehm, J. (2000). The empirical testability of Skog’s theory of collective drinking behaviour. Drug and Alcohol Review, 19, 391-399.
125. Rehm, J. & Bondy, S. (2000). Moderater Alkoholkonsum und Morbidität und Mortalität bei Verdauungskrankheiten. Verdauungskrankheiten,
18(6), 277-282.
124. Jain, M.G., Ferrence, R.G., Rehm, J.T., Bondy, S.J., Rohan, T.E., Ashley, M.J., Cohen, J.E., & Miller, A.B. (2000). Alcohol and breast cancer
mortality in a cohort study. Breast Cancer Research and Treatment. 64. 201-209.
123. Rehm, J., Sempos, C.T., Kohlmeier, L., Myers, G., Thefeld, W., Gunter, E., Thamm, M., Dortschy, R., Murphy, R., Feinlieb, M., & Hoffmeister, H.
(2000). A comparison of serum total cholesterol levels and their determinants between the Federal Republic of Germany and the United
States. European Journal of Epidemiology, 16, 669-675.
- 30 –
122. Frick, U., Rehm, J., Knoll, A., Reifinger, M., & Hasford, J. (2000). Perception of traffic accident risk and decision to drive under light alcohol
consumption – A double blind experimental study. Journal of Substance Abuse, 11 (3), 241-251.
121. Rehm, J. & Fischer, B. (2000). Heroingestütze Therapie für Opiatabhängige - weder Allheilmittel noch Teufelswerk. Suchttherapie, 1 (2), 5762.
120. Ivis, F.J., Adlaf, E.M., & Rehm, J. (2000). Incorporating the AUDIT into a general population survey: a methodological experiment. Drug and
Alcohol Dependence, 60, 97-104.
Editorial:
119. Rehm, J. (2000). Alcohol consumption and mortality. What do we know and where should we go? Addiction, 95 (7), 989-995.
118. Rehm, J. & Gmel, G. (2000). Gaps and needs in international alcohol epidemiology. Journal of Substance Use, 5 (1), 6-13.
117. Single, E., Rehm, J., Robson, L., & Van Truong, M. (2000). The relative risks and aetiologic fractions of different causes of death and disease
attributable to alcohol, tobacco and illicit drug use in Canada. Canadian Medical Association Journal, 162 (12), 1669-1675.
116. Fischer, B., Rehm, J., & Blitz-Miller, T. (2000). Injection drug use and preventive measures: a comparison of Canada and Western European
jurisdictions over time. Canadian Medical Association Journal, 162 (12), 1709-1713.
115. Rehm, J., Gmel, G., & Her, M. (2000). Alcohol consumption, time series methodology and disease outcomes. Addiction, 95 (3), 352-354.
114. Rehm, J. (2000). Re: „Alcohol intake assessment: the sober facts”. American Journal of Epidemiology, 151 (4), 436-438.
113. Ali, R., Auriacombe, M., Casas, M., Cottler, L., Farrell, M, Kleiber, D., Kreuzer, A., Ogborne, A., Rehm, J., & Ward, P. (1999). Report of the
external panel on the evaluation of the Swiss Scientific Studies of Medically Prescribed Narcotics to Drug Addicts. Sucht, 45 (3), 160-170.
112. Xie, X. Rehm, J., Single, E., & Robson, L. (1999). Methodological issues and selected economic consequences of substance use in Ontario.
Addiction Research, 7 (5), 417-431.
111. Fischer, B., Medved, W., Gliksman, L., & Rehm, J. (1999). Illicit opiate use in Toronto: a profile of current users. Addiction Research, 7 (5),
377-415.
110. Her, M., Giesbrecht, N., Room, R., & Rehm, J. (1999). Implications of privatizing/deregulating alcohol retail sales: projections of alcohol
consumption in Ontario. Journal of Substance Abuse, 10 (4), 355-373.
109. Fischer, B., Gliksman, L., Rehm, J., Daniel, N., & Medved, W. (1999). Comparing opiate users in methadone treatment with untreated opiate
users: results of a follow-up study with a Toronto opiate user cohort. Canadian Journal of Public Health, 90 (5), 299-303.
108. Murray, R.P., Rehm, J., Shaten, J., & Connett, J.E. (1999). Does social integration confound the relation between alcohol consumption and
mortality in the Multiple Risk Factor Intervention Trial (MRFIT)? Journal of Studies on Alcohol, 60 (6), 740-745.
107. Frick, U., Rehm, J., Krischker, S., & Cording, C. (1999). Length of stay in a German psychiatric hospital as a function of patient and
organizational characteristics - a multilevel analysis. International Journal of Methods in Psychiatric Research, 8 (3), 146-161.
106. Üstün, T.B., Saxena, S., Rehm, J., & Bickenbach, J. (1999). Are disability weights universal? WHO/NIH Joint Project CAR Study Group. Lancet,
354, 1306.
105. Her, M., Giesbrecht, N., Room, R., & Rehm, J. (1999). Privatizing alcohol sales and alcohol consumption: evidence and implications.
Addiction, 94 (8), 1125-1139.
104. Giesbrecht, N., Her, M., Room, R., & Rehm, J. (1999). Impacts of privatization: what do we know and where should we go? Addiction, 94 (8),
1146-1153.
103. Bondy, S.J., Rehm, J., Ashley, M.J., Walsh, G., Single, E., & Room, R. (1999). Low-risk drinking guidelines: the scientific evidence and its
implications. Canadian Journal of Public Health, 90 (4), 264-270.
102. Bondy, S.J., Ashley, M.J., Rehm, J.T., & Walsh, G. (1999). Do Ontarians drink in moderation? A baseline assessment against Canadian Low-Risk
Drinking Guidelines. Canadian Journal of Public Health, 90 (4), 272-276.
101. Rehm, J., Üstün, T.B., Saxena, S., Nelson, C.B., Chatterji, S., Ivis, F., & Adlaf, E. (1999). On the development and psychometric testing of the
WHO screening instrument to assess disablement in the general population. International Journal of Methods in Psychiatric Research, 8 (2),
110-122.
100. Üstün, T.B., Rehm, J., Chatterji, S., Saxena, S., Trotter, R., Room, R., & Bickenbach, J. (1999). Multiple-informant ranking of the disabling
effects of different health conditions in 14 countries. Lancet, 354, 111-115.
99. Rehm, J. (1999). Draining the ocean to prevent shark attacks? The empirical foundation of modern alcohol policy. Nordisk Alkohol-&
Narkotikatidskrift (Nordic Alcohol and Drugs Journal, English supplement), 16, 46-54.
98. Zakhari, S., Goldberg, D.M., Wolkoff, I.J., Werner, M., Rehm, J., Room, R., & Babor, T.F. (1999). Publicizing the benefits and risks of moderate
alcohol consumption. Annals of the Royal College of Physicians and Surgeons of Canada, 32 (4), 235-239.
97. Rehm, J. & Gmel, G. (1999). Patterns of alcohol consumption and social consequences. Results from an eight-year follow-up study in
Switzerland. Addiction, 94 (6), 899-912.
96. Nelson, C.B., Rehm, J., Üstün, T.B., Grant, B., & Chatterji, S. (1999). Factor structures for DSM-IV substance abuse disorder criteria endorsed
by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction, 94 (6), 843-855.
95. Allison, K.R., Edlaf, E.M., Ialomiteanu, A., & Rehm, J. (1999). Predictors of health risk behaviours among young adults: analysis of the National
Population Health Survey. Canadian Journal of Public Health, 90 (2), 85-89.
94. Rehm, J., Bondy, S., Sempos, C.T., & Vuong, C.V. (1999). Re: Alcohol consumption and CHD morbidity and mortality. American Journal of
Epidemiology, 149 (7), 683.
93. Rehm, J., Greenfield, T.K., Walsh, G., Xie, X., Robson, L., & Single, E. (1999). Assessment methods for alcohol consumption, prevalence of high
risk drinking and harm: a sensitivity analysis. International Journal of Epidemiology, 28 (2), 219-224.
92. Kennedy, C., Sato, H., Tazaki, M., Iseta, T., Iwasaki, S., Oho, M., & Rehm, J. (1999). Japanese-United States cultural differences on
disablements: a Japanese interpretation. Journal of Social Policy and Social Work 3, 41-51.
(also published in Japanese in the Japanese Journal of Psychiatric Rehabilitation and in Spanish in Revista de Psiquitria)
- 31 –
91. Xie, X., Robson, L., Single, E., Rehm, J., & Paul, J. (1999). The economic consequences of smoking in Ontario. Pharmacological Research, 39
(3), 185-191.
90. Single, E., Robson, L., Rehm, J., & Xie, X. (1999). Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada.
American Journal of Public Health, 89(3), 385-390.
89. Rehm, J., Frick, U., & Bondy, S. (1999). A reliability and validity analysis of an alcohol-related harm scale for surveys. Journal of Studies on
Alcohol, 60(2), 203-208.
Editorial:
88. Rehm, J. (1999). Review papers in substance abuse research. Addiction, 94(2), 173-176.
87. Bondy, S. & Rehm, J. (1998). The interplay of drinking patterns and other determinants of health. Drug and Alcohol Review, 17(4), 399-411.
86. Robson, L.S., Single, E., Xie, X., & Rehm, J. (1998). The cost of alcohol-attributable injuries and poisonings in Canada, 1992. Contemporary
Drug Problems, 25(3), .421-439.
85. Üstün, T.B., Chatterji, S., & Rehm, J. (1998). Limitations of diagnostic paradigm: it doesn't explain "need". Archives of General Psychiatry, 55,
1145-1146.
84. Her, M. & Rehm, J. (1998). Alcohol consumption and all-cause mortality in Europe 1982-1990: a pooled cross-section time-series analysis.
Addiction, 93, 1335-1340.
83. Fischer, B. & Rehm, J. (1998). Intoxication, the law and criminal responsibility - A sparkling cocktail at times: the case studies of Canada and
Germany. European Addiction Research, 4, 89-101.
82. Walsh, G.W., Bondy, S., & Rehm, J. (1998). Review of Canadian low risk drinking guidelines and their effectiveness. Canadian Journal of Public
Health, 89, 241-247.
81. Single, E., Robson, L., Xie, X., & Rehm, J. (1998). The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction, 93, 9911006.
80. Rehm, J. (1998). Measuring alcohol consumption: how about adopting usual epidemiological standards. Addiction, 93, 970-972.
79. Wild, T.C., Graham, K., & Rehm, J. (1998). Blame and punishment for alcohol-related aggression: when is the perpetrator culpable?
Addiction, 93, 677-687.
78. Rehm, J. (1998). Measuring quantity, frequency and volume of drinking. Alcoholism: Clinical and Experimental Research, 22, 4S-14S.
77. Xie, X., Rehm, J., Single, E., Robson, L., & Paul, J. (1998). The economic costs of alcohol abuse in Ontario. Pharmacological Research, 37, 241249.
76. Xie, X., Rehm, J., Single, E., Robson, L., & Paul, J. (1998). The economic costs of illicit drug use in Ontario, 1992. Health Economics, 7, 81-85.
(also in Electronic Health Economics Letters, 1998, 2, 8-14).
75. Gmel, G., Rehm, J., & Ghazinouri, A. (1998). Alcohol and suicide in Switzerland - an aggregate-level analysis. Drug and Alcohol Review, 17, 2737.
74. Fischer, B. & Rehm, J. (1997). The case for a heroin substitution trial in Canada. Canadian Journal of Public Health, 88, 367-370.
73. Rehm, J., Bondy, S., Sempos, C.T., & Vuong, C.V. (1997). Alcohol consumption and coronary heart disease morbidity and mortality. American
Journal of Epidemiology, 146, 495-501.
Editorial:
72. Rehm, J. (1997). Patterns of drinking and harm. Contemporary Drug Problems, 24, 417-423.
71. Ross, H., Rehm, J., & Walsh, G. (1997). Patterns of alcohol consumption and psychiatric disorders among Ontario adults. Contemporary Drug
Problems, 24, 533-556.
70. Fischer, B., Kendall, P., Rehm, J., & Room, R. (1997). Charting WHO-goals for licit and illicit drugs for the year 2000: are we “on track”? Public
Health, 111, 271-275.
69. Rehm, J. & Fischer, B. (1997). Deutsche Suchtforschung im Wandel - Perspektiven für die Zukunft. Bericht zum Statusseminar
“Suchtforschung” des Förderschwerpunkts “Biologische und psychosoziale Faktoren von Drogenmißbrauch und –abhängigkeit” des
Programms der Bundesregierung in Bad Honnef 1996. Sucht, 43, 163-169.
68. Stockwell, T., Single, E., Hawks, D., & Rehm, J. (1997). Sharpening the focus of alcohol policy from aggregate consumption to harm and risk
reduction. Addiction Research, 5, 1-9.
67. Rehm, J., Bondy, S., & Room, R. (1997). Auf dem Weg zu effektiven Richtlinien für einen wenig riskanten Alkoholkonsum. Sucht, 43, 89-90.
(translated article Nr. 51: Towards effective low risk guidelines on alcohol consumption in Addiction, 91, 31-32).
66. Fichter, M.M., Narrow, W.E., Roper, M.T., Rehm, J., Elton, M., Rae, D.S., Locke, B.Z., & Regier, D.A. (1997). Sociodemographic factors and
prevalence rates in mental illness in Germany and the United States. The Journal of Nervous and Mental Disease, 185, 276-277.
65. Ashley, M.J., Ferrence, R., Room, R., Bondy, S., Rehm, J., & Single, E. (1997). Moderate drinking and health. Implications of recent evidence.
Canadian Family Physician, 43, 687-694.
64. Rehm, J., Ashley, M.J., & Dubois, G. (1997). Alcohol and health: individual and population perspectives. Addiction, 92, Supplement 1, S109115 (published on behalf of the World Health Organization, Europe).
63. Fischer, B. & Rehm, J. (1996). Alcohol consumption and liability of offenders in the German criminal system. Contemporary Drug Problems,
23, 707-729.
62. Rehm, J., Ashley, M.J., Room, R., Single, E., Bondy, S., Ferrence, R., & Giesbrecht, N. (1996). On the emerging paradigm of drinking patterns
and their social and health consequences. Addiction, 91, 1615-1621.
61. Walsh, G. & Rehm, J. (1996). Daily drinking and harm. Contemporary Drug Problems, 23, 465-478.
60. Fichter, M.M., Narrow, W.E., Roper, M.T., Rehm, J., Elton, M., Rae, D.S., Locke, B.Z., & Regier, D.A. (1996). Prevalence of mental illness in
Germany and the United States: comparison of the Upper Bavarian Study (UBS) and the Epidemiologic Catchment Area (ECA) program. The
- 32 –
Journal of Nervous and Mental Disease, 184, 598-606.
59. Rehm, J. & Bondy, S. (1996). Risk functions, low risk drinking guidelines, and the benefits of moderate drinking. Addiction, 91, 1439-1441.
58. Gmel, G. & Rehm, J. (1996). Zum Problem der Schätzung des Alters beim Drogeneinstieg in Querschnittsbefragungen am Beispiel der
schweizerischen Gesundheitsbefragung. Sozial- und Präventivmedizin 41, 257-261.
57. Rehm, J. & Arminger, G. (1996). Alcohol consumption in Switzerland 1987-1993. Adjusting for differential effects of assessment techniques
on the analysis of trends. Addiction, 91, 1335-1344.
56. Frick, U., Rehm, J., Thien, U., & Spuhler, T. (1996). Zur Konstruktion und Validierung eines Indikators für Alkoholprobleme in der
schweizerischen Gesundheitsbefragung. Sozial- und Präventivmedizin, 41, 133-142.
55. Vaucher, S., Rehm, J., Benvenuti, J., & Müller, R. (1996). Jugendliche und Zugänglichkeit zu alkoholischen Getränken. Eine Umfrage zu
Kenntnissen und Einhaltung gesetzlicher Bestimmungen zur Abgabe alkoholischer Getränke an 13- und 15jährige Jugendliche im Kanton
Waadt. Abhängigkeiten, 2, 4-13.
54. Rehm, J. (1996). The development of AA in a country with an existing out-patient lay-person help system: The case of German-speaking
Switzerland. Contemporary Drug Problems, 23, 77-91.
53. Rehm, J. (1996). Alcohol and all-cause mortality. International Journal of Epidemiology, 25, 215-216.
52. Rehm, J., Room, R., & Anderson, P. (1996). Meeting report: WHO working group on population levels of alcohol consumption. Oslo,
December 14-16, 1994. Addiction, 91, 275-283.
(Originally published only under Anderson, but see note in Addiction, 91, (6), p. 896)
51. Rehm, J., Bondy, S., & Room, R. (1996). Towards effective low risk guidelines on alcohol consumption. Addiction, 91, 31-32.
50. Vaucher, S., Rehm, J., Benvenuti, J., & Müller, R. (1995). Young teenagers and access to alcohol in a Swiss canton. Evidence from
observational testing and from a telephone survey. Addiction, 90, 1619-1625.
49. Fahrenkrug, H. & Rehm, J. (1995). Trinkkontexte und Freizeitaktivitäten in der Vorphase alkoholbezogener Straßenverkehrsunfälle junger
Fahrerinnen und Fahrer in der Schweiz. Sucht, 41, 169-180.
48. Fichter, M.M., Rehm, J., Elton, M., Dilling, H., & Achatz, F (1995). Mortality risk and mental disorders: longitudinal results from the Upper
Bavarian Study. Psychological Medicine, 25, 297-307.
47. Rehm, J. & Sempos, C.T. (1995). Alcohol consumption and mortality - questions about causality, confounding and methodology. Addiction,
90, 493-498.
46. Rehm, J. & Sempos, C.T. (1995). Alcohol consumption and all-cause mortality. Addiction, 90, 471-480.
45. Mariolini, N. & Rehm, J. (1995). Alcoholics Anonymous and its finances: The interrelationship of the material and the spiritual. Alcoholism
Treatment Quarterly, 12, (4), 39-59.
44. Rehm, J., Béroud, G., & Müller, R. (1994). Folienrauchen in der Schweiz: Ergebnisse einer Expertenbefragung. Sozial- und Präventivmedizin,
39, 370-371.
43. Rehm, J. (1994). Aktuelle Prävalenz des Konsums illegaler Drogen in der Schweiz. Neue Daten aus der Schweizerischen Gesundheitsbefragung
1992/93. Drogalkohol, 18, 85-94.
Editorial:
42. Eisenbach-Stangl, I. & Rehm, J. (1994). Die Anonymen Alkoholiker und das professionelle Behandlungssystem. Wiener Zeitschrift für
Suchtforschung, 17, 1-4.
41. Rehm, J. (1994). Anonyme Alkoholiker und professionelles Behandlungssystem in der deutschsprachigen Schweiz. Wiener Zeitschrift für
Suchtforschung, 17, 15-18.
40. Fahrenkrug, H. & Rehm, J. (1994). Drinking patterns, risk taking and road accidents of young drivers: Results of a Swiss case-control study.
Sozial- und Präventivmedizin, 39, 227-238.
39. Rehm, J. (1994). Reliabilität und Stabilität des Indikators für Alkoholkonsum in der Schweizerischen Gesundheitsbefragung. Drogalkohol, 18,
3-8.
38. Abbet, J.-P., Rehm, J., & Spinatsch, M. (1994). Missing values in responses to questions on drug use: The case of classroom questionnairesurveys in Swiss public schools. Addiction Research, 1, 367-376.
37. Rehm, J. & Spuhler, T. (1993). Measurement error in alcohol consumption: The Swiss Health Survey. European Journal of Clinical Nutrition,
47, Suppl. 2, S25-S30.
36. Rehm, J., Efionayi-Mäder, D., & Abbet, J.-P. (1993). Das Schnüffeln von lösemittelhaltigen Produkten in der Schweiz. Ergebnisse einer
Repräsentativbefragung der 15-/16jährigen SchülerInnen. Drogalkohol, 17, 99-108.
35. Rehm, J. (1993). Methodological approaches and problems in research into alcohol-related accidents and injuries. Addiction, 88, 885-896.
34. Rehm, J. (1993). Don't think: believe and act! The derivation from philosophical pragmatism of the principles of the "Alcoholics Anonymous".
Addiction Research, 1, 109-118.
33. Rehm, J., Maffli, E., & Mathey, M.C. (1993). Die Rolle von Statistik und Forschung für die Praxis in den Bereichen Prävention und Therapie des
Alkoholmissbrauchs. Suchtprobleme und Sozialarbeit, 61, 50-60.
32. Mensink, G.B.M., Kohlmeier, L., Rehm, J., & Hoffmeister, H. (1993). The relationship between coffee consumption and serum cholesterol
under consideration of smoking history. European Journal of Epidemiology, 9, 140-150.
31. Müller, R., Fahrenkrug, H., & Rehm, J. (1993). Neue Daten zum Alkoholkonsum in der Schweizer Bevölkerung. Drogalkohol, 17, 33-37.
30. Rehm, J., Fichter, M.M., & Elton, M. (1993). Effects on mortality of alcohol consumption, smoking, physical activity, and close personal
relationships. Addiction, 88, 101-112.
Editorial:
29. Rehm, J. & Room, R. (1992). Mutual help for alcohol-related problems: Studies of Al-Anon and of alternatives to Alcoholics Anonymous.
- 33 –
Contemporary Drug Problems, 19, 555-562.
28. Rehm, J., Mariolini, N., Huber, M., Klingemann, H., & Besson, J. (1992). Die Selbshilfeorganisation der Anonymen Alkoholiker in der
deutschsprachigen Schweiz. Drogalkohol, 16, 141-152.
27. Kohlmeier, L., Arminger, G., Bartolomeycik, S., Bellach, B., Rehm, J., & Thamm, M. (1992). Pet birds as an independent risk factor for lung
cancer: case-control study. British Medical Journal, 305, 986-989.
26. Rehm, J., Arminger, G., & Kohlmeier, L. (1992). Using follow-up data to avoid omitted variable bias: An application to cardiovascular
epidemiology. Statistics in Medicine, 11, 1195-1208.
25. Rehm, J. (1992). An wen sollen sich präventive Maßnahmen richten? Anmerkungen zur statistisch-theoretischen Basis von
Präventionsprogrammen, die sich an die Allgemeinbevölkerung wenden. Drogalkohol, 16, 21-32.
24. Kohlmeier, L., Rehm, J., & Hoffmeister, H. (1990). Lifestyle and trends in worldwide breast cancer rates. In: D.L. Davis & D.G. Hoel (Eds.),
Trends in cancer mortality in industrial countries. Annals of the New York Academy of Sciences (Vol. 609, pp. 259-268). New York: New York
Academy of Sciences.
23. Mensink, G.B.M., Rehm, J., Kohlmeier, L., & Hoffmeister, H. (1990). Die Kaffeepause, ein Risikofaktor für Herz-Kreislauf-Mortalität? Zur
erhöhenden Wirkung von Kaffee auf die Serumcholesterinwerte. Bundesgesundheitsblatt, 33, 547-552.
22. Häußler, A., Rehm, J., & Kohlmeier, L. (1990). Bundeslebensmittelschlüssel (BLS). AID Verbraucherdienst, 35, 179-187.
21. Häußler, A., Rehm, J., Naß, E., & Kohlmeier, L. (1990). Ernährung, Krankheit, Gesundheit - Wechselwirkungen. Bundesgesundheitsblatt, 33,
94-96.
20. Wagner, E., Frick, U., & Rehm, J. (1990). Bautenkonflikte in Österreich 1960 bis 1987. II. Analyse der Koalitionsbildungen unter den
Bautengegnern und Beurteilung ihrer Wirksamkeit. SWS Rundschau, 30, 23-55.
19. Wagner, E., Frick, U., & Rehm, J. (1989). Bautenkonflikte in Österreich 1960 bis 1987. I. Analyse umstrittener Großprojekte. SWS Rundschau,
29, 467-491.
18. Bisson, S. & Rehm, J. (1989). Wie lassen sich gesundheitsrelevante Einstellungen verändern? Königs- und Schleichwege der Persuasion.
Medizin Mensch Gesellschaft, 14, 181-189.
17. Koloska, R., Rehm, J., & Fichter, M.M. (1989). Ist die Beschwerden-Liste valide? Diagnostika, 35, 248-259.
16. Rehm, J. (1988). Welchen Beitrag leistet das Konzept der Zusammenhangstäuschung ('illusory correlation') zum Erkenntnisfortschritt in der
Stereotypenforschung? Zeitschrift für Sozialpsychologie, 19, 236-242.
15. Rehm, J., Lilli, W., & Strack, F. (1988). Soziale Kategorisierung und Gedächtnisspeicherung von individuellen Attributen. Zeitschrift für
Sozialpsychologie, 19, 202-205.
14. Rehm, J., Lilli, W., & Eimeren, B. van (1988). Reduced intergroup differentiation as a result of self-categorization in overlapping categories. A
quasi-experiment. European Journal of Social Psychology, 18, 375-379.
13. Rehm, J., Witzke, W., Fichter, M.M., Eiberger, T., & Koloska, R. (1988). Was messen psychiatrische Skalen? Ein empirischer Vergleich.
Diagnostika, 34, 227-243.
12. Rehm, J. (1988). Individuelles Risikoverhalten, präventive Massnahmen und Augenfälligkeit - Ein Kommentar zu "Der statistische Wert eines
Menschenlebens" von Walter Krämer, MMG 13, 36-41. Medizin Mensch Gesellschaft, 13, 210-211.
11. Frick, U., Rehm, J., Fichter, M.M., & Koloska, R. (1988). Therapeutische Rollenorientierung und soziale Repräsentationen von stationären
Alkoholismus-Patienten. Zeitschrift für Soziologie, 17, 218-226.
10. Rehm, J., Steinleitner, M., & Lilli, W. (1987). Wearing uniforms and aggression - a field experiment. European Journal of Social Psychology,
17, 357-360.
9. Rehm, J., Servay, W., & Irle, M. (1986). Wie sucht der Täter 'seine' Bank aus? Ergebnisse und praktische Folgerungen einer Täterbefragung.
Kriminalistik, 40, 581-584.
8. Rehm, J. (1986). Theoretische und methodologische Probleme bei der Erforschung von Vorurteilen: II. Vorurteil und menschliche
Konstruktion der Realität - Neue Erkenntnisse zu alten Phänomenen? Zeitschrift für Sozialpsychologie, 17, 74-86.
7. Rehm, J. (1986). Theoretische und methodologische Probleme bei der Erforschung von Vorurteilen: I. Vorurteil und Realität - Ist das
klassische Forschungsprogramm der Vorurteilsforschung gescheitert? Zeitschrift für Sozialpsychologie, 17, 18-30.
6. Lilli, W. & Rehm, J. (1986). The formation of prejudicial judgements as an interaction between heuristic processes and social identity of the
judge: The case of traffic accident participation. European Journal of Social Psychology, 16, 79-81.
5. Lilli, W. & Rehm, J. (1985). Fortschritt in der Vorurteilsforschung? Oder: Gelingt die wissenssoziologische Erweiterung des Vorurteilskonzepts?
Zeitschrift für Sozialpsychologie, 16, 284-288.
4. Rehm, J. & Servay, W. (1985). Erste Schlüsse auf Deliktsverlagerungen... Zum Sinn der Täterbefragung im Rahmen der Prävention.
Kriminalistik, 39, 390-391.
3. Strack, F. & Rehm, J. (1984). Theorie testen oder Varianz aufklären? Überlegungen zur Verwendung der Effektgröße als Gütemaß für
experimentelle Forschung. Zeitschrift für Sozialpsychologie, 15, 81-85.
2. Lilli, W. & Rehm, J. (1984). Theoretische und empirische Untersuchungen zum Phänomen der Zusammenhangstäuschung. II. Entwicklung
eines Modells zum quantitativen Urteil und Diskussion seiner Implikationen für die soziale Urteilsbildung. Zeitschrift für Sozialpsychologie, 15,
60-73.
1. Lilli, W. & Rehm, J. (1983). Theoretische und empirische Untersuchungen zum Phänomen der 'illusorischen Korrelation' (illusory correlation).
I. Ableitung von Randbedingungen für das Auftreten von Effekten der illusorischen Korrelation aus dem Konzept der Verfügbarkeits(availability-) Heuristik. Zeitschrift für Sozialpsychologie, 14, 251-261.
- 34 –
2 Monographs, edited books or journals
2.1 Professional editors:
Anderson, P., Braddick, F., Conrod, P., Gual, A., Hellman, M., Matrai, S., Miller, D., Nutt, D., Rehm, J., Reynolds, J. & Ysa, T. (2016). The new
governance of addictive substances and behaviours. Oxford, U.K.: Oxford University Press.
Anderson, P., Rehm, J., & Room, R. (2015). The impact of addictive substances and behaviours on individual and societal well-being. Oxford, UK:
Oxford University Press. ISBN: 978-0-19-871400-2
Boyle, P., Boffetta, P., Lowenfels, A.B., Burns, H., Brawley, O., Zatonski, W. & Rehm, J. (2013). Alcohol. Science, policy and public health. Oxford:
Oxford University Press. ISBN: 978-0-19-965578-6
Wittchen, H.-U., Bühringer, G., & Rehm, J. (2011). Ergebnisse und Schlussfolgerungen der PREMOS (PREdictors, Moderators and Outcome of
Substitution treatments)-Studie: Effekte der langfristigen Substitution Opioidabhängiger: Prädiktoren, Moderatoren und Outcome.
Suchtmedizin in Forschung und Praxis, 13(5) (ISSN 1437-5567).
Results and Conclusions for the PREMOS (PREdictors, Moderators and Outcome of Substitution treatments) study.
Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J., Hill, L., Holder, H., Homel, R., Livingstone, M., Österberg, E.,
Rehm, J., Room, R., & Rossow, I. (2010). El alcohol: un producto de consumo no ordinario. Washington, DC: Organizacion Panamericana de la
Salud.
(Spanish translation of Babor et al., 2010)
Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J., Hill, L., Holder, H., Homel, R., Livingstone, M., Österberg, E.,
nd
Rehm, J., Room, R., & Rossow, I. (2010). Alcohol: no ordinary commodity. Research and public policy. 2 edition. Oxford: Oxford University
Press.
Babor, T.F., Caulkins, J.C., Edwards, G., Fischer, B., Foxcroft, D.R., Humphreys, K., Obot, I.S., Rehm, J., Reuter, P., Room, R., Rossow, I., & Strang, J.
(2010). Drug policy and the public good. Oxford: Oxford University Press.
Kraus, L., & Rehm, J. (2005). Cocaine: Prevalence, use patterns and interventions. Special Issue: Sucht. 51 (4), 196-239.
Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J., Gruenewald, P., Hill, L., Holder, H., Homel, R., Österberg, E.,
Rehm, J., Room, R., & Rossow, I. (2005). Alkohol: kein gewöhnliches Konsumgut. Forschung und Alkoholpolitik. Göttingen, etc.: Hogrefe.
(ISBN 3-8017-1923-5).
(German translation of Babor et al., 2003; appended by chapters on alcohol policy in German-speaking countries and edited by L. Kraus, J.
Rehm, G. Gmel, A. Uhl and F. Fröhner)
Rehm, J., Room, R., & Rossow, I. (2005). Alkohol ingen vanlig handelsvara. Stockholm: Folkhälsoinstitutet (National Institute of Public
Health). (ISBN: 91-7257-313-9).
(Swedish translation of Babor et al., 2003)
Rehm, J., Room, R., & Rossow, I. (2003). Alcohol: no ordinary commodity. Research and public policy. Oxford and London: Oxford University
Press.
Fischer, B., Rehm, J., Uchtenhagen, A., & Kirst, M. (2002). Compulsory Treatment. Special topic section: European Addiction Research, 8(2), 52-93.
Rehm, J. & Gmel, G. (2001). Alcohol, illicit drugs and the global burden of disease. Special issue: European Addiction Research, 12 (3), 95-157.
Üstün, T.B., Chatterji, S., Bickenbach, J.E., Trotter, R.T. II, Room, R., Rehm, J., & Saxena, S. (2001). Disability and culture: universalism and diversity.
Seattle: Hogrefe and Huber.
Uchtenhagen, A. & Rehm, J. (2000). Schwerpunktthema: Heroin in der Drogentherapie. Special Issue: Suchttherapie. 1 (2).
Rehm, J. (1997). Patterns of drinking and harm. Special issue: Contemporary Drug Problems, 24.
Mäkelä, K., Arminen, I., Bloomfield, K., Eisenbach-Stangl, I., Helmersson Bergmark, K., Kurube, N., Mariolini, N., Olafsdottir, H., Peterson, J. H.,
Phillips, M., Rehm, J., Room, R., Rosenqvist, P., Rosovsky, H., Stenius, K., Swiatkiewicz, G., Woronowicz, B., & Zielinski, A. (1996). Alcoholics
Anonymous as a mutual-help movement: A study in eight societies. Madison: The University of Wisconsin Press.
Fahrenkrug, H., Rehm, J., Müller, R., Klingemann, H., & Linder, R. (1995). Drogues illégales en Suisse 1990-1993. La situation dans les cantons et en
Suisse. Zürich:Seismo.
Fahrenkrug, H., Rehm, J., Müller, R., Klingemann, H., & Linder, R. (1995). Illegale Drogen in der Schweiz 1990-1993. Die Situation in den Kantonen
und der Schweiz. Zürich:Seismo. (German version of Drogues illégales en Suisse 1990-1993)
Eisenbach-Stangl, I., & Rehm, J. (1994). Die Anonymen Alkoholiker und das professionelle Behandlungssystem. Special issue: Wiener Zeitschrift für
Suchtforschung, 17.
Rehm, J., & Room, R. (1992). Mutual help for alcohol-related problems: Studies of AI-Anon and of alternatives to Alcoholics Anonymous. Special
issue: Contemporary Drug Problems, 19.
Eisenbach-Stangl, I. & Rehm, J. (1992). Trunksucht und Selbstreform. Die Gemeinschaft der Anonymen Alkoholiker in Deutschland, Österreich, der
Schweiz und Italien. Special issue: Drogalkohol, 16.
Rehm, J. & Gadenne, V. (1990). Intuitive predictions and professional forecasts. Cognitive processes and social consequences. Oxford: Pergamon
Press.
Fichter, M.M. in collaboration with Meller, I., Witzke, W., Weyerer, S., Rehm, J., Dilling, H., & Elton, M. (1990). Verlauf psychischer Erkrankungen in
der Bevölkerung. Berlin: Springer.
2.2 Editions of international, governmental and non governmental organizations:
Popova, S., Lange, S., Burd, L., & Rehm, J. (2015). The burden and economic impact of Fetal Alcohol Spectrum Disorder in Canada. Toronto: CAMH.
ISBN: 978-1-77114-226-7 (Print); ISBN: 978-1-77114-227-4 (PDF)
- 35 –
available under
http://www.camh.ca/en/research/news_and_publications/reports_and_books/Documents/Burden%20and%20Eco%20Costs%20FASD%20Fe
b%202015.pdf
Rehm, J., Gmel, G., Probst, C., & Shield, K.D. (2015). Lifetime-risk of alcohol-attributable mortality based on different levels of alcohol consumption
in seven European countries. Implications for low-risk drinking guidelines. Toronto, On, Canada: Centre for Addiction and Mental Health.
ISBN (Digital) 978-1-7714-206-9; ISBN (Print) 978-1-77114-205-2
available under
http://www.camh.ca/en/research/news_and_publications/reports_and_books/Documents/Lifetime%20Risk%20of%20AlcoholAttributable%20Mortality.pdf
Rehm, J., & Hingson, R. (2013). Measuring the Burden. Alcohol’s evolving impact on individuals, families, and society. Issue of: Alcohol Research:
Current Reviews, 35 (2).
Room, R., Jernigan, D., Carlini, B. H., Gmel, G., Gureje, O., Mäkelä, K., Marshall, M., Medina Mora, M. E., Monteiro, M., Natera, G., Parry, C.,
Partanen, J., Real, T., Rehm, J., Riley, L., Saxena, S. & Shield, K.D. (2013). El alcohol y los países en desarrollo. Una perspectiva de salud
pública. Washington, Mexico: Organización Panamericana de la Salud & Fondo de Cultura Económica.
Marmet, S., Gmel, G.(sen.), Gmel, G.(jun.), Frick, H., & Rehm, J. (2013). Alcohol-attributable mortality in Switzerland between 1997 and 2011.
Lausanne: Addiction Suisse.
http://www.addictionsuisse.ch/fileadmin/user_upload/Endbericht_2013_-_Mortalit%C3%A4t.pdf
Rehm, J., Shield, K.D., Rehm, M.X., Gmel, G., & Frick. U. (2012). Alcohol consumption, alcohol dependence, and attributable burden of disease in
Europe: potential gains from effective interventions for alcohol dependence. Toronto, Canada: Centre for Addiction and Mental Health. ISBN:
978-1-77114-046-1
http://www.camh.ca/en/research/news_and_publications/reports_and_books/Pages/default.aspx
ISBN: 978-1-77114-047-8 (PDF); ISBN: 978-1-77114-048-5 (HTML); ISBN: 978-1-77114-049-2 (Epub)
Popova, S., Stade, B., Lange, S., Bekmuradov, D., & Rehm, J. (2012). Economic impact of Fetal Alcohol Syndrome and Fetal Alcohol Spectrum
Disorder. A systematic literature review. Toronto, Canada: Centre for Addiction and Mental Health. ISBN: 978-1-77052-994-6.
https://knowledgex.camh.net/reports/Documents/economic_impact_fas_litreview12.pdf
Popova, S., Stade, B., Lange, S., Bekmuradov, D. et Rehm, J. (2012). Répercussions économiques du syndrome d’alcoolisation foetale (SAF) et de
l’ensemble des troubles causés par l’alcoolisation foetale (ETCAF). Analyse documentaire systématique. Toronto, Canada: Centre de
toxicomanie et de santé mentale. ISBN: 978-1-77114-015-7.
https://knowledgex.camh.net/reports/Documents/economic_impact_fas_litreview12_FR.pdf
Popova, S., Stade, B., Lange, S., Bekmuradov, D., Mihic, A., & Rehm, J. (2012). Methodology for estimating the economic impact of Fetal Alcohol
Spectrum Disorder. Toronto, Canada: Centre for Addiction and Mental Health. ISBN: 978-1-77052-990-8.
https://knowledgex.camh.net/reports/Documents/Popova_etalMethodologySummary_March30_12Final_E.pdf
Popova, S., Stade, B., Lange, S., Bekmuradov, D., Mihic, A. et Rehm, J. (2012). Méthode d’estimation des répercussions économiques de l’ensemble
des troubles causés par l’alcoolisation foetale. Toronto, Canada: Centre de toxicomanie et de santé mentale. ISBN: 978-1-77052-999-1.
https://knowledgex.camh.net/reports/Documents/Popova_etalMethodologySummary_March30_12Final_FR.pdf
Langlois, K.A., Samokhvalov, A.V., Rehm, J., Spence, S.T., & Connor Gorber, S.K. (2011). Descriptions des états de santé au Canada: maladies
mentales. Statistique Canada no 82-619-MIF2005002 au catalogue (ISBN: 978-1-100-98278-6). Ottawa : Statistique Canada,
Langlois, K.A., Samokhvalov, A.V., Rehm, J., Spence, S.T., & Connor Gorber, S.K. (2011). Health state descriptions for Canadians: mental illnesses.
Statistics Canada, catalogue no. 82-619-MIE2005002 (ISBN: 978-1-100-19649-7). Ottawa: Statistics Canada.
Ialomiteanu, A, Adlaf, E, Mann, RE, Rehm, J. (2011). CAMH Monitor eReport: addiction and mental health indicators among Ontario adults, 19772009. Toronto, ON: Centre for Addiction and Mental Health.
Üstün, T.B., Kostanjsek, N., Chatterji, S., & Rehm, J. (2010). Measuring health and disability. Manual for WHO Disability Asssessment Schedule.
Geneva: World Health Organization. ISBN: 9789241547598
Chisholm, D., Rehm, J., Frick, U., & Anderson, P. (2009). Alcohol policy cost-effectiveness briefing notes for 22 European countries. London:
Institute of Alcohol Studies.
Individual country reports are available in pdf format at: http://www.ias.org.uk/buildingcapacity/index.html
Ialomiteanu, A.R., Adlaf, E.M., Mann, R.E., & Rehm, J. (2009). CAMH Monitor Report. Addiction and mental health indicators among Ontario adults
1977-2007. Toronto: Centre for Addiction and Mental Health. [ISBN number: 978-1-77052-440-8 (print)]
Rehm, J., Anderson, P., Kanteres, F., Parry, C.D., Samokhvalov, A.V., & Patra, J. (2009). Alcohol, social development and infectious disease.
Toronto: Centre for Addiction and Mental Health. [ISBN number: 978-1-77052-444-6 (print)]
Zatonski, W., Manczuk, M., Sulkowska, U., and HEM Project Team (2008). Closing the health gap in the European Union. Warsaw, Poland: Cancer
Epidemiology and Prevention Division, the Maria Sklodowska-Curie Memorial Cencer Center and Institute of Oncology. [ISBN:
9788388681493] (J. Rehm was Principal Co-Investigator of HEM)
Rehm, J., Gnam, W. H., Popova, S., Patra, J., & Sarnocinska-Hart, N. (2008). Avoidable Cost of Alcohol Abuse in Canada 2002. Toronto: Centre for
Addiction and Mental Health.
[ISBN: 978-0-88868-783-8 (print), 978-0-88868-784-5 (PDF), 978-0-88868-785-2 (HTML)]
Rehm, J., Gnam, W. H., Popova, S., Patra, J., & Sarnocinska-Hart, N. (2008). Avoidable Cost of Alcohol Abuse in Canada 2002. Highlights. Toronto:
Centre for Addiction and Mental Health.
Rehm, J., Gnam, W. H., Popova, S., Patra, J., & Sarnocinska-Hart, N. (2008). Coûts évitables liés à l’abus d’alcool au Canada en 2002. Points
saillants.
Taylor, B., Rehm, J., Trinidad, J.; Aburto, C.; Bejarano, J.; Cayetano, C.; Kerr-Correa, F.; Piazza-Ferrand, M., Gmel, G., Graham, K., Greenfield, T.,
- 36 –
Laranjeira, R., Lima, M., Magri, R., Monteiro, M., Medina-Mora, M., Munne, M., Romero, M., Tucci, A., & Wilsnack, S. (2007). Alcohol, gender,
culture and harms in the Americas: PAHO Multicentric Study final report. Washington, D. C.: Pan American Health Organization (PAHO). (ISBN
978 92 75 12828 2).
Taylor, B., Rehm, J., Trinidad, J.; Aburto, C.; Bejarano, J.; Cayetano, C.; Kerr-Correa, F.; Piazza-Ferrand, M., Gmel, G., Graham, K., Greenfield, T.,
Laranjeira, R., Lima, M., Magri, R., Monteiro, M., Medina-Mora, M., Munne, M., Romero, M., Tucci, A., & Wilsnack, S. (2007). Alcohol,
género, cultura y daños en las Américas: reporte final del estudio multicéntrico OPS. Washington, D.C.: Organizatión Panamericana de la
Salud (OPS). (ISBN 978 92 75 32851 4).
Neuenschwander, M., Rehm, J., & Schnoz, D. (2007). Kurzintervention bei Jugendlichen mit Tabakkonsum – Projekt KIM4U. Zurich: Research
Institute for Public Health and Addiction (Forschungsbericht aus dem Institut für Sucht- und Gesundheitsforschung Nr. 234).
WHO Collaborative Study Group on Alcohol and Injuries (2007). WHO Collaborative Study on Alcohol and Injuries: Final Report. Geneva: World
Health Organization. (IISBN 978 92 4 159219 2) Available in English, Russian and Spanish from:
http://www.who.int/substance_abuse/publications/alcohol_injuries_final_report.pdf
Rehm, J., Giesbrecht, N., Popova, S., Patra, J., Adlaf, E., & Mann, R. (2007). Survol des bienfaits et méfaits de la consommation d’alcool – incidence
sur les politiques de prévention au Canada. CAMH Research Document Series 169. Toronto, Canada: Centre for Addiction and Mental Health.
(ISBN: 978-0-88868-004-4 (print) / 978-0-88868-005-1 (pdf)). Available from:
http://www.camh.net/Research/Research_publications/Newsletter/Winter%202007/Alcohol_riskbenefits_Overview_French_final_%202007.
pdf
Rehm, J., Giesbrecht, N., Popova, S., Patra, J., Adlaf, E., & Mann, R. (2007). Overview of positive and negative effects of alcohol consumption –
implications for preventive policies in Canada. CAMH Research Document Series 168. Toronto, Canada: Centre for Addiction and Mental
Health. (ISBN: 978-0-88868-001-3 (print) / 978-0-88868-002-0 (pdf)). Available from:
http://www.camh.net/Research/Research_publications/Newsletter/Winter%202007/positive_negative_effect_alcohol.html
Rehm, J., Schnoz, D., Sulkowska, U., & Patra, J., with assistance of D. Chisholm (2007). Comparative analysis of cost-effectiveness of evidence-based
measure to reduce smoking-attributable mortality in Switzerland. Zurich: Research Institute for Public Health and Addiction
(Forschungsbericht aus dem Institut für Sucht- und Gesundheitsforschung Nr. 226).
Collins, D., Lapsley, H., Brochu, S., Easton, B., Pérez-Gómez, A., Rehm, J., & Single, E. (2006). International guidelines for the estimation of avoidable
costs of substance abuse. Ottawa: Health Canada.
Collins, D., Lapsley, H., Brochu, S., Easton, B., Pérez-Gómez, A., Rehm, J., & Single, E. (2006). Lignes directrices internationales pour l’estimation des
coûts évitables de l’abus des substances. Ottawa: Health Canada.
Frick, U., Ammann,J., Rehm, J., & Uchtenhagen, A. (2006). Diacetylmorphin in peroraler Verabreichung bei opioid-abhängigen Probanden: 2-Jahres
Follow-up. Zurich: Research Institute for Public Health and Addiction (Forschungsbericht aus dem Institut für Sucht- und
Gesundheitsforschung Nr. 218).
Schnoz, D., Salis Gross, C., Gmel, G. Kündig, H., Grubenmann, D., Rehm, J. (2006). Drinking alcohol in public spaces, disruptive behaviour and public
reactions: A pilot study. Zurich: Research Institute for Public Health and Addiction (Forschungsbericht aus dem Institut für Sucht- und
Gesundheitsforschung Nr. 217).
Sarsh, B., Fischer, B., & Rehm, J. (2006). Understanding and preventing the multi-fold health problem of smoking in youth: The role of
socioeconomic status, depressive symptoms and cultural factors. Socioeconomic status (SES) and smoking among adolescents: a review.
Zurich: Research Institute for Public Health and Addiction (Forschungsbericht aus dem Institut für Sucht- und Gesundheitsforschung Nr. 215a).
Rehm, J., Roerecke, M., & Patra, J. (2006). Alcohol attributable mortality and burden of disease in Switzerland – Epidemiology and
recommendations for alcohol policy. Zurich: Research Institute for Public Health and Addiction (Forschungsbericht aus dem Institut für Suchtund Gesundheitsforschung Nr. 214).
Rehm, J., Baliunas, D., Brochu, S., Fischer, B., Gnam, W., Patra, J., Popova, S., Sarnocinska-Hart, A., & Taylor, B. in collaboration with E. Adlaf, M.
Recel, E. Single (2006). The costs of substance abuse in Canada 2002. Highlights. Ottawa, Canada: Canadian Centre on Substance Abuse.
(ISBN 1-896323-94).
Rehm, J., Baliunas, D., Brochu, S., Fischer, B., Gnam, W., Patra, J., Popova, S., Sarnocinska-Hart, A., & Taylor, B. in collaboration with E. Adlaf, M.
Recel, E. Single (2006). The costs of substance abuse in Canada 2002. Ottawa, Canada: Canadian Centre on Substance Abuse (ISBN number 1897321-10-4).
Haydon, E., Roerecke, M., Giesbrecht, N., Rehm, J. & Kobus-Matthews, M. (2006). Chronic disease in Ontario and Canada: determinants, risk
factors and prevention priorities. Summary of Full Report. Toronto: CAMH, Ontario Chronic Disease Prevention Alliance and Ontario Public
Health Association.
factors and prevention priorities. Toronto: Ontario Chronic Disease Prevention Alliance and Ontario Public Health Association.
Haydon, E., Roerecke, M., Giesbrecht, N., Rehm, J., & Kobus-Matthews, M. (2005). Chronic disease in Ontario and Canada: determinants, risk
factors and prevention priorities. Toronto: CAMH Research Document Series No. 205.
Connor, J., Broad, J., Jackson, R., Vander Hoorn, S., & Rehm, J. (2005). The burden of death, disease and disability due to alcohol in New Zealand.
Wellington: Alcohol Advisory Council of New Zealand. (ISBN 0-478-11627-6; ISSN: 1174-2801).
Taylor, B., & Rehm, J. (2005). When Risk Factors Combine: The Interaction between Alcohol and Smoking for Aerodigestive Cancer, Coronary Heart
Disease, and Traffic and Fire Injury. Zurich: Addiction Research Institute (Forschungsbericht aus dem Institut für Suchtforschung Nr. 200).
Rehm, J., Zähringer, S., Egli, S., & Patra, J. (2004). Epidemiologic and economic evaluation of different forms of tobacco prevention for Switzerland.
An analysis of exemplary interventions using secondary data. Zurich: Addiction Research Institute (Forschungsbericht aus dem Institut für
Suchtforschung Nr. 189).
Fischer, B., & Rehm, J., in collaboration with Haydon, E., Fallu, J.-S. (2004). Cannabis prevention among youth (with special focus on gender
differences. Zurich: Addiction Research Institute (Forschungsbericht aus dem Institut für Suchtforschung Nr. 178).
Fallu, J.-S., Rehm, J., & Zähringer, S. (2004). Recension des écrits sur les drogues de synthèse en Europe avec un regard de plus près en Suisse et ses
- 37 –
pays voisins: pharmacologie, prévalence, profils, facteurs de risque, méfaits et prévention. Zurich: Addiction Research Institute (Rapport de
recherche de Institut de recherche sur les addictions No. 177).
Rehm, J. (2004). Werbung und Alkoholkonsum - Wissenschaftliche Grundlagen und Konsequenzen für politische Massnahmen. Zurich: Addiction
Research Institute (Forschungsbericht aus dem Institut für Suchtforschung Nr. 176).
Rehm, J., Fischer, B., & Haydon, E. (2003). Reducing the risks, harms and costs of HIV/AIDS and injecting drug use: A synthesis of the evidence base
for development of policies and programs. Ottawa: Health Canada. (Also Conference Paper #4 for the 2nd International Policy Dialogue on
HIV/AIDS in Warsaw, Poland, November 12-14, 2003).
Rehm, J., Lengler, R., Bolliger, H., Uchtenhagen, A., & Fischer, B. (2003). Erhebung des Behandlungsbedarfs für Personen mit primären
Opioidproblemen im Kanton Tessin. Zurich: Addiction Research Institute (Forschungsbericht aus dem Institut für Suchtforschung Nr. 162).
Rehm, J., Lengler, R., Bolliger, H., Uchtenhagen, A., &Fischer, B. (2003). Rilevamento del fabbisogno di trattamento per persone con problemi
primari in relazione al consumo di oppiacei nel Canton Ticino. Rapporto finale. Zurich: Addiction Research Institute (Forschungsbericht aus
dem Institut für Suchtforschung Nr. 162. Zürich).
Hartwig, C., Lerch, S., Rehm, J., & Gschwend, P. (2003). Unerwünschte Arzneimittelwirkungen in der Heroin-gestützten Behandlung (HeGeBe) im
Zusammenhang mit verschiedenen Applikationsformen in den Jahren 2001-2002. Zurich: Addiction Research Institute (Forschungsbericht aus
dem Institut für Suchtforschung Nr. 157).
Grichting, E., Frei, A.& Rehm, J. (2002). Evaluation des Treffpunkts für Alkoholikerinnen und Alkoholiker t-alk. Zurich: Addiction Research Institute
(Forschungsbericht aus dem Institut für Suchtforschung Nr. 143).
Rehm, J. & Uchtenhagen, A. unter Mitarbeit von D. Dombrowski (2001). Metaanalyse schweizerischer Arbeiten zur Verwendung von Methadon als
Substitutionsmittel bei der Behandlung von Opioidabhängigkeit. Zurich: Addiction Research Institute (Forschungsbericht aus dem Institut für
Suchtforschung Nr. 133).
Güttinger, F., Gschwend, P., Schulte, B., Rehm, J., & Uchtenhagen, A. (2001). Untersuchung der Langzeitverläufe in und nach der Heroin gestützten
Therapie. Zurich: Addiction Research Institut (Forschungsbericht aus dem Institut für Suchtforschung Nr. 132).
Frei, A. & Rehm, J. (2001). Komorbidität. Psychische Störungen bei Opiatabhängigen in Heroin gestützter Behandlung. Zurich: Addiction Research
Institute (Forschungsbericht aus dem Institut für Suchtforschung Nr. 128).
Kordinationsstelle des FOS (KOFOS; zusammengestellt von S. Schaaf, M. Reichlin, E. Grichting und J. Rehm unter Mitarbeit von H. Bolliger) (2001).
Der Forschungsverbund stationäre Suchttherapie FOS im Jahr 2000. Tätigkeitsbericht und Jahresstatistik. Vergleich von Klientinnen und
Klienten mit unterschiedlichem KonsummusterZürich: Addiction Research Institute (Forschungsbericht aus dem Institut für Suchtforschung
Nr. 119).
th
U.S. Department of Health and Human Services (2000). 10 Special Report to the U.S. Congress on Alcohol and Health. Chapter authors: Ashley,
M.J., Rehm, J., & Bondy, S. Measuring health risks and benefits of alcohol (pp. 3-27). Bethesda: NIAAA.
Rey-Riek, S., Gschwend, P., & Rehm, J. (2000). Befragung von Apothekern und Ärzten zur Ritalinverschreibung in der Schweiz. Zurich: Addiction
Research Institut (Forschungsbericht aus dem Institut für Suchtforschung Nr. 117).
Single, E., Ashley, M.J., Bondy, S., Rankin, J., Rehm, J. (2000). Evidence Regarding the Level of Alcohol Consumption Considered to be Low-Risk for
Men and Women. Canberra: Commonwealth Department of Health and Aged Care.
http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/alc-comp.pdf?q=publications/synopses/_files/alc-comp.pdf
Adlaf, E.M., Ivis, F., Ialomiteanu, A., Bondy, S., Rehm, J., Room, R., & Walsh, G. (1998). The Ontario Drug Monitor, 1997. Technical Guide. Toronto:
Addiction Research Foundation (ISBN: 0-88868-312-x; ARF Research Document Series No. 140).
Her, M. & Rehm, J. (1998). The cost-effectiveness of the use of naltrexone in alcoholism treatment. Toronto: Addiction Research Foundation (ISBN:
0-88868-311-1; ARF Research Document Series No. 139).
Frick, U. & Filipp, G. in collaboration with Raos, J., Gmeiner, H.-J., Höpflinger, U., Rehm, J., Knoll, A., & Lanzerath, M. (1997). Gesundheitsberufe im
Land Salzburg. Berufs- und Lebenssituation. Salzburg: Amt der Salzburger Landesregierung.
Stewart, J., Rehm, J., Fischer, B., Gliksman, L., Medved, W., Brands, B., & Blake, J. (1997). The social costs of untreated opiate use. Toronto:
Addiction Research Foundation (ISBN: 0-88868-302-2; ARF Research Document Series No. 137).
Adlaf, E., Ivis, F., Bondy, S., Rehm, J., Room, R., & Walsh, G. (1997). The Ontario Drug Monitor, 1996. Technical Guide. Toronto: Addiction Research
Foundation (ISBN: 0-88868-293-x; ARF Research Document Series No. 132).
Her, M., Giesbrecht, N., Rehm, J., & Room, R. (1996). Projected effects on alcohol consumption resulting from privatization/deregulation of liquor
control in Ontario. Toronto: Addiction Research Foundation (ISBN: 0-88868-280-8; ARF Research Document Series No. 128).
Projet du Groupe de concertation intercantonal sur les objectifs de la politque sanitaire (GCI) & Coopération intercantonale en matière d’analyse
des données issues de la première Enquête suisse sur la santé (ESS). Amman, P., Beer, V., Bisig, B., Gmel, G., Gurtner, F., Junker, C., Minder, C.,
Rehm, J., Schaub, T., Schiffer, J., Spuhler, T., Walsh, G., Wietlisbach, V., Zemp, E., & Zimmermann, E. (1996). Enquête suisse sur la santé 19921993. Analyse comparée Vaud-Suisse (pp. 53-62). Lausanne: Institut suisse de la santé publique.
(Similar reports were written for the cantons of Berne, Fribourg, Genève, and Valais)
Single, E., Robson, L., Xie, X., & Rehm, J. in collaboration with Moore, R., Choi, B., Desjardins, S., & Anderson, J. (1996). The costs of substance
abuse in Canada. Ottawa: Canadian Centre on Substance Abuse (ISBN: 1-896323-18-9).
Xie, X., Rehm, J., Single, E., & Robson, L. (1996). The economic costs of alcohol, tobacco and illicit drug abuse in Ontario: 1992. Toronto: Addiction
Research Foundation (ISBN: 0-88868-274-3; ARF Research Document Series No. 127).
Interkantonale Kooperation bei der Auswertung der Daten der 1. Schweizerischen Gesundheitsbefragung (SGB) (1996). Die Gesundheit im Kanton
Aargau. Lausanne: Schweizerisches Institut für Gesundheitswesen (IfG).
(Similar reports were written for the cantons of Basel, Bern, Freiburg, Graubünden, and Wallis.
Frick, U., Rehm, J., John, J., Thamm, M., & Laschat, M. (1994/95). Substitutionspotentiale stationärer medizinischer Leistungen im Land Salzburg.
Eine mehrstufige Delphibefragung. Salzburg: Amt der Salzburger Landesregierung.
World Health Organization (WHO, Regional Office for Europe) (1992). European summary on drug abuse. First Report. Compiled by H. Klingemann,
- 38 –
C. Goos, R. Hartnoll, A. Jablensky, and J. Rehm. Kopenhagen:WHO, Regional Office for Europe.
Rehm, J. & Servay, W., unter Mitarbeit von S. Bisson (1989). Wohnungseinbruch aus Sicht der Täter. Sonderband der Forschungsreihe des
Bundeskriminalamtes. Wiesbaden: BKA.
Servay, W. & Rehm, J. (1986). Bankraub aus Sicht der Täter. Täterleitende Faktoren bei Raubüberfällen auf Geldinstitute. Band 19 der
Forschungsreihe des Bundeskriminalamtes. Wiesbaden: BKA.
- 39 –
3 Book chapters
In press or accepted for publication:
published:
145. Medina Mora, M.E., Monteiro, M., Room, R., Rehm, J., Jernigan, D., Sanchez-Moreno, D., Real, T. (2016). Alcohol and alcohol use disorders.
In: Patel, V., Chisholm, D., Vos, T., Medina Mora, M.E., Dua, T.,( eds.), Mental, Neurological and Substance Use Disorders. Vol. 8 of Disease
rd
Control Priorities in Developing Countries 3 ed. Washington, DC: World Bank.
144. Vos, T., Blore, J., Flaxman, A.D., Peterson, H.M., & Rehm, J. (2015). Cause-specific mortality rates. In: Flaxman, A.D., Vos, T. & Murray, C.J L.
(eds.), An integrative metaregression framework for descriptive epidemiology (pp. 171-174). Seattle, Wa: University of Washington Press,.
143. Monteiro, M.G., Rehm, J., Shield, K.D., & Stockwell, T. (2015). Alcohol consumption: an overview of international trends. Reference Module
in Biomedical Sciences. Elsevier online via science direct. doi: 10.1016/B978-0-12-801238-3.03186-X.
142. Shield, K.D., Popova, S., & Rehm J. (2015). The burden of disease and injury caused by alcohol. Reference Module in Biomedical Sciences.
Elsevier online via science direct. doi: 10.1016/B978-0-12-801238-3.03188-3
141. Rehm, J., Probst, C., & Shield, D. (2015). Burden of disease: the epidemiological aspects of addiction. In: el-Guebaly, N., Carrà, G., & Galanter,
M. (Eds.), Textbook of addiction treatment: international perspectives (pp 65-78). Milano, Italy: Springer. doi: 10.1007/978-88-470-5322-9_4
140. Anderson, P., Rehm, J., & Room, R. (2015). Introduction to addictive behaviours. In: P. Anderson, J. Rehm, & R. Room (Eds.), The impact of
addictive substances and behaviours on individual and societal well-being (pp. 1-11). Oxford, UK: Oxford University Press.
139. Shield, K.D., & Rehm, J. (2015). The effects of addictive substances and addictive behaviours on physical and mental health. In: P. Anderson,
J. Rehm, & R. Room (Eds.), The impact of addictive substances and behaviours on individual and societal well-being (pp. 77-118). Oxford, UK:
Oxford University Press.
138. Shield, K.D., Rehm, M.X. & Rehm, J. (2015). Social costs of addiction in Europe. In: P. Anderson, J. Rehm, & R. Room (Eds.), The impact of
addictive substances and behaviours on individual and societal well-being (pp. 181-188). . Oxford, UK: Oxford University Press.
137. Room, R., Sankaran, S., Schmidt, L. A., Mäkelä, P., & Rehm, J. (2015). Addictive substances and socioeconomic development. In: P. Anderson,
J. Rehm, & R. Room (Eds.), The impact of addictive substances and behaviours on individual and societal well-being (pp. 189-214). Oxford, UK:
Oxford University Press.
136. Rehm, J., Room, R., & Anderson, P. (2015). Conclusions In: P. Anderson, J. Rehm, & R. Room (Eds.), The impact of addictive substances and
behaviours on individual and societal well-being (pp. 239-245). Oxford, UK: Oxford University Press.
rd
135. Shield, K.D., & Rehm, J. (2014). Alcohol, impact on health. Reference Module in Biomedical Sciences 3 edition. Elsevier online via science
direct. doi: 10.1016/B978-0-12-801238-3.00162-8.
http://ac.els-cdn.com/B9780128012383001628/3-s2.0-B9780128012383001628-main.pdf?_tid=c06aaf08-d624-11e4-946600000aacb362&acdnat=1427641586_52227bb3016d1c92d193deb1598540a9
134. Rehm, J., Probst, C., Kraus, L., & Lev-Ran, S. (2014). The addiction concept revisited. In P. Anderson, G. Bühringer, & J. Colom (Eds.),
Reframing addiction: policies, processes and pressures. (pp. 103-117). Barcelona, Spain: ALICE RAP. ISBN: 978-84-697-1647-2 Available
online: www.alicerap.eu.
133. Popova, S. & Rehm, J. (2014). Substance involvement and physical health: Unintentional injury, organ-specific diseases, HIV, and cancer
(Chapter 10). In K. J. Sher (Ed.), The Oxford Handbook of Substance Use Disorders. New York: Oxford University Press. [epub ahead of print
September 2014] doi: 10.1093/oxfordhb/9780199381708.013.13
132. Gmel, G., Labhart, F., Rehm, J., Rylett, M., & Shield, K.D. (2014). Alcohol consumption. In World Health Organization (Eds.), Global status
report on alcohol and health (pp. 27-43). Geneva: World Health Organization.
131. Rehm, J., Shield, K.D., & Stevens, G. (2014). Health consequences. In World Health Organization (Eds.), Global status report on alcohol and
health (pp. 45-57). Geneva: World Health Organization.
130. Rehm, J., & Shield, K. (2014). Alcohol consumption. In: Steward, B.W., & Wild, C.P. (Eds.), World Cancer Report 2014 (pp. 97-107). Lyon:
International Agency for Research on Cancer.
129. Shield, K., Rehm, J., & Monteiro, M. (2013). Alcohol consumption and drinking patterns in the Americas. In: Cherpitel, C.J., Borges, G.,
Giesbrecht, N., Monteiro, M., & Stockwell, T. (Eds.), Prevention of alcohol-related injuries in the Americas: from evidence to policy action (pp.
5-16). Washington, DC: Pan American Health Organization.
128. Shield, K., Rehm, J., & Monteiro, M. (2013). The burden of injuries attributable to alcohol in the Americas. In: Cherpitel, C.J., Borges, G.,
Giesbrecht, N., Monteiro, M., & Stockwell, T. (Eds.), Prevention of alcohol-related injuries in the Americas: from evidence to policy action (pp.
17-26). Washington, DC: Pan American Health Organization.
127. Rehm, J., Gmel, G., Rehm, M.X., Scafato, E., & Shield, K.D. (2013). What can alcohol do to European societies? In: P. Anderson, F. Braddick, J.
nd
Reynolds, & A. Gual (Eds.), Alcohol policy in Europe: evidence from AMPHORA. 2 edition. (pp. 4-16). Barcelona: The AMPHORA project.
Available online: http://amphoraproject.net/w2box/data/e-book/AM_E-BOOK_2nd%20edition%20-%20final%20Sept%202013.pdf
126. Shield, K.D., Rylett, M.J., Gmel, G., & Rehm, J. (2013). Part 1. Trends in alcohol consumption and alcohol-attributable mortality in the EU in
2010. In: World Health Organization Regional Office for Europe (Eds.), Status report on alcohol and health in 35 European countries 2013 (pp.
3-14). Copenhagen: WHO Regional Office for Europe. ISBN 978 92 890 0008 6.
125. Anderson, P., Casswell, S., Parry, C., & Rehm, J. (2013). Alcohol. In: Leppo, K., Ollila, E., Peña, S., Wismar, M. & Cook, S. (Eds.), Health in All
Policies: seizing opportunities, implementing policies (pp. 225-254). Helsinki, Finland: Ministry of Social Affairs and Health. ISBN 978-952-003406-1.
124. Rehm, J., & Shield, K.D. (2013). Key studies of alcohol and disease. In: Boyle, P., Boffetta, P., Lowenfels, A.B., Burns, H., Brawley, O., Zatonski,
W. & Rehm, J. (Eds.), Alcohol. Science, policy and public health (pp. 13-23). Oxford: Oxford University Press. ISBN: 978-0-19-965578-6
123. Gmel, G., Shield, K.D., & Rehm, J. (2013). Tools for estimating alcohol consumption. In: Boyle, P., Boffetta, P., Lowenfels, A.B., Burns, H.,
Brawley, O., Zatonski, W. & Rehm, J. (Eds.), Alcohol. Science, policy and public health (pp. 107-114). Oxford: Oxford University Press. ISBN:
- 40 –
978-0-19-965578-6
122. Gmel, G., Labhart, F., Shield, K.D., Rylett, M., Lachenmeier, D.W. & Rehm, J. (2013). A global overview of alcohol consumpiton patterns. In:
Boyle, P., Boffetta, P., Lowenfels, A.B., Burns, H., Brawley, O., Zatonski, W. & Rehm, J. (Eds.), Alcohol. Science, policy and public health (pp.
115-124). Oxford: Oxford University Press. ISBN: 978-0-19-965578-6
121. Lachenmeier, D.W., Gmel, G., & Rehm, J. (2013). Unrecorded alcohol consumption. In: Boyle, P., Boffetta, P., Lowenfels, A.B., Burns, H.,
Brawley, O., Zatonski, W. & Rehm, J. (Eds.), Alcohol. Science, policy and public health (pp. 132-142). Oxford: Oxford University Press. ISBN:
978-0-19-965578-6
120. Samokhvalov, A., Shuper, P.A., & Rehm, J. (2013). Infectious Disease. In: Boyle, P., Boffetta, P., Lowenfels, A.B., Burns, H., Brawley, O.,
Zatonski, W. & Rehm, J. (Eds.), Alcohol. Science, policy and public health (pp. 300-306). Oxford: Oxford University Press. ISBN: 978-0-19965578-6
119. Samokhvalov, A.V., Araki, K.F., Selby, P., & Rehm, J. (2012). Alcohol-related seizure disorders. In M. Reuber & S. C. Schachter (Eds.),
Borderland of epilepsy revisited (pp. 144-154). New York, NY: Oxford University Press.
118. Rehm, J. (2012). What can alcohol do to European societies. In: P. Anderson, F. Braddick, J. Reynolds, & A. Gual (Eds.), Alcohol policy in
Europe: evidence from AMPHORA. The AMPHORA project. Available online: http://amphoraproject.net/view.php?id_cont=45
117. Lachenmeier, D., & Rehm, J. (2012). Unrecorded alcohol – No worries besides ethanol: a population-based probabilistic risk assessment. In:
P. Anderson, F. Braddick, J. Reynolds, & A. Gual (Eds.), Alcohol policy in Europe: evidence from AMPHORA. The AMPHORA project. Available
online: http://amphoraproject.net/view.php?id_cont=45
116. Shield, K.D., Kehoe, T., Gmel, G., Rehm, M.X., & Rehm, J. (2012). Societal burden of alcohol. In: Anderson, P., Møller, L. & Galea, G. (Eds.),
Alcohol in the European Union. Consumption, harm and policy approaches (pp. 10-28). Copenhagen, Denmark: World Health Organization
Regional Office for Europe. [ISBN 978 92 890 0264 6]
115. Ajdacic-Gross, V., & Rehm, J. (2011). Pyschische Erkrankungen und Suizide. In F. Gutzwiller & F. Paccaud (Eds.), Sozial-und Präventivmedizin Public Health 4th edition (pp. 269-284). Bern, Switzerland: Huber. [ISBN: 978-3-456-84964-5]
114. Rehm, J, Frick, U. (2011). Moderater Alkoholkonsum. In M.V. Singer, A. Batra, & K. Mann (Eds.), Alkohol und Tabak. Grundlagen und
Folgeerkankungen (pp. 35-41). Stuttgart, Germany: Georg Thieme Verlag.
113. Rehm, J., & Frick, U. (2011). Alkohol und Infektionskrankheiten. In M.V. Singer, A. Batra, & K. Mann (Eds.), Alkohol und Tabak. Grundlagen
und Folgeerkankungen (pp. 480-484). Stuttgart, Germany: Georg Thieme Verlag.
112. Patra, J., Samokhvalov, A.V., & Rehm, J. (2011). Epidemiology of alcohol abuse: extent and nature of the problem. In H. Ghodse, H. Herrman,
M. Maj, & N. Sartorius (Eds.), Substance abuse disorders (pp. 101-123). West Sussex, UK: John Wiley.
111. Schmidt, L.A., Mäkelä, P., Rehm, J. &. Room, R. (2010). Alcohol: equity and social determinants. In: E. Blas & A. Sivasankara Kurup (Eds.),
Equity, social determinants and public health programmes (pp. 11-29). Geneva: World Health Organization.
110. Sempos, C.T., Looker, A.C., McGee, D.L., & Rehm, J. (2010). Iron and heart disease: a review of the epidemiologic data (pp. 279-298). In: S.
Yehuda and D.I. Mostofsky (Eds.), Nutrition and Health: Iron Deficiency and Overload (pp. 279-298). New York City: Humana. doi:
10.1007/978-1-59745-462-9_16
109. Rehm, J., & Patra, J. (2010). Psychoactive substance use: epidemiology and burden of disease. In: World Health Organization, ATLAS on
substance use (2010): Resources for the prevention and treatment of substance use disorders (pp.7-8). Geneva: World Health Organization.
108. Rehm, J. & Fischer, B. (2010). Harm reduction in an open and experimenting society. In: T. Rhodes, T. & .D. Hedrich (Eds.), Harm reduction:
evidence, impacts and challenges. European Monitoring Centre for Drugs and Drug Addiction Monographs (pp. 79-85). Luxembourg:
Publication Office of the European Union. (ISBN: 978-92-9168-419-9)
107. Rehm, J., & Room, R. (2009). Aggregate versus individual data as bases for modeling the impact of alcohol on injury. In: C.J. Cherpitel, G.
Borges, N. Giesbrecht, D. Hungerford, M. Peden, V. Poznyak, R. Room, & T. Stockwell (Eds.), Alcohol and injuries. Emergency department
studies in an international perspective (pp. 95-106). Geneva, Switzerland: World Health Organization. Available at
http://www.who.int/substance_abuse/msbalcinuries.pdf
106. Rehm, J., Popova S., & Patra, J. (2009). Alcohol-attributable injury in a global perspective. In: C.J. Cherpitel, G. Borges, N. Giesbrecht, D.
Hungerford, M. Peden, V. Poznyak, R. Room, & T. Stockwell (Eds.), Alcohol and injuries. Emergency department studies in an international
perspective (pp. 41-51). Geneva, Switzerland: World Health Organization. Available at
http://www.who.int/substance_abuse/msbalcinuries.pdf
105. Popova, S. & Rehm, J. (2009). Cancer, drugs, and alcohol. In: P. Korsmeyer & H.R. Kranzler (Eds.), Encyclopedia of Drugs, Alcohol & Addictive
Behavior (3rd ed, Vol.1, pp. 269-274). New York: Macmillan Reference USA.
104. Rehm, J., Patra, J., Baliunas, D., Popova, S., Roerecke, M. & Taylor, B. (2008). Alcohol, The burden of disease of. In: K. Heggenhougen & S.
Quah (Eds.), International Encyclopedia of Public Health (Vol. 1, pp. 135-151). San Diego: Academic Press.
103. Monteiro, M., Rehm, J., Taylor, B., & Stockwell, T. (2008). Alcohol consumption: overview of international trends. In: In: K. Heggenhougen &
S. Quah (Eds.), International Encyclopedia of Public Health (Vol. 1, pp. 98-108). San Diego: Academic Press.
102. Rehm, J. (2007). Erfaringer fra Schweiz – heroinstøttet substitutionsbehandling af opod-abhængighed i Schweiz. In: Høring om lægeordineret
heroin (pp. 21-23). Copenhagen: Teknologi-rådet.
101. Rehm, J., Chisholm, D., & Room, R. (2006). Priorities in health – Cost effectiveness of different interventions to reduce alcohol-related harm in
developing countries. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances. Bd.
2. Prävention (pp. 60-63). Bern: Bundesamt für Gesundheit.
100. Rehm, J., Zähringer, S., Egli, S., & Patra, J. (2006). Epidemiologic and economic evaluation of different forms of tobacco prevention for
Switzerland: an analysis of exemplary interventions using secondary data. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG /
Recherches de l’OFSP en matière de dépendances. Bd. 2. Prävention (pp. 56-59). Bern: Bundesamt für Gesundheit.
99. Kuntsche, E., Rehm, J., Gmel, G., Wicki, M., & Grichting, E. (2006). L’ European School Survey Project on Alcohol and Other Drugs (ESPAD) en
Suisse. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances. Bd. 2. Prävention
(pp. 11-18). Bern: Bundesamt für Gesundheit.
- 41 –
98. Kuntsche, E., Rehm, J., Gmel, G., Wicki, M., & Grichting, E. (2006). Das European School Survey Project on Alcohol and Other Drugs (ESPAD) in
der Schweiz. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances. Bd. 2.
Prävention (pp. 3-10). Bern: Bundesamt für Gesundheit.
97. Rehm, J., Chisholm, D., Room, R., & Lopez, A. (2006). Alcohol. In: World Health Health Organization & Disease Control Priorities Project
(Eds.), Disease control priorities related to mental, neurological, developmental and substance abuse disorders (pp. 57-76). Geneva: World
Health Organization.
96. Rehm, J., Chisholm, D., Room, R., & Lopez, A. (2006). Alcohol. In: D.T. Jamison, J.G. Breman, A.R. Measham, G. Alleyne, M. Claeson, D.B.
nd
Evans, P. Jha, A. Mills, & P. Musgrove (Eds.), Disease Control Priorities in Developing Countries (2 edition; pp. 887-906). Washington: Oxford
University Press and World Bank. http://www.ncbi.nlm.nih.gov/books/NBK11720/
95. Taylor, B., Rehm, J. & Gmel, G. (2006). Moderate alcohol consumption and the gastrointestinal tract. In: M.V. Singer & D.A. Brenner (Eds.),
Alcolhol and the digestive tract (pp. 15-26). Basel: Karger.
reprint of 254
94. Taylor, B., & Rehm, J. (2006). Moderate alcohol consumption and diseases of the gastrointestinal system: a review of pathophysiological
processes. In: M.V. Singer & D.A. Brenner (Eds.), Alcolhol and the digestive tract (pp. 27-34). Basel: Karger.
reprint of 253
93. Hauser, S., Frick, U., Eichhammer, P., & Rehm, J. (2006). Cognitive factors influencing symptom report on complaints allegedly related to
electromagnetic fields: research strategies and results. In: C. del Pozo, D.Papameleti, P.Wiedemann, & P.Ravazzani (Eds.), Risk Perception and
th
Risk Communication in EMF: Tools, Experiences and Strategies. Proceedings JRC/EIS-EMF Workshop, Ispra 13 July 2004. (pp. 66-75).
Brussels: European Commission Directorate General Joint Research Centre, Institute for Consumer Health and Protection.
http://www.jrc.cec.eu.int/eis-emf/documents.cfm
92. Kuntsche, E., Gmel, G. & Rehm, J. (2005). Binge Trinken in Europa und Empfehlungen für die Schweiz. In: Bundesamt für Gesundheit (Ed.),
Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances. Bd. 1. Grundlagenforschung (pp. 10-13). Bern: Bundesamt für
Gesundheit.
91. Fallu, J.-S., & Rehm, J. (2005). Recension des écrits sur les drogues de synthèse, en Europe, avec un regard rapproché sur la Suisse et les pays
voisins : pharmacologie, prévalence, profils and prévention. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de
l’OFSP en matière de dépendances. Bd. 1. Grundlagenforschung (pp. 25-37). Bern: Bundesamt für Gesundheit.
90. Lengler, R., Rehm, J., Uchtenhagen, A., Fischer, B., & Bolliger, H. (2005). Erhebung des Behandlungsbedarfs von Personen mit primärer
Opioidabhängigkeit im Kanton Tessin. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de
dépendances. Bd. 1. Grundlagenforschung (pp. 46-53). Bern: Bundesamt für Gesundheit.
89. Lerch, S., Hartwig, C., Rehm, J., & Gschwend, P. (2005). Unerwünschte Arzneimittelwirkungen in der heroingestützen Behandlung (HeGeBe)
im Zusammenhang mit verschiedenen Applikationsformen in den Jahren 2001 und 2002 in der Schweiz. In: Bundesamt für Gesundheit (Ed.),
Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances. Bd. 1. Grundlagenforschung (pp. 71-79). Bern: Bundesamt für
Gesundheit.
88. Gruppe Schweizer Alkoholpolitik (2005). Alkoholpolitische Massnahmen in der Schweiz 2004 – was ist realisiert und was bringt die Zukunft?
In: Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J., Gruenewald, P., Hill, L., Holder, H., Homel, R.,
Österberg, E., Rehm, J., Room, R., & Rossow, I. Alkohol: kein gewöhnliches Konsumgut. Forschung und Alkoholpolitik (pp. 334-344).
Göttingen, etc.: Hogrefe. (ISBN 3-8017-1923-5). [Alcohol policy measures in Switzerland 2004 – was has been realized and what is the
future?]
(The Gruppe Schweizer Alkoholpolitik consisted of :Abderhalden, I., Barth, A.-R., Daeppen, J.-B., Erard, L., Frick, U., Gmel, G., Graf, M., Meier, S.
Rehm, J. & Rihs-Middel, M.)
87. Rehm, J. (2005). Alkoholkonsum, Gesamtmortalität und Morbidität. In: M.V. Singer & S. Teyssen (Eds.), Alkohol und Alkoholfolgekrankheiten.
Grundlagen, Diagnostik, Therapie. 2., vollständig überarbeitete und aktualisierte Auflage (pp. 577-587). Berlin: Springer.
86. Rehm, J., & Uchtenhagen, A., in collaboration with Dombrowski, D. (2005). Methadon als Substitutionsmittel bei der Behandlung von
Opioidabhängigkeit in der Schweiz: ein Ueberblick. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en
matière de dépendances 1999-2001 (pp. 63-66). Bern: Bundesamt für Gesundheit.
85. Gschwend, P., Eschmann, S., Güttinger, F., Hosek, M., Rehm, J., & Uchtenhagen, A. (2005). Acht Jahre Erfahrung mit der heroingestüzten
Behandlung in der Schweiz – aktuelle Ergebnisse und künftige Weiterentwicklung. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des
BAG / Recherches de l’OFSP en matière de dépendances 1999-2001 (pp. 73-83). Bern: Bundesamt für Gesundheit.
84. Rehm, J., Gschwend, P., Steffen, T., Gutzwiller, F., Dobler-Mikola, A., & Uchtenhagen, A. (2005). Die heroingestüzte Behandlung in der
Schweiz: Machbarkeit, Sicherheit und Wirksamkeit. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en
matière de dépendances 1999-2001 (pp. 84-88). Bern: Bundesamt für Gesundheit.
83. Arbeitsgruppe HeGeBe Doppeldiagnosen, Frei, A., & Rehm, J. (2005). Komorbidität: psychische Störungen bei Opiatabhängigen zu Beginn
einer Heroin gestützten Behandlung. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de
dépendances 1999-2001 (pp. 92-99). Bern: Bundesamt für Gesundheit.
82. Güttinger, F., Gschwend, P., Rehm, J., & Uchtenhagen, A. (2005). Untersuchung der Langzeitverläufe in und nach der Heroin gestützten
Therapie (6-Jahres-Followßup der ersten Eintrittskohorte 1994-95). In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG /
Recherches de l’OFSP en matière de dépendances 1999-2001 (pp. 100-104). Bern: Bundesamt für Gesundheit.
81. Gschwend, P., Eschmann, S., Lezzi, S., Gutzwiller, F., Rehm, J., Steffen, T., & Uchtenhagen, A. (2005). Aufbau eines Behandlungsmonitorings
für die heroingestützte Behandlung. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de
80. Gschwend, P., Eschmann, S., Lezzi, S., Gutzwiller, F., Rehm, J., & Uchtenhagen, A. (2005). Weiterführung und –entwicklung des Monitorings
der heroingestützten Behandlung. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de
79. Frei, A. & Rehm, J. (2005). Die Prävalenz psychischer Komorbidität unter Opiatabhängigen: eine Metaanalyse bisheriger Studien. In:
78.
77.
76.
75.
74.
73.
72.
71.
70.
69.
68.
67.
66.
65.
64.
63.
63.
62.
61.
60.
59.
58.
57.
- 42 –
Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances 1999-2001 (pp. 125-129). Bern:
Bundesamt für Gesundheit.
Güttinger, F. & Rehm, J. (2005). Hilfe- und Unterstützungsbedarf für Kokain- und Crackkonsumierende. In: Bundesamt für Gesundheit (Ed.),
Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances 1999-2001 (pp. 130-133). Bern: Bundesamt für Gesundheit.
Rehm, J. & Weekes, J. (2005). Abus de médicaments d’ordonnance. In: Centre Canadien de lutte contre l’alcoolisme et les toxicomanies (Ed.),
Toxicomanie au Canada: Enjeux et options actuels (pp. 30-37). Ottawa: Centre Canadien de lutte contre l’alcoolisme et les toxicomanies.
Rehm, J. & Weekes, J. (2005). Abuse of controlled prescription drugs. In: Canadian Centre on Substance Abuse (Ed.), Substance Abuse in
Canada: current challenges and choices (pp. 30-37). Ottawa: Canadian Centre on Substance Abuse.
Rehm, J., Single, E., & Fischer, B. (2005). Heroin prescription and public health. Epidemiological considerations and the need for evidencebased cost-effective Interventions. In: Swiss Federal Office of Public Health: M. Rihs-Middel, R. Hämmig, / N. Jacobshagen (Eds.), Heroinassisted treatment. Work in progress (pp. 365-373). Bern: Huber.
Adlaf, E.M., & Rehm (2005). Survey design and methodology. In: E.M. Adlaf, P. Begin, & E. Sawka (Eds.), Canadian Addiction Survey (CAS): A
national survey of Canadians’ use of alcohol and other drugs: Prevalence of use and related harms: Detailed report (pp. 11-19). Ottawa:
Canadian Centre on Substance Abuse.
Rehm, J. & Room, R. (2005). The global burden of disease attributable to alcohol, tobacco and illicit drugs. In T. Stockwell, P. Gruenewald, J.
Toumbourou, & W. Loxley (eds.), Preventing harmful substance use: The evidence base for policy and practice (pp. 25-41). Chichester: Wiley.
Rehm, J., Room, R., Monteiro, M., Gmel, G., Graham, K., Rehn, N., Sempos, C.T., Frick, U., & Jernigan, D. (2004). Alcohol use. In: M. Ezzati, A.D.
Lopez, A. Rodgers, & C.J.L. Murray (Eds.), Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to
Selected Major Risk Factors. Volume 1 (pp. 959-1108). Geneva: World Health Organization. ISBN 92 4 158031 3
Heeb, J.-L., Gmel, G., & Rehm, J. (2004). Besteuerung und Spirituosenkonsum in der Schweiz. In: Bundesamt für Gesundheit (Ed.),
Suchtforschung des BAG 1999-2001 Band 2-3: Prävention/ Recherches de l’OFSP en matière de dépendances 1999-2001. Volume 2-3:
Prévention. (pp. 14-17). Bern: Bundesamt für Gesundheit.
Hüsler, G., Michaud, P.A. & Rehm, J. (2004). supra-f: Wirksamkeit der Interventionen – erste Trends. In: Bundesamt für Gesundheit (Ed.),
Suchtforschung des BAG 1999-2001 Band 2-3: Prävention/ Recherches de l’OFSP en matière de dépendances 1999-2001. Volume 2-3:
Prévention. (pp. 70-75). Bern: Bundesamt für Gesundheit.
Hüsler, G., & Rehm, J. (2004). Entwicklungsschritte im supra-f Programm. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG 19992001 Band 2-3: Prävention/ Recherches de l’OFSP en matière de dépendances 1999-2001. Volume 2-3: Prévention. (pp. 81-88). Bern:
Rehm, J., Frick, U., & Fischer, B. (2004). Zur Ökonomie des Suchtmittelgebrauchs. In: F. Tretter, B. Erbas, & G. Sonntag (Hrsg.), Oekonomie
der Sucht und Suchttherapie (pp. 233-244). Lengerich, Berlin: Pabst.
Babor, T., & the Alcohol and Public Policy Group (2004). Alcohol policy and the public good: As simple as one, two, three? In R. Müller & H.
Klingemann (Eds.), From science to action? 100 years later - Alcohol politics revisited (pp. 29-47). Dordrecht/Boston/London: Kluwer
Academic Publishers.
Kuo, M., Heeb, J.-L., Gmel, G., & Rehm, J. (2004). Does price matter? The effect of decreased price on spirits consumption in Switzerland. In
R. Müller & H. Klingemann (Eds.), From science to action? 100 years later - Alcohol politics revisited (pp. 113-123). Dordrecht/Boston/London:
Kluwer Academic Publishers.
Gmel, G. & Rehm, J. (2003). Social consequences of alcohol consumption. In: Health Promotion Unit (Eds.). Think before you drink. Less is
more. Proceedings of International Conference - Alcohol Policy, a Public Health Perspective (pp.52 78). Dublin: Health Promotion Unit,
Departement of Health and Children, Ireland (ISBN 0-9544914-1-6).
Rehm, J. (2003). Zur vergleichenden Bewertung von Interventionen im Bereich Alkohol: Welche Massnahme ist am kosteneffektivsten? In:
Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances 1999-2001. Band 1. (pp. 115118). Bern: Bundesamt für Gesundheit.
Rehm, J. (2003). Mortality and disability due to alcohol consumption. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG /
Recherches de l’OFSP en matière de dépendances 1999-2001. Band 1. (pp. 112-114). Bern: Bundesamt für Gesundheit.
Rehm, J. (2003). Epidemiologische Grundlagen für Alkoholintervention – ein schweizerischer Beitrag zu „Alcohol Policy and the Public Good
II“. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances 1999-2001. Band 1.
(pp. 109-111). Bern: Bundesamt für Gesundheit.
Gmel, G. & Rehm, J. (2003). Durchschnittskonsum, Trinkmuster, soziale und gesundheitliche Konsequenzen. In: Bundesamt für Gesundheit
(Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances 1999-2001. Band 1. (pp. 101-107). Bern: Bundesamt für
Gesundheit.
Rey-Riek, S., Gschwend, P., Eschmann, S., Moldovanyi, A. & Rehm, J. (2003). Klinisches Monitoring der heroingestützten Behandlung in der
Schweiz. In: Bundesamt für Gesundheit (Ed.), Suchtforschung des BAG / Recherches de l’OFSP en matière de dépendances 1999-2001. Band
1. (pp. 58-62). Bern: Bundesamt für Gesundheit.
Rehm, J. (2003). Scientific evaluations of opioid-assisted substitution treatment. In M. Kuntze, F. Müller-Span, D. Ladewig & A.H. Bullinger
(Eds.), Basic and clinical science of opioid addiction. Bibliotheca Psychiatrica, 170, (pp.33-38). Basel: Karger.
Üstün, T.B., Rehm, J., & Chatterji, S. (2002). Multiple-informant ranking of the disabling effects of different health conditions in 14 countries.
In: C.J.L. Murray, J. A. Salomon, C.D. Mathers & A.D. Lopez (Eds.) Summary measures of population health: concepts, ethics, measurement
and applications. (pp. 581-592). Geneva: World Health Organization (ISBN 9-24-154551-8).
Rehm, J. & Single, E. (2002). Reasons for and effects of low risk drinking guidelines. In: G. Bühringer (Ed.), Strategien und Projekte zur
Reduktion alkoholbedingter Störungen (pp. 78-90). Lengerich: Pabst (ISBN: 3-936142-73-4).
Rehm, J., Gschwend, P., Brun, S., Uchtenhagen, A., & Lezzi, S. (2002). Verweildauer und Austritte in der Heroin gestützten Behandlung von
1994 bis 2000. Eine Übersicht. In: Bundesamt für Gesundheit; M. Rihs-Middel, N. Jacobshagen & A. Seidenberg (Eds.). Ärztliche
Verschreibung von Betäubungsmitteln: Praktische Umsetzung und wichtigste Ergebnisse (pp. 239-244). Bern: Huber.
- 43 –
56. Rehm, J. (2002). Alkoholkonsum und Gesamtmortalität und Morbidität - Gibt es positive Auswirkungen eines moderaten regelmäßigen
Alkoholkonsums? In: M.V. Singer & S. Teyssen (Eds.), Kompendium Alkohol (pp. 447-457). Heidelberg: Springer.
55. Fischer, B., Rehm, J., & Kim, G. (2001). ‘Quality of Life’ (QoL) in illicit drug addiction treatment and research: concepts, evidence and
questions. In: B. Westermann, C. Jellinek, and G. Bellmann (Eds.), Substitution: Zwischen Leben und Sterben (pp. 21-40). Weilheim: Beltz
Deutscher Studienverlag.
54. Trotter, R.T. II, Rehm, J., Chatterji, S., Room, R. & Üstün, T.B. (2001). Cross-cultural applicability research (CAR) methods. In: T.B. Üstün, S.
Chatterji, J.E. Bickenbach, R.T. Trotter II, R. Room, J. Rehm, & S. Saxena (Eds.), Disability and culture: universalism and diversity (pp. 37-62).
53. Paglia, A., Rehm, J., & Room, R. (2001). Site description Toronto – Canada. In: T.B. Üstün, S. Chatterji, J.E. Bickenbach, R.T. Trotter II, R. Room,
J. Rehm, & S. Saxena (Eds.), Disability and culture: universalism and diversity (pp. 85-93). Seattle: Hogrefe and Huber.
52. Room, R., Rehm, J., Trotter, R.T. II, Paglia, A., & Üstün, T.B. (2001). Cross-cultural views on stigma, valuation, parity, and societal values
towards disability. In: T.B. Üstün, S. Chatterji, J.E. Bickenbach, R.T. Trotter II, R. Room, J. Rehm, & S. Saxena (Eds.), Disability and culture:
universalism and diversity (pp. 247-291). Seattle: Hogrefe and Huber.
51. Rehm, J., Trotter, R.T. II, Chatterji, S., & Üstün, T.B. (2001). The structure and stability of the proposed international classification. In: T.B.
Üstün, S. Chatterji, J.E. Bickenbach, R.T. Trotter II, R. Room, J. Rehm, & S. Saxena (Eds.), Disability and culture: universalism and diversity (pp.
293-308). Seattle: Hogrefe and Huber.
50. Üstün, T.B., Chatterji, S., Bickenbach, J.E., Trotter, R.T. II, Room, R., Rehm, J., & Saxena, S. (2001). Summary and conclusions. In: T.B. Üstün, S.
Chatterji, J.E. Bickenbach, R.T. Trotter II, R. Room, J. Rehm, & S. Saxena (Eds.), Disability and culture: universalism and diversity (pp. 309-321).
49. Rehm, J. & Rossow, I. (2001). The impact of alcohol consumption on work and education. In: H. Klingemann & G. Gmel (Eds.) Mapping social
consequences of alcohol consumption (pp. 67-77). Dordrecht: Kluwer.
48. Rossow, I., Pernanen, K., & Rehm, J. (2001). Accidents, suicide and violence. In: H. Klingemann & G. Gmel (Eds.), Mapping social
consequences of alcohol consumption (pp. 93-112). Dordrecht: Kluwer.
47. Rehm, J. (2001). Concepts, dimensions and measures of alcohol-related social consequences. A basic framework for alcohol-related benefits
and harm. In: H. Klingemann & G. Gmel (Eds.), Mapping social consequences of alcohol consumption (pp. 11-19). Dordrecht: Kluwer.
46. Fischer, B., Kirst, M., Rehm, J., Marsh, D., Bondy, S., & Tyndall, M. (2000). The phenomenon of so-called “other drug use” among opiate
addicts in the North American context: evidence, consequences, questions. In: C. Jellinek, B. Westermann, & G.U. Bellmann (Hrsg.),
Beigebrauch: offene Fragen der Substitution (pp. 95-117). Weinheim: Deutscher Studienverlag.
45. Bondy, S.J., Cohen, J.E., & Rehm, J. (2000). Past trends in tobacco use and some thoughts on future trends. In: R. Ferrence, J. Slade, R. Room,
& M. Pope (Eds.), Nicotine and Public Health (pp. 311-325). Washington: American Public Health Association.
44. Rehm, J. & Fischer, B. (2000). Kosten, Nutzen und Effizienz der Opiatsubstitution. In: J. Zerdick (Hrsg.), Suchtmedizin im Dialog. 9.
Suchtmedizinischen Kongress der DGS (pp. 71-78). Berlin: Verlag für Wissenschaft und Bildung.
43. Gmel, G. & Rehm, J. (2000). Conditions de logement et situation professionnelle. In: Office fédéral de la statistique (Ed.), Santé et
comportements vis-à-vis de la santé en Suisse 1997 (pp. 59-64). Neuchâtel: Office fédéral de la statistique.
42. Gmel, G. & Rehm, J. (2000). Wohn- und Arbeitssituation. In: Bundesamt für Statistik (Ed.), Gesundheit und Gesundheitsverhalten in der
Schweiz 1997 (pp. 62-67). Neuchâtel: Bundesamt für Statistik.
41. Fischer, B. & Rehm, J. (1999). Argumentos a favor de un ensayo de tratamiento de sustitución con heroína en Canadá. In: S. Inchaurraga et
al. (Eds.), Drogas y políticas públicas el modelo de reducción de daños (pp. 105-117). Rosario: Universidad de Rosario.
40. Rehm, J. (1999). Alkoholkonsum und Gesamtmortalität und Morbidität - Gibt es positive Auswirkungen eines moderaten regelmäßigen
Alkoholkonsums? In: M.V. Singer & S. Teyssen (Eds.), Alkohol und Alkoholfolgekrankheiten. Grundlagen, Diagnostik, Therapie (pp. 552-561).
Berlin: Springer.
39. Rehm, J. (1999). Ökonomische Aspekte von Substanzmißbrauch. In: M. Gastpar, K. Mann, & H. Rommelspacher (Eds.), Lehrbuch der
Suchterkrankungen (pp. 118-127). Stuttgart: G. Thieme Verlag.
38. Rehm, J. & Bondy, S. (1998). Alcohol and all-cause mortality: an overview. In D.J. Chadwick & J.A. Goode (Eds.), Alcohol and cardiovascular
diseases (Symposium on alcohol and cardiovascular diseases, held at the Novartis Foundation, London, 7-9 October 1997) (pp. 223-232).
Chichester, UK: Wiley.
37. Rehm, J. & Mariolini, N. (1998). AA in Switzerland - different organizations for different cultural traditions? In: I. Eisenbach-Stangl & P.
Rosenqvist (Eds.), Diversity in unity. Studies of Alcoholics Anonymous in eight societies (pp. 113-129). Helsinki: Nordic Council for Alcohol and
Drug Research.
36. Frick, U., Rehm, J., Wolff, K.-E., & Laschat, M. (1998). Obstetricians’ attitudes on perinatal risk: the role of quantitative and conceptual scaling
procedures. In: J. Blasius & M. Greenacre (Eds.), Visualization of categorical data (pp. 71-84). San Diego: Academic Press.
35. Rehm, J. & Fischer, B. (1997). Measuring harm: implications for alcohol epidemiology. In: M. Plant, E. Single, & T. Stockwell (Eds.), Alcohol:
minimising the harm. What works? (pp. 248-261). London: Free Association Books Ld.
34. Frick, U., Rehm, J., & Thien, U. (1997). On the latent structure of the Beck Depression Inventory (BDI): Using the “somatic” subscale to
evaluate a clinical trial. In: J. Rost & R. Langeheine (Eds.), Applications of latent trait and latent class models in the social sciences (pp. 305313). Münster:Waxman Verlag.
33. Paglia, A., de Groh, M., Rehm, J., & Ferrence, R. (1996). Knowledge of health risks. In: Stephens, T. & Morin, M., Health Canada (Eds.), Youth
Smoking Survey, 1994. Technical Report (pp. 121-151). Ottawa: Minister of Supply and Services Canada.
32. Stephens, T., Adlaf, E. M., Bondy, S.J., & Rehm, J. (1996). Survey methods. In: Stephens, T. & Morin, M., Health Canada (Eds.), Youth Smoking
Survey, 1994. Technical Report (pp. 23-36). Ottawa: Minister of Supply and Services Canada.
31. Meller, I., Fichter, M.M., & Rehm, J. (1996). Biographische Aspekte der Vulnerabilität für affektive Erkrankungen: Ergebnisse einer
epidemiologischen Feldstudie. In: H.-J. Möller & A. Deister (Eds.), Vulnerabilität für affektive und schizophrene Erkrankungen (pp. 33-42).
- 44 –
Wien: Springer.
30. Rehm, J., Gmel, G., & Walsh, G. (1996). Verhaltensweisen-Lebensgewohnheiten. In: Interkantonale Kooperation bei der Auswertung der
Daten der 1. Schweizerischen Gesundheitsbefragung (SGB). Die Gesundheit im Kanton Aargau (pp. 53-62). Lausanne: Schweizerisches Institut
für Gesundheitswesen (IfG).
(Similar reports were written for the cantons of Basel, Bern, Freiburg, Graubuenden, and Wallis).
29. Rehm, J., Gmel, G., & Walsh, G. (1996). Comportements-habitutes de vie. In: Projet du Groupe de concertation intercantonal sur les objectifs
de la politque sanitaire (GCI) & Coopération intercantonale en matière danalyse des données issues de la première Enquête suisse sur la
santé (ESS). Enquête suisse sur la santé 1992-1993. Analyse comparée Vaud-Suisse (pp. 53-62). Lausanne: Institut suisse de la santé
publique.
(Similar reports were written for the cantons of Berne, Fribourg, Genève, and Valais)
28. Rehm, J. & Fichter, M.M. (1995). Stichprobenerwägungen bei Verlaufsstudien in der psychiatrischen Epidemiologie. In: J. Margraf & H.
Kunath (Eds.), Methodische Ansätze in der Public Health-Forschung (pp. 180-190). Regensburg: Roderer.
27. Rehm, J. (1995). Modes de consommation et répartition des drogues en Suisse. In: Fahrenkrug, H., Rehm, J., Müller, R., Klingemann, H., &
Linder, R. (Eds.), Drogues illégales en Suisse 1990-1993. La situation dans les cantons et en Suisse (pp. 13-34). Zürich:Seismo.
26. Rehm, J. (1995). Konsumformen und Verbreitung illegaler Drogen in der Schweiz. In: Fahrenkrug, H., Rehm, J., Müller, R., Klingemann, H., &
Linder, R. (Eds), Illegale Drogen in der Schweiz 1990-1993. Die Situation in den Kantonen und der Schweiz (pp. 13-33). Zürich: Seismo.
(German version of 27)
25. Rehm, J. (1995). Situation sociale des consommateurs de drogues. In: Fahrenkrug, H., Rehm, J., Müller, R., Klingemann, H., & Linder, R. (Eds.),
Drogues illégales en Suisse 1990-1993. La situation dans les cantons et en Suisse (pp. 35-54). Zürich:Seismo.
24. Rehm, J. (1995). Zur sozialen Lage der Drogenkonsumentinnen. In: Fahrenkrug, H., Rehm, J., Müller, R., Klingemann, H., & Linder, R. (Eds.),
Illegale Drogen in der Schweiz 1990-1993. Die Situation in den Kantonen und der Schweiz (pp. 35-53). Zürich: Seismo.
(German version of 25)
23. Rehm, J. & Strack, F. (1994). Kontrolltechniken. In: T. Herrmann & W. Tack (Eds.), Methodologische Grundlagen der Psychologie (pp. 508555). Enzyklopädie der Psychologie, Themenbereich B, Serie 1, Band 1. Göttingen: Hogrefe.
22. Rehm, J. & Frick, U. (1993). Zum Zusammenhang von sportlicher Aktivität und Medikamentenkonsum in der Allgemeinbevölkerung der
Schweiz. In: Kamber, M. (Ed.), Dopingprävention (pp. 75-87). Magglingen:Eidgenössische Sportschule (Nr. 54 der Schriftenreihe der
Eidgenössischen Sportschule Magglingen).
21. Rehm, J. (1993). Causal models and misspecification. In: Clayton, D., Arminger, G., & Fuhrer, R. (Eds.), Latent variable and causal modelling in
clinical,epidemiological and social science research. Le Vésinet (France): Institut national de la santé et de la recherche médicale (INSERM).
20. Institut suisse de prévention de l'alcoolisme et autres toxicomanies (ISPA) (1993). Chiffres et données sur l'alcool et les autres drogues 1993.
Lausanne: ISPA. (ISBN: 2-88183-039-0; Responsible for chapters on tobacco and medication)
19. Schweizerische Fachstelle für Alkohol und andere Drogenprobleme (SFA) (1993). Zahlen und Fakten zu Alkohol und anderen Drogen 1993.
Lausanne: SFA. (ISBN: 2-88183-036-6; Responsible for chapters on tobacco and medication)
18. Klingemann, H. & Rehm, J. (1992). Country profiles. In: World Health Organization (WHO, Regional Office for Europe , Ed.), European
summary on drug abuse. First Report. Compiled by H. Klingemann, C. Goos, R. Hartnoll, A. Jablensky, and J. Rehm. (pp. 33-92).
Kopenhagen:WHO, Regional Office for Europe.
17. Rehm, J., Frick, U., & Fichter, M.M. (1992). Klinisches Urteil und vorhergesagter Behandlungserfolg. In: M.M. Fichter & U. Frick (Eds.),
Therapie und Verlauf des Alkoholismus - Auswirkungen auf Patient und Angehörige (pp. 177-204). Berlin: Springer.
16. Frick, R., Thien, U., & Rehm, J. (1992). Der Einsatz von "Latenter Klassenanalyse" bei Therapiestudien, deren Zielkriterium eine Rating Skala
ist. In: H. Heimann & D. Hartmann-Lange (Eds.), BMFT Studien zu Therapie und Rückfallprophylaxe chronischer psychischer Erkrankungen im
Erwachsenenalter. Nachlese zum Symposium am 2.-3.4. in Dresden (pp. 41-55). Tübingen: Universität
15. Rehm, J. & Frick, U. (1991). Rôle social, représentations sociales et la prévision du comportement: Un exemple empirique tiré de la thérapie
de l'alcoolisme. In: J.-L. Beauvois, R.-V. Joule & J.-M. Monteil (Eds.), Perspectives cognitives et conduites sociales 3: Quelles cognitions?
Quelles conduites? (pp. 65-80). Cousset (Fribourg, CH): DelVal.
14. Häußler, A., Rehm, J., Naß, E., & Kohlmeier, L. (1991). Data bases for nutritional epidemiology: the food code of the German Federal Republic
(BLS). In: L. Kohlmeier (Ed.), The diet history method (pp. 103-108). London: Smith-Gordon, Nishimura.
13. Rehm, J., Bisson, S., & Servay, W. (1990). Natürliche und künstliche Experten für die Vorhersage der Zukunft. In: M. Härter (Ed.), Auf dem
Weg zum Prognoseautomaten (pp. 14-23). Köln: Verlag TÜV Rheinland.
12. Bisson, S., Rehm, J., Servay, W., & Irle, M. (1990). Nutzung des Täterwissens - Zur Prävention von Wohnungseinbrüchen in der
Bundesrepublik Deutschland. In: C. Frank & G. Harrer (Eds.), Der Sachverständige im Strafrecht. Kriminalitätsverhütung. FORENSIA - Jahrbuch
1 (pp. 124-134). Berlin: Springer.
11. Fichter, M.M., Rehm, J., & Witzke, W. (1990). Verlauf psychischer Erkrankungen in der Bevölkerung. In: M.M. Fichter, Verlauf psychischer
Erkrankungen in der Bevölkerung (pp. 274-307). Berlin: Springer.
10. Meller, I., Fichter, M.M., & Rehm, J. (1990). Krankheitsverhalten: Inanspruchnahme medizinischer Dienste. In: M.M. Fichter, Verlauf
psychischer Erkrankungen in der Bevölkerung (pp. 232-254). Berlin: Springer.
9. Rehm, J., Koloska, R., Witzke, W., & Fichter, M.M. (1990). Familienklima und psychische Erkrankungen bei Jugendlichen. In: M.M. Fichter,
Verlauf psychischer Erkrankungen in der Bevölkerung (pp. 180-186). Berlin: Springer.
8. Fichter, M.M., Witzke, W., Weyerer, S., Meller, I., Rehm, J., Dilling, H., & Hippius, H. (1990). Ergebnisse der oberbayerischen
Verlaufsuntersuchung. In: M.H. Schmidt (Ed.), Fortschritte in der Psychiatrischen Epidemiologie. Ergebnisse aus dem
Sonderforschungsbereich 'Psychiatrische Epidemiologie' (pp. 91-116). Weinheim: VCH.
7. Arminger, G. & Rehm, J. (1989). Models for analyzing non-metric dependent variables: applications to nutritional epidemiology. In: L.
Kohlmeier & E. Helsing (Eds.), Epidemiology, nutrition, and health (pp. 67-78). London: Smith-Gordon, Nishimura.
6.
5.
4.
3.
2.
1.
- 45 –
Rehm, J. (1989). Searching for the culprit: identification of causal foods. In: L. Kohlmeier & E. Helsing (Eds.), Epidemiology, nutrition, and
health (pp. 47-55). London: Smith-Gordon, Nishimura.
Fichter, M.M., Rehm, J., Witzke, W., Meller, I., Leibl, K., Eiberger, T., Weyerer, S., Dilling, H., & Hippius, H. (1988). Verlauf affektiver Störungen
in der oberbayerischen Feldstudie: Ein lineares Kausalmodell verlaufsbeeinflussender Faktoren. In: D. von Zerssen & H.J. Möller (Eds.),
Affektive Störungen. Diagnostische, epidemiologische, biologische und therapeutische Aspekte (pp. 84-98). Berlin: Springer.
Rehm, J. & Servay, W. (1988). Der intuitive Kern von Energieprognosen. In: M. Härter (Ed.), Energieprognostik auf dem Prüfstand (pp. 31-48).
Köln: Verlag TÜV Rheinland.
Lilli, W. & Rehm, J. (1988). Judgmental processes as bases of intergroup conflict. In: W. Stroebe, A.W. Kruglanski, D. Bar-Tal, & M. Hewstone
(Eds.), The social psychology of intergroup conflict: Theory, research and applications (pp. 29-45). Berlin, Heidelberg, New York: Springer.
Fichter, M.M., Koch, H.-J., Rehm, J., & Weyerer, S. (1987). Adversity and the risk of mental illness: Preliminary results of the Upper Bavarian
Restudy. In: M.C. Angermeyer (Ed.), From social class to social stress (pp. 133-152). Berlin, Heidelberg, New York: Springer.
Irle, M., Rehm, J., & Servay, W. (1986). Täterwissen für die Bekämpfung von Raubüberfällen auf Geldinstitute - Erste Ergebnisse eines
laufenden Forschungsprojektes. In: Bundeskriminalamt (Ed.), Symposium: Nutzung der Sicht des Täters und des Täterwissens für die
Verbrechensbekämpfung (pp. 115-126). Wiesbaden: BKA.
- 46 –
4 Book reviews, abstracts, short contributions, articles without peer review
(excluding routine indexing of abstracts like in "Addiction Abstracts")
119. Schwarzinger, M., Thiébaut, S., Mallet, V., & Rehm, J. (2015). The counfounding role of severe comorbidities and alcohol use disorders on
prognosis in chronic hepatitis C virus infection: An analysis of the 2008–2012 French National hospital discharge database. Journal of
Hepatology, 62(4), S237. doi:10.1016/S0168-8278(15)30104-5
118. Samokhvalov, A.V., Sproule, B., Selby, P., & Rehm, J. (2015). Oral naloxone for methadone-induced constipation: preliminary results of a
randomized placebo-controlled trial. European Psychiatry , 30(supplement 1), 1919. doi: http://dx.doi.org/10.1016/S0924-9338(15)31469-3
117. Lange, S., Shield, K.D., Koren, G., Rehm, J. & Popova, S. (2015). Quantifying the disparity between two methods of ascertaining the prevalence
of maternal alcohol consumption during pregnancy. Health Science Inquiry (Canadian Society for Epidemiology and Biostatistics – Top
Abstracts from the 2014 National Student Conference) http://healthscienceinquiry.ca/archives/900
116. Rehm, J. (2013). Treatment decreases mortality in alcohol dependent persons. Alcohol and Alcoholism, 48(S 1), i3. ISSN: 0735-0414.
115. Kerridge, B.T.. Saha, T.D., Gmel, & Rehm, J. (2012). Are addictions a distinguishable entity? Implications for DSM-5 disorders. Alcoholism:
Clinical and Experimental Research, 36 Supplement S2, S208. DOI: 10.1111/j.1530-0277.2012.01917.x
114. Rehm, J. (2012). Substance use disorders: more than heavy consumption? First results from an ALICE RAP project on different
conceptualizations of addiction in Europe. Alcoholism: Clinical and Experimental Research, 36 Supplement S2, S209. DOI: 10.1111/j.15300277.2012.01917.x
113. Lange, S., Rehm, J. Bekmuradov, D., Mihic, A., & Popova, S. (2012). Risk of incarceration for individuals with prenatal alcohol exposure.
American Journal of Epidemiology, 176(1), 80. [PMID: 22745060]
112. Rehm, J., Rehm, M.X., Shield, K.D., Gmel, G., Frick, U., & Mann, K. (2012). Alkoholkonsum, Alkoholabhängigkeit und Gesundheitsschäden in
Deutschland. Szenarien eines verbesserten Zugangs zur Behandlung der Alkoholabhängigkeit. Toronto: CAMH & Dresden: Technische
Universität.
111. Lachenmeier, D.W. & Rehm, J. (2012). Is illegally produced alcohol really a great threat to public health in the UK? Rapid response British
Medical Journal, http://www.bmj.com/content/344/bmj.e1146/rr/571398
110. Rehm, J. (2010). Alcohol use and TB: is there a causal connection? International Journal of Tuberculosis and Lung Disease, 14(11) Supplement
2, S7.
109. Behrendt, S., Böhm, I., Wittchen, H.-U., Bühringer, G., Rehm, J., Höfler, M., Lieb, R., & Beesdo-Baum, K. (2010). Alcohol use disorder
symptoms in adolescence and early adulthood: a prospective longitudinal community study. Alcoholism: Clinical and Experimental Research,
34(6), Supplement, 179A.
108. Behrendt, S., Böhm, I., Wittchen, H.-U., Bühringer, G., Rehm, J., Höfler, M., Lieb, R., & Beesdo-Baum, K. (2010). Alkoholstörungssymptome bei
Jugendlichen und jungen Erwachsenen in der Allgemeinbevölkerung: Eine prospektiv-longitudinale Studie. Zeitschrift für Klinische Psychologie
und Psychotherapie, 39(1)Supplementum 1/10, S.4.
107. Fischer, B., Gittens, J., Kendall, P., & Rehm, J. (2009). Authors’ response. Public Health, 123(2), 149-150. [PMID: 19157470].
106. Schmidt, L., Rehm, J., Room, R., & Mäkelä, P. (2008). Broadening the frame for debate on public health policies regarding alcohol. Rapid
response. http://www.bmj.com/cgi/eletters/337/nov06_2/a2364
105. Rehm, J. & Lachenmeier, D. (2008). Composition of alcohol from markets in different countries. Alcoholism: Clinical and Experimental
Research, 32(6 supplement) , 293a.
104. Behrendt, S., Wittchen, H.-U., Höfler, M., Lieb, R., Low, N.C.P., Rehm, J. & Beesdo, K. (2008). The risk and consequences of tolerance as first
alcohol dependence symptom in adolescence: results from a prospective longitudinal community study. Alcoholism: Clinical and
Experimental Research, 32(6 supplement), 130a.
103. Greenfield, T.K., Lapp, W., Bond, J., Kerr, W., Kaskutas, L.A., & Rehm, J. & Beesdo, K. (2008). Ethanol in beer, wine and spirits drinks in a 28day prospective diaries: physiological validity and implications for measurement. Alcoholism: Clinical and Experimental Research, 32(6
supplement), 126a.
102. Rehm, J., Mohapatra, S., Popova, S., Patra, J., & Duhig, A. (2008). Economic costs of heavy drinking and alcohol dependence in major market
economies. Alcoholism: Clinical and Experimental Research, 32(6 supplement), 120a.
101. Rehm, J. (2008). Review of Dubovski, S.L. & Dubovski, N.L. (2007). Psychotropic Drug Prescriber's Survival Guide. Ethical Mental Health
Treatment in the Age of Big Pharma. New York: Norton. Addiction, 103(3), 515. DOI:10.1111/j.1360-0443.2008.02143_1.x
100. Fischer, B., Rehm, J., & Firestone-Cruz, M. (2007). Reply to Oyemade (2007) re: Illicit opioid use and its key characteristics: a select overview
and evidence from a Canadian multisided cohort of illicit opoid users. Canadian Journal of Psychiatry, 52, 335-336.
99. Grichting, E., Salis Gross, C. Rehm, J., Kaufmann, B., & Rigter, H. (2006). Résultats du sondage mené auprès de jeunes appartenant à des
groupes à risque, âgés de 13 à 18 ans, portant sur l'utilisation du cannabis et les comportements à problèmes qui lui sont associés. Bern:
Office Fédéral de la santé publique. http://www.bag.admin.ch/themen/drogen/00042/00643/00646/02287/index.html?lang=fr
98. Grichting, E., Salis Gross, C. Rehm, J., Kaufmann, B., & Rigter, H. (2006). Ergebnisse der Befragung zu Cannabisgebrauch und assoziiertem
Problemverhalten bei 13- bis 18-jährigen Jugendlichen aus Risikogruppen. Bern: Bundesamt für Gesundheit.
http://www.bag.admin.ch/themen/drogen/00042/00643/00646/02287/index.html?lang=de
97. Wittchen, H.U., Apelt, S.M., Soyka, M., Gastpar, M., Backmund, M., Goelz, J., Kraus, M., Tretter, F., Schaefer, M., Siegert, J., Guenther, A.,
Rehm, J., & Buehringer, G. (2006). One year retention rates and outcomes of methadone and buprenorphine maintenance treatments: a
nationwide prospective longitudinal study of 2694 patients. European Neuropsychopharmacology, 16 (Suppl. 4), S504-S505.
96. Greenfield, T.K., Bond, J., Nayak, M.B., Kairouz, S., Rehm, J., Monteiro, M.G., & Obot, I.S. (2006). Patterns of drinking by gender in seven
drinking settings: A 12-country analysis. Alcoholism: Clinical and Experimental Research, 30 (Supplement), 82A.
95. Popova, S., Fischer, B., & Rehm, J. (2006). Letter to the editor. Public Health, 120, 1091.
94. Arbeitsgruppe Cannabismonitoring (2005). Cannabiskonsum in der Schweiz und die Konsequenzen – Ein aktueller Überblick 2004. Bern:
93.
92.
91.
90.
89.
88.
87.
86.
85.
84.
83.
82.
81.
80.
79.
78.
77.
76.
75.
74.
73.
72.
71.
70.
69.
68.
67.
66.
65.
- 47 –
http://www.suchtundaids.bag.admin.ch/themen/sucht/forschung/unterebenen/02216/index.html?language=de&dir2=&schriftgrad=?schriftg
rad=
Groupe de travail Monitoring Cannabis (2005). La consommation de cannabis en Suisse et ses conséquences : vue d’ensemble 2004. Bern:
Office Fédéral de la santé publique.
http://www.suchtundaids.bag.admin.ch/themen/sucht/forschung/unterebenen/02216/index.html?language=fr&dir2=&schriftgrad=?schriftgr
ad=
Ye, Y., Cherpitel, C., Bond, J., Borges, G., Rehm, J., Macdonald, S., Room, R., Sovinova, H., Csemy, L., & Marais, S. (2005). Validity of selfreported drinking prior to injury compared to BAC in a cross-national emergency room study. Alcoholism: Clinical and Experimental Research,
29 (Supplement to 5), 155A.
Rehm, J. & Taylor, B. (2005). Volume of alcohol consumption, patterns of drinking and burden of disease in the European region 2002 –
implications for alcohol policy. Background document to the 10th Meeting of National Counterparts for Alcohol Policy in the WHO European
Region at Stockholm, Sweden. Kopenhagen: WHO European Region.
Mohler-Kuo, M., Rehm, J., Heeb, J.L. (2004). Does decrease price have an effect on spirits consumption and alcohol-related problems?
Alcoholism: Clinical and Experimental Research, 28(8 Supplement), 84A.
Rehm, J. (2004). Folgen des Cannabiskonsums bei Jugendlichen. Kommentar zu Macleod, J. Et al., Psychological and social sequaelae of
cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet, 2004, 363: 15791588. infomed-screen, 8(8), 59.
Gmel, G., Heeb, J.-L., & Rehm, J. (2003). Research and the alcohol industry. Addiction, 98(12), 973-975.
Zhang, B., Ferrence, R., Cohen, J., Ashley, M.J., Rehm, J., Bondy, S., Rohan, T., Jain, M., & Miller, A. (2003). Lung cancer mortality and smoking
cessation among middle-aged women by age at quitting. Ann Epidemiol, 13, 588.
Rehm, J. (2003). Review of T. Norström (2002). Alcohol in postwar Europe. Consumption, drinking patterns and policy responses in 15
European countries. Stockholm: National Institute of Public Health (ISBN 9 1220 1992 8). Addiction, 98(7), 1007-1008.
Gmel, G., & Rehm, J. (2003). Negative Alkohol-Folgen wiegen schwerer. Ärztliche Praxis: Die Zeitung für den Hausarzt, 55(10), 11.
Rehm, J. (2003). Gesellschaftsreform als soziales Experiment – Ein unzeitgemäßes Projekt oder der Ausweg aus erstarrten Sachzwängen in
der Alkoholpolitik. Review of R. Room (2002). The effects of Nordic alcohol policies. What happens to drinking and harm when alcohol
controls change. Helsinki: Nordic Council for Alcohol and Drug Research. (ISBN 951-53-2450-5). Sucht, 49(2), 129-130.
Rehm, J. (2003). Kritische Betrachtungen von Kosten-Nutzen Überlegungen zum Alkohol. In: Institut für Suchtforschung am KH Maria Ebene
& Amt der Vorarberger Landesregierung (Ed.), Enquete Jugend und Alkohol (pp. 3-4). Bregenz: Amt der Vorarlberger Landesregierung.
Rehm, J. (2003). Causal chain analysis: Rehm replies to Finney. Addiction, 98(4), 534-535.
Fischer, B., Brissette, S., Brochu, S., Bruneau, J., El-Guebaly, N., Noël, L., Rehm, J., Tyndall, M. (2002). „OPICAN“: a multisite cohort study of
untreated illicit opiate users in Canada. Journal of Urban Health, 79, suppl.1, S69.
Rehm, J. (2002). Review of R. Longabaugh & P.W. Wirtz (2001). Project MATCH hypotheses: results and causal chain analyses. Bethesda,
Md.: National Institute on Alcohol Abuse and Alcoholism (ISBN 0 16 050916 5). Addiction, 97, 1477-1478.
th
Rehm, J. (2001). Review of A. Springer & A. Uhl (2000). Illicit drugs. Patterns of use – Patterns of response. Proceedings of the 10 Annual
ESSD Conference on Drug Use and Drug policy in Europe. Innsbruck: Studienverlag. Suchttherapie, 2 (1), 180.
Rehm, J., Gschwend, P., Uchtenhagen, A. & Güttinger, F. (2001). Heroin-assisted treatment for opioid dependence in Switzerland – An
overview. In: National Bureau of Controlled Drugs (NBCD) under the auspices of Department of Health Taiwan R.O.C. (Eds.), 2001 Taipei
International Conference on Drug Abuse (pp. 77-85). Taipei, R.O.C.: NBCD.
Couzigou, P., Grønbæk, M., Klatsky, A.L., Orgogozo, J.-M., Poikolainen, K., Rehm, J., Renaud, S., Shaper, A.G. & Weill, J. (2001). The health
effects of light to moderate alcohol consumption. Focus, 2, 3-6.
Fischer, B., Rehm, J., & Kim, G. (2001). Whose quality of life is it, really? Rapid response to Carr, A.J. & Higginson, I.J. (2001). Are quality of life
measures patient centered? BMJ, 322, 1357-1360, published on BMJ webpage.
Room, R. & Rehm, J. (2001). Authorship, inclusion and hierarchy. Addiction, 96, 509-510.
Rehm, J. (2000). Review of: I. Maltzman (2000). Alcoholism. A review of its characteristics, etiology, treatments and controversies. Boston:
Kluwer. Addiction, 95, 1444-1445.
Frick, U, Krischker, S., Cording, C., & Rehm, J. (2000). Äpfel und Birnen vergleichen? Die Berücksichtigung von Patientenmix und
Organisationsmerkmalen beim praktischen Vergleich von 8 psychiatrischen Kliniken. Der Nervenarzt, 71, Supplement 1, S16-17.
Rehm, J., Ferrence, R., Cohen, J., & Gucciardi, E. (2000). Cigarette price and smoking behaviours in Canadian provinces: a longitudinal
analysis. Toronto: OTRU.
Rehm, J. (1999). Review of H. Parker, J. Aldridge & F. Measham (1998). lllegal leisure. The normalization of adolescent recreational drug use.
London: Routledge. Addiction, 94 (3), 442-443.
Xie, X., Rehm, J., Single, E., Robson, L., & Paul, J. (1998). The economic costs of illicit drug use in Ontario, 1992. Electronic Health Economics
Letters, 2, 8-14.
Rehm, J. (1998). Is moderate alcohol intake healthy? Alcoholism: Clinical and Experimental Research, 22, 139A.
Rehm, J. (1998). Treating alcoholism: the importance of background. Lancet, 351, 917.
Fischer, B. & Rehm, J. (1998). Why Canada needs to begin a heroin trial? The Journal, January/February, 5.
Bondy, S., Ashley, M.J., & Rehm, J. (1997). Long-term cognitive effects of drinking (response to letter by P. Kenny). Canadian Family
Physician, 43, 1341-1342.
Frick, U., Rehm, J., Knoll, A., & Reifinger, M. (1997). Der Einfluß von moderatem Alkoholtrinken und erlebter kognitiver Beeinträchtigung auf
die Fahrentscheidung von jungen Autofahrern. Das Gesundheitswesen, 59, A44-A45.
- 48 –
64. Rehm, J. (1997). Review of S.E. Finkel (1995). Causal analysis with panel data. Sage Unversity Series on Quantitative Applications in the Social
Sciences, 07/105. Thousand Oaks, CA: Sage. Statistics in Medicine, 16, 1547-1548.
63. Single, E., Robson, L., Desjardins, S., Xie, X., Rehm, J., Anderson, J., Choi, B., & Moore, R. (1996). The economic costs of substance abuse in
th
Canada, 1992. In: American Public Health Association (Ed.), Empowering the disadvantaged. Social justice in public health. 124 Annual
Meeting & Exposition, Abstracts (p. 276). New York, N.Y.: APHA.
62. Rehm, J. & Sempos, C.T. (1996). Alcohol consumption and mortality. Abstract. Population Index, 62, No. 2, 20193.
61. Rehm, J. & Fischer, B. (1996). Preface from the Canadian editors. In: Swiss Federal Office of Public Health & Addiction Research Foundation
rd
(Ed.), Swiss Methadone Report. Narcotic substitution in the treatment of heroin addicts in Switzerland (ii-iii). 3 Edition. Toronto: Addiction
Research.
60. Single, E., Robson, L., Xie, X., & Rehm, J. in collaboration with Moore, R., Choi, B., Desjardins, S., & Anderson, J. (1996). Les coûts de lábus de
substances au Canada. Une étude sur léstimation des coûts. Points saillants. Ottawa: Centre Canadien de lutte contre lalcoolisme et les
toxicomanies.
59. Single, E., Robson, L., Xie, X., & Rehm, J. in collaboration with Moore, R., Choi, B., Desjardins, S., & Anderson, J. (1996). The costs of substance
abuse in Canada. A cost estimation study. Highlights. Ottawa: Canadian Centre on Substance Abuse.
58. Rehm, J. (1996). Review of M.J. Ashley & R. Ferrence (Eds.) Moderate Drinking and Health: The scientific evidence. Contemporary Drug
Problems, 1994, 21, no. 1. Addiction, 91, 440.
57. Simon, R., Balsa, C.M.M., Barrio Anta, G., Frischer, M., Kontula, O., O'Hare, E., O'Higgins, K., Orta, J.V., Rehm, J., & Schmidt, D. (1995).
Population surveys in epidemiological research on drug use in Europe: core items and methodological aspects. Council of Europe. Cooperation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (Pompidou-Group) (P-PG/Epid (95) 19).
56. Rehm, J. & Sempos, C.T. (1995). Alcohol consumption and mortality - questions about causality, confounding and methodology. Short
version. Alcohol Digest, 12, 48, 17.
55. Apfelbaum, M., Durlach, V., & Rehm, J. (1995). Alcool et athérosclérose. Recherche et alcoologie. La lettre d’information de l’IREB, nr. 6, 1-2.
54. Frick, U., Rehm, J., Knoll, A., & François, Y. (1995). Wie nehmen Jugendliche Risiken wahr? Ergebnisse einer Latente-Klassen-Analyse der
WHO-Schülerstudie in der Schweiz. Das Gesundheitswesen, 57, 585.
53. Frick, U. & Rehm, J. (1994). Wissensintegration zur morbiditätsorientierten Bedarfsplanung im stationären Sektor bei unvollständiger
Wissensbasis. Das Gesundheitswesen, 56, X.
52. Frick, U. & Rehm, J. (1994). Ein loglineares Modell zur Antizipation von Angebotseffekten in der stationären Versorgung. Das
Gesundheitswesen, 56, XXXIII.
51. Rehm, J. & Spuhler T. (1994). Measurement error in alcohol consumption: the Swiss Health Survey. Short version. Alcohol Digest, 11, 42, 1213.
49./50. Rehm, J. & Müller, R. (1994). Alkoholkonsum und kardiovaskuläre Mortalität / Consommation d'alcool et mortalité cardiovasculaire.
Bulletin des Bundesamtes für Gesundheitswesen, Nr. 16, 230-233.
48. Frick, U. & Rehm, J. (1994). Medizinische Versorgung von Kindern im Grossraum Wien. Kurzfassung. Wien: Wiener Krankenanstaltenverbund.
relationships. Abstract. Population Index, 59, No. 4, 40171.
46. Rehm, J. (1993). Book review of Wang, C. (1993). Sense and nonsense of statistical inference: Controversy, misuse and sublety. New York:
Dekker. ISCB News, Nr. 15, 24.
45. Rehm, J. (1993). Book review of Keup, W. (1993). Missbrauchsmuster bei Abhängigkeit von Alkohol, Medikamenten und Drogen.
Frühwarnsystemdaten für die BRD 1976-1990. Freiburg: Lambertus. Drogalkohol, 17, 149.
relationships. Short version. Alcohol Digest, 10, 38-8.
43. Rehm, J. (1993). Une méta-analyse des recherches sur l'alcool et les maladies cardio-vasculaires. Quelles conclusions pour la prévention?
Revue d'épidémiologie et de santé publique, 41, S77-S78.
42. International Collaborative Study on AA - ICSAA (1993). Meeting Report. ICSAA Fourth Working Meeting: Mexico City, Mexico, October 19-23,
1992. Addiction, 88, 1137-1138.
41. Spuhler, T. & Rehm, J. (1993). Ergebnis-Unterschiede bei persönlichen und schriftlichen Befragungen. FlipChart, 2, 7-8.
40. Rehm, J. (1993). Sozialepidemiologie - mehr als nur ein Schlagwort? Book review of: Badura, D. & Kickbusch, I. (Eds.) (1991). Health
promotion research. Towards a new social epidemiology. WHO Regional Publications. European Series No. 37. Drogalkohol, 17, 61-62.
39. Rehm, J. (1993). Möglichkeiten und Grenzen der Verlagerung von Leistungen vom stationären in den ambulanten Bereich. In: Amt der
Salzburger Landesregierung (Eds.) Gesundheitsanalyse- und Prognosesystem Salzburg (pp. 12-14), Salzburg: Landespressebüro. Unterlagen
zum Pressegespräch 28.4. 1993.
38. Rehm, J. (1993). Pflegepersonalangebot in Gegenwart und Zukunft. In: Amt der Salzburger Landesregierung (Eds.) Gesundheitsanalyse- und
Prognosesystem Salzburg (pp. 10-11), Salzburg: Landespressebüro. Unterlagen zum Pressegespräch 28.4. 1993.
37. Fahrenkrug, H. & Rehm, J. (1992). Sozialepidemiologie alkoholbezogener Straßenverkehrsunfälle junger Erwachsener. Überarbeiteter
Schlußbericht eines durch den Schweizerischen Nationalfonds geförderten Projekts. Lausanne: Schweizerische Fachstelle für Alkohol- und
andere Drogenprobleme. Arbeitsbericht der Forschungsabteilung 22/1992.
36. Rehm, J. & Thamm, M. (1992). Ist Alkohol ein protektiver Faktor für kardiovaskuläre Krankheiten, oder sind entsprechende Ergebnisse die
Folge von methodischen Artefakten? Book review of: Veenstra, J. & van der Heij, D.G.. (1992). Alcohol and cardiovascular disease.
Wageningen: Pudoc. Drogalkohol, 16, 61-65.
35. Fahrenkrug, H. & Rehm, J. (1992). Epidémiologie sociale des accidents de la route dus à l'alcool chez les jeunes adultes. Lausanne: Swiss
- 49 –
Institute for the Prevention of Alcohol and Drug Problems.
34. Rehm, J. (1991). Book review of: Lippmann, E.D. (1990). Drogenabhängigkeit: Familientherapie und Prävention. Berlin: Springer. Drogalkohol,
15, 146-147.
33. Mariolini, N. & Rehm, J. (1991). "Die Freude des Lebens" und "Wir sagen wieder Ja zum Leben". Kongreßberichte der AA-Treffen in Delémont
und Offenburg. Drogalkohol, 15, 137-139.
32. Frick, U. & Rehm, J. (1991). Psychometric models concerning rating scales and inventories as endpoint measures in behavioural intervention
trials. In: Society for Cinical Trials/International Society for Clinical Biostatistics, Program and abstracts of the joint meeting (p. A16). Brussels,
Belgium, Juli 8-12, 1991.
31. Arminger, G. & Rehm, J. (1991). Measurement error and design. In: I. Guggenmoos-Holzmann (Ed.), Quantitative Methoden in der
Epidemiologie (p. 180). Berlin: Springer.
30. Fleck, K., Rehm, J., & Hoffmeister, H. (1991). Alkoholkonsum und Blutdruck beim Nationalen Untersuchungssurvey. In:
Bundesgesundheitsamt, Tätigkeitsbericht 1990 (p. 228). München: MMV.
29. Kohlmeier, L., Mensink, G.B.M., Rehm, J., Hermann-Kunz, E., Häußler, A., & Maierhofer, B. (1991). Entwicklung eines vollautomatisierten
Instruments für Ernährungserhebungen: Diet History. In: Bundesgesundheitsamt, Tätigkeitsbericht 1990 (pp. 226-228). München: MMV.
28. Thamm, M., Rehm, J., & Kohlmeier, L. (1991). The behaviour of selected biomarkers of naturally occuring antioxidants. In: F.J. Kok & P. van't
Veer (Eds.), Biomarkers of dietary exposure (p. 128). London: Smith-Gordon, Nishimura.
27. Haraldsdottir, J. & Rehm, J. (1991). Workshop report: New diet history methods. In: L. Kohlmeier (Ed.), The diet history method (pp. 126127). London: Smith-Gordon, Nishimura.
26. Rehm, J. (1990). Ernährung und Mortalitätsrisiken einer/s 42jährigen Deutschen. Bundesgesundheitsblatt, 33, Titelblatt.
25. Kohlmeier, L., Rehm, J., Hoffmeister, H., Murphy, R., Sempos, C., & Feinleib, M. (1990). Determinants of total serum cholesterol and
cholesterol lipoprotein levels in the Federal Republic of Germany and in the United States. CVD Epidemiology Newsletter, Nr. 46, 76.
24. Bisson, S. & Rehm, J. (1990). Wie lassen sich gesundheitsrelevante Einstellungen verändern? Königs- und Schleichwege der Persuasion.
extracta dermatologica, 14, 75-76.
(short version of the article in Medizin Mensch Gesellschaft, 1989)
23. Rehm, J. (1990). Book review of: J. Steensberg, Environmental health decision making - The politics of disease prevention. Stockholm:
Almquist & Wiksell, 1989. Bundesgesundheitsblatt, 33, 173.
22. Rehm, J. & Kohlmeier, L. (1990). Fortschritte in der Ernährungsepidemiologie? Bericht über das 'Second Meeting on Nutritional Epidemiology'
in Berlin (West). Bundesgesundheitsblatt, 33, 15-16.
21. Rehm, J., Naß, E., & Kohlmeier, L. (1990). Ein Vergleich der Mortalitätsrisiken 1951 und 1987. In: Bundesgesundheitsamt, Tätigkeitsbericht
1989 (pp. 235-237). München: MMV.
20. Rehm, J. & Frick, U. (1990). Einige praktische Aspekte der Modellierung von kausalen Beziehungen in der Epidemiologie. In:
19. Rehm, J., Naß, E., Häußler, A., & Kohlmeier, L. (1990). Überprüfung und Validierung des Bundeslebensmittelschlüssels (BLS). In:
Bundesgesundheitsamt, Tätigkeitsbericht 1989 (pp. 234-235). München: MMV.
18. Mensink, G., Kohlmeier, L., Rehm, J., & Hoffmeister, H. (1990). Die Beziehung zwischen Kaffeekonsum und Cholesterin im Serum in der
Bundesrepublik Deutschland. In: Bundesgesundheitsamt, Tätigkeitsbericht 1989 (p. 230). München: MMV.
17. Kohlmeier, L., Rehm, J., & Hoffmeister, H. (1990). Entwicklungen des Brustkrebs und mögliche Ursachen. In: Bundesgesundheitsamt,
Tätigkeitsbericht 1989 (pp. 224-225). München: MMV.
16. Häußler, A., Naß, E., Rehm, J., & Kohlmeier, L. (1990). Software auf Basis des Bundeslebensmittelschlüssels (BLS) - Ein Überblick.
Ernährungsumschau, 37, 152.
15. Rehm, J., Häußler, A., Naß E., & Kohlmeier, L. (1990). Der Bundeslebensmittelschlüssel Version II - Ein Überblick. Ernährungsumschau, 37,
152.
Editorial:
14. Rehm, J. (1990). Einige Gedanken zur Ernährungsepidemiologie heute. Bundesgesundheitsblatt, 33, 1.
13. Rehm, J. (1989). Neuer Bundeslebensmittelschlüssel (BLS II) ab sofort verfügbar. Bundesgesundheitsblatt, 32, 520.
12. Mensink, G.B.M., Kohlmeier, L., Rehm, J., & Hoffmeister, H. (1989). Die Beziehung zwischen Kaffeekonsum und Cholesterin im Serum in der
Bundesrepublik Deutschland. Journal of Clinical Chemistry and Clinical Biochemistry, 27, 753-754.
11. Kohlmeier, L. & Rehm, J. (1989). Krank durch Ernährung? Bericht über das von der WHO und dem BGA veranstaltete 'First Meeting on
Nutritional Epidemiology' in Berlin (West) 26.-28.11. 1988. Bundesgesundheitsblatt, 32, 18-20.
10. Rehm, J., Lang, P., & Melchert, H.-U. (1989). Zusammenhänge zwischen der Einnahme von verschiedenen Untergruppen von
Psychopharmaka in der bundesdeutschen Bevölkerung. In: Bundesgesundheitsamt, Tätigkeitsbericht 1988 (pp. 216-217). München: MMV.
9. Kohlmeier, L., Rehm, J., Hendrichs, A., Lang, P., & Arminger, G. (1989). Regressionsmodelle zur Schätzung von Einflußgrößen in
Kohortenstudien. In Bundesgesundheitsamt, Tätigkeitsbericht 1988 (pp. 215-216). München: MMV.
8. Kohlmeier, L., Rehm, J., Hendrichs, A., Lang, P., & Arminger, G (1989). Einflußfaktoren auf Serum Cholesterin bei Jugendlichen. In:
7. Rehm, J. (1988). Kontrastanalyse als Methode der Wahl zur Auswertung von varianzanalytischen Versuchsplänen? In: W. Schönpflug (Eds.),
Bericht über den 36. Kongreß der Deutschen Gesellschaft für Psychologie in Berlin 1988 (Bd. 1, p. 157). Göttingen: Hogrefe.
6. Luthardt, B., Rehm, J., & Brötz, A. (1988). Atomkriegsangst bei Jugendlichen: Zusammenhänge zwischen Kontrollerwartung,
Bewältigungsstrategien und Ängsten. In: W. Schönpflug (Eds.), Bericht über den 36. Kongreß der Deutschen Gesellschaft für Psychologie in
Berlin 1988 (Bd. 1, pp. 125-126). Göttingen: Hogrefe.
5. Rehm, J., Servay, W., & Irle, M. (1987). Wie sucht der Täter 'seine' Bank aus? Ergebnisse und praktische Folgerungen einer Täterbefragung.
4.
3.
2.
1.
- 50 –
Wirtschaftsschutz und Sicherheitstechnik, Number 8-9, 382-388.
(slightly modified version of the article in Kriminalistik, 1986)
Servay, W. & Rehm, J. (1987). Banküberfall. Psychologie heute, 14, 3, 46-49.
Lilli, W. & Rehm, J. (1985). Subjektive und normative Komponenten des Vorurteils. Ein integrativer Bezugsrahmen der Vorurteilsbildung. In:
D. Albert (Eds.), Bericht über den 34. Kongreß der Deutschen Gesellschaft für Psychologie in Wien 1984 (pp. 510-512). Göttingen: Hogrefe.
Rehm, J. (1983). Gegenverkehr auf der Einbahnstraße. Book review of: Henri Tajfel (1982). Gruppenkonflikt und Vorurteil. Bern: Huber.
psychologie heute, 10, 78-79.
Lilli, W. & Rehm, J. (1983). Illusorische Korrelation und Verfügbarkeitsheuristik: Experimentelle Studien zu den Entstehungsbedingungen von
Zusammenhängen zwischen zwei Sachverhalten. In: G. Lüer (Eds.), Bericht über den 33. Kongreß der Deutschen Gesellschaft für Psychologie
in Mainz 1982 (pp. 318-321). Göttingen: Hogrefe.
- 51 –
5 Final reports of research projects
Shuper, P.A., Joharchi, N., Smarandita-Arbone, I., Imtiaz, S., & Rehm, J. (2015). Tuberculosis in association with mental health, substance abuse,
and alcohol abuse: systematic review and recommendations on research priorities. Toronto, Canada: Centre for Addiction and Mental
Health. (Report to PAHO)
Shield, K.D., Probst, C., Rylett, M., Hasan, O.S.M., & Rehm, J. (2015). Trends in alcohol indicators for achieving the voluntary global targets for noncommunicable disease control between 2010 and 2014. (Report to WHO Headquarters).
Marmet, S., Gmel, G.(sen.), Gmel, G.(jun.), Frick, H., & Rehm, J. (2013). Alcohol-attributable mortality in Switzerland between 1997 and 2011.
Lausanne: Addiction Suisse. (Report to the Swiss Federal Office of Public Health)
Kraus, L., Gmel, G., Shield, K.D., Frick, H., Piontek, D., Pabst, A., Gomes de Matos, E., & Rehm, J. (2013). Machbarkeitsstudie Alkoholmonitor
Deutschland. Alkoholkonsum, negative Folgen, Kosten, Behandlung und Prävention. Munich, Germany: Institut für Therapiestudien. (Report
to the German Ministry of Health)
Rehm, J. & Shield, K. (2012). Discussion of the outcome indicator for alcohol of the Comprehensive Global Monitoring Framework for the
Prevention and Control of Non-Communicable Diseases. Report prepared for WHO HQ April 2012. Toronto: WHO Collaborating Centre for
Mental Health and Addictions.
Rehm, J., Gmel G. jun., & Shield, K. (2012). Discussion of the outcome indicator for alcohol of the Comprehensive Global Monitoring Framework for
the Prevention and Control of NCDs. Report prepared for the Regional Technical Consultation on NCD Surveillance, Monitoring & Evaluation,
Oslo, 9 – 10 February 2012. Toronto: WHO Collaborating Centre for Mental Health and Addictions.
Rehm, J., & Frick, U., in collaboration of S. Popova, J. Patra, S. Lev-Ran (2011). Consistently estimated epidemiologic indicators for substance use
disorders in Canada after 2000. Report to the Mental Health Commission of Canada. Toronto: CAMH.
Williams, R.J., Rehm, J., & Stevens, R.M.G. (2011). The social and economic impacts of gambling. Final report prepared for the Canadian
Consortium for Gambling Research. Lethbridge, Canada: University of Lethbridge.
Rehm, J. & Room, R. (2007). Indicators for monitoring alcohol-attributable harm. Geneva: WHO, Department of Mental Health and Substance
Abuse, Management of Substance Abuse (Internal document for the meeting of the WHO Technical Advisory Group on Alcohol Epidemiology
at Geneva, Switzerland).
Patra, J., Popova, S., Rehm, J., Bondy, S., Flint, R., & Giesbrecht, N. (2007). Economic cost of chronic disease in Canada 1995-2003. Report
contracted by and prepared for the Ontario Chronic Disease Prevention Alliance and the Ontario Public Health Association.
Rehm, J. (2006). Operationalization of indicator for “Level of harmful use of alcohol”. Geneva: WHO, Department of Mental Health and Substance
Abuse, Management of Substance Abuse (Internal document for the meeting of the WHO Technical Advisory Group on Alcohol Epidemiology
at Geneva, Switzerland).
Rehm, J., Giesbrecht, N., Popova, S., Patra, J., Adlaf, E., & Mann, R. (2006). Survol des bienfaits et méfaits de la consommation d’alcool –
incidences sur les politiques de prévention au Canada. Toronto: Centre for Addiction and Mental Health. Report contracted by Health
Canada.
http://www.camh.net/Research/Research_publications/Newsletter/Winter%202007/Alcohol_riskbenefits_Overview_French_final_%202007.
pdf
Rehm, J., Giesbrecht, N., Popova, S., Patra, J., Adlaf, E., & Mann, R. (2006). Overview of positive and negative effects of alcohol consumption –
implications for preventive policies in Canada. Toronto: Centre for Addiction and Mental Health. Report contracted by Health Canada.
http://www.camh.net/Research/Research_publications/Newsletter/Winter%202007/Alcohol_riskbenefits_Overview_english_final_%202007.
pdf
Rehm, J., Patra, J., Baliunas, D., Popova, S., Roerecke, M., & Taylor, B. (2006). Alcohol-attributatble burden of disease comparisons 2000-2005.
Geneva: WHO, Department of Mental Health and Substance Abuse, Management of Substance Abuse (Internal document for the meeting of
the WHO Technical Advisory Group on Alcohol Epidemiology at Geneva, Switzerland).
Rehm, J., Patra, J., Baliunas, D., Popova, S., Roerecke, M., & Taylor, B. (2006). Alcohol consumption and the global burden of disease 2002.
Geneva: WHO, Department of Mental Health and Substance Abuse, Management of Substance Abuse (Internal document for the meeting of
the WHO Technical Advisory Group on Alcohol Epidemiology at Geneva, Switzerland).
factors and prevention priorities. Report prepared for the Ontario Chronic Disease Prevention Alliance and the Ontario Public Health
Association. Funded by Public Health Agency of Canada to the Ontario Public Health Association.
Giesbrecht, N., Roerecke, M., & Rehm, J. (2005). Alcool and maladies chroniques. Incidences sur les politiques et les stratégies de préventions au
Canada.
Document d’information preparé pour le Groupe de travail sur la Stratégie nationale sur l’alcool. Put on the website of national framework in
07-2006 :
http://www.nationalframework-cadrenational.ca/detail_f.php?id_sub=1&id_top_sub=2
Giesbrecht, N., Roerecke, M., & Rehm, J. (2005). Alcohol and chronic disease. Implications for policies and prevention strategies in Canada.
Background paper prepared for the National Working Group on Alcohol Policy.
Put on the website of national framework in 07-2006 :
http://www.nationalframework-cadrenational.ca/detail_e.php?id_sub=1&id_top_sub=2
WHO Collaborative Study Group on Alcohol and Injuries (2005). WHO Collaborative Study on Alcohol and Injuries. Final Report. Geneva: World
Health Organization.
Mann, R.E., Rehm, J., Giesbrecht, N., Room, R., Adlaf, E., Gmel, G., Graham, K., Österberg, E., Smart, R., & Roerecke, M. (2005). Alcohol distribution,
alcohol retailing and social responsibility. A report submitted to the Beverage Alcohol System Review Panel of the Ontario Ministry of
Finance. http://www.beveragealcoholreview.on.ca/pubs/camh.htm
(published as background document of the Ontario Alcohol System Review: http://www.beveragealcoholreview.on.ca/en/report.htm )
- 52 –
Connor, J., Broad, J., Jackson, R., Vander Hoorn, S., & Rehm, J. (2004). The burden of death, disease and disability due to alcohol in NZ. Final report
to the Alcohol Advisory Council of NZ.
Babor, T., Room, R., & Rehm, J. (2004). Alcohol's role in the Global Burden of Disease: implications for alcohol policy. Final report submitted to
WHO for publication.
Rehm, J. (2003). Alcohol, addiction and public health. Working Paper No. 33 for Disease Control Priorities Project (available at www.dcp.org).
Neuman, M.G. & Rehm, J. (2003). Alcohol, infectious disease and liver cirrhosis: implications for therapy of HIV and hepatitis C viral infections.
Final report to WHO.
Rehm, J., Michaud, C., Ezzati, M., & Murray, C.J.L. (2003). Disability adjusted life years (DALYs) as a measure of alcohol-related burden of disease
(BOD): conceptual, methodological and empirical considerations. Final report to NIAAA. NIAAA Contract No. N01AA12013. Toronto &
Boston: Centre for Addiction and Mental Health & Harvard University.
Haydon, E., Fischer, B., Strike, C., Rehm, J., & Millson, P. (2002). Crack use and Hepatitis C in Canada: A review of research evidence and questions.
Final report submitted to Health Canada based on contract number BL0722152038.
Fischer, B., Rehm, J., & Robins, A. (2002). Supervised Injection Sites (SIS) pilot study in Canada: evaluation framework proposal. Submitted to
Canada’s Drug Strategy Secretariat/Health Canada March 28, 2002 (Revision date April 15, 2002)
Rehm, J., Gmel, G., Room, R., Monteiro, M., Graham, K., Gutjahr, E., Jernigan, D., & Sempos, C.T. (2001). Alcohol as a risk factor for burden of
disease. Paper submitted to WHO for inclusion in World Health Report 2002.
Rehm, J. & Gmel, G. (2001). Average volume of alcohol consumption, drinking patterns and related burden of mortality in young people in Europe.
Paper submitted to WHO for WHO European Ministerial Conference on Young People and Alcohol. Stockholm, Sweden.
Cohen, J., Ashley, M.J., Ferrence, R., Northrup, D., Rehm, J. Studlar, D., & de Guia, N. (2000). Factors associalted with Canadian legislators’ support
for tobacco control and other public health measures. Final report submitted to Health Canada’s National Health Research and Development
Program (NHRDP).
Rehm, J., Ferrence, R., Cohen, J., & Gucciardi, E. (2000). Cigarette price and smoking behaviours in Canadian provinces: a longitudinal analysis.
Final report submitted to the National Cancer Institute of Canada.
Single, E., Ashley, M.J., Bondy, S., Rankin, J., & Rehm, J. with the assistance of Dobbins, M. (1999). Evidence regarding the level of alcohol
consumption considered to be low-risk for men and women. Final report submitted to the Australian Commonwealth Department of Health
and Aged Care.
Ali, R., Auriacombe, M., Casas, M., Cottler, L., Farrell, M, Kleiber, D., Kreuzer, A., Ogborne, A., Rehm, J., & Ward, P. (1999). Report of the external
panel on the evaluation of the Swiss Scientific Studies of Medically Prescribed Narcotics to Drug Addicts. Geneva: World Health Organization.
Rehm, J. (1998). Summary report according to the terms of reference for evaluators of the Swiss Studies on Medical Prescription of Narcotics to
Drug Dependents. Report submitted to the World Health Organization.
Rehm, J. & Holder, A. (1998). Report on the Barbados Rapid Assessment Survey on the Extent of Substance Abuse in Communities and for
Describing the Relevant Services to Respond to Substance-Related Problems. October 1997 - May 1998. Report submitted to the (Barbados)
National Council on Substance Abuse.
Ashley, M.J., Rehm, J., & Bondy, S. (1998). Health risks and benefits of alcohol consumption: balancing disparate relationships for individual and
th
population health. Report submitted to NIAAA to be included in the 10 Special Report to the U.S. Congress on Alcohol and Health.
Ashley, M.J., Goodstadt, M., Ellis, E., Heughan, D., Rehm, J., Salmers, B. (1996). A report of the committee to recommend draft guidelines on lowrisk drinking for the Province of Ontario. Low-risk drinking guidelines project. Phase 1: review of the scientific evidence. Report submitted to
the Ontario Ministry of Health, Substance Abuse Bureau.
Single, E., Robson, L., Xie, X., Rehm, J., in collaboration with Moore, R., Choi, B., Desjardins, S., & Anderson, J. (1996). The costs of substance abuse
in Canada. Final report submitted to the (Canadian) National Health Research and Development Program (NHRDP).
Single, E., Robson, L., Xie, X., Rehm, J., Desjardins, S., Anderson, J., Choi, B., & Moore, R. (1996). The costs of substance abuse in Canada: A progress
report. Submitted to the (Canadian) National Health Research and Development Program (NHRDP).
Rehm, J., Arminger, G., & Frick, U. (1995). Kausalmodelle zu subjektiven Gesundheitsindikatoren, Inanspruchnahme und Gesundheitsverhalten als
Basis für Prävention - Das Beispiel der Salzburger Gesundheitsbefragungen. Revidierter Endbericht an das Amt der Salzburger
Landesregierung. Bensheim, Toronto: Institut für sozialwissenschaftliche Computeranalysen und Methoden e.V.
Rehm, J., Sempos, C.T., Vuong, C., Chien, C.-Y., & Walsh, G. (1995). Alcohol consumption and all-cause mortality. The NHANES I and NHANES II
follow-up studies. Report for the WHO Working Group on Alcohol Consumption and Health at Oslo, Norway, October, 9-13 (ICP ALDT94 02
MT 12/6).
Frick, U., Laschat, M., & Rehm, J. (1995). Neonatologische Versorgung in Wien: Struktur, Bedarf, sowie Aspekte der Verzahnung zu
Nachbardisziplinen. Endbericht zur Studie "Bedarfsplanung in der Neonatologie, der pädiatrischen Intensivplanung und der Geburtshilfe" an
den Wiener Krankenanstaltenverbund. Bensheim, München: Institut für sozialwissenschaftliche Computeranalysen und Methoden e.V.
(ICAM).
Simon, R., Balsa, C.M.M., Barrio, G.A., Frischer, M., Kontula, O., O'Brian, M., O'Hara, E., O'Higgins, K., Rehm, J., Schmidt, D., & Vincente Orta, J.
(1995). Proceedings of the Sub-Group Population Surveys. Submitted to the Co-operation Group to Combat Drug Abuse and Illicit Trafficking
in Drugs (Pompidou-Group).
Fischer, B. & Rehm, J. (1995). Alcohol consumption and liability in the German criminal system. Toronto: Addiction Research Foundation.
Rehm, J. & Room, R. (1995). Population levels of alcohol consumption. Report on the WHO working group meeting in Oslo, December 14-16, 1994,
submitted to WHO Europe (EUR/ICP/ADA 035).
Frick, U., Rehm, J., John, J., Thamm, M., & Laschat, M. (1995). Substitutionspotentiale stationärer Leistungen im Bundesland Salzburg - eine
mehrstufige Delphibefragung. Endbericht an das Amt der Salzburger Landesregierung. Bensheim, Lausanne, München: Institut für
sozialwissenschaftliche Computeranalysen und Methoden e.V.
Rehm, J., Arminger, G., & Frick, U. (1994). Kausalmodelle zu subjektiven Gesundheitsindikatoren, Inanspruchnahme und Gesundheitsverhalten als
- 53 –
Basis für Prävention - Das Beispiel der Salzburger Gesundheitsbefragungen. Endbericht an das Amt der Salzburger Landesregierung.
Bensheim, Toronto: Institut für sozialwissenschaftliche Computeranalysen und Methoden e.V.
Rehm, J., Sempos, C.T., Vuong, C., Chien, C.-Y., & Frick, U. (1994). Alcohol consumption and all-cause mortality. Report for the WHO Working Group
on Population Levels of Alcohol Consumption at Oslo, Norway, November, 14-16, 1994.
Vaucher, S., Rehm, J., Benvenuti, J., & Müller, R. (1994). Les jeunes et l'accessibilité à l'alcool. Test empirique sur les connaissances et la
complaisance des serveurs face à la consommation de boissons alcooliques par les jeunes de 13 et 15 ans. Rapport du départment de
o
Recherche N . 24. Lausanne: Institut suisse de prévention de l'alcoolisme et autres toxicomanies (ISPA).
Frick, U. & Rehm, J. (1994). Stellungnahme zur Bedeutung des Wilhelminenspitals für den Bereich der Kinderinfektiologie aus epidemiologischer
und regionalanalytischer Sicht. Endbericht an den Wiener Krankenanstaltenverbund. Bensheim & München: Institut für
sozialwissenschaftliche Computeranalysen und Methoden e.V. in Zusammenarbeit mit bias, Ges. für biometrische Analysen und
Studienbetreuung mbH.
Ayer, S., François, Y., & Rehm, J. (1994). Opération Nez rouge. Hiver 1993-1994. Evaluation auprès des usagers/ Aktion "Rote Nase" ("Nez rouge"),
Vorläufiger Evaluationsbericht für den Zeitraum Winter 1993-1994. Lausanne: Institut suisse de prévention de l'alcoolisme et autres
toxicomanies (ISPA).
Frick, U. & Rehm, J. unter Mitarbeit von S. Puffarth, A.Knoll, A. Miesner, H. Fassmann, R. Giffinger, L. Riedl, S. Bisson, M. Laschat & T. Zwingers
(1994). Versorgungs-Szenarien im stationären Sektor 1992-2003. Erreichbarkeit stationärer wie ambulanter Einrichtungen, räumliche
Behandlungsallokation und Standort-Optimierung in der medizinischen Versorgung von Kindern und Jugendlichen im Grossraum Wien.
Endbericht zum Teil 2 der Studie "Medizinische Versorgung von Kindern im Grossraum Wien" an den Wiener Krankenanstaltenverbund (2
Bände: Textband und Materialienband). Bensheim & München: Institut für sozialwissenschaftliche Computeranalysen und Methoden e.V in
Zusammenarbeit mit bias, Ges. für biometrische Analysen und Studienbetreuung GmbH.
Frick, U. & Knoll, A. unter Mitarbeit von S. Puffarth, J. Rehm, A. Miesner, H. Fassmann, R. Giffinger, L. Riedl, M. Laschat, & T. Zwingers (1994).
Prognose des stationären medizinischen Bedarfs für Kinder und Jugendliche im Grossraum Wien 1991-2003. Revidierter Endbericht zum Teil 1
der Studie "Medizinische Versorgung von Kindern im Grossraum Wien" an den Wiener Krankenanstaltenverbund (2 Bände: Textband und
Materialienband). Bensheim:Institut für sozialwissenschaftliche Computeranalysen und Methoden e.V.
Fichter, M.M. & Rehm, J. (1993). Verlaufsmodelle psychischer Erkrankungen in der Bevölkerung. Abschlußbericht an die Deutsche
Forschungsgemeinschaft.
therein:
Fichter, M.M., Blaschke, D.C., Rehm, J., & Krüger, R. Prävalenz psychischer Erkrankungen in der Bevölkerung (ICD 9). Vergleich der
Erhebungsergebnisse auf der Basis multipler Datenquellen (ärztliches Interview, Angaben des Hausarztes, sekundär-statistische Angaben der
Kranken- und Rentenversicherungen sowie stationärer psychiatrischer Inanspruchnahme) mit den Ergebnissen der Interviewererhebung
allein. pp.9-136
Fichter, M.M., Blaschke, D.C., & Rehm, J. Psychiatric Comorbidity: Results of the Upper Bavarian Study. pp. 167-194.
Rehm, J., Fichter, M.M., Frick, U., & Elton, M. Facteurs d'influence sur les troubles mentaux des jeunes adolescent(e)s et des adolescent(e)s:
L'exemple du suivi longitudinal en Haute-Bavière, pp. 212-222.
Fichter, M.M., Rehm, J., & Blaschke, D.C. Inzidenz psychischer Erkrankungen in der Bevölkerung. pp. 223-317.
Fichter, M.M., Rehm, J., Elton, M., & Dilling, H. Mortality risk and mental disorders: longitudinal results from the Upper Bavarian Study, pp. 318331.
Rehm, J., Fichter, M.M., & Elton, M. (1993). Effects on mortality of alcohol consumption, smoking, physical activity, and close personal
relationships: The Upper Bavarian Follow-Up Study. pp. 332-349.
Maffli, E., Mariolini, N., Nielsen, P., Rehm, J., & Hoefliger, A. (1993). Clinique la Métairie, Unité des maladies de la dépendance. Un premier bilan.
Lausanne, Nyon: Schweizerische Fachstelle für Alkohol- und andere Drogenprobleme (SFA) & Clinique la Métairie.
Rehm, J. (1993). Bericht über das Expertenhearing "Alkoholkonsum und Herz-Kreislauf-Krankheiten" der Eidgenössischen Kommission für
Alkoholfragen am 28.5. 1993 in Bern. Bericht an die Eidgenössischen Kommission für Alkoholfragen.
Fichter, M.M., Quadflieg, N., & Rehm, J. (1993). Kausalmodelle zum Verlauf der Bulimia Nervosa. In: M.M. Fichter, Verlaufsuntersuchung über
Risikofaktoren bulimischer Eßstörungen (pp. 347-372). Bericht an das Bundesministerium für Forschung und Technologie (BMFT).
Abbet, J.-P., Efionayi-Mäder, D., & Rehm, J. (1993). La santé des jeunes dans le canton de Vaud. Comparaison avec l'ensemble de la Suisse.
Résultats d'une enquête sur la vie quotidienne et la santé des écoliers de 11 à 16 ans, réalisée sous l'égide de l'Organisation mondiale de la
santé (OMS Europe Kopenhagen). Lausanne: ISPA. Schlussbericht an den Kanton.
(Similar reports were written for the cantons of Fribourg and Neuchâtel).
Rehm, J., Abbet, J.-P., & Efionayi-Mäder, D. (1993). Gesundheitsverhalten der Jugendlichen in Basel-Stadt. Ein Vergleich zur Gesamtschweiz. Eine
Untersuchung im Rahmen des Projekts "Gesundheitsverhalten von 11-16jährigen SchülerInnen in der Schweiz" unter Schirmherrschaft der
Weltgesundheitsorganisation (WHO Europa Kopenhagen). Lausanne: SFA. Schlußbericht an den Kanton.
(Similar reports were written for the cantons of Graubünden and Uri).
Efionayi-Mäder, D., Abbet, J.-P., & Rehm, J. (1993). Gesundheitsverhalten der Jugendlichen im Kanton Bern. Ein Vergleich zur Gesamtschweiz. Eine
Untersuchung im Rahmen des Projekts "Gesundheitsverhalten von 11-16jährigen SchülerInnen in der Schweiz" unter Schirmherrschaft der
Weltgesundheitsorganisation (WHO Europa Kopenhagen). Lausanne: SFA. Schlußbericht an den Kanton.
(Similar reports were written for the cantons of Glarus, St. Gallen and Luzern).
Rehm, J. & Mariolini, N. (1993). Life-story telling within the Alcoholics Anonymous movement in Switzerland. Schlußbericht an den
Schweizerischen Nationalfonds zur Förderung der wissenschaftlichen Forschung (Partly in German, French and English).
H. Klingemann, in Zusammenarbeit mit J. Rehm (1992). Country profiles. In: WHO, First European summary of drug abuse (ESDA). 1985-1989/90.
Revised draft report to the Regional Office of the World Health Organization.
Fahrenkrug, H. & Rehm, J. (1991). Sozialepidemiologie alkoholbezogener Straßenverkehrsunfälle junger Erwachsener. Schlußbericht an den
Schweizerischen Nationalfonds zur Förderung der wissenschaftlichen Forschung.
- 54 –
Fichter, M.M. & Rehm, J. unter Mitarbeit von M. Elton & D. Blaschke (1991). Verlaufsmodelle psychischer Erkrankungen. Bericht an die Deutsche
Forschungsgemeinschaft.
Rehm, J., Kohlmeier, L., Sempos, C., & Murphy, R. (1990). Determinants of total serum cholesterol and cholesterol lipoprotein levels in the Federal
Republic of Germany and Berlin (West) and in the United States. Proposed analysis plan and preliminary results. Joined report to the Federal
Health Office, Germany, and the National Center for Health Statistics, USA.
Rehm, J. & Servay, W. (1989). Wohnungseinbruch aus Sicht der Täter. Abschlußbericht an das Bundeskriminalamt. Mannheim: Universität
Mannheim.
Wagner, E., Frick, U., & Rehm, J. (1988). Bautenkonflikte in Österreich 1960 bis 1987. Vollerhebung und Analyse umstrittener Großbauprojekte.
Forschungsbericht für das Internationale Bureau für Politik- und Sozialforschung. Wien, München, Berlin.
Fichter, M.M., unter Mitarbeit von Meller, I., Witzke, W., Weyerer, S., Rehm, J., & Koloska, R. (1988). Die oberbayerische Verlaufsuntersuchung:
Psychische Erkrankungen in der Bevölkerung. Abschlußbericht an die Deutsche Forschungsgemeinschaft.
Fichter, M.M. & Frick, U., unter Mitarbeit von Buchroithner, F., Gottschlich, M., Koloska, R., Kurz-Adam, M., Postpischil, F., Rehm, J., Timm, K., &
Zendler, A. (1988). Kontrollierte Therapie-Evaluations-Studie bei rückfallgefährdeten Alkoholikern mit systematischer Einbeziehung der
Angehörigen. Abschlußbericht an die Wilhelm-Sander-Stiftung.
Servay, W. & Rehm, J. (1986). Bankraub aus Sicht der Täter. Abschlußbericht an das Bundeskriminalamt. Mannheim: Universität Mannheim.
- 55 –
6 Presentations at meetings and conferences, webinars
Invited presentation:
559. Rehm, J (2016, February 17-18). The harm from addictions. Presentation at the “A-Debate: U-Turn on Addictions. Biological and social
sciencies to reframe drug policy”, at Barcelona, Spain.
558. Lachenmeier, D., & Rehm, J (2016, February 17-18). Toxicology and ranking ofaddictive drugs. Presentation at the “A-Debate: U-Turn on
Addictions. Biological and social sciencies to reframe drug policy”, at Barcelona, Spain.
557. Bühringer, G., Behrendt, S., Forberger, S., Neumann, M., Probst, C., & Rehm, J (2016, January 13). Alice Rap – über 200 Wissenschaftler, 21
Teilprojekte, 5 Jahre Forschung zu psychotropen Substanzen und Glücksspielen: Wird die Welt jetzt besser? Research rounds Clinical
Pyschology and Psychotherapy at the Technische Universität Dresden at Dresden, Germany.
[Alice RAP – over 200 scientists, 21 projects, 5 years of research on psychoactive substances and gambling: is the world becoming a better
place now?]
556. Rehm, J., Elvik, R., Shield, K.D., & Imtiaz, S. (2015, December 16-17). Estimate of road traffic fatalities associated with drug use. Presentation
at the Second Technical Consultation on Drug Use and Road Safety at Mallorca, Spain.
555. Rehm, J. (2015, December 16-17). Interventions to address drug use and road traffic injury. Presentation at the Second Technical
Consultation on Drug Use and Road Safety at Mallorca, Spain.
554. Rehm, J. (2015, November 30). Trends in global alcohol consumption. Presentation at the Carnegie Investment Bank at Copenhagen,
Denmark.
553. Rehm, J. (2015, November 28). Some thoughts about the epidemiology, public health impact and cost-effectiveness of the Integrated Care
Pathway “Major Depression – Alcohol Dependence”. Presentation at the Canadian Pathways Conference 2015 at Toronto, Canada.
552. Kuitunen-Paul, S., Trautmann, S., Pieper, L., Manthey, J., Wittchen, H.-U., & Rehm, J. (2015, November 25-28). Welche Patienten mit
Alkoholabängigkeit werden in der primärärztlichen Versorgung erkannt? Poster at the DGPPN Kongress at Berlin, Germany.
551. Pieper, L., Manthey, J., Trautmann, S., Paul, S., Wittchen, H.-U., & Rehm, J. (2015, November 25-28). Patienten mit Abhängigkeit in der
spezialisierten Versorgung in Deutschland – Ergebnisse der APC Studie. Poster at the DGPPN Kongress at Berlin, Germany.
550. Trautmann, S., Pieper, L., Kuitunen-Paul, S., Manthey, J., Wittchen, H.-U., & Rehm, J. (2015, November 25-28). Prävalenz und Behandlung der
Alkoholabhängigkeit in der primärärztlichen Versorgung in Deutschland Poster at the DGPPN Kongress at Berlin, Germany.
549. Rehm, J. (2015, November 23-25). Drug use and health outcomes, disability weights, causality, RRs, PAFs. Presentation at the Meeting of the
WHO Technical Advisory Group on Alcohol and Drug Epidemiology at Geneva, Switzerland.
548. Rehm, J. (2015, November 23-25). Comparison of illicit drug-attributable with alcohol- and tobacco-attributable global disease burden.
Presentation at the Meeting of the WHO Technical Advisory Group on Alcohol and Drug Epidemiology at Geneva, Switzerland.
547. Rehm, J. (2015, November 23-25). Research priorities for global substance use epidemiology. Presentation at the Meeting of the WHO
Technical Advisory Group on Alcohol and Drug Epidemiology at Geneva, Switzerland.
546. Wojnar, M., Mantehy, J., & Rehm, J. (2015, November 23-25). APC: Alcohol dependence in primary and specialist care in Europe - treatment
coverage. Presentation at the Meeting of the WHO Technical Advisory Group on Alcohol and Drug Epidemiology at Geneva, Switzerland.
545. Rehm, J. & Shield, K.D. (2015, November 13). Alcohol consumption, unrecorded alcohol and alcohol-attributable mortality in Europe 1990 –
2014. Presentation at the WHO European Region meeting on alcohol and mortality at Barcelona, Spain.
544. Rehm, J. (2015, November 13). Impacte del consum d’alcohol en la nostra societat i les estratègies més efectives per reduir-ne els danys
[Impact of alcohol consumption in our society and the most effective strategies to reduce damage]. Presentation at the Jornada Veus el que
beus of the Generalitat de Catalunya at Barcelona, Spain.
543. Rehm, J. (2015, November 12). Proposed consensus paper: emphasizing the need for action. Presentation at the “International expert
forum: screening and intervention for harmful alcohol use as a tool to improve the management of hypertension in primary care” at the
Public Health Agency of Catalonia at Barcelona, Spain.
542. Rehm, J. (2015, November 12). The Expert Roundtable Project: a multi-disciplinary initiative to reduce the mortality burden of noncommunicable diseases. Presentation at the “International expert forum: screening and intervention for harmful alcohol use as a tool to
improve the management of hypertension in primary care” at the Public Health Agency of Catalonia at Barcelona, Spain.
541. Rehm, J. (2015, November 9). Cannabis without the hot air. Presentation and public discussion with David Nutt at Monk School of Global
Affairs at Toronto, Canada.
540. Rehm, J. (2015, October 19-21). Burden attributable to alcohol use disorders as risk factor for suicide. Presentation at the WHO meeting
“Substance use and suicide in the international context” at Geneva, Switzerland.
- 56 –
539 Rehm, J. (2015, October 16). Alcohol use disorders, health and treatment interventions. Presentation at the meeting “New drinking habits –
new treatment” at Stockholm, Sweden.
538 Rehm, J. (2015, September 21-22). Alcohol and cancer. Presentation at the project meeting on “The proportion of cancer attributable to
lifestyle and environmental factors in France” at the International Agency for Research on Cancer at Lyon, France.
537 Rehm, J. (2015, August 31). Need for earlier intervention in alcohol dependence – evidence from a large cross-sectional study. Presentation
th
at the Satellite symposium “The natural history of alcohol dependence – importance of early and continuous intervention” of the 28 ECNP
Congress at Amsterdam, The Netherlands.
536 Rehm, J. (2015, August 18). Recent changes in the global modelling of alcohol as a risk factor and alcohol use disorders. Presentation at the
University of Queensland, School of Public Health, Brisbane, Australia.
535 Rehm, J. (2015, August 13). Cannabis policy in Canada 2015. Presentation at the National Drug and Alcohol Research Centre, Randwick,
Sydney, Australia.
534 Rehm, J. (2015, August 6-9). Alcohol use and HIV/AIDS. Presentation at the 123rd Annual Convention of the American Psychological
Association at Toronto, Canada.
533 Rehm, J. (2015, July 29). Addressing stigma and discrimination related to mental Illness and substance use issues while promoting recovery
oriented practices in primary healthcare. Presentation at the Anti-Stigma Initiative Final Symposium Agenda at Toronto, Canada.
532 Rehm, J. (2015, July 7-9). Alcohol as a risk factor for health – the evidence. Presentation at the workshp on National Alcohol Polcy organized
by the (Jamaican) Ministry of Health, the National Council on Drug Abuse, and the American Health Organization at Kingston, Jamica.
531 Rehm, J. (2015, July 7-9). Data needs and gaps with respect to a national alcohol policy in Jamaica. Presentation at the workshp on National
Alcohol Polcy organized by the (Jamaican) Ministry of Health, the National Council on Drug Abuse, and the American Health Organization at
Kingston, Jamica.
529. Rehm, J. (2015, July 7-9). What policies work and World Health Organization strategy. Presentation at the workshp on National Alcohol Polcy
organized by the (Jamaican) Ministry of Health, the National Council on Drug Abuse, and the American Health Organization at Kingston,
Jamica.
528. Rehm, J. (2015, July 7-9). Towards a national alcohol policy in Jamaica. Presentation at the workshp on National Alcohol Polcy organized by
the (Jamaican) Ministry of Health, the National Council on Drug Abuse, and the American Health Organization at Kingston, Jamica.
527. Rehm, J. (2015, June 22-23). Very cost-effective interventions to reduce the harmful use of alcohol. Presentation at the Consultation by the
World Health Organization on Updating Appendix 3 of the Global NCD Action Plan 2013-2020 at Geneva, Switzerland.
526. Rehm, J. (2015, June 18). Alkoholabhängigkeit und assoziierte Erkrankungen. [Alcohol dependence and associated disease] Presentation at
th
the 5 Symposium for an active alcohol therapy at Berlin, Germany.
525. Anderson, P., Gual, T., Rehm, J., Lachenmeier, D., & Gell, L. (2015, June 4). Addictions, drug policy framework and public health. Lunchtime
seminar at the World Health Organization, at Genvea, Switzerland.
524. Rehm, J., Anderson, P., Manthey, J., Shield, K.D. & Gual, T. (2015, June 1-5). Redefinition of alcohol addiction as heavy drinking over time:
st
Implications for brief interventions and treatment. Presentation at the 41 Annual Alcohol Epidemiology Symposium of the Kettil Bruun
Society, at Munich, Germany.
th
523. Rehm, J. (2015, May 31-June 4). Addiction, health and treatment interventions. Presentation at the 13 International Conference on
Treatment of Addictive Behaviours at Odense, Denmark.
522. Rehm, J. (2015, May 22). Alcohol-attributable burden of disease in Africa - past, current and future. Presentation at the South African
Medical Research Council at Cape Town, South Africa.
521. Rehm, J. (2015, May 14). Alcohol use disorders – why do they not get treatment and what could be done? Presentation at the Department of
Psychiatry at Toronto, Canada.
520. Schwarzinger, M., Thiébaut, S.P., Mallet, V., & Rehm, J. (2015, April 22-26). The confounding role of severe co-morbidities and alcohol use
disorders on prognosis in chronic hepatitis C virus infection: an analysis of the 2008-2012 French National Hospital Discharge Database.
th
Presentation the 50 International Liver Congress of the European Association of the Study of the Liver at Vienna, Austria.
519. Rehm, J. (2015, April 23). Baseline Alcohol Screening and Intervention Survey (BASIS) in five European countries. Project rationale and high
level project plan. Presentation at the Steering group meeting at Barcelona, Spain.
518. Rehm, J. (2015, April 21-23). Cannabis and public health, a broad overview. Presentation at WHO “Scientific Meeting on Harms to Health Due
to Cannabis Use” at Stockholm, Sweden.
- 57 –
Invited presentations as Chair:
517. Rehm, J. (2015, January 28/29; February 13; March 12; April 21). Update on Expert Roundtable project across all five countries. Presentation
at the Expert Roundtable Meeting B: Screening and intervention for harmful alcohol use as a tool to improve the management of
hypertension in primary care at Frankfurt; Germany, Barcelona, Spain; Helsinki, Finland; London, UK; Brussels, Belgium via Skype).
Invited webinar
516. Rehm J. (2015, March 18). How do we measure mental health and addictions at a population level? Webinar hosted by EE-net and the CAMH
Health Promotion Resource Centre at Toronto, Canada.
515. Rehm, J. (2015, March 10). Risk factors and public health - new approaches. Presentation at the Catalan Agency of Public Health, Barcelona,
Spain.
514. Rehm, J. (2015, March 4). Early intervention. Alcohol screening in the management of hypertension. Presentation at the Lundbeck Global
Commercial Conference at Copenhagen, Denmark.
513. Rehm, J. (2015, March 3). Impacting on the price of alcoholic beverages as a policy option. Presentation at a special meeting invited by the
Latvian Parliament on Economic and Social Justification to Limit the Availability of Alcohol, Riga, Latvia.
http://www.saeima.lv/lv/aktualitates/saeimas-zinas/23171-konference-saeima-diskute-par-alkohola-pieejamibas-ierobezosanas-politiku
512. Rehm, J. (2015, February 25). Alcohol and psychiatry. An explosive relationship? Presentation at the Sessió del Servei de Psiquiatria i
Psicologia, Barcelona, Spain.
511. Rehm, J. (2015, February 12). Evaluation of “Sober and healthier Estonia”. Presentation at the Public Health Institute of Estonia, Tallinn,
Estonia.
510. Rehm, J. (2015, February 4). Integración de la investigación científica en el trabajo en el hospital práctico. Presentation at the Hospital Clinic
Barcelona, Spain.
509. Rehm, J. (2015, February 2). What if we screened for alcohol in all new hypertensives? Presentation at the Idibaps Seminar, Barcelona, Spain.
508. Rehm, J. (2014, December 10). On the diagnosis of substance use disorders. Presentation at the session “Addiction issues: background
information and current challenges” of the European Monitoring Centre on Drugs and Drug Abuse at Lisbon, Portugal.
th
507. Rehm, J. (2014, December 9). Developments in alcohol epidemiology and their relevance for alcohol policy. Presentation at the 16 Meeting
of the OECD Health Committee on “Alcohol Policy: Addressing the Harmful Use of Alcohol” at Paris, France.
506. Rehm, J., & Roerecke, M. (2014, December 8-10). Integrated surveillance of noncommunicable diseases (iNCD) - Completeness and
availability of existing NCD data. Presentation at the WHO European Region Country Consultation on Integrated NCD surveillance at Vilnius,
Lithuania.
505. Gual, A., &Rehm, J. (2014, December 1-2). Alcohol Dependence in Primary and Specialized Care in Europe – the APC study. Presentation at
the 6th International Scientific Nalmefene Advisory Board at Frankfurt, Germany.
th
504. Rehm, J. (2014, November 27-28). Neurological and mental health and addiction aspects of alcohol. Presentation at the 6 European Alcohol
Conference at Brussels, Belgium.
503. Rehm, J. (2014, November 27-28). Why does EU need an Alcohol Strategy to help support Member States in reducing alcohol related harm?
th
Setting the scene. Presentation at the 6 European Alcohol Conference at Brussels, Belgium.
502. Rehm, J. (2014, November 26). How does consumption level affect the risk of death from alcohol? Presentation at the Joint Action on
Reducing Alcohol Related Harm (RARHA) meeting at Brussels, Belgium.
501. Rehm, J. (2014, November 25). “Heavy use over time” as definition for substance use disorders. Presentation at the paper award ceremony
of the European Monitoring Centre on Drugs and Drug Abuse at Lisbon, Portugal.
500. Rehm, J. (2014, November 15-16). The hidden side of alcohol. Presentation at the “Progress in mind: focus on alcohol use disorders”
symposium at Paris, France.
499. Gilmore, I., & Rehm, J. (2014, November 15-16). Effectiveness of public health initiatives on treatment systems. Presentation at the
“Progress in mind: focus on alcohol use disorders” symposium at Paris, France.
498. Rehm, J. (2014, November 4). How can science help set low-risk drinking guidelines in European countries? New data from 7 European
countries with diverse drinking habits and potential implications. Presentation at the European Expert Meeting within the European Union
co-funded joint action on “Reducing alcohol-related harm” at Rome, Italy.
497. Rehm, J. (2014, October 26). Rationale for alcohol screening and intervention in hypertensive patients in Finland. Presentation at the Expert
Roundtable Meeting: Screening and intervention for harmful alcohol use as a tool to improve the management of hypertension in primary
- 58 –
care at Helsinki, Finland.
Webinar
496. Rehm, J. (2014, October 7). The need for alcohol policy in the Caribbean. Presentation at the CARIBAPAN (Caribbean Alcohol Policy and
Action Network) Webinar.
495. Rehm, J. (2014, October 3). Mortality and burden of disease due to alcohol consumption in Europe and in the Netherlands. Presentation at
the Conference on Alcohol, Health and Policy at Amsterdam, The Netherlands.
494. Rehm, J. (2014, September 4). What evidence base and process is needed to improve primary care financial incentives for the management
of harmful alcohol use in patients with hypertension? Presentation at the Lundbeck meeting at Copenhagen, Denmark.
493. Rehm, J. (2014, August 27-29). Epidemiology of internet behaviour and addiction. A case study from Canada. Presentation at the WHO
Meeting on public health implications of behavioural addictions associated with excessive use of internet, computers, smart phones and
similar electronic devices at Tokyo, Japan.
492. Rehm, J. (2014, August 27-29). Public policy and health system responses to internet gambling: feasibility, effectiveness, costs
and public health benefits. A case study from Canada. Presentation at the WHO Meeting on public health implications of behavioural
addictions associated with excessive use of internet, computers, smart phones and similar electronic devices at Tokyo, Japan.
491. Rehm, J. (2014, August 25). Alcohol epidemiology in the Americas. Presentation and Webinar at the PAHO, Washington D.C., US.
490. Rehm, J. (2014, June 24-26). Addiction, heavy use, treatment and public health. Presentation at the Global Addiction 2014 conference at
Rome, Italy.
489. Anderson, P., Gual, A., & Rehm, J. (2014, June 24-26). ALICE RAP: Addiction Health Footprint as a tool for improving global health.
Presentation at the Global Addiction 2014 conference at Rome, Italy.
488. Rehm, J. (2014, June 17-19). Global perspective and lessons learnt in alcohol policy. Presentation at the CARIAD 40 specialized workshop
“Towards evidence-based alcohol policy in Trinidad & Tobago and the Caribbean” at Crowne Point, Tobago.
487. Rehm, J. (2014, June 17-19). Alcohol consumption and alcohol-attributable burden of disease in Trinidad & Tobago and the Caribbean.
Presentation at the CARIAD 40 specialized workshop “Towards evidence-based alcohol policy in Trinidad & Tobago and the Caribbean” at
Crowne Point, Tobago.
486. Rehm, J. (2014, June 17-19). Trinidad &Tobago alcohol policy implementation strategy and global knowledge base. Presentation at the
CARIAD 40 specialized workshop “Towards evidence-based alcohol policy in Trinidad & Tobago and the Caribbean” at Crowne Point, Tobago.
485. Rehm, J. (2014, June 4). Examining the international evidence base supporting alcohol identification and treatment – does this reflect the
policy reality? Presentation at the Expert Roundtable Meeting: Addressing alcohol misuse with a focus on managing comorbidities such as
hypertension in primary care at London, England.
484. Rehm, J. (2014, June 3). Rationale for alcohol screening and intervention in hypertensive patients in Germany. Presentation at the Expert
care at Frankfurt, Germany.
483. Rehm, J. (2014, June 2). Rationale for alcohol screening and intervention in hypertensive patients in Belgium. Presentation at the Expert
care at Brussels, Belgium.
482. Rehm, J. (2014, May 14). Alcohol attributable deaths in the WHO European Region. Presentation at the WHO meeting of National Focal
Points for Alcohol Policy in the WHO European Region at Geneva, Switzerland.
481. Rehm, J. (2014, May 12-14). Capacity building workshop: Monitoring and surveillance. Presentations at Second meeting of the global
network of WHO national counterparts for implementation of the Global strategy to reduce the harmful use of alcohol at Geneva,
Switzerland.
480. Rehm, J. (2014, May 8). Alcohol consumption, patterns of drinking, associated burden and the role of treatment. Presentation at the
Symposium on alcohol and harm at the Danish Embassy at Vilnius, Lithuania.
479. Rehm, J. (2014, May 7). Erfahrungen mit der Alkoholprävention in Europa: Welche Maßnahmen sind wirksam? Presentation at the 9.
Steierische (Styrian) Gesundheitskonferenz at Graz, Austria.
478. Rehm, J. (2014, May 6). Rationale for screening and intervention in hypertensive patients. Presentation at the Expert Roundtable Meeting:
Screening and intervention for harmful alcohol use as a tool to improve the management of hypertension in primary care at Barcelona, Spain.
477. Shield, K. & Rehm, J. (2014, April 9-11). Evaluating and monitoring alcohol consumption and alcohol-attributable harms in the Americas.
nd
- 59 –
Presentation at the 2 Meeting of the Pan American Network on Alcohol and Public Health (PANNAPH) at Cartagena, Colombia.
476. Rehm, J. (2014, April 9). What alcohol can do to European societies… An update 2014. Presentation at the Alcohol Prevention Day at Rome,
Italy.
475. Rehm, J. & Gual, A. (2014, March 7-8). Alcohol use disorders, burden of disease, consequences of reduction and prevalence in primary health
care. Presentation at the Symposium “The future of addiction research revisited” at Mannheim, Germany.
Invited poster:
474. Rehm, J. for CRISM Ontario (2014, March 6-7). Canadian Research Initiative in Substance Misuse (CRISM) – Ontario-based team for
intervention research in substance misuse. Presentation at the CIHR CRISM workshop at Ottawa, Canada.
473. Rehm, J. (2013, February 12). ADELPHI – what can be done if the true Audit scores are underestimated? Presentation at Lundbeck,
Copenhagen, Denmark.
472. Rehm, J. (2013, February 12). APC Study – First overview for Lancet submission? Presentation at Lundbeck, Copenhagen, Denmark.
th
471. Rehm, J. (2013, November 21). The burden of alcohol-related health harm. Presentation at 13 plenary meeting of the European Alcohol and
Health Forum at Brussels, Belgium.
470. Rehm, J. (2013, November 18-19). Alcohol Treatment. Why is Treatment for Alcohol Dependence so Important? Presentation at the
Norwegian Alkoholkonferansen (national alcohol conference) 2013 at Oslo, Norway.
469. Rehm, J. (2013, November 18-19). Alcohol dependence treatment: comparative approaches. Presentation at the Norwegian
Alkoholkonferansen (national alcohol conference) 2013 at Oslo, Norway.
468. Rehm, J. (2013, November 15). Alcohol and cancer - The global picture: from epidemiological results to action. Presentation at Toronto
Cancer Prevention Coalition meeting on “Cancer and alcohol: myths, evidence, action and precautionary policies” at Toronto, Canada.
467. Rehm, J. (2013, November 12). Reframing addictions: heavy use over time. Presentation at ALICE RAP EU Policy Seminar at Brussels, Belgium.
466. Rehm, J. (2013, November 12). Social costs of addiction. Presentation at ALICE RAP EU Policy Seminar at Brussels, Belgium.
465. Rehm, J., & Gual, A. (2013, November 7-8). Alcohol treatment policy and the AMPHORA project. Presentation at Annual SSA Symposium at
York, UK (via Skype).
464. Rehm, J. (2013, November 4-5). Alcohol dependence treatment guidelines and practice in Europe. Presentation at the Nalmefene
International Advisory Board Meeting at Lisbon, Portugal.
463. Rehm, J. (2013, October 31). Alcohol consumption and public health. Presentation at the Catholic University of Korea at Seoul, Korea.
462. Rehm, J. (2013, October 29-31). Alcohol as a risk factor for NCD and other health harm. Presentation at the Global Health Conference at
Seoul, Korea.
461. Rehm, J. & Shield, K. (2013, October 12-13). Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe. Presentation at the
Nordic-Baltic Alcohol and Drug Policy Network (NordAN) conference at Tallinn, Estonia (via Skype).
th
460. Rehm, J. (2013, October 5-9). Why we need to prioritize addiction treatments. Presentation at the educational update session of the 26
European College of Neuropsychopharmacology Congress at Barcelona, Spain.
459. Rehm, J. (2013, September 9-10). Can economic research make a difference? The example of alcohol treatment. Presentation at the
International Conference on `Future challenges for addiction research at Zurich`, Switzerland.
458. Rehm, J. (2013, September 8-11). Treatment decreases mortality in alcohol dependent patients. Presentation at the 14. Congress of the
European Society for Biomedical Research on Alcoholism at Warsaw, Poland.
457. Rehm, J. (2013, June 13). Alcohol in the European Union – consumption and attributable mortality. Presentation at the European Day of the
8th Global Conference on Health Promotion at Helsinki, Finland.
456. Rehm, J. (2013, June 6-7). Alcohol dependence treatment guidelines and practice in Europe. Presentation at the 7e Edition de l’ALBATROS,
Congrès International d’Addictologie at Paris, France.
455. Rehm, J. (2013, June 6-7). Nouvelles données épidemiologiques des dommages liées à l’alcool. Presentation at the 7e Edition de l’ALBATROS,
Congrès International d’Addictologie at Paris, France.
454. Parry, C., Shield, K., & Rehm, J. (2013, June 3-7). The global burden of alcohol: estimates of the Global Burden of Disease 2010 Study,
th
shortcomings and future steps to improve these estimates. Presented at the 39 Annual Alcohol Epidemiology Symposium of the Kettil Bruun
- 60 –
Society, at Kampala, Uganda.
453. Rehm, J. (2013, May 25). Friendly fool or pitiful pal? New data on the burden of alcohol consumption and dependence in Europe.
Presentation at the 1. National Symposium on Addiction at Brussels, Belgium.
452. Rehm, J. (2013, May 7-10). Impact of alcohol on society -alcohol dependence and mortality. Presentation at the Global Addiction and
Europad Joint Conference 2013 at Pisa, Italy.
451. Rehm, J. & Shield, K.D. (2013, April 26-27). Alcohol in the European Union – consumption and harm. Presentation at the Global Alcohol Policy
Symposium at Istanbul, Turkey.
450. Rehm, J. (2013, April 25). Alcohol in the European Union – consumption and harm. Discussion on alcohol consumption data. Presentation at
the WHO meeting of National Focal Points for Alcohol Policy in the WHO European Region at Istanbul, Turkey.
rd
449. Rehm, J. (2013, April 23-25). Reframing addictions: Heavy use over time. Presentation at the 3 Plenary Meeting of Alice Rap at Barcelona,
Spain
448. Rehm, J. (2013, April 3-5). Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.
Presentation at the Alcohol Policy 16 Conference at Washington, US.
447. Rehm, J. & Ezzati, M. (2013, March 18-20). Estimates of alcohol-attributable disease burden generated in the GBD 2010 project. Presentation
at the WHO Meeting of the Technical Advisory Group on Alcohol Epidemiology at Geneva, Switzerland.
446. Rehm, J. & Borges, G. (2013, March 18-20). Estimates of disease burden attributable to alcohol use disorders. Presentation at the WHO
Meeting of the Technical Advisory Group on Alcohol Epidemiology at Geneva, Switzerland.
445. Rehm, J. & Parry, C. (2013, March 18-20). Implications of recent developments in estimation of alcohol-attributable burden for WHO
activities related to monitoring alcohol consumption and alcohol-related harm. Presentation at the WHO Meeting of the Technical Advisory
Group on Alcohol Epidemiology at Geneva, Switzerland.
444. Rehm, J. (2013, March 10-11). Burden and cost of alcohol, tobacco and illegal drugs addictions in Europe. Presentation at the European
College of Neuropsychopharmacology Consultation Meeting at Nice, France.
443. Rehm, J. (2013, March 8). The global burden of alcohol-attributable disease including harm to others. Presentation at the First National
Roundtable on Girls, Women and Alcohol at Toronto, Canada.
442. Rehm, J. (2013, February 27-28). Vergessene Mehrheit – Suchtbehandlung im Krankenhaus als „Sekundärbelastung“ - Was ist das Problem?
Presentation at the 7th Rhein-Main Zukunftskongress Krankenhaus und Partner at Offenbach, Germany.
441. Rehm, J. (2013, February 21). Prescription opioid abuse and dependence - Lessons from a new form of drug addiction. The Twenty First
Thomas James Okey Lecture at the Institute of Psychiatry at London, UK.
440. Shield, K.D., & Rehm, J. (2013, February 14-15). Revisiting alcohol-attributable problems. Presentation at 7th National Alcohol Conference at
Bangkok, Thailand.
439. Rehm, J. (2013, February 11-12). Taxation of alcoholic beverages from a public health perspective. Presentation at ThaiHealth-WHO editorial
board meeting for the development of a WHO resource tool on alcohol pricing and taxation policies at Bangkok, Thailand.
438. Popova S., with help of Rehm, J., Lange, S., & Shield, K. (2013, February 1). Overview of trends in epidemiology of substance use (alcohol) and
its consequences in pregnancy. Presented at WHO meeting on “Developing Guidelines on the Identification and Management of Psychoactive
Substance Use and Abuse Disorders in Pregnancy”, PAHO/AMRO, WHO Regional Office for the Americas, Washington D.C., USA.
437. Rehm, J. (2013, January 29-February 1). Alcohol policy – international and national. Presentation at the CIHR Strategic Training Program in
Public Health Policy at the University Club, Toronto, Canada.
436. LeCavalier, J. & Rehm, J. (2012, January 30). The economic costs of substance use and abuse and potential collaborations. Presentation at
CCSA at Ottawa, Canada.
Invited workshop:
435. Rehm, J. & Frick, U. (2013, January 26). Alkoholprobleme in der allgemeinmedizinischen Versorgung. Trainingsprogramm für Früherkennung
und Kurzintervention. Workshop for primary care physicians, organized with the Carinthian Phycians’ Chamber at Klagenfurt, Austria.
Invited workshop:
435. Kraus, L. & Rehm, J. (2013, January 24). Machbarkeitsstudie Alkoholmonitor Deutschland. Alkoholkonsum, negative Folgen, Kosten,
Behandlung und Prävention. Presentation at the German Ministry of Health at Berlin, Germany.
434. Rehm, J. (2012, December 5-6). Update on EU projects and on-going WHO initiatives. Presentation at the Nalmefene International Advisory
Board Meeting at Brussels, Belgium.
- 61 –
433. Rehm, J. (2012, November 29). Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.
Presentation at the Symposium at the INSERM Workshop Alcohol at Paris, France.
432. Rehm, J. (2012, November 22). Nüchtern betrachtet: Wie groß ist die Krankheitslast und was kann man dagegen tun?. Presentation at the
Symposium at the DGPPN Kongress „Einstieg in den Ausstieg: Neue Strategien zur Behandlung von Alkoholabhängigkeit“ at Berlin, Germany.
431. Rehm, J. (2012, November 16). Friendly fool or pitiful pal? New data on the burden of alcohol consumption and dependence in Europe.
Presentation at the International Expert Meeting on Alcohol Dependence at Amsterdam, the Netherlands.
430. Rehm, J. (2012, November 8). The burden of alcohol consumption and the role of dependence: implications for the treatment system.
Presentation at the at conference “Addiction - a different brain, a different way of life” at Tallinn, Estonia.
429. Rehm, J. (2012, November 7). The burden of alcohol consumption and the role of dependence – with special reference to EU and Estonia.
th
Presentation at the 4 Alcohol Conference of the National Institute for Health Development at Tallinn, Estonia.
427. Rehm, J. (2012, October 22). What do we know and where should we go? Presentation at the MRC meeting on Priorities and Opportunities
in Research into Alcohol Misuse at London, UK.
426. Rehm, J. (2012, October 18-19). Monitoring and population health impact of alcohol – what have we learned from AMPHORA? Presentation
at European Debate on Evidence-based Alcohol Policy at Stockholm, Sweden.
425. Rehm, J. (2012, October 15-18). Improving treatment of alcohol use disorders: major challenges, new objectives and the role of
th
pharmacological treatment. Presentation at the 14 conference of the International Society for Addiction Medicine at Geneva, Switzerland.
424. Rehm, J. (2012, October 15-18). Concept of addiction from epidemiological, cultural and legal perspectives. The ALICE RAP study.
th
Presentation at the 14 conference of the International Society for Addiction Medicine at Geneva, Switzerland.
423. Lange, S., Rehm, J., Shield, K. & Popova, S. (2012, September 21-23). The prevalence of children with Fetal Alcohol Spectrum Disorder and
prenatal alcohol exposure in various child care systems: An international review. Poster at the Third Annual Brain Development Conference,
at Toronto, Canada.
422. Rehm, J. (2012, September 22). Current Perspective in Management of Patients with Alcohol Dependence in Canada. Presentation at the
Consultant Meeting on Alcohol Dependence Treatment in Canada, at Toronto, Canada.
421. Rehm, J., Roerecke, M., & Gmel, G. (2012, September 17). Mortality consequences of nalmefene vs. placebo as medications for alcohol
dependence. Presentation at Lundbeck, Copenhagen, Denmark.
420. Rehm, J. (2012, June 27). Interventions for alcohol dependence in Europe and Denmark – a missed opportunity to improve public health.
Presentation at a workshop at the Danish Parliament, Copenhagen, Denmark.
419. Rehm, J. (2012, June 26). Alkoholkonsum, Alkoholabhängigkeit und Gesundheitsschäden in Deutschland. Szenarien eines verbesserten
Zugangs zur Behandlung der Alkoholabhängigkeit. Presentation at the 2. Symposium for an improved alcohol therapy at Berlin, Germany.
418. Rehm, J. (2012, June 25). Alkoholerkrankung Erwachsener in Deutschland und Europa [Alcohol dependence in Germany and Europe] – der
Alcohol Comparator Report 2012. Presentation at the AktivA media federal conference at Berlin, Germany.
417. Rehm, J. & Gheorghe, P. (2012, June 19). The cost of food insecurity. Presentation to at the Knowledge Exchange Forum “Identifying Policy
Interventions to Reduce Household Food Insecurity” at Toronto, Canada.
416. Rehm, J. (2012, June 13). Population health impact of alcohol – what have we learned from AMPHORA? Presentation at the AMPHORA
meeting at Barcelona, Spain.
415. Rehm, J. (2012, June 11). The experimenting society – best ways to improve population health in the 21st century. Presentation at King’s
College, London, UK.
414. Popova, S., Lange, S., & Rehm, J. (2012, June 4-8). Health care burden and cost associated with Fetal Alcohol Syndrome in Canada. Paper
presented to Kettil Bruun Society (KBS) 2012 - 38th Annual Alcohol Epidemiology Symposium of the KBS in Stavanger, Norway.
413. Rehm, J. (2012, May 24). Understanding alcohol-dependent patients in primary care – a research protocol. Presentation to the APC study
group at at Tallinn, Estonia.
412. Rehm, J. (2012, May 23-24). Reduction of drinking as a goal for alcohol dependence treatment. Presentation at the Nalmefene Medical
Board Meeting at Tallinn, Estonia.
411. Lange, S., Rehm, J. Bekmuradov, D., Mihic, A., & Popova, S. (2012, May 13-14). Risk of incarceration for individuals with prenatal alcohol
exposure. Poster presented to the Canadian Society for Epidemiology and Biostatistics (CSEB) 2012 National Student Conference in
- 62 –
Saskatoon, Saskatchewan Canada.
The poster presentation won an award for 1st place. The abstract was selected and accepted for publication in the American Journal of
Epidemiology
410. Rehm, J. (2012, May 10). Interventions for alcohol dependence in Europe: A missed opportunity to improve public health. Presentation at the
launch of the report: ‘Interventions for alcohol dependence in Europe: A missed opportunity to improve public health’ at the European
Parliament at Brussels, Belgium.
409. Rehm, J. (2012, April 30). Alcohol dependence in Canada. What do we know? Where could we go? Presentation at Lundbeck Canada at
Montreal, Canada.
408. Rehm, J. (2012, April 18-19). The burden of alcohol related health harm in the EU. Presentation at the Committee on National Alcohol Policy
and Action of the European Commission, Health and Consumers Directorate General, at Luxembourg, Luxembourg.
407. Rehm, J. (2012, April 13-15). Alcohol dependence – a public health challenge. Presentation at the Lundbeck Symposium “Focus on CNS
Disorders 2012” at Dublin, Ireland.
406. Rehm, J. (2012, April 2). International comparisons on burden of mental disease. Presentation at the Ontario Public Health Convention,
session on “Burden of Mental Health and Addictions in Ontario” at Toronto, Canada.
405. Rehm, J. (2012, March 27). The societal burden of alcohol. Presentation at a WHO European Region conference on “Alcohol in the European
Union 2012” at Copenhagen, Denmark.
404. Rehm, J. (2012, March 27). Alcohol consumption, alcohol dependence, and attributable burden of disease: potential gains from effective
interventions for alcohol dependence. Presentation at a Lundbeck internal meeting, Copenhagen, Denmark.
403. Rehm, J. (2012, March 13). Economic costs and gains from alcohol in Europe. Presentation at the Lundbeck Advisory Board on Alcohol Policy
at Berlin, Germany.
402. Rehm, J. & Frick, U. (2012, February 29). La consommation d’alcool, ses mésusages et leurs conséquences dans l’UE. Presentation at the
Colloque international “Vers un plan national alcool” at Luxembourg, Luxembourg.
401. Rehm, J. (2012, February 24). Friendly fool or pitiful pal? New data on the burden of alcohol consumption and dependence in Europe.
Presentation at the International Expert Meeting on Alcohol Dependence at Copenhagen, Denmark.
400. Rehm, J. (2012, February 13-15). Global Burden of Disease, spread of alcohol and aims of alcohol policy. Presentation at the Global Alcohol
Policy Conference at Nonthaburi, Thailand.
399. Popova, S., Patra, J., & Rehm, J. (2012, February 13-15). Comparison of prevalence and incidence of fetal alcohol syndrome and fetal alcohol
spectrum disorder in different countries. Poster presented at the Global Alcohol Policy Conference at Nonthaburi, Thailand.
398. Bekmuradov, D., Rehm, J., Lange, S., & Popova, S. (2012, February 13-15). What is the economic burden of prenatal exposure to alcohol?
Presentation at the Global Alcohol Policy Conference at Nonthaburi, Thailand.
397. Rehm, J. (2012, February 13-15). Alcohol and communicable diseases: where do we stand with the evidence of a relationship? Presentation
at the Global Alcohol Policy Conference at Nonthaburi, Thailand.
396. Rehm, J. (2012, February 9-10). The outcome indicator for alcohol of the Comprehensive Global Monitoring Framework for the Prevention
and Control of NCDs. Presentation at the WHO European Region Regional Consultation on Noncommunicable Diseases Surveillance,
Monitoring and Evaluation at Oslo, Norway.
395. Rehm, J. (2012, February 5-7). WHO International Study on Alcohol, Health and Development: HIV/AIDS component. Presentation at the
Technical Consultation on Alcohol and Infectious Diseases at Cape Town, South Africa.
394. Rehm, J. (2012, January 26). An outline of Europe’s consumption of alcohol and its burden. Presentation at the Nalmefene Media Advisory
Board at London, UK.
393. Rehm, J. (2012, January 16-17). Alcohol consumption, alcohol dependence and health burden in Europe. Presentation at the Lundbeck
Advisory Board on Alcohol Policy at Bruxelles, Belgium.
392. Rehm, J. (2011, December 5-7). Alcohol dependence: burden of disease. Presentation at the Global Addiction Conference at Lisbon, Portugal.
391. Rehm, J. (2011, November 23). Roundtable discussion: Integrated approach to addressing hazardous and harmful alcohol consumption at
Bruxelles, Belgium.
390. Rehm, J. (2011, September 3-7). The burden of disorders of the brain – 2030 projections have become reality! Presentation at the 24th
European College of Neuropsychopharmacology at Paris, France.
- 63 –
389. Rehm, J. & Frick, U. (2011, August 18 – September 3). Disability Adjusted Life Years (DALYs): adaption of disability weights for the US and
opportunities for Austria. Presentation at European Forum Alpbach 2011 “Justice – Responsibility for the Future” at Alpbach, Austria.
388. Rehm, J. (2011, June 14-16). Alcohol epidemiology and alcohol-attributable burden - Relationship between alcohol consumption and major
nd
health conditions. Presentation at the 2 International Conderence Global Health & Preventive Medicine at Heidelberg, Germany.
387. Rehm, J. (2011, June 6-8). Sustainability of therapeutic success of addiction treatment from an economic perspective [Nachhaltigkeit der
Suchtbehandlung unter gesundheitsökonomischen Aspekten]. Presentation at the 24. Kongress des Fachverbandes Sucht at Heidelberg,
Germany.
386. Rehm, J. (2011, May 23-27). Classifying, counting and costing addictions. Presentation at the Kickoff Meeting of Addictions in
Comptemporary Europe – Reframing Addictions Project at Barcelona, Spain.
385. Rehm, J. (2011, May 23-27). Methodological questions in assessing prevalence of addiction in Europe. Presentation at the Kickoff Meeting of
Addictions in Comptemporary Europe – Reframing Addictions Project at Barcelona, Spain.
384. Anderson, P., & Rehm, J. (2011, May 3-5). Alcohol-attributable burden of disease in Europe. Presentation at the WHO meeting of National
Counterparts for Alcohol Policy in the WHO European Region and the AMPHORA Expert meeting at Zurich, Switzerland.
Webinar
383. Rehm, J. (May 2, 2011). Epidemiology of alcohol and burden of disease related to non-communicable diseases in the Americas. Presentation
at PAHO Webinar on "Alcohol, Non-Communicable Diseases and Public Health".
382. Rehm, J. (2011, April 28-29). Harmful use of alcohol: what is the relationship with non-communicable
diseases and what can be done to reduce alcohol-related harm. Presentation at the First Global Ministerial Conference on Healthy Lifestyles
and Noncommunicable Disease Control at Moscow, Russia.
381. Kehoe, T., Shield, K., Gmel, G., & Rehm, J. (2011, April 11-15). Modelling alcohol consumption as a distribution and determining the impact of
the distribution on estimated alcohol-attributable harms. Paper presented at the 37th Annual Alcohol Epidemiology Symposium of the Kettil
Bruun Society at Melbourne, Australia.
380. Popova, S., Lange, S., Mihic, A., Bekmuradov, D., & Rehm, J. (2011, April 11-15). Fetal Alcohol Spectrum Disorder prevalence estimates in
correctional systems: a systematic literature review. Paper resented at the 37th Annual Alcohol Epidemiology Symposium of the Kettil Bruun
Society at Melbourne, Australia.
379. Kehoe, T., Shield, K., Gmel, G., & Rehm, J. (2011, April 11-15). Modelling alcohol consumption as a distribution and determining the impact of
the distribution on estimated alcohol-attributable harms. ? Paper presented at the 37th Annual Alcohol Epidemiology Symposium of the
Kettil Bruun Society at Melbourne, Australia.
378. Rehm, J., Shield, K., & Shuper, P. (2011, April 11-15). Is alcohol causally related to HIV incidence? Paper presented at the 37th Annual Alcohol
Epidemiology Symposium of the Kettil Bruun Society at Melbourne, Australia.
377. Rehm, J. (2011, March 21). Mental health, alcohol and illegal drug policy: strengthening integrated care in the Americas. Presentation at the
Symposium on Strengthening Mental Health Plans and Services in the Americas at Toronto, Canada.
376. Rehm, J., for Sornpaisarn, B., Shield, K., & Rehm, J. (2011, March 16-17). Policies to favor low alcohol content are not always desirable.
Presentation at the meeting “Policies Favouring Lower Alcohol Content Beverages” at Copenhagen, Denmark.
375. Popova, S., Lange, S., Bekmuradov, D., Stade B., MacKay, H., Johnston, M., & Rehm, J. (2011, March 2-5). Economic impact of Fetal Alcohol
Spectrum Disorder in Canada (FASD): Putting the pieces together. Abstract presented at the 4th International Conference on Fetal Alcohol
Spectrum Disorder, Vancouver, BC, Canada.
nd
374. Rehm, J. (2010, December 1-2). Economia del Alcohol come problema de Salud Publica. Presentation at the 2 Seminario Internacional
sobre Politicas de Alcohol at Santiago, Chile.
nd
373. Rehm, J. (2010, December 1-2). Estudios Nacionales de Costos Evitables: El caso de Canada. Presentation at the 2 Seminario Internacional
sobre Politicas de Alcohol at Santiago, Chile.
372. Rehm, J. (2010, November 15-16). Alcohol consumption, alcohol use disorders and attributable burden of disease: epidemiological
considerations. Presentation at the National Congress on Alcohol Research (Congresso Nacional de Alcoologia) at Lisbon, Portugal.
371. Rehm, J. (2010, November 14). Alcohol policy in a global perspective. Presentation at the Lisbon Unit for Alcoholism at Lisbon, Portugal.
st
370. Rehm, J. (2010, November 11-15). Alcohol use and TB: is there a causal connection? Presentation at the 41 Union World Conference on
Lung Health: Tuberculosis, HIV and lung health: from research and innovation to solutions at Berlin, Germany.
369. Rehm, J. (2010, November 6-10). New evidence on burden of disease from alcohol and epidemiological support for the WHO's Global Alcohol
Strategy. Presentation at 138th Meeting of the American Public Health Association at Denver, Co, USA.
368. Popova, S., Patra, J., & Rehm, J. (2010, November 3-5). Prevalence of fetal alcohol syndrome in the Global Burden of Disease region. Poster
st
presented at 1 European Conference on FASD at Kerkrade, the Netherlands.
367. Popova, S. & Rehm, J. (2010, November 2-3). The international collaborative research project: Determining the prevalence and incidence of
Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Spectrum Disorder (FASD) in the selected countries. Proposal presented to the World Health
- 64 –
Organization Meeting for the Project on Alcohol, Health and Development. Rolduc, Kerkrade, the Netherlands.
366. Rehm, J. (2010, October 19-20). Environmental and cultural influences: measuring intake pattern by country/venue. Presentation at the
NIAAA Center Directors’ Meeting at Berkeley, California, USA.
365. Shuper, P., Joharchi, N., Irving, H., Fletcher, D., Kovacs, C., Loutfy, M., Walmsley, S., Wong, D., & Rehm., J. (2010, July 18-23). Predictors of
suboptimal adherence to antiretroviral therapy among HIV monoinfected versus HIV/HCV coinfected individuals. Paper presented at the XVIII
International AIDS Conference, Vienna, Austria.
364. Rehm, J. (2010, May 31-June 4). Do surveys in alcohol epidemiology still make sense? Or: the role of alcohol surveys in the future! Paper
presented at the 36th Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Lausanne, Switzerland.
363. Shield, K., & Rehm, J. (2010, May 31-June 4). Measuring alcohol consumption in the Canadian Alcohol and Drug Use Monitoring Survey
(CADUMS). Paper presented at the 36th Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Lausanne, Switzerland.
362. Popova, S., Stade, B., & Rehm, J. (2010, May 31-June 4). Methodology for estimating the economic impact of Fetal Alcohol Spectrum
Disorder. Paper presented at the 36th Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Lausanne, Switzerland.
361. Bekmuradov, D., Rehm, J., Stade, B., & Popova, S. (2010, May 31-June 4). Limitations of existing studies estimating cost of Fetal Alcohol
Spectrum Disorder. Paper presented at the 36th Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Lausanne,
Switzerland.
360. Rehm, J. (2010, May 6-7). Estimation of prevalence of opioid addiction for the EU. Presentation at the “Cost of Disorders of the Brain in
Europe 2010” meeting at Nice, France.
359. Rehm, J., Patra, J., & Popova, L. (2010, May 6-7). Estimation of prevalence of alcohol addiction globally and for the EU: a systematic literature
review. Presentation at the “Cost of Disorders of the Brain in Europe 2010” meeting at Nice, France.
358. Rehm, J. (2010, April 29). The global health, social and economic impact of alcohol consumption. Presentation at the Italian Alcohol
Prevention Day 2010 at Rome, Italy.
th
357. Rehm, J. (2010, April 26). Einführung in die Suchtprävention: Was wirkt?. Presentation at the 9 Bayerischem Suchtforum at München,
Germany.
356. Rehm, J. (2010, April 22). Alcohol consumption: epidemiology and policy implications. Presentation at the Community Forum Owen Sound,
Canada.
355. Fischer, B., & Rehm, J. (2010, February 22). Scientific conclusions of Drug Policy and the Public Good. Presentation at the book launch of
Babor et al., Drug Policy and the Public Good at Toronto, Canada.
354. Rehm, J. (2010, February 10). How to best derive summary measures of health? Presentation at the Duke-National University of Singapore
Seminar at Singapore, Singapore.
353. Rehm, J. (2009, November 9-10). Indicators for alcohol consumption and attributable health harm. Presentation at the AMPHORA work
package leaders meeting at Barcelona, Spain.
352. Rehm, J. (2009, October 19-21). Indicators for alcohol-attributable health harm. Presentation at the World Health Organization “Meeting on
indicators for monitoring alcohol, drugs and other psychoactive substance use consumption, substance-attributable harm and societal
responses” at Valencia, Spain.
351. Popova, S., Stade, B., Bekmuradov, D., & Rehm, J. (2009, October 11-16). Economic impact of Fetal Alcohol Syndrome and Fetal Alcohol
Spectrum Disorders. A systematic literature review. Presented at the 52nd International Council on Alcohol and Addictions (ICAA)
Conference, Estoril, Portugal.
350. Paglia-Boak, A., Ialomiteanu, A., Mann, R.E., Adlaf, E., & Rehm, J. (2009, October 8). Self-Reported substance use, mental and physical health
indicators among the Ontario population by Local Health Integration. Poster and presentation at the 2009 Health Research Showcase:
Ministry of Health and Long-Term Care, Toronto, Canada.
349. Patra, J., Popova, S. & Rehm, J. (2009, October 8). Street prescription opioid abuse in Ontario: implications for interventions. Poster and
presentation at the 2009 Health Research Showcase: Ministry of Health and Long-Term Care, Toronto, Canada.
348. Rehm, J., Popova, S., Patra, J., Gnam, W.H., & Sarnocinska-Hart, A. (2009, October 8). Avoidable cost of alcohol abuse in Canada 2002. Poster
and presentation at the 2009 Health Research Showcase: Ministry of Health and Long-Term Care, Toronto, Canada.
347. Rehm, J. (2009, October 2). Alcohol, alcohol use disorders and burden of disease. Presentation at the Center for Alcohol and Addiction
Studies, Brown University at Alcohol Providence, RI, USA.
346. Popova, S. & Rehm, J. (2009, September 24-25). WHO International Study on Alcohol, Health and Development: FASD component.
Presentation at WHO meeting on alcohol, health and development: agenda for international research at Stockholm, Sweden.
- 65 –
345. Rehm, J. (2009, September 24-25). WHO International Study on Alcohol, Health and Development: HIV component. Presentation at WHO
meeting on alcohol, health and development: agenda for international research at Stockholm, Sweden.
344. Rehm, J. (2009, September 22-23). Alcohol and Global Burden of Disease and Injury – focusing on infectious diseases. Presentation at the
Global Expert Meeting on Alcohol, Health and Social Development at Stockholm, Sweden.
343. Rehm, J. & Patra, J. (2009, September 21-22). Alcohol and Burden of Disease and Injury in the WHO European Region. Presentation at the
Expert Conference on Alcohol and Health at Stockholm, Sweden.
342. Rehm, J. (2009, September 18). Methodological basis for determining risk relations for alcohol. Presentation at the Drinking Guidelines
Expert Advisory Panel Meeting of the National Alcohol Strategy Advisory Committee at Ottawa, Canada.
341. Rehm, J. (2009, September 2). Calculation of alcohol-attributable deaths and burden of disease. Presentation at the European Commission
“Committee on Data Collection, Indicators and Definitions” at Luxembourg.
340. Rehm, J. (2009, July 13-15). Methodological problems in estimating total per capita consumption. Presentation at WHO Steering Committee
Meeting for the Global Information System on Alcohol and Health at Geneva, Switzerland.
339. Rehm, J. (2009, June 29). National and international policy trends in the Americas, Caribbean, and in the world. Presentation at the
International Research Capacity-Building Program for Health and Related Professionals to Study Drug Issues in Latin America and
theCaribbean at Toronto, Canada.
nd
338. Rehm, J. (2009, June 20-24). Alcohol, alcohol use disorders and burden of disease. 1st Annual Ting-Kai Li Plenary Lecture at the 32 Annunal
Research Society on Alcohoholism Scientific Conference at San Diego, USA.
337. Rehm, J. (2009, May 6-8). Making connections — the questions we have to answer. Presentation at the conference on the occasion of the
15. anniversary of the European Monitoring Centre for Drugs and Drug Addiction “Identifying Europe’s information needs for effective drug
policy” at Lisbon, Portugal.
336. Popova, S., Patra, J., & Rehm J. (2009, April 27-30). Cost-effectiveness of different intervention strategies in reducing tobacco-attributable
morbidity in Canada. Joint Conference of the Society for Research on Nicotine and Tobacco (SRNT) and the SRNT-Europe. Dublin, Ireland.
335. Rehm, J., Mann, R., & Patra, J. (2010, April 21). Alcohol and disability with special consideration of traffic injury –
analysis, evaluation and consequences. Presentation at the Italian Alcohol Prevention Day 2009 at Rome, Italy.
334. Lachenmeier, D.W., Kanteres, F., & Rehm, J. (2009, February 12-13). Acetaldehyde: an underrated lifestyle and nutritional cancer risk factor.
Presentation at 46. Wissenschaftlicher Kongress der Deutschen Gesellschaft für Ernährung, at Giessen, Germany.
333. Rehm, J. (2009, February 4). The Disease Burden of Mental and Substance Use Disorders. Presentation at the Bühler-Kolloquium at Dresden,
Germany.
332. Rehm, J., Chisholm, D., Godfrey, C., & Scafato, E. (2009, January 15-16). Integrated alcohol policy making: the need for standardized
indicators. Presentation at the AMPHORA kick-off meeting at Baralona, Spain.
th
331. Rehm, J. (2008, November 17-18). Problem drug use – conceptual and methodical considerations. Presentation at the 29 Meeting of the
European Monitoring Centre for Drugs and Drug Addiction at Lisbon, Portugal.
330. Rehm, J. & Room, R. (2008, November 13-14). The Global Burden of Alcohol Misuse: New Epidemiological Data. Presentation at the 2008 SSA
Annual Conference at York, UK.
329. Rehm, J. (2008, November 13). Drug policy update. Presentation at the CAMH Board of Directors at Toronto, Canada.
328. Rehm, J. (2008, November 6-7). Learning from an international experience: finding best estimates of risk for chronic diseases and alcohol
consumption. Presentation at the 2008 Consensus Conference: Toward an Inventory of Chronic Disease Risk Factors at Ottawa, Canada.
327. Rehm, J. (2008, October 25-29). Increase in consumption, increase in problems. Presentation at 136th Meeting of the American Public Health
Association at San Diego, CA, USA.
326. Rehm, J. (2008, October 7-8). Estimating attributable fractions. Presentation at the workshop of WP3 "Impact of alcohol consumption on
patterns of chronic disease incidence in Europe" of the European Prospective Investigation into Cancer and Nutrition (EPIC) at Potsdam,
Germany.
325. Rehm, J., Frick, U., & Irving, H. (2008, September 25). Estimating Disability Weights for a U.S. Burden of Disease Study. Presentation at the
Lawton Chiles International House on the National Institutes of Health Campus, sponsored by the National Institute on Alcohol Abuse and
Alcoholism and the John E. Fogarty International Center for Advanced Study in the Health Sciences at Bethesda, US.
324. Rehm, J., with assistance of Taylor, B. & Popova, S. (2008, June 15-18). Alcohol and infectious diseases – causal considerations. Presentation
- 66 –
at the MRC/WHO/CDC Technical Meeting on alcohol and infectious diseases at Cape Town, South Africa.
323. Rehm & Lönnroth, K., with assistance of Patra, J. (2008, June 15-18). Resumé: is alcohol consumption causally linked to active tuberculosis
and can we estimate alcohol-attributable fractions? Presentation at the MRC/WHO/CDC Technical Meeting on alcohol and infectious
diseases at Cape Town, South Africa.
322. Baliunas, D., in collaboration with Rehm, J. (2008, June 15-18). An attempt to conduct a meta-analysis on alcohol and the risk of HIV.
Presentation at the MRC/WHO/CDC Technical Meeting on alcohol and infectious diseases at Cape Town, South Africa.
321. Rehm & Baliunas, D. (2008, June 15-18). Resumé: Is alcohol consumption causally linked to HIV infection? Presentation at the
MRC/WHO/CDC Technical Meeting on alcohol and infectious diseases at Cape Town, South Africa.
320. Rehm, J. & Lachenmeier, D. (2008, June 27 – July 2). Composition of alcohol from markets in different countries. Presentation at the 2008
Joint Scientific Meeting of the Research Society on Alcoholisms and the International Society for Biomedical Research on Alcoholism at
Washington, USA.
319. Behrendt, S., Wittchen, H.-U., Höfler, M., Lieb, R., Low, N.C.P., Rehm, J. & Beesdo, K. (2008, June 27 – July 2). The risk and consequences of
tolerance as first alcohol dependence symptom in adolescence: results from a prospective longitudinal community study. Poster at the 2008
Joint Scientific Meeting of the Research Society on Alcoholisms and the International Society for Biomedical Research on Alcoholism at
Washington, USA.
318. Greenfield, T.K., Lapp, W., Bond, J., Kerr, W., Kaskutas, L.A., & Rehm, J. & Beesdo, K. (2008, June 27 – July 2). Ethanol in beer, wine and spirits
drinks in a 28-day prospective diaries: physiological validity and implications for measurement. Poster at the 2008 Joint Scientific Meeting of
the Research Society on Alcoholisms and the International Society for Biomedical Research on Alcoholism at Washington, USA.
317. Rehm, J., Mohapatra, S., Popova, S., Patra, J., & Duhig, A. (2008, June 27 – July 2). Economic costs of heavy drinking and alcohol dependence
in major market economies. Poster at the 2008 Joint Scientific Meeting of the Research Society on Alcoholisms and the International Society
for Biomedical Research on Alcoholism at Washington, USA.
316. Rehm, J. & Scafato, E. (2008, June 17-18). European framework for evaluating the effectiveness and cost-effectiveness of integrated
population based measures. Presentation at the Alcohol Measures for Public Health Research Alliance (AMPHORA) work package leaders
meeting at Barcelona, Spain.
315. Patra, J., Rehm, J., Fischer, B., Popova, S., & Mohapatra, S. (2008, June 14-19). The prevalence of the non-medical prescription opioids and
th
illegal opioids use in Canada. Presentation at the 70 Annual Meeting of College on Problems of Drug Dependence in San Juan, Puerto Rico.
314. Greenfield, T.K., Bond, J., Ye, Y., Lapp, B., Nayak, M., Kairouz, S., Rehm, J., Monteiro, M., Obot, I.S., Plant, M., Rahav, G., Kuendig, H., Kuntsche,
S., Ibanga, A., Allamani, A., Vidal, A., Wilsnack, S., & Ahlstrom, S. (2008, June 2-6). Gender differences in public and private drinking contexts:
th
A multi-level GENACIS analysis. Presentation at the 34 Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society for Social and
Epidemiological Research on Alcohol in Victoria BC, Canada.
313. Popova, S., Rehm, J., Patra, J., Gnam, W., SarnocinskaHart, A., & Mann, R. (June 2-6, 2008). Alcohol-related laws and avoidable burden and its
th
costs due to motor vehicle accidents in Canada, 2002. Presentation at the 34 Annual Alcohol Epidemiology Symposium of the Kettil Bruun
Society for Social and Epidemiological Research on Alcohol in Victoria BC, Canada.
The paper was nominated as the best among early investigators and received the Ole-Jorgen Skog Award.
312. Rehm, J. (2008, April 29). Monitoring of alcohol use and attributable harm from an international perspective. Presentation at the World
Health Organization Headquarters, Geneva, Switzerland.
311. Rehm, J. (2008, April 28). Monitoring update. Presentation at the Informal Technical Meeting on Alcohol Data at World Health Organization
Headquarters, Geneva, Switzerland.
310. Rehm, J. (2008, April 8). From science to recommendations: how to construct scientifically based low risk drinking guidelines. Presentation at
the University of California, Berkeley, School of Public Health, Advanced Alcohol Research Seminar, Berkeley, CA, USA.
309. Rehm, J. (2008, April 1 and April 3). Background on valuation of disease states. Presentation at the National Institute of Health DALY
workshops at Rockville, MD, USA.
308. Rehm, J. & Mohapatra, S. (2008, March 11). The economic impact of alcohol dependence and the potential for interventions: literature
review and proposal for a new study. Presentation at Eli Lilly Corporate Center at Indianapolis, IN, USA.
307. Popova, L., Rehm, J., Patra, J., & Baliunas, D. (2008, February 26-27). Avoidable mortality due to shifting the smoking distribution: the
example of Canada. Poster at the 4th Annual Symposium for Research to Inform Tobacco Control 2008 at Portland, OR, USA.
306. Rehm, J. (2008, February 19-20). Monitoring global alcohol consumption – Data sources and methods. Presentation at the World Health
Organization Open Informal Meeting on Alcohol Production and Distribution Data at Geneva, Switzerland.
305. Rehm, J. (2008, February 15). Valuation of disease states. Presentation at the National Institute for Alcohol Abuse and Alcoholism Disability
Weighting Workshop at Rockville, MD, USA.
- 67 –
304. Frick, U. & Rehm, J. (2008, February 15). People vs. Time. Some implications of TTO and PTO preference measurement. Presentation at the
National Institute for Alcohol Abuse and Alcoholism Disability Weighting Workshop at Rockville, MD, USA.
303. Rehm, J. (2007, November 24-25). Alcohol and injury – studies in the emergency room. Presentation at the Institute for Nutritional Sciences,
Chinese Academy of Sciences at Shanghai, P.R. China.
rd
302. Rehm, J. (2007, November 21-22). Alcohol, No Ordinary Commodity: Global Perspectives. Presentation at the 3 National Conference on
Alcohol at Bangkok, Thailand.
301. Rehm, J. (2007, November 15). The impact of alcohol on health. Presentation at the Alcohol Programme 2004-2007 Seminar by the Finnish
Ministry for Social Affairs and Health at Helsinki, Finland.
300. Rehm, J. (2007, November 13). The burden by alcohol. Presentation at the European Alcohol Conference on “Reducing the harm caused by
alcohol: a coordinated European response” by the Royal College of Pysicians at London, UK.
299. Rehm, J. (2007, November 12). Alcohol and health – the impact of per capita consumption, patterns of drinking, drinking frequency and
motives. Presented at the DHS annual meeting at Mannheim, Germany.
298. Rehm, J., Patra, J. & Popova (2007, October 31). The burden of cancer attributable to alcohol drinking in Canada 2002. Presented at the
CAMH and Toronto Cancer Prevention Coalition Seminar on “Alcohol, Cancer and Public Policy” at Toronto, Canada.
297. Rehm, J. (2007 October 23). Alcohol in Europe. Presentation at the Final Conference "The Evolution of Health Following Enlargement – HEM
Closing the Gap" at Brussels, Belgium.
296. Rehm, J. (2007, October 18-19). Estimating alcohol-attributable consequences – methodological considerations and implications. Presented
at the ICAP Advisory Group Meeting on “Measuring psychosocial benefits of drinking and other health-related behavior” at Paris, France.
295. Fischer, B., Patra, J. & Rehm, J. (2007, October 11). Exploring poly-substance use typologies in a cohort of illicit opioid and other drug users
(OPICAN): A latent class analysis. Presented at the Canadian Society of Addiction Medicine (CSAM) Annual Scientific Meeting 2007 at Ottawa,
Canada.
294. Rehm, J. & Patra, J. (2007, September 16). Alcohol exposure and premature mortality in Europe. Global burden of disease and levels of
damage and costs from alcohol in Canada -- new data re alcohol and cancer. Presented at a Pre-Conference Workshop to the Canadian Public
Health Association Meeting at Ottawa, Canada.
293. Rehm, J. (2007, July 2-3). Alcohol exposure and premature mortality in Europe. Presentation at the Investigator’s meeting of the project
HEM - Closing the Gap - Reducing Premature Mortality. Baseline for Monitoring Health Evolution Following Enlargement at Warsaw, Poland.
292. Rehm, J. (2007, July 2-3). Alcohol and CVD – biological and epidemiological relations. Presentation at the Investigator’s meeting of the
project HEM - Closing the Gap - Reducing Premature Mortality. Baseline for Monitoring Health Evolution Following Enlargement at Warsaw,
Poland.
291. Rehm, J. (2007, June 24-30). Cannabis dependence - A real dependence? Presentation at the EFCAP/International Congress of Law and
Mental Health at University of Padua, Italy.
290. Giesbrecht, N., Haydon, E., Roerecke, M., Rehm, J., & Kobus-Matthews M. (2007, June 10-15). Reducing chronic disease in Canada:
Challenges, opportunities & prevention priorities. Paper presented at the 19th International Union for Health Promotion and Education
World Conference in Vancouver, B.C., Canada.
289. Zatonski, W., Sulkowska, U., Manczuk, M., Rehm, J., Boffetta P., Lowenfels A., & La Vecchia C. (2007, June 4-8). Liver cirrhosis mortality: time
trends in Europe. Paper presented at the 33rd Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Budapest, Hungary.
288. Manczuk, M., Lowenfels, A., Sulkowska, U., Rehm, J., & Zatonski W. (2007, June 4-8). Male-female differences in life expectancy: role of
alcohol. Paper presented at the 33rd Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Budapest, Hungary.
287. Rehm, J., Sulkowska, U., Manczuk, M., Boffetta, P., Powles P., Popova, S., & Zatonski W. (2007, June 4-8). Alcohol accounts for a high
proportion of premature mortality in central and eastern Europe. Paper presented at the 33rd Annual Alcohol Epidemiology Symposium of
the Kettil Bruun Society at Budapest, Hungary.
286. Room, R., Österberg, E., Ramstedt, M., & Rehm, J. (2007, June 4-8). Towards a general model for explaining stasis and change in alcohol
consumption. Paper presented at the 33rd Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Budapest, Hungary.
285. Rehm, J. (2007, May 25). Heroin-assisted substitution treatment for opioid dependence in Switzerland. Paper presented at the Hearing of
the Danish parliamentary subcommittee on Social Affairs and the subcommittee on Health considering prescribed heroin at Copenhagen,
Denmark. (www.tekno.dk for all the proceedings)
284. Rehm, J. (2007, May 24). Treatment and harm reduction monitoring tools of the European Monitoring Centre for Drugs and Drug Addiction
- 68 –
th
(EMCDDA). Paper presented at the 36 meeting of REITOX Heads of Focal Points at EMCDDA. Lisbon, Portugal.
283. Rehm, J. & Chisholm, D. (2007, May 9-10). Economic and health impact assessment. Paper presented at the Steering Committee Meeting of
the EU project “Building Capacity” at Barcelona, Spain.
282. Patra, J., Fischer, B., & Rehm, J. (2007, May 7-10). Poly-substance use typologies in a multi-site cohort of illicit opioid and other drug users in
Canada – a latent class analysis (LCA). Paper presented at the Symposium "Monitoring alcohol and other drug related harm: building systems
to support better policy" at Victoria, Canada.
281. Rehm, J. & Room, R. (2007, May 7-10). Monitoring of alcohol and illicit drug use and attributable harm from an international perspective.
Paper presented at the Symposium "Monitoring alcohol and other drug related harm: building systems to support better policy" at Victoria,
Canada.
280. Patra, J., Fischer, B., & Rehm, J. (2007, May 7-10). Poly-substance use typologies in a multi-site cohort of illicit opioid and other drug users in
Canada – a latent class analysis (LCA). Paper presented at the Symposium "Monitoring alcohol and other drug related harm: building systems
to support better policy" at Victoria, Canada.
279. Rehm, J. (2007, April 12). Estimating alcohol-attributable mortality and burden of disease for Italy – what is avoidable? Presentation at the
Italian Alcohol Prevention Day 2007 at Rome, Italy.
http://www.epicentro.iss.it/temi/alcol/adp07_slide.asp
278. Fischer, B., Kalousek, K., & Rehm, J. (2007, March 22-23). Characterizing an awakening giant: The phenomenon of prescription opioid abuse in
North America. Presentation at 1st Meeting of the International Society for the Study of Drug Policy (ISSDP at Oslo, Norway.
277. Rehm, J. (2007, March 13). Sicherstellung und Finanzierung der Substitution – eine ökonomische Betrachtung der Behandlungsform.
Presentation at the Expert Workshop of the Bavarian Academy on Addiction on Substitution Treatment for Opioid Addicts at Munich,
Germany.
276. Rehm, J. (2007, March 13). Kosten und Kosteneffektivität der Heroin-gestützten Behandlung in Deutschland. Presentation at the Expert
Workshop of the Bavarian Academy on Addiction on Substitution Treatment for Opioid Addicts at Munich, Germany.
275. Rehm, J. (2007, March 8). International perspective on alcohol and harm. Presentation at SHORE, Massey University at Auckland, New
Zealand.
274. Rehm, J. & Frick, U. (2007, January 12). Effectiveness of prescribed heroin tablets for treatment of severely addicted heroin users.
Presentation at the CAMH Addiction Program Rounds at Toronto, Canada.
273. Rehm, J. (2006, December 4). Alcohol-attributable mortality and burden of disease in Switzerland – Epidemiology and recommendations for
alcohol policy. Presentation at the Swiss Office of Public Health at Berne, Switzerland.
272. Rehm, J. (2006, November 27-28). The costs of substance abuse in Canada 2002. Presentation at the expert meeting on “Methodology and
use of cost of illness results in drugs field in the European Union” at the European Monitoring Centre for Drug and Drug Addiction (EMCDDA)
at Lisbon, Portugual.
st
271. Rehm, J. (2006, October 21-22). The global burden of disease attributable to alcohol and illicit drugs in the beginning of the 21 century.
Presentation at the Conference of the Nordic Alcohol and Drug Policy Network at Oslo, Norway.
st
270. Rehm, J. (2006, October 20). The global burden of disease attributable to alcohol and illicit drugs in the beginning of the 21 century.
Presentation at the Directorate for Health and Social Affairs at Oslo, Norway.
269. Rehm, J., Baliunas, D., & Sulkowska, U. (2006, October 16-17). Injury in Central and Eastern Europe in comparison to EU 15. Presentation at
the II. Working Meeting on adult premature mortality at Warsaw, Poland.
268. Rehm, J. (2006, October 16-17). Alcohol exposure as relevant to burden of disease in different parts of Europe. Presentation at the II.
Working Meeting on adult premature mortality at Warsaw, Poland.
267. Rehm, J. (2006, October 10-13). Public health problems related to alcohol consumption: disease burden attributable to alcohol worldwide.
Presentation at the WHO Expert Committee Meeting on Problems Related to Alcohol Consumption at Geneva, Switzerland.
266. Rehm, J. (2006, October 10-13). Alcohol availability and consumption in a global perspective (including trends). Presentation at the WHO
Expert Committee on Problems Related to Alcohol Consumption at Geneva, Switzerland.
265. Rehm, J. (2006, September 21-22). Considerations for an indicator of alcohol-attributable harm in Canada. Presentation at the meeting of
the (Canadian) Surveillance Committee at Ottawa, Canada.
264. Fischer, B., Rehm, J., & Brands, B. (September 13-15). Changing profiles of illicit opioid and other drug users: Implications for the treatment
system. Presented at the 16th International Addiction Congress “ Von Heroin-gestützter Behandlung bis zu Drogenkonsumräumen” at
- 69 –
Hamburg, Germany.
262. Rehm, J. (2006, September 14). The global burden of disease attributable to alcohol – An Update. Lunchtime seminar at the World Health
Organization Headquarters at Geneva, Switzerland.
262. Rehm, J. (2006, September 13-15). Potential composite indicators for alcohol exposure and alcohol-related harm. Presentation at the
meeting of the WHO Technical Advisory Group on Alcohol Epidemiology at Geneva, Switzerland.
261. Rehm, J. (2006, September 13-15). New estimates of alcohol-attributable burden of disease for 2002 and comparisons 2000-2005.
Presentation at the meeting of the WHO Technical Advisory Group on Alcohol Epidemiology at Geneva, Switzerland.
260. Rehm, J. (2006, September 13-15). Estimating alcohol-attributable mortality and global burden of disease – methodological considerations
and implications. Presentation at the meeting of the WHO Technical Advisory Group on Alcohol Epidemiology at Geneva, Switzerland.
259. Rehm, J. (2006, August 28). Strukturelle und gesetzliche Massnahmen der Alkoholprävention: ein Überblick. Presentation at the (Swiss)
Federal Commission for Alcohol-Related Problems at Berne, Switzerland.
258. Rehm, J. (2006, August 18). Estimating alcohol-attributable mortality and global burden of disease – methodological considerations and
implications. Presentation at the (U.S.) National Institute of Alcohol Abuse and Alcoholism, Rockville, MD.
257. Perkonigg, A., Rehm, J., & Wittchen, H.U. (2006, June 16-17). 10-years’ course of alcohol abuse and alcohol dependence from adolescence to
th
adulthood: findings on onset and stability from a prospective community study. Poster at the 68 Annual Meeting of the College on Problems
of Drug Dependence (CPDD) at Scottsdale, AZ, USA.
256. Rehm, J. (2006, June 16-17). Alcohol, alcohol-attributablye injury and other alcohol-related disease conditions. Presentation at the
Investigator’s meeting of the project HEM - Closing the Gap - Reducing Premature Mortality. Baseline for Monitoring Health Evolution
Following Enlargement at Warsaw, Poland.
255. Rehm, J. (2006, May 25 -26). Key future research questions on mediators and moderators of behaviour change processes in substance use
nd
and abuse. Presentation at the 2 Meeting of the German Addiction Research Network at Dresden, Germany.
254. Rehm, J. & Taylor, B. (2006, May 22). Volume of alcohol consumption, patterns of drinking and burden of disease globally and in the Americas
2002. Presentation at the Universidade Estadual Paulista, Campus de Botucatu, Faculdade de Medicina, Departamento de Neurologia e
Psiquiatria at Botucatu, Brazil.
253. Rehm, J., Patra, J. & Taylor, B. (2006, May 17-18). Harm, benefits, and net effects of moderate drinking in adults. Presentation at the
Symposium “Moderate consumption of alcohol: Health risks and benefits” at Harvard University, Cambridge, USA.
252. Rehm, J. (2006, May 11). The global burden of disease attributable to alcohol. Presentation to senior executives of SAB Miller at London, UK.
251. Rehm, J., Fischer, B., & Brands, B. (2006, March 23-25). Changing profiles of illicit opioid and other drug users: Implications for the role of
heroin prescription within the treatment system. Presentation at the Symposium “Heroin-assisted treatment – an innovative element of the
drug support system” at Cologne, Germany.
250. Rehm, J. (2006, March 8). The global burden of disease attributable to alcohol. Presentation at the World Health Organization Open
Consultations with Representatives of Alcohol Industry, Agricultural and Trade Sectors at Geneva, Switzerland.
249. Fischer, B., Allard, C., & Rehm, J. (2006, February 23). Cannabis use: considerations for public health policy. Presentation at the Mental
Health and Addiction Research Network of B.C. Research Colloqium: 'Cannabis Use, Mental Health and Addiction', at Vancouver, Canada.
248. Rehm, J. (2006, February 16). Preparation of a modularized research design/proposal to conduct a Canadian study to estimate avoidable
costs of alcohol use/abuse. Presentation to Health Canada at Ottawa, Canada.
247. Rehm, J. & Frick, U. (2006, February 10-11). Changing the environment is more effective than changing the person! Review of the evidence
basis for preventing alcohol-related harm. Presentation at the congress “Empirically based prevention strategies – Implications for obesity” at
Essen, Germany.
246. Rehm, J. for the working group of the Second Canadian Cost Study (2006, February 6). Morbidity, mortality and indicators for level of law
enforcement attributable to alcohol, illegal drugs and tobacco in Ontario, 2002 Presentation to the Provincial Health Education Enforcement
Partnership Planning and Advisory Committee Meeting at Toronto, Ontario, Canada.
245. Rehm, J. (2005, December 6). Alcohol and chronic disease. Imlications for policies and prevention strategies in Canada. Presentation at the
National Alcohol Strategy Working Group at Edmonton, Alberta, Canada.
244. Rehm, J. (2005, December 2-3). Contributions of health economics to substance use research. Presentation at the First Meeting BMBF
Addiction Research Network at Mannheim, Germany.
- 70 –
243. Rehm, J., & Taylor, B. (2005, November 28-30). Volume of alcohol consumption, patterns of drinking and burden of disease in the Americas
2002. Presentation at the 1st Conferencia Pan-Americana de Politicas Publicas sobre Alcool at Brasilia, Brazil.
242. Rehm, J., & Frick, U. in collaboration of Room, R. & Babor, T. (2005, November 24-25). Alkoholpolitik und Alkoholprogramme international.
Presentation at the 7. Österreichische Präventionstagung at Vienna, Austria.
241. Rehm, J., Mancyuk, M., Sulkowska, U., Taylor, B., & Zatonski, W. (2005, November 21-22). Co-variation between alcohol consumption and
liver cirrhosis death in Europe. Presentation at Working meeting on adult premature mortality in the European Union at Warsaw, Poland.
240. Taylor, B., Rehm, J., Mancyuk, M., Sulkowska, U., & Zatonski, W. (2005, November 21-22). Co-variation between alcohol consumption and
injury death in Europe. Presentation at Working meeting on adult premature mortality in the European Union at Warsaw, Poland.
239. Rehm, J., Mancyuk, M., Sulkowska, U., Boffetta, P., Patra, J., & Zatonski, W. (2005, November 21-22). Alcohol-related mortality in seven
European countries 2001. Presentation at Working meeting on adult premature mortality in the European Union at Warsaw, Poland.
238. Rehm, J. (2005, September 28). Latent growth curve modeling and other new statistical techniques. What is the benefit for epidemiological
and clinical projects? Presentation at the Dresden University of Technology at Dresden, Germany.
237. Baliunas, D., Rehm, J., Patra, J., Popova, S., Taylor, B. & Kaiserman, M. (2005, September 18-21). Estimating smoking-attributable mortality for
the Canadian population. Poster at Canadian Public Health Association 96th Annual Conference “Mapping the Future of Public Health: People,
Places and Policies” at Ottawa, Canada.
236. Patra, J., Rehm, J., & Popova S. (2005, September 18-21). Alcohol related burden of disease in Canada in 2001. Poster at Canadian Public
Health Association 96th Annual Conference “Mapping the Future of Public Health: People, Places and Policies” at Ottawa, Canada.
235. Popova S., Rehm, J., & Patra, J. (2005, September 18-21). Illegal drug related burden of disease in Canada in 2001. Presentation at Canadian
Public Health Association 96th Annual Conference “Mapping the Future of Public Health: People, Places and Policies” at Ottawa, Canada.
234. Rehm, J. (2005, September 10). Gesundheitliche und soziale Folgen verschiedener Trinkmuster bei Alkoholkonsum. Presentation at the Falk
Workshop on alcohol-associated diseases in gastroenterology and hepatology at Mannheim, Germany.
233. Rehm, J., Gmel, G., & Taylor, B. (2005, June 22-23). Avoidable burden: conceptual and methodological issues in epidemiology. Presentation
at the Workshop on guidelines for the estimation of the avoidable costs of substance use and abuse by Health Canada at Ottawa, Canada
232. Rehm, J. (2005, June 15). The global burden of disease attributable to alcohol, tobacco and illicit drugs. Presentation at McMaster University,
Department of Psychiatry & Behavioural Neurosciences, at Hamilton, Canada.
231. Rehm, J. (2005, June 7-9). Burden associated with alcohol use. Presentation at the World Health Organization Consultative Meeting on
Alcohol and Public Health at Geneva, Switzerland
230. Rehm, J. (2005, June 4-6). Substance abuse by the young: the health burden and effective strategies for intervention. Presentation at the
th
16 Annual General Assembly (AGA) and Conference of the European Foundation Centre at Budapest, Hungary.
229. Taylor, B. & Rehm, J. (2005, May 29- June 3). Proposed changes in alcohol retailing in Ontario: An estimate of health and social outcomes
under several scenarios. Presentation at the Meeting of the Kettil Bruun Society at Riverside, California.
228. Rehm, J. & Taylor, B. (2005, April 13-15). Volume of alcohol consumption, patterns of drinking and burden of disease in the European region
2002 – implications for alcohol policy. Presentation at the 10th Meeting of National Counterparts for Alcohol Policy in the WHO European
Region at Stockholm, Sweden.
227. Fallu, J.S. & Rehm, J. (2005, April 11-13). Les coûts de l’abus de substances au Canada. Presentation at the Congrès national en toxicomanie
Rondpoint 2005 at Montréal, Canada.
226. Rehm, J. (2005, March 11). Proposed changes in alcohol retailing in Ontario: An estimate of social and health costs of several scenarios.
Presentation at the Ontario Public Health Association meeting on “Alcohol – No ordinary Commodity II” at Toronto, Canada.
225. Rehm, J. (2005, March 10). Alcohol, burden of disease, and policy. What do we know and where should we go? Presentation at the
University of Toronto, Public Health Sciences, Canada.
224. Rehm, J., Frick, U., Schnoz, D. & Neuenschwander, M. (2005, March 4). Illegale Drogen in der Stadt Zürich – Stand 2004/2005. Presentation
for representatives of the City of Zurich, Switzerland.
223. Arbeitsgruppe Cannabis Monitoring (PI: Rehm, J., & Dubois-Arber, Francoise) (2005, March 1). Monitoring der Cannabis-Problematik in der
Schweiz/Monitoring de la problématique du Cannabis en Suisse. Analysen, Probleme und Entwicklungen in der Schweiz nach dem Scheitern
der Revision des BetmG. Presentation at the Swiss Federal Office of the Public Health at Berne, Switzerland.
222. Rehm, J. (2005, February 8). Alcohol and burden of disease in New Zealand – implications for policy. Presentation at the Alcohol Advisory
Council of New Zealand seminar at Christchurch, New Zealand.
- 71 –
221. Rehm, J. (2005, February 8). Alcohol and burden of disease – general methodology and global results. Presentation at the Alcohol Advisory
Council of New Zealand seminar at Christchurch, New Zealand.
220. Rehm, J. (2005, February 7). Alcohol and burden of disease in New Zealand – implications for policy. Presentation at the Alcohol Advisory
Council of New Zealand seminar at Wellington, New Zealand.
219. Rehm, J. (2005, February 7). Alcohol and burden of disease – general methodology and global results. Presentation at the Alcohol Advisory
Council of New Zealand seminar at Wellington, New Zealand.
th
218. Rehm, J. (2004, October 27). Estimating the social costs of substance abuse. Presentation at the Health Canada Symposium at the 11
Canadian Conference on International Health at Ottawa, Canada.
217. Rehm, J. (2004, October 26). Alcohol and chronic disease burden. Presentation at the RISK Annual Planning Day at Huntsville, Canada.
216. Mohler-Kuo, M., Rehm, J., Heeb, J.L. & Gmel, G. (2004, September 29 - October 2). Does decrease price have an effect on spirits consumption
and alcohol-related problems? Presentation at the International Society for Biomedical Research on Alcoholism 12th World Congress on
Biomedical Alcohol Research at Heidelburg/Mannheim, Germany.
215. Rehm, J. (2004, September 24-26). Alcohol, education and persuasion – What works? Presentation at the 2004 MADD (Mothers against
drunk driving) Canada National Leadership conference at Toronto, Canada.
214. Rehm, J. (2004, September 24-26). Alcohol, harm and policy interventions. Presentation at the 2004 MADD (Mothers against drunk driving)
Canada National Leadership conference at Toronto, Canada.
213. Andlin-Sobocki, P. & Rehm, J. (2004, September 17-19). Epidemiology and cost of substance use disorders. Presentation at the Joint Expert
Meeting on the Cost of Diseases of the Brain in Europe, Stockholm, Sweden.
212. Rehm, J. (2004, September 17). Alcohol dependence in Europe – trying to make sense of the data. Presentation at the SORAD, Stockholm,
Sweden.
211. Rehm, J., Chisholm, D., Frick, U., van Ommeren, M., & Monteiro, M. (2004, August 13-14). The comparative cost-effectiveness of
interventions for reducing the burden of heavy alcohol use. Presentation at the Symposium on the Economics of Substance Use - Individual
Behaviour, Social Interactions, Markets, and Politics, Lund, Sweden.
210. Rehm, J. (2004, May 24-26). Valuation. Presentation at the joint UNECE/WHO/Eurostat meeting on the measurement of health status at
Geneva, Switzerland.209. Bédard, A., Noël, L., Bradet, R., Fischer, B., Rehm, J., Brissette, S., Brochu, S., Bruneau, J., el-Guebaly, N., Tyndall,
M.W., & Wild, CT. (2004, May 13-16). Drug Combination among untreated illicit opiate users at the Quebec City site – the OPICAN cohort at
baseline. Abstract, presented to Canadian Association for HIV Research (CAHR): 13th Annual Canadian Conference on HIV/AIDS Research,
Montreal, Canada.
208. Bradet, R., Noël, L., Fisher, B., Rehm, J., Brissette, S., Brochu, S., Bruneau, J., El-Guebaly, N., Tyndall, MW., & Wild, CT. (2004, May 13-16).
Predictors of health and social services use by untreated illicit opiate users across Canada – the OPICAN cohort at Baseline. Abstract,
presented to Canadian Association for HIV Research (CAHR): 13th Annual Canadian Conference on HIV/AIDS Research, Montreal, Canada.
207. Brissette, S., Bruneau, J., Brochu, S., el-Guebaly, N., Fisher, B., Noël, L., Rehm, J., Tyndall, MW., Wild, CT., & Mun, P. (2004, May 13-16) Drug
use patterns of illicit opiate users in five Canadian cities: the OPICAN study. Abstract, presented to Canadian Association for HIV Research
(CAHR): 13th Annual Canadian Conference on HIV/AIDS Research, Montreal, Canada.
206. Noël, L., Bradet, R., Bédard, A., Fisher, B., Rehm, J., Brissette, S., Brochu, S., Bruneau, J., El-Guebaly, N., Tyndall, M.W., & Wild, CT. (2004, May
13-16). Health and social service utilization by illicit opiate users not in treatment in Canada – the OPICAN cohort at Baseline. Abstract,
presented to Canadian Association for HIV Research (CAHR): 13th Annual Canadian Conference on HIV/AIDS Research, Montreal, Canada.
205. Noël, L., Fisher, B., Rehm, J., Brissette, S., Brochu, S., Bruneau, J., El-Guebaly, N., Tyndall, M.W., Wild, CT., & Bradet, R., (2004, May 6-7).
Consommation d’opiacés, marginalité et vulnérabilité au VIH au VHC – Cohorte OPICAN. Presented to 10e Colloque provincial en maladies
infectieuses: Vulnérabilities et prevention en maladies infectieuses, Montreal, Canada.
204. Rehm, J. (2004, March 29-31). Alcohol epidemiology as basis for cost-effectiveness considerations of interventions. Presentation at the WHO
meeting on mental health economics at Geneva, Switzerland.
203. Rehm, J. (2004, February 27). Preventing alcohol problems: international best practices. Presentation at the research and planning meeting
of the Centre for Addiction and Mental Health's Alcohol Policy & Research Group, OPHA Alcohol Work Group, Association to Reduce Alcohol
Promotion in Ontario and Alcohol Policy Network at Toronto, Canada.Invited presentation:
202. Rehm, J. (2004, February 23-24). Alcohol and burden of disease – epidemiology and policy implications. Presentation at the FOCUS/odap
Annual Meeting at Scarborough, Canada.Invited presentation:
- 72 –
201. Rehm, J. (2004, February 20). Alcohol, tobacco and illegal drugs: burden of disease and effective interventions. Presentation at the Office of
Research and Surveillance of the Drug Strategy and Controlled Substances Programme in HECS at Ottawa, Canada.Invited presentation:
200. Rehm, J. & Chisholm, D. (2004, February 10). The comparative cost-effectiveness of interventions for reducing the burden of heavy alcohol
use. Presentation at the advanced alcohol research seminar of the Alcohol Research Group and the Prevention Research Center at Berkely,
Ca., USA.Invited presentation:
199. Rehm, J. (2004, February 3). Alcohol and global burden of disease – epidemiology and policy implications. Presentation at the Institute for
Social and Preventive Medicine at the University of Lausanne, Lausanne, Switzerland.Invited presentation:
198. Jernigan, D., Room, R. & Rehm, J. (2003, November 24). Alcohol in development and in health and social policy. Presentation at the World
Bank event “Mental Health and the Global Agenda: What Role for the World Bank?” at Washington, DC, USA.Invited presentation:
197. Rehm, J. (2003, November 22-23). The global burden of disease 2000 attributable to alcohol, tobacco and illicit drugs, and implications for
interventions. Presentation at the Institute of Neurosciences, Mental Health and Addiction Second Annual Meeting at Toronto, Canada.196.
Rehm, J. (2003, November 15-19). Alcohol-related global burden of disease. Presentation at the American Public Health Association
131st Annual Meeting and Exposition at San Francisco, California, US.
195. Greenfield, T., Ye, Y., Bond, J.,, Kerr, W., Rehm, J., & Nayak, M. (2003, November 15-19). Most of the alcohol consumed in the US drunk is not
drunk safely: The health policy implications. Presentation at the American Public Health Association 131st Annual Meeting and Exposition at
San Francisco, California, US.
194. Rehm, J., Güttinger, F., & Frick, U. (2003, November 12). Arbeitsplatz und Konsum von Alkohol, Tabak und illegalen Drogen. Was
Wissenschaft und Forschung dazu zu sagen haben. Presentation at the symposion on substance abuse at the workplace at Berne,
Switzerland.Invited workshop:
193. Rehm, J. (2003, November 2-5). Alcohol: no ordinary commodity — Epidemiology, interventions and evidence-based policies Workshop
organized at the 54th Annual Ontario Public Health Association Conference at Windsor, Ontario, Canada.Invited presentation:
192. Rehm, J. (2003, November 2-5). Alcohol and burden of disease – epidemiology and policy implications. Presentation at the 54th Annual
Ontario Public Health Association Conference at Windsor, Ontario, Canada.Invited presentation:
191. Rehm, J. (2003, October 24-25). Alcohol and global burden of disease and injuries. Presentation at the International Workshop “The social
cost of alcohol abuse” at Neuchâtel, Switzerland.Invited presentation:
190. Rehm, J. (2003, October 22). Alcohol attributable mortality and burden of disease with special reference to selected Central and Eastern
European countries. Presentation at the “Health transformation in accession countries” meeting at Warsaw, Poland.Invited presentation:
189. Rehm, J. (2003, September 25). Alcohol and global burden of disease – epidemiology and implications for a New Zealand burden of disease
study. Presentation for the Alcohol Advisory Council of New Zealand at Wellington, New Zealand.Invited presentation:
188. Rehm, J. (2003, September 22-23). Alcohol, addiction and public health. Presentation at the Addiction Workshop of the Disease Control
Priorities Project, sponsored by the Fogarty International Center, the National Institutes of Health and the Bill and Melinda Gates Foundation
at Mumbai, India.Invited presentation:
187. Rehm, J. (2003, June 16-18). Epidemiologische und ökonomische Spekte zum Substanzmittelgebrauch und –missbrauch. Presentation at the
th
16 Congress of the GCAA German Council on Alcohol and Addiction at Heidelberg, Germany.Invited presentation:
186. Rehm, J. (2003, May 22-23). Alcohol and global burden of disease – epidemiology and cost-effectiveness of interventions. Presentation at
nd
the 2 Regensburg Symposion on psychiatry and health economics at Regensburg, Germany.Invited presentation:
185. Rehm, J. (2003, May 22). Ökonomische Aspekte der Sucht. Presentation at the Symposion to honor the lifetime contributions of Professor
Dieter Ladewig at Basle, Switzerland.Invited presentation:
184. Fischer, B. & Rehm, J. (2003, March 19-20). Safer Injection Facilities in Europe and Australia: Evidence and Implications. Presentation at the
‘Time for Action’ Conference at Ottawa, Canada.Invited presentation:
183. Rehm, J. & Room, R. (2003, February 28). The global burden of disease 2000 for alcohol, tobacco and illicit drugs. Presentation at the
National Drug Research Institute meeting on “Preventing risky drug abuse and harm: what are best bets for policy?” at Freemantle,
Australia.Invited presentation:
182. Rehm, J. & Room, R. (2003, February 24-27). The global burden of disease attributable to alcohol, tobacco and illicit drugs. Presentation at
the International Research Symposium on “Preventing substance use, risky drug and harm: what is evidence-based policy?” at Freemantle,
Australia.Invited presentation:
181. Rehm, J. (2003, February 12). Alcohol and global burden of disease – epidemiology and implications. Presentation at the WHO - Beverage
Company Representatives meeting to discuss health-related alcohol issues at Geneva, Switzerland.Invited presentation:
180. Rehm, J. (2003, January 6). Lohnt sich (Sucht-)Prävention? Ein Bericht aus der Forschung. Presentation at the Enquete ARI Forum at Zurich,
Switzerland.Invited presentation:
179. Rehm, J. (2002, November 12). Kritische Betrachtung von Kosten-Nutzen Überlegungen zum Alkohol. Presentation at the Enquete „Jugend
und Alcohol“ der Vorarlberger Landesregierung at Bregenz, Austria.Invited presentation:
178. Rehm, J. & Fischer, B. (2002, November 8-9). Ethical aspects in addiction research and interventions. Presentation at the INMHA-CIHR
(Institute of Neurosciences, Mental Health and Addicitons/Canadian Institutes of Health Research) workshop on neuroethics at Toronto,
Canada.Invited presentation:
177. Rehm, J. & Frick, U. (2002, October 25). Ökonomie des Suchtmittelgebrauchs Addiction and public health. Presentation at the Tagung der
Bayerischen Akademie für Suchtfragen „Sucht und Ökonomie“ at Munich, Germany.Invited presentation:
176. Rehm, J., In collaboration with Management of Substance Dependence (Maristela Monteiro, Nina Rehn) (2002, October 7-11). Alcohol and
burden of disease. Results from the WHO-Comparative Risk Assessment. Presentation at the WHO Meeting of Interested Parties at Geneva,
Switzerland.
175. Rehm, J. (2002, September 27). Addiction and public health. Presentation at the Saint Michael Hospital Mental Services Grand Rounds at
Toronto, Canada.
174. Rehm, J. (2002, September 22-27). Alcohol-related morbidity, mortality and disability. Presentation at the World Forum Drugs,
Dependencies. Impacts and responses at Montréal, Canada.
- 73 –
st
173. Rehm, J. & Gmel, G. (2002, September 15-18). Usefulness and limitations of survey and mortality data. Presentation at the 1 China
International Symposium on Alcohol and Health, organized by the Beijing SiJi Exchange Center for Science and Technology of China
Association for Science and Technology, WHO-Shanghai Collaborating Center for Health Education and Promotion, University of NebraskaLincoln, USA; at Shanghai, China.
172. Rehm, J. & Gmel, G. (2002, September 15-18). Alcohol-related burden of disease and effectiveness of different interventions, in China and
st
globally. Presentation at the 1 China International Symposium on Alcohol and Health, organized by the Beijing SiJi Exchange Center for
Science and Technology of China Association for Science and Technology, WHO-Shanghai Collaborating Center for Health Education and
Promotion, University of Nebraska-Lincoln, USA; at Shanghai, China.
th
171. Rehm, J. (2002, September 4-6). Suchttherapie und Suchtforschung: Paradigmen zwischen Alltag und Visionen. Presentation at the 14
International Congress on Addiction at the special symposioum devoted to the lifetime contributions of Ambros Uchtenhagen at Zurich,
Switzerland.
170. Rehm, J. (2002, September 4-6). Economic questions and the prevention of drug abuse: Too much motherhood and apple pie may be
th
detrimental to rational programs. Presentation at the 14 International Congress on Addiction at Zurich, Switzerland.Invited presentation:
169. Rehm, J. (2002, September 2-4). Zur vergleichenden Bewertung von Interventionen im Bereich Alkohol: welche Massnahme ist am
nd
kosteneffektivsten? Presentation at the 2 Swiss meeting of researchers with practioners at Zurich, Switzerland.Invited presentation:
168. Rehm, J. (2002, Juni 20-21). Swiss experiences in heroin-assisted treatment. Presentation at the 3rd Network Meeting on the Medical
Prescription of Heroin at Utrecht, NL.Invited presentation:
167. Rehm, J. (2002, June 14). Modelle regionaler Therapieangebote für Abhängigkeitserkrankungen – das Beispiel Ontario. Vortrag am
Symposium at Meiringen, Switzerland.
166. Rehm, J., Gmel, G., & Frick, U. (2002, June 3-7). Average volume of alcohol consumption, patterns of drinking and coronary heart disease
th
(CHD) mortality. Presentation at the 28 Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Paris, France.
165. Rehm, J., Gschwend, P., Uchtenhagen, A., & Güttinger, F. (2002, April 25-27). Evaluation of heroin-assisted substitution treatment for opioid
dependence in Switzerland – an overview. Presentation at the Conference on „Models of medication supported treatment for opioid addicts“
organized jointly by WHO, the German Federal Ministry of Health (BMG) and DLR Gesundheitsforschung, Bonn at Velen, Germany.Invited
presentation:
164. Rehm, J. (2002, April 17-20). Measuring disability in health surveys – Theoretical considerations and experiences from Canada and Germany.
Presentation at the WHO conference on Health and disability at Trieste, Italy.Invited presentation:
163. Rehm, J. (2002, April 3). Von der “burden of disease” Forschung zur Konzeption eines integrierten Versorgungssystems am Beispiel Ontario.
Presentation at the Forel Klinik at Ellikon, Switzerland.
162. Rehm, J. (2001, November 3-4 and November 10-11). Prävention und Schadensminderung bez substanzbezogenen Süchten. Presentations at
the central continuous education for the Austrian pharmacists (Österreichische Ärztekammer) at Salzburg and Vienna, Austria.
161. Rehm, J. (2001, November, 2). Wissenschaftliche Evaluation opiatgestützter Behandlungen. Presentation at the Syposium on opiate-assisted
treatment at the Psychiatric University Hospital at Basel, Switzerland.
th
160. Rehm, J (2001, October 21-25). The health and social burden attributable to alcohol. Presentation at the 129 Annual Meeting of the
American Public Health Association at Atlanta, U.S.
159. Rehm, J., Gschwend, P., Uchtenhagen, A. & Güttinger, F. (2001, September 4-6). Heroin-assisted treatment for opioid dependence in
Switzerland – An overview. Presentation at the 2001 Taipei International Conference on Drug Abuse at Taipei, Taiwan, R.O.C.
158. Rehm, J., Gmel, G., Room, R., Monteiro, M., Graham, K., Gutjahr, E., Jernigan, D., & Sempos, C.T. (2001, June 23-26). Alcohol as a risk factor
for burden of disease. Presentation at the WHO meeting on Comparative Risk Analysis at Geneva, Switzerland.
157. Rehm, J. (2001, June 15-16). Empirisch basierte Gesundheitsplanung. Das Konzept der WHO und seine Umsetzung am Beispiel der
th
Gesundheitssurveys 2000 und 2001. Presentation at the 10 annual meeting of the Gesellschaft für Gesundheitsforschung und Epidemiologie
at Dresden, Germany.
156. Rehm, J., Frick, U., & Üstün, T.B. (2001, June 15-16). Krankheitsbedingte Behinderungen: Von der Konzeption im WHO-ICIDH zur Messung.
th
Presentation at the 10 annual meeting of the Gesellschaft für Gesundheitsforschung und Epidemiologie at Dresden, Germany.
155. DeGuia, N.A., Cohen, J.E., Ashley, M.J., Ferrence, R., Rehm, J., Studlar, D.T., & Northrup (2001, June 13-16). Dimensions underlying legislator
support for tobacco control. Poster at the Congress of Epidemiology 2001, Toronto, Canada
154. Rehm, J. & Gmel, G. (2001, May 28-June1). Average volume of alcohol consumption, drinking patterns and related burden of disease in young
th
people in Europe. Presentation at the 27 Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Toronto, Canada.
- 74 –
153. Rehm, J. (2001, May 14). The costs of public policies to fight illegal drugs. Summary report prepared for and presented at the Special Senate
Committee on Illegal Drugs, Ottawa, Canada
152. Rehm, J. & Gmel, G. (2001, May 7-11). Estimating alcohol distributions in WHO regions of the world. Presentation for WHO Experts’ Meeting
on Assessment of Alcohol as a Risk Factors for the Global Burden of Disease at Geneva, Switzerland.
151. Fischer, B., Rehm, J., & Kirst, M. (2001, May 1-4). Harm reduction for intravenous drug users (IDUs): international initiatives, programs and
st
evidence. Presentation at the 1 Canadian Hepatitis C Conference, Montreal, Canada.
150. Uchtenhagen, A., Gschwend, P., Rehm, J., & Rey-Riek, S. (2001, March 13-15). Erfahrungen mit der heroingestützten Behandlung in der
Schweiz. Vortrag auf der 42. Frühjahrstagung DGPT, Mainz, Germany.
149. Rehm, J. (2001, February 23-24). Medical and psychosocial treatment and counseling within the Swiss heroin-assisted treatment for opiate
addicts. Presentation at the International Network Conference on “Heroin-assisted treatment and its place in substitution treatment” at
Berne, Switzerland.
148. Rehm, J. & Gmel, G. (2001, February 19-21). Average volume of alcohol consumption, drinking patterns and related burden of disease in
young people in Europe. Presentation at the WHO European Ministerial Conference on Young People and Alcohol. Stockholm, Sweden.
147. Eschmann, S. & Rehm, J. (2001, January 29-30). The epidemiology of harmful alcohol use and alcohol dependence. Presentation at the WHO
experts meeting on alcohol as a risk factor for the burden of disease, Geneva, Switzerland.
146. Rehm, J. & Gmel (2001, January 29-30). Alcohol-related burden of disease in young people in Europe. Presentation at the WHO experts
meeting on alcohol as a risk factor for the burden of disease, Geneva, Switzerland.
145. Rehm, J., Gmel, G. et al. (2000, December 5-7). Alcohol as a risk factor in the Global Burden of Disease Study 2000 (GBD 2000). Presentation
at the WHO CRA conference, Auckland, New Zealand.
144. Rehm, J. (2000, November 13). Der europäische Aktionsplan Alkohol 2000-2005. Vortrag bei der Pressekonferenz zur Vorstellung des
Eidgenössischen Aktionsplans für Alkohol, Bern, Switzerland.
143. Rehm, J. & Fischer, B. (2000, November 3-5). Kosten, Nutzen und Effizienz der Opiatsubstitution. Vortrag auf dem 9. Suchtmedizinischen
Kongreß der Deutschen Gesellschaft für Suchtmedizin, Münster, Germany.
142. Rehm, J. & Room, R. (2000, November 2-3). Dependence: prevalence and relevance. Paper presented at the Annual Symposium of the
Society for the Study of Addiction on “The nature and treatment of dependence”, Leeds, UK.
141. Frick, U. & Rehm, J. (2000, October 3-6). Length of stay in a psychiatric hospital as a function of patient and organizational characteristics. A
th
multilevel analysis. Paper presented at the 5 International Conference on Social Science Methodology, Cologne, Germany.
140. Rehm, J. (2000). Moderater Alkoholkonsum – positive Auswirkungen auf die Gesundheit. Vortrag bei der Fortbildungsverantstaltung
“Alkoholkonsum, Genuß und Mißbrauch – Eine Bilanz nach 30 Jahren”, Stuttgart, Germany.
139. Frick, U, Krischker, S., Cording, C., & Rehm, J. (2000, September 20-23). Äpfel und Birnen vergleichen? Die Berücksichtigung von Patientenmix
und Organisationsmerkmalen beim praktischen Vergleich von 8 psychiatrischen Kliniken. Vortrag beim Kongress 2000 der Deutschen
Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde, Aachen, Germany.
138. Rehm, J. (2000, June 1-3). Methodological and ethical issues in studying social costs of illicit opiate addiction. Presentation at the Canadian
Institutes of Health Research (CIHR)-Funded Workshop on Illicit Opiate Addiction in Canada at Toronto, Canada.
137. Gmel, G., Rehm, J, Room, R., & Greenfield, T.K. (2000, April 3-7). Dimensions of alcohol-related social harm in survey research. Presentation
at the special meeting of the Kettil Bruun Society "Measuring drinking patterns, alcohol problems, and their connection: an international
research conference" at Skarpö, Stockholm, Sweden.
136. Rehm, J & Gmel, G. (2000, April 3-7). Aggregating dimensions of alcohol consumption to predict medical and social consequences.
Presentation at the special meeting of the Kettil Bruun Society "Measuring drinking patterns, alcohol problems, and their connection: an
international research conference" at Skarpö, Stockholm, Sweden.
135. Rehm, J., Ashley, M.J., Gmel, G., Gutjahr, E., Single, E., Bondy, S., & Rankin, J. (2000, February 23-28). Health benefits of alcohol consumption:
- 75 –
an overview. Paper presented at the WHO Euro meeting on the revision of “Alcohol Policy and the Public Good” at Copenhagen, Denmark.
134. Rehm, J. (1999, October 1-2). Discussion of H. Holder ‘Cost-effectiveness of addiction treatment’. Presentation at the International
st
Conference to inaugurate the 1 Chair in Addiction Research in Germany, Mannheim, Germany.
133. Wall, R., Rehm, J., Fischer, B., Brands, B., Gliksman, L., Stewart, J., Medved, W., & Blake J. (1999, August 18-21). Social costs of untreated
th
opioid dependence. Presentation at the 8 Canadian Conference on Health Economics, Edmonton, Alberta, Canada.
132. Rehm, J., Saxena, S., & Üstün, T.B. (June, 9-10). WHO instruments for assessment of disability and functioning (WHO-DAS II). Presentation at
the VII European College for Study Methods in Clinical Trials in Neuropsychiatry at Strasbourg, France.
131. Rehm, J. & Üstün, T.B. (June, 9-10). Burden of schizophrenia and its use in cost-effectiveness estimation of antipsychotics. Presentation at
the VII European College for Study Methods in Clinical Trials in Neuropsychiatry at Strasbourg, France.
130. Rehm, J. (1999; June 6)). DALYs, addiction and mental health. Presentation at the CRTI Clinical and Research Seminars at the CAMH, Toronto,
Canada.
129. Rehm, J., Greenfield, T.K., & Rogers, J.D. (1999, May 31 - June 4). Alcohol, gender, ethnicity and all-cause mortality. Paper presented at the
th
25 Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Montreal, Canada.
128. Ivis, F., Adlaf, E., &Rehm, J. (1999, May 31 - June 4). Wording and ordering effects in the AUDIT in a general population telephone survey.
th
Paper presented at the 25 Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Montreal, Canada.
127. Her, M., Giesbrecht, N., Room, R., & Rehm, J. (1999, May 31 - June 4). Impacts of deregulating alcohol sales in Ontario, Canada: four scenarios
th
based on projected changes in physical and economic access to alcohol. Paper presented at the 25 Annual Alcohol Epidemiology Symposium
of the Kettil Bruun Society at Montreal, Canada.
126. Rehm, J. (1999, May 31 - June 4). Measuring drinking patterns over the past 50 years – from scientific description to public health
th
surveillance. Paper presented at the 25 Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Montreal, Canada.
125. Rehm, J. & Room, R. (1999, April 28-29). Impacts on young people’s health of drinking and alcohol policy. Presented at the WHO-Euro
interdisciplinary preparatory expert meeting at Skarpö, Sweden.
124. Rehm, J. (1999, March 10-12). Heroin prescription and Public Health research. Problems in epidemiological methodology. Presentation at
the International Symposium: “Heroin-assisted treatment for dependent drug users: state of the art and new research perspectives.
Discussion of scientific findings and political implications.” of the Swiss Federal Office of Public Health and the University Psychiatric Services,
University of Berne, Berne, Switzerland.
123. Rehm, J. (1999, February 18-21). Draining the ocean to prevent shark attacks. Or: the empirical foundation of modern alcohol policy.
Presentation at the First Research Conference for the project: “A Comparative Analysis of Alcohol Policy and its Effect in the EU-states” at
Stockholm, Sweden.
123. Wall, R., Rehm, J., Stewart, J., Fischer, B., Brands, B., Gliksman, L., & Blake, J. (1999, February 3). The economic harm of untreated opiate use
in Toronto. Presentation at McMaster University, Polinomics, Hamilton, Canada.
122. Rehm, J. (1998, September 27). Propose the negative in a public symposium at the session “This House Believes that the Royal College should
Publicize the Benefits as Well as the Risks of Moderate Drinking to the Canadian Public”. Presentation and Discussion at the 1998 Annual
Meeting of the Royal College of Physicians and Surgeons of Canada at Toronto, Canada.
122. Rehm, J. (1998, September 11-12). Exploring DALY disability weights: Eine WHO-Studie zur Weiterentwicklung des DALY Konzepts.
th
Presentation at the 7 yearly meeting of the Gesellschaft für Gesundheitsforschung und Epidemiologie e.V. at Munich, Germany.
121. Rehm, J. (1998, August 27-29). Draining the ocean to prevent shark attacks – different approaches for prevention of alcohol-related harm.
Presentation at the meeting of the Nordic Council for Alcohol and Drug Research on “Consumption of alcohol and drugs and control in a
changing society” at Hangö, Finland.
120. Rehm, J. (1998, July 4). Was ist und was will die Internationale Klassifikation der Schäden, Aktivitäten und Partizipation (ICIDH-2)?
Presentation at the Interdisciplinary meeting for the revision of the ICIDH in Switzerland at Zurich, Switzerland.
119. Rehm, J. (1998, June 27-July 2). Is moderate alcohol intake healthy? Presentation at the Ninth Congress of the International Society for
Biomedical Research on Alcoholism at Copenhagen, Denmark.
118. Rehm, J. & Gmel, G. (1998, February 1-5). Patterns of alcohol consumption and social consequences – results from an eight-year follow-up
study in Switzerland. Presentation at the Second International Conference on Social and Health Effects of Different Drinking Patterns at
Perth, Australia.
117. Rehm, J. & Bondy, S.J. (1998, February 1-5). Choosing adequate measures for different outcomes of alcohol consumption. Presentation at
the Second International Conference on Social and Health Effects of Different Drinking Patterns at Perth, Australia.
116. Bondy, S.J. & Rehm, J. (1998, February 1-5). The interplay of drinking patterns and other determinants of health. Presentation at the Second
International Conference on Social and Health Effects of Different Drinking Patterns at Perth, Australia.
- 76 –
115. Rehm, J., Catz, M., & Frick, U. (1998, January 29-31). Monitoring of outcomes and costs in out-patient treatment of substance abuse in
Ontario, Canada: practical experiences in the conceptualization and implementation of a system for quality assurance. Presentation at the 3.
Hamburger Workshop “Qualität im Gesundheitswesen” at Hamburg, Germany.
114. Frick, U., Rehm, J., & Catz, M. (1998, January 29-31). Psychometrics as a tool in quality measurement: a comparison between two psychiatric
assessment batteries in Canada and Germany. Poster presented at the 3. Hamburger Workshop “Qualität im Gesundheitswesen” at
Hamburg, Germany.
113. Rehm, J. (1997, November 2-5). Concurrent disorders, mortality and morbidity - selected results and open questions. Presentation at the
Conference on “Co-occuring substance use and mental disorders: functional relations and clinical implications” at Toronto, Canada.
112. Rehm, J., & Trotter, R. (1997, October 30-31). Summary and discussion of ICIDH-2 Beta Field Trials testing issues. Presentation at the Annual
Meeting on the ICIDH of the WHO Collaborating Centre for the Classification of Diseases for Noth America at Ottawa, Canada.
111. Rehm, J., Bondy, S., & Ashley, M.J. (1997, October 18). Campaigns and core messages - up-to-date and state of the art form a research
perspective? Presentation at the Symposium "The promotion of low-risk drinking patterns in the general public - strategies and messages” of
the Swiss Institute for the Prevention of Alcohol and Drug Problems (SIPA) and the Swiss Federal Office of Public Health at Zurich, Switzerland.
110. Rehm, J. & Bondy, S. (1997, October, 6-9). Alcohol and all-cause mortality: an overview. Presentation at the Novartis Foundation Symposium
No. 216 „Alcohol and cardiovascular diseases“. London, United Kingdom.
109. Frick, U., Rehm, J., Knoll, A. & Reifinger, M. (1997, September 29 - October 1). Der Einfluß von moderatem Alkoholtrinken und erlebter
kognitiver Beeinträchtigung auf die Fahrentscheidung von jungen Autofahrern. Presentation at the annual meeting of the Deutschen
Gesellschaft für Sozialmedizin und Prävention (DGSMP), Schwerin, Germany.
108. Trotter, R., Rehm, J., Chatterji, S., & Kennedy, C. (1997, July 10-11). WHO protocol on ICIDH-2 Beta Field Trials. Presentation at the meeting
“ICIDH: The Revision Process and the American Disabilities Act, Toward a Resolution of Issues” (National Institute for Disability and
Rehabilitation Research), Silver Spring, Maryland, USA.
107. Kendall, P., Brands, B., Fischer, B., Gliksman, L., Medved, W., & Rehm, J. (1997, April 21-23). A harm reduction approach to opiate use in
Metropolitan Toronto. Paper presented at the Conference on Cities and Addiction, Rotterdam, Netherlands.
106. Rehm, J. (1997, May 12-14). Assessment methods for alcohol consumption, prevalence of high risk drinking and harm - a sensitivity analysis.
Paper presented at the NIAAA International Workshop on Consumption Measures and Models for Use in Policy Development and Evaluation,
Bethesda, Maryland, USA.
105. Rehm, J. (1997, May 12-14). Alcohol consumption in Switzerland 1987-1993: measurement error and effects of assessment techniques on the
analysis of trends. Paper presented at the NIAAA International Workshop on Consumption Measures and Models for Use in Policy
Development and Evaluation, Bethesda, Maryland, USA.
104. Frick, U., Rehm, J., Knoll, A. & Reifinger, M. (1997, May 6-7). Risikowahrnehmung und Risikoentscheidungen unter Alkoholeinfluß - Ein
kontrolliertes Experiment an jungen AutofahrerInnen. Presentation at the workshop on risk communication at the University of Bremen,
Bremen, Germany.
103. Fichter, M.M., Quadflieg, N., & Rehm, J. (1997, March). Langzeitverlauf von Bulimia nervosa und „Binge Eating Disorder.“ Presentation at the
Tagung der Deutschen Gesellschaft für Verhaltensmedizin, Jena, Germany.
102. Rehm, J. (1997, March 21-23). Potential future patterns of nicotine use and risk reduction. Presentation at the workshop on
Alternative
Nicotine Delivery Systems. Harm Reduction and Public Health (Organizers: Addiction Research Foundation, Ontario Tobacco Research Unit,
American Society of Addiction Medicine), Toronto, Canada.
101. Frick, U., Laschat, M., & Rehm, J. (1997, March 18-21). Sind „utilities“ valide Zielgrößen ökonomischer Evaluationen? Erfahrungen aus der
Neonatologie. Presentation at the 43. Biometrisches Kolloquium der Deutschen Region der Internationalen Biometrischen Gesellschaft,
Munich, Germany.
100. Rehm, J. (1997, March 18-21). Richtlinien und Praxis in ökonomischen Evaluationen von Pharmazeutika in Kanada. Presentation at the 43.
Biometrisches Kolloquium der Deutschen Region der Internationalen Biometrischen Gesellschaft, Munich, Germany.
99. Rehm, J. (1997, February 28). Different cultures, different forms of treatment, different outcomes. Presentation at the Workshop on
"Effectiveness of inpatient vs. outpatient treatment for substance abuse and dependence - New empiricial findings, policy implications for
ARF? ", Addiction Research Foundation, Toronto, Canada.
98. Rehm, J., Ross, H., & Walsh, G. (1997, February 20-21). Alternative methods of measuring outcomes in monitoring system. Presentation at
the Symposion on Monitoring Outcomes of Substance Abuse Treatment Systems, Addiction Research Foundation, Toronto, Canada.
97. Rehm, J. (1996, November 27-28). The state of the art in epidemiological addiction research (Trends in der epidemiologischen
Suchtforschung). Paper presented at the Statusseminar zum Förderschwerpunkt Suchtforschungdes Programms Gesundheitsforschung
- 77 –
2000 der Deutschen Bundesregierung, Bad Honnef, Germany.
96. Single, E., Robson, L., Xie, X., & Rehm, J. in collaboration with Moore, R., Choi, B., Desjardins, S., & Anderson, J. (1996, November 17-21). The
economic costs of substance abuse in Canada, 1992. Paper presented at the annual meeting of the American Public Health Association, New
York, N.Y., USA.
95. Single, E., Robson, L., & Rehm, J. (1996, October 19). Morbidity and mortality attributable to substance abuse in Canada. Paper presented at
the annual meeting of the Canadian Medical Society on Alcohol and other Drugs, Toronto, Canada.
94. Frick, U., Knoll, A., & Rehm, J. (1996, October 11-12). Die Wahrnehmung gesundheitsbezogener Risiken durch Jugendliche I: Explorative und
konfirmatorische Latent-Class-Analysen. Presentation at the workshop ‚Risikoberechnung – Risikowahrnehmung“ der AG Ethik und
Verantwortung in der Biometrie der Deutschen Region der Internationalen Biometrischen Gesellschaft, Berlin, Germany.
93. Wild, C.T., Graham, K., Rehm, J., & Paglia, A. (1996, Ocotber 7-10). Blame and punishment for alcohol-related aggression: factors affecting
judgement about the perpetrator. International Conference on Intoxication and Aggressive Behaviour: Understanding and Preventing AlcoholRelated Violence, Toronto, Canada.
92. Rehm, J., Arminger, G., Frick, U., & Raos, J. (1996, September 16-20). Subjective factors in visits to physicians in Salzburg, Austria. Poster
presented at the 6th International Conference on System Science in Health Care, Barcelona, Spain.
s attitud
91. Frick, U., Rehm, J., & Laschat, M. (1996, September 16-20). Obstetrician
scaling procedures. Paper presented at the 6th International Conference on System Science in Health Care, Barcelona, Spain.
90. Rehm, J., Bondy, S., & Ferrence, R. (1996, June 21). Cancer and heart disease: Implications for alcohol prevention. Presentation at the
Anthony B. Miller Symposium: Future directions in cancer control. Department of Preventive Medicine and Biostatistics, Toronto, Canada.
89. Stockwell, T., Single, E., Hawks, D., & Rehm, J. (1996, June 3-7). Sharpening the focus of alcohol policy from aggregate consumption to harm
nd
and risk reduction. Paper presented at the 22 Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Edinburgh, Scotland.
88. Murray, R., Rehm, J., Shaten, J., & Connett, J. (1996, June 3-7). Social integration as a moderator between alcohol consumption and mortality:
nd
the MRFIT trial. Paper presented at the 22 Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Edinburgh, Scotland.
87. Rehm, J. (1996, May 23). Alcohol and heart disease. From epidemiological knowledge to prevention. Presentation at the German Federal
Institute for Infectious and Non-communicable Diseases, Berlin, Germany.
86. Rehm, J., Vaucher, S., & Xie, X. (1996, May 4-8). Alcohol-related health problems, hospitalizations and mortality in young adults in Ontario,
1991/92. Presentation at the Tenth International Alcohol Policy Conference
Reducing risk amo
85. Fichter, M.M. , Quadflieg, N., & Rehm, J. (1996, April 26-28). Six-year long-term course and risk factors in Bulimia Nervosa. Presentation at the
th
7 International Conference on Eating Disorders, New York, N.Y., USA.
84. Rehm, J. (1995, October, 20). Alcohol and mortality. From epidemiological findings to public health consequences. Presentation at the CRTI
Clinical and Research Seminars at the ARF, Toronto, Canada.
83. Rehm, J., Sempos, C.T., Vuong, C., Chien, C.-Y., & Walsh, G. (1995, October, 9-13). Alcohol consumption and all-cause mortality. The NHANES I
and NHANES II follow-up studies. Paper presented at the WHO Working Group on Alcohol Consumption and Health at Oslo, Norway.
82. Rehm, J. & Arminger, G. (1995, June 3-9). Alcohol consumption and alcohol-related problems in Switzerland 1987-1993. Adjusting for
st
differential effects of assessment techniques on the analysis of trends. Paper presented at the 21 Annual Alcohol Epidemiology Symposium
of the Kettil Bruun Society at Porto, Portugal.
st
81. Adlaf, E., et al. (1995, June 3-9). Alcohol consumption and suicide in Canada. Paper presented at the 21 Annual Alcohol Epidemiology
Symposium of the Kettil Bruun Society at Porto, Portugal.
st
80. Rehm, J. & Gmel, G. (1995, June 3-9). Alcohol consumption and suicide in Switzerland. Paper presented at the 21 Annual Alcohol
Epidemiology Symposium of the Kettil Bruun Society at Porto, Portugal.
79. Rehm, J. (1995, May 30). Consommation modérée et maladies cardiovasculaires - une recension. Paper presented at the matinée of the
Institut de Recherches Scientifiques sur les Boissons (IREB) on "Alcool et cœur: apports et limites de l'épidémiologie".
78. Gervasoni, J.P., Estermann, J., Maag, V., & Rehm, J. (1995, March 26-30). Estimation of the number of heroin and cocaine users in
Switzerland: utility for the global evaluation. Paper presented at the 6th International Conference on the Reduction of Drug Related Harm at
Florence, Italy.
77. Rehm, J., Sempos, C.T., Vuong, C., Chien, C.-Y., & Frick, U. (1994, November, 14-16). Alcohol consumption and all-cause mortality. Paper
presented at the WHO Working Group on Population Levels of Alcohol Consumption at Oslo, Norway.
76. Rehm, J. (1994, September 12-14). The development of AA in a temperance culture: The case of German-speaking Switzerland. Paper
presented at the International Conference on Addiction and Mutual Help Movements in a Comparative Perspective at Toronto, Canada.
75. Rehm, J. (1994, September 12-14). The finances of AA. Paper presented on behalf of ICSAA at the International Conference on Addiction and
Mutual Help Movements in a Comparative Perspective at Toronto, Canada.
74. Rehm, J, François, Y., & Le Gauffey, Y. (1994, September 1-3). The prevalence of eating disorders in adolescent school children in Switzerland.
Poster au Congrès international pré-adolescence: Recherche et clinique à Lausanne, Switzerland.
73. François, Y., Rehm, J., & Le Gauffey, Y. (1994, September 1-3). Les troubles alimentaires abordés dans une enquête sur la santé des préadolescents suisses. Communication orale au Congrès international pré-adolescence: Recherche et clinique à Lausanne, Switzerland.
72. Frick, U., Rehm, J., & Knoll, A. (1994, July 25-29). An example of missing value imputation in large patient data bases. Poster presented at the
th
- 78 –
15 Meeting of the International Society for Clinical Biostatistics at Basle, Switzerland.
71. Rehm, J. (1994, June 20). Prävalenzschätzungen in der Schweiz auf der Basis der Drogentoten. Vortrag beim Bundesamt für
Gesundheitswesen, Bern, Switzerland.
70. Vaucher, S., Rehm, J., Benvenuti, J., & Müller, R. (1994, June 3-4). Young teenagers and access to alcohol. Test of bartenders' knowledge and
th
obedience of laws about serving alcoholic beverages to 13-year-old and 15-year-old teenagers. Paper presented at the 20 Annual Alcohol
Epidemiology Symposium of the Kettil Bruun Society at Rüschlikon, Switzerland.
th
69. Rehm, J., & Frick, U. (1994, June 3-10). Alcohol consumption and suicide in Switzerland. Paper presented at the 20 Annual Alcohol
th
68. Rehm, J., & Sempos, C.T. (1994, June 3-10). Alcohol consumption and all cause mortality. Paper presented at the 20 Annual Alcohol
67. Rehm, J. (1994, June 3-4). Verlaufsstudien und Stichprobengewichtung in der psychiatrischen Epidemiologie. Vortrag beim 1. Workshop des
Forschungsverbundes Public Health Sachsen über Forschungsmethodik, Dresden, Germany.
66. Rehm, J., Frick, U. & Thien U. (1994, May 15-20). On the role of LCA in the validation of psychometric scales. Presentation at the IPN
Symposium "Applications of latent trait and latent class models in the social sciences" at the Akademie Sankelmark, Germany.
65. Frick, U., Rehm, J., & Thien U. (1994, May 15-20). Constructing and cross-validating a "soft" indicator for alcohol problems. Presentation at the
IPN Symposium "Applications of latent trait and latent class models in the social sciences" at the Akademie Sankelmark, Germany.
64. Frick, U. & Rehm, J. (1994, April 13). Präsentation der Kinderstudie. Symposium "Gesunde Kinder. Medizinische Versorgung von Kindern im
Grossraum Wien" im Rathaus Wien, Austria.
63. Rehm, J. (1994, March 22). Alcohol consumption and all cause mortality. Presentation at the Addiction Research Foundation, Toronto,
Canada.
62. Rehm, J. & Fichter, M.M. (1994, March 18). Mental disorders and mortality in Upper Bavaria. Presentation at the First Scientific Meeting of
the Swiss Society of Psychiatric Epidemiology at Prilly-Lausanne, Switzerland.
61. Rehm, J. (1993, November 7). Skalenbildung im Rahmen der Schweizerischen Gesundheitsbefragung. Vortrag anlässlich der Sitzung der
Begleitgruppe zur Schweizerischen Gesundheitsbefragung im Bundesamt für Statistik, Bern, Switzerland.
60. Rehm, J. (1993, October 28-30). Why the SPSS programme should not be used to analyze cluster-sampling data! Presentation at the WHOHBSC meeting at Lausanne, Switzerland.
th
59. Rehm, J. (1993, October 18-20). Causal models and misspecification. Presentation at the 59 Atelier de formation of the Institut national de la
santé et de la recherche médicale (INSERM) "Latent variable and causal modelling in clinical, epidemiological and social science research" at
Le Vésinet, France.
58. Rehm, J. (1993, September 27-30). Une méta-analyse des recherches sur l'alcool et les maladies cardio-vasculaires. Quelles conclusions pour
la prévention? Communication orale au congrès "Epidémiologie et santé publique" à Bordeaux, France.
57. Frick, U., Zwingers, T., Rehm, J., & Reiter, A. (1993, September 21-24). Impact of study design on sequential test procedures for detecting
th
averse drug effect. Examples from a multicenter trial childhood lymphoma. Paper presented at the 14 Meeting of the International Society
for Clinical Biostatistics at Cambrigde, United Kingdom.
th
56. Fahrenkrug, H. & Rehm, J. (1993, September 20-22). Chasing the dragon in Switzerland: Fact or fiction. Paper presented at the 4 Annual
Conference on Drug Issues and Drug Policy at Rome, Italy.
55. Rehm, J. (1993, June 24-25). Alkoholkonsum und koronare Herzkrankheiten - Eine Metaanalyse zur Vorbereitung präventiver Konsequenzen.
Poster auf der wissenschaftlichen Tagung der Schweizerischen Gesellschaft für Sozial- und Präventivmedizin in Zürich, Switzerland.
th
54. Rehm, J. & Spuhler, Th. (1993, June 7-11). Measurement error in alcohol consumption: The Swiss Health Survey. Paper presented at the 19
Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Krakow, Poland.
53. Fahrenkrug, H. & Rehm, J. (1993, June 7-11). Leisure-time activities of young Swiss men and the risk of alcohol-related road accidents. Paper
th
presented at the 19 Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Krakow, Poland.
th
52. Rehm, J. & Frick, U. (1993, June 7-11). Alcohol and suicide in Switzerland. A first data overview. Paper presented at the 19 Annual Alcohol
Epidemiology Symposium of the Kettil Bruun Society at Krakow, Poland.
51. Rehm, J. & Frick, U. (1993, May 20-22). Zum Zusammenhang von sportlicher Aktivität und Medikamentenkonsum in der
Allgemeinbevölkerung. Vortrag für den Arbeitskreis "Strategien und Richtlinien für die Bestimmung von Doping im Breitensport" auf dem
Symposium 1993 "Dopingprävention" der Eidgenössischen Sportschule Magglingen, Switzerland.
50. Abbet, J.-P. & Rehm, J. (1993, March 6). Comportements à risque et environnement à risque pour les jeunes adolescents. Vortrag auf dem 1.
Symposium des Club suisse pour la santé des adolescents in Bern, Switzerland.
49. Rehm, J. & Fichter, M.M. (1992, December 4-5). L'interview de Goldberg comme mesure des troubles mentaux: l'exemple du suivi longitudinal
e
en Haute-Bavière. Poster à la 18 réunion scientifique de l'Association des épidémiologistes de langue française "Epidémiologie et santé
mentale" à Beaune, France.
48. Frick, U., Rehm, J. & Fichter, M.M. (1992, December 4-5). Facteurs d'influence sur les troubles mentaux des jeunes adolescent(e)s et des
e
adolescent(e)s: l'exemple du suivi longitudinal en Haute-Bavière. Communication orale à la 18 réunion scientifique de l'Association des
épidémiologistes de langue française "Epidémiologie et santé mentale" à Beaune, France.
- 79 –
th
47. Rehm, J. & Spuhler, T. (1992, October 12-14). Measurement error in alcohol consumption: The Swiss Health Survey. Vortrag beim 4 Meeting
on Nutritional Epidemiology: Validation Issues - Quality Control and Measurement Error in Berlin, Germany.
46. Fahrenkrug, H. & Rehm, J. (1992, May 30 - June 5). Alcohol consumption, lifestyle and road accidents of young drivers. Results from a Swiss
th
case-control study. Paper presented at the 18 Annual Alcohol Epidemiology Symposium at Toronto, Canada.
45. Rehm, J., Frick, U., & Weber, A. (1992, April 21-24). Latent class analysis in the validation process of psychometric scales: The example of the
somatic subscale of the Beck Depression Inventory (BDI). Paper presented at the Biennial Conference of the Society for Multivariate Analysis
in the Behavioral Sciences at Nijmegen, The Netherlands.
44. Rehm, J. (1992, March 25-27). Comment faire des prévisions épidémiologiques sur la base de modèles incomplets? Communication orale à la
e
17 réunion scientifique de l'Association des épidémiologistes de langue française à Lausanne, Switzerland.
43. Frick, U. & Rehm, J. (1992, February 16-21). Soziale Repräsentationen von Krankheiten bei professionellen Helfern in Abhängigkeit von deren
Berufsrollen. Vortrag beim Kongreß für Klinische Psychologie und Psychotherapie, Berlin, Germany.
42. Rehm, J., Mariolini, N., Klingemann, H., Besson, J., & Huber, M. (1991, June 9-14). AA in Switzerland - Cultural diversity and the founding
th
fathers' tales. Paper presented at the 17 Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society at Sigtuna, Sweden.
41. Rehm, J. (1990, October 25). Using cohort data to avoid omitted variable bias: An application to nutritional epidemiology. Informal
Epidemiology Seminar, Harvard School of Public Health, Boston, USA.
40. Kern, H., Boldt, F., Rehm, J., Kohlmeier, L., & Hoffmeister, H. (1990, October 18-21). Fitness-Training und Ausdauer-Training im Vergleich:
Veränderungen im Lipid-Stoffwechsel. Vortrag beim 32. Deutschen Sportärztekongreß in München, Germany.
th
39. Rehm, J. & Frick, U. (1990, September 18-20). Some practical aspects of structural equation modelling in epidemiology. 11 International
Meeting on Clinical Biostatistics at Nîmes, France.
38. Rehm, J. (1990, July 23). Zur Schätzung von linearen Modellen bei unvollständigen Datensätzen. Vortrag beim Biometrischen Zentrum für
Therapieforschung GmbH, München, Germany.
37. Frick, U. & Rehm, J. (1990, June 19-23). The social (re)construction of 'child abuse'. - An empirical study about the medical decision making
th
process. 8 General Meeting of the European Association of Experimental Social Psychology at Budapest, Hungary
th
36. Rehm, J., Frick, U., & Weber, A. (1990, June 19-23). The influence of perceived control on clinical prediction. 8 General Meeting of the
European Association of Experimental Social Psychology at Budapest, Hungary.
35. Häußler, A., Rehm, J., Naß, E., & Kohlmeier, L. (1990, April 5-6). Der Bundeslebensmittelschlüssel Version II - Ein Überblick inklusive Software.
Zwei Poster auf dem 27. Wissenschaftlichen Kongreß der Deutschen Gesellschaft für Ernährung in München, Germany.
34. Rehm, J. (1990, March 16-17). Der Bundeslebensmittelschlüssel (BLS II). Vortragauf der Tagung 'Nahrung - Ernährung - Gesundheit' des
Verbands der Diplomierten Diätassistentinnen Österreichs in Vienna, Austria.
33. Symposion 'Methodologische Fragen der Psychologie' (1990, March 14-16) Veranstalter: Prof. Dr. T. Herrmann & Prof. Dr. W. Tack in Bad
Homburg, Germany.
32. Einbrüche sind keine Zufälle - Ursachen, Risikofaktoren, Verhütung. (1989, December 7). Together with W.J. Friedrich, H. Posny, and R.
Wassermann. Pressekonferenz im Hotel Steigenberger, Berlin, Germany.
31. Experiences in using new methods in nutritional epidemiology - Possibilities and problems in various large-scale methods. (1989, October 23nd
25). Together with R.A. Goldbohm (Zeist, NL), J. Haraldsdóttir (Kopenhagen, DK), Kersting, M. (Dortmund, D). 2 meeting on nutritional
epidemiology - Diet History, Berlin, Germany.
30. Rehm, J. & Naß, E. (1989, October 9-10). Poster zu ernährungsbedingten Risiken und zum Vergleich der Mortalitätsrisiken heute und vor 40
Jahren beim Deutschen Gesundheitsforum, Berlin, Germany.
29. Fichter, M.M., Elton, M., & Rehm, J. (1989, May 8-10). Prädiktoren für Auslösung und Verlauf psychischer Erkrankungen bei Kindern:
Ergebnisse der oberbayerischen Verlaufsuntersuchung in der Bevölkerung. Vortrag auf der XXI. Wissenschaftlichen Tagung der Deutschen
Gesellschaft für Kinder- und Jugendpsychiatrie in München, Germany.
28. Rehm, J. & Frick, U. (1989, April 24-26). Rôle social, représentations sociales et la prévision du comportement. - Un exemple empirique tiré de
e
la thérapie de l'alcoolisme. Presentation at the 3 Table Ronde: Cognitions et conduites sociales à Nancy, France.
27. Rehm, J. (1989, January 25-27). Comment les malfaiteurs choisissent-ils leur cible? Presentation at the International INSIG Seminar on
Security in Banking at Paris, France.
26. Rehm, J. (1989, January 11-13). Panel-Modelle mit Differenzenbildung und autoregressiven Effekten mit LISREL und LISCOMP. Vortrag auf der
zweiten ZUMA-Arbeitsgruppensitzung 'Auswertung von Panel-Daten' in Mannheim, Germany.
25. Rehm, J. (1988, November 28-30 ). Searching for the culprit: The identification of causal foods. Presentation at the First Meeting on
Nutritional Epidemiology, Berlin, Germany.
24. Rehm, J., Bisson, S., & Servay, W. (1988, September 8-9). 'Natürliche' und 'künstliche' Experten. Vortrag auf dem 6. GEE-Prognose-Workshop
'Auf dem Weg zum Prognose-Automaten' in Freudenstadt, Germany.
23. Wagner, E., Frick, U., & Rehm, J. (1988, August 1-3). Conflicts about building projects in Austria 1960-1987. A typology and analyses about
coalitions of opponents. International Conference on Social Justice and Societal Problems at Leiden, The Netherlands.
22. Rehm, J. & Frick, U. (1988, June 12-15). Kontrastanalyse als Alternative zur klassischen Varianzanalyse und ihre Durchführung auf dem PC.
Vortrag auf der 20. Arbeitstagung der Arbeitsgruppen Computational Statistics und Statistische Auswertungssysteme auf Schloß Reisensburg,
- 80 –
Germany.
21. Rehm, J., Dickenberger, D., Lilli, W., & Strack, F. (1988, April 8-9). Systematische Beobachtung unter kontrollierten Randbedingungen - das
Experiment in den Sozialwissenschaften. Vortrag auf der Frühjahrssitzung der Sektion Methoden der Deutschen Gesellschaft für Soziologie in
Berlin, Germany.
20. Bisson, S. & Rehm, J. (1988, March 28-31). Sind Experten bessere Wahlprognostiker? Vortrag auf der 30. Tagung experimentell arbeitender
Psychologen in Marburg, Germany.
19. Rehm, J. (1988, February 19). Neuere Methoden bei der Auswertung von varianzanalytischen Versuchsplänen. Vortrag beim Biometrischen
Zentrum für Therapieforschung GmbH, München, Germany.
18. Fichter, M.M., Meller, I., & Rehm, J. (1987, September 15-17). The course of affective and psychosomatic disorders in a community sample.
Symposium on 'Epidemiology and the Prevention of Mental Disorder' from the World Association at Reikjavik, Island.
17. Rehm, J. (1987, July 2-4). 'Daß nicht sein kann, was nicht sein darf...' Oder: Gibt es einen Erkenntnisfortschritt in der Vorurteilsforschung?
Vortrag auf der 1. Tagung der Fachgruppe Sozialpsychologie in Münster, Germany.
16. Prognosen - Glaskugel und Fata Morgana der Wissenschaft? (1987, June 6). Mit Prof. Dr. Frankenberg, Prof. Dr. G. von Kortzfleisch, Prof. Dr.
M. Irle und Prof. Dr. W. Müller. Veranstaltung zum Dies Academicus der Universität Mannheim, Germany.
15. Fichter, M.M., Frick, U., Koloska, R., & Rehm, J. (1987, June 16-20). Evaluation of inpatient therapy of alcoholics including significant others in
th
therapy. Poster presented at the 18 Annual Meeting of the Society for Psychotherapy Research at Ulm, Germany.
th
14. Rehm, J. & Fichter, M.M. (1987, May 19-24). The role of life events and chronic difficulties in the onset of affective disorders. 7 General
Meeting of the European Association of Experimental Social Psychology at Varna, Bulgaria.
13. Rehm, J., Koloska, R., & Fichter, M.M. (1987, April 12-16). Zur Validierung der deutschen Übersetzung der PERI-Demoralisationsskala. Vortrag
auf der 29. Tagung experimentell arbeitender Psychologen in Aachen, Germany.
12. Koloska, R., Rehm, J., & Fichter, M.M. (1987, April 12-16). Ist die Beschwerden-Liste valide? Vortrag auf der 29. Tagung experimentell
arbeitender Psychologen in Aachen, Germany.
11. Frick, U., Rehm, J., Koloska, R., & Fichter, M.M. (1987, April 12-16). Therapeutische Handlungsfelder und klinisches Urteil über stationäre
Alkoholismus-Patienten. Vortrag auf der 29. Tagung experimentell arbeitender Psychologen in Aachen, Germany.
10. Rehm, J. & Servay, W. (1986, September 5-6). Der intuitive Kern von Energieprognosen. Vortrag auf der Tagung der Gesellschaft für
Energiewirtschaft und Energiepolitik e.V. 'Psychologie der Prognose', Schloß Haigerloch, Germany.
9. Rehm, J. & Steinleitner, M. (1986, March 23-27). Intergruppenverhalten, De-Individuation und aggressive Handlungen. Ein Feldexperiment.
Vortrag auf der 28. Tagung experimentell arbeitender Psychologen in Saarbrücken, Germany.
8. Eimeren, B. van, Rehm, J., & Lilli, W. (1986, March 23-27). Soziale Kompensation als alternativer Lösungsweg bei negativer sozialer Identität.
Vortrag auf der 28. Tagung experimentell arbeitender Psychologen in Saarbrücken, Germany.
7. Irle, M., Rehm, J., & Servay, W. (1985, November 26-27). Täterwissen für die Bekämpfung von Raubüberfällen auf Geldinstitute - Erste
Ergebnisse eines laufenden Forschungsprojektes. Vortrag auf dem Symposium des Bundeskriminalamtes 'Nutzung der Sicht des Täters und
des Täterwissens für die Verbrechensbekämpfung', Wiesbaden, Germany.
6. Rehm, J., Servay, W., & Lilli, W. (1985, October). Sozialpsychologische Methoden und Umfrageforschung: Am Beispiel einer Untersuchung mit
Strafgefangenen. Vortrag auf der Herbstsitzung der Sektion Methoden der Deutschen Gesellschaft für Soziologie in Mannheim, Germany.
5. Lilli, W. & Rehm, J. (1985, February 15-17). Fortschritt in der Vorurteilsforschung? Oder: Gelingt die wissenssoziologische Erweiterung des
Vorurteilskonzeptes? Eine Auseinandersetzung mit dem Buch 'Soziale Vorurteile und soziale Urteile' von Bernd Estel unter Berücksichtigung
des aktuellen Standes der Forschung. Beitrag zur 2. Tagung der Arbeitsgruppe Sozialpsychologie in Landau, Germany.
4. Rehm, J. & Strack, F. (1984, May 11-13). Kritische Anmerkungen zur Forderung nach formalisierten Verfahren zur Entscheidung über
psychologische Theorien. Vortrag auf dem 3. Internationalen Kongreß Kritische Psychologie in Marburg, Germany.
3. Rehm, J., Lilli, W., & Strack, F. (1984, April 15-19). Soziale Kategorisierung und Gedächtnisspeicherung von individuellen Merkmalen. Vortrag
auf der 26. Tagung experimentell arbeitender Psychologen in Erlangen/Nürnberg, Germany.
2. Lilli, W. & Rehm, J. (1983, October 13-17). Social identity and prejudice: Heuristic biases in quantitative judgements about traffic accident
causation. European-Israeli conference on group processes and intergroup conflict. Kibbuz Sheyafim, Israel.
1. Strack, F. & Rehm, J. (1983, March 27-31). Theorie testen oder Varianz aufklären? Überlegungen zur Verwendung der Effektgröße als
Gütemaß für experimentelle Forschung. Vortrag auf der 25. Tagung experimentell arbeitender Psychologen in Hamburg, Germany.

updated December 15, 1997

Transcription

Similar documents

Alcohol-attributable mortality in Switzerland

ADS Reizuberflutung Ritalin

Sie k nnen Flash nicht herunterladen und m chten die Publikation

Publikationen

Niedrigzinsumfeld und die Auswirkungen auf die